000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|1405|3010|lyfalmen|V0045|1689|1|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1405||1405|3010||1 000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|30215|39439|lyfsjukr|||1|1,8|0|24,0000|Icepharma hf|Roche|Epóetín||30215||30215|39439||2 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|45403|58329|lyfsjukr|||1|1,8|0|36,0000|Icepharma hf|Roche|Epóetín||45403||45403|58329||2 000153|A02BC0102|Losec|sh-tfl|20|mg|7|stk|1|þpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|9739|14481|lyfalmen|V0457|6582|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||9739||9739|14481||2 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|28384|38442|lyfalmen|V0475|13739|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||28384||28384|38442||2 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|36913|49230|lyfalmen|V0540|19911|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||36913||36913|49230||2 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|4373|6252|lyfsjukr|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||4373||4373|6252||1 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|4259|8251|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||4259||4259|8251||1 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|11713|16428|lyfsjukr|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||11713||11713|16428||1 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|14881|21363|lyfalmen|||1|0,36|0|4,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||14881|21363||1 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|29554|39922|lyfalmen|||1|0,72|0|8,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||29554|39922||1 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|þpakki||N02CC04|01.03.1999|30.04.2015|R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|4210|6871|lyfalmen|||1|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||4210||4210|6871||1 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GSK|0|0|0|100|IKR|2175|3110|lyfsjukr|||1|5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3110||1 000530|J07BF0301|Imovax Polio|stl|||0,5|ml|20|áf.spr|án nála|J07BF03|01.06.2005||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|25717|35069|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||25717||25717|35069||2 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|4480|7243|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4480||4480|7243||1 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2915|5089|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2915||2915|5089||1 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|pokar||B05BA02|01.04.2004||R|0|0|0|0|0|1|KAB|0|0|0|100|DKK|14340|19695|lyfsjukr|||1|1000|0||Icepharma hf|Fresenius Kabi AB|Fitusambönd||14340||14340|19695||2 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2824|4963|lyfalmen|||1|30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||2824||2824|4963||1 000663|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|pokar||B05BA02|01.12.2014||R|0|0|0|0|0|1|KAB|0|0|0|100|DKK|34700|45017|lyfsjukr|||1|6000|0||Icepharma hf|Fresenius Kabi AB|Fitusambönd||34700||34700|45017||2 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|3331|5661|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3331||3331|5661||1 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|96033|121298|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||96033||96033|121298||2 000957|H01AC0101|Genotropin|sts|5|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.05.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|20402|27234|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||20402||20402|27234|31.5.2015|1 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|4987|7130|lyfsjukr|||1|0,5|0|1,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||4987||4987|7130||1 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|þpakki||M01AH01|01.03.2003||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|1342|2923|lyfalmen|V0037|1829|1|10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1342||1342|2923||1 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4462|7218|lyfalmen|||1|30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||4462||4462|7218||1 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14756|21205|lyfalmen|V0115|11873|1|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||14756||14756|21205||1 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1965|3781|lyfalmen|V0050|2431|1|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1965||1965|3781||1 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|24936|32873|lyfsjukr|||1|2,5|0|5,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||24936||24936|32873||1 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5610|8798|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5610||5610|8798||1 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3457|5835|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||3457||3457|5835||1 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.03.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|883|2177|lyfalmen|V0038|2177|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||800||800|2177||1 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.03.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2456|4026|lyfalmen|V0039|3829|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2143||2143|4026||1 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|20257|27054|lyfsjukr|||1|4104|0||Icepharma hf|Fresenius Kabi|Blöndur||20257||20257|27054||2 001599|B03AC0002|Venofer|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.07.2005||R|0|0|0|0|G|0|VIF|0|0|1|100|CHF|16287|23142|lyfalmen|V0637|20505|1|25|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||16287||16287|23142||1 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|28078|36781|lyfsjukr|||1|6160|0||Icepharma hf|Fresenius Kabi|Blöndur||28078||28078|36781||2 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|2234|3194|lyfsjukr|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||2234||2234|3194||1 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|4485|7249|lyfalmen|V0444|7249|1|15|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Brinzólamíð||4485||4485|7249||1 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|þpakki||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|366|1580|lyfalmen|V0004|551|1|7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||366||366|1580||1 001954|N05AX0802|Rison|filmhtfl|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1946|2315|lyfalmen|V0291|2315|2|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||900||900|2315||1 001957|N05AX0802|Rison|filmhtfl|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|6936|7958|lyfalmen|V0297|6720|2|60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||5000||5000|7958||1 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|0|BIG|0|0|1|100|SEK|3788|6290|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||3788||3788|6290||2 001965|N05AX0802|Rison|filmhtfl|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|3353|3760|lyfalmen|V0292|3760|2|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||1950||1950|3760||1 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|2500|4517|lyfalmen|V0004|2206|1|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||2500||2500|4517||1 001986|N05AX0802|Rison|filmhtfl|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|5263|5770|lyfalmen|V0296|5343|2|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||3410||3410|5770||1 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3318|5643|lyfalmen|V0011|2942|1|56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3318||3318|5643||1 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|þpakki||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|657|1981|lyfalmen|V0005|612|1|7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||657||657|1981||1 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3679|6140|lyfalmen|V0005|2449|1|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3679||3679|6140||1 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.01.2000||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|4320|7022|lyfalmen|||1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||4320|7022||2 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|þpakki|stakskammtar|A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4718|7570|lyfalmen|V0011|2627|1|50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4718||4718|7570||1 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|23657|31283|lyfsjukr|||1|5760|0||Icepharma hf|Fresenius Kabi|Blöndur||23657||23657|31283||2 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|þpakki|stakskammtar|A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7778|11782|lyfalmen|V0012|2649|1|50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||7778||7778|11782||1 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2874|5032|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2874||2874|5032||1 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|15813|22542|lyfalmen|V0492|3513|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||15813||15813|22542||1 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|82628|104626|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||82628|104626||2 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|42118|54243|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||42118|54243||2 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|21442|28528|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||21442|28528||2 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|G|0|ACA|0|0|1|100|IKR|||lyfalmen|V0362|2047|2|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín|||||2307||1 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|SEK|3057|5269|vetorma|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|||3057||3057|5269||2 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1164|2678|lyfalmen|||1|5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||1164||1164|2678||2 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|0|1|0|1|ALL|0|0|0|100|SEK|23479|31061|lyfsjukr|||1|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||23479||23479|31061||1 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|12973|14440|lyfalmen|V0089|2688|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||9709||9709|14440||1 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|9660|14372|lyfalmen|V0515|4102|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||9660||9660|14372||1 003099|L01DB0104|Myocet|irþ|50|mg|2|sett|1|pakki|ördreifa|L01DB01|01.07.2006||R|0|0|0|1|0|1|TBV|0|0|0|100|DKK|185173|232163|lyfsjukr|||1|2|0||Vistor hf|Teva Pharma B.V.|Doxórúbicín||185173||185173|232163||2 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|16431|23324|lyfalmen|V0253|6307|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||16431||16431|23324||1 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|31886|42871|lyfalmen|V0516|5474|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||31886||31886|42871||1 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|8810|13202|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||8810||8810|13202||1 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|13009|18996|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||13009||13009|18996||1 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007|30.04.2015|R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|188743|236603|lyfsjukr|||1|150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||188743||188743|236603||2 003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|6277|9716|lyfalmen|V0356|8786|1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||6277||6277|9716||1 003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5885|9176|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||5885||5885|9176||1 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2878|5038|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||2878||2878|5038||1 003859|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|glas||N05AH02|01.10.2014||R|2|0|0|0|G|0|AGT|0|0|0|100|XEU|2054|3903|lyfalmen|||2|100|0|8,3300|Actavis Group hf|Actavis Group hf|Klózapín||2054||2054|3903||1 003880|N05AH0205|Clozapine Actavis|töflur|100|mg|500|stk|1|glas||N05AH02|01.06.2015||R|2|0|0|0|G|0|AGT|0|0|0|100|XEU|36820|48278|lyfalmen|||2|500|0|166,6700|Actavis Group hf|Actavis Group hf|Klózapín||36161||36161|48278||1 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1017|2025|lyfalmen|V0151|1647|2|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||689||689|2025||1 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|þpakki||M01AB05|01.03.1984||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|545|1826|lyfalmen|||1|20|0|10,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||545||545|1826||1 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2389|2560|lyfalmen|V0322|2296|2|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||1078||1078|2560||1 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|1975|3795|lyfalmen|V0469|1902|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||1975||1975|3795||1 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|17578|23722|lyfsjukr|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||17578||17578|23722||1 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|7350|11193|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||7350||7350|11193||1 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1 004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4450|7201|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||4450||4450|7201||1 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|þpakki||N06AB06|01.05.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|550|1833|lyfalmen|||1|7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||550||550|1833||1 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|þpakki||N05CD01|01.12.2000||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|1059|2534|lyfalmen|||1|30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1059||1059|2534||1 004184|L03AC0101|Proleukin|stl/irs|||1|hgl|1|pakki||L03AC01|01.10.2013||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|30287|39529|lyfsjukr|||1|1|0|5,5000|Vistor hf|Novartis Healthcare A/S|Aldesleukín||30287||30287|39529||1 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5082|8071|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||5082||5082|8071||1 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|7523|11431|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||7523||7523|11431||1 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|10438|15443|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||10438||10438|15443||1 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|19563|26191|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Limited|Voricónazól||19563||19563|26191||1 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|þpakki||A04AA01|01.01.2009||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|5893|5276|lyfalmen|V0381|3815|1|10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||3051||3051|5276||1 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|7146|13728|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||7146||7146|13728||1 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|3015|5226|lyfalmen|||1|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||3015||3015|5226||2 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|4022|6612|lyfalmen|V0226|2668|1|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||4022||4022|6612||2 004500|N02AX0208|Zytram|forðatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|7561|11483|lyfalmen|V0228|4929|1|56|0|37,3333|Icepharma hf|Norpharma |Tramadól||7561||7561|11483||2 004502|J07BC0101|Engerix-B|stl|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2358|4322|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefnavakar||2358||2358|4322||1 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2907|2617|lyfalmen|V0494|2617|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||1119||1119|2617||1 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2556|2666|lyfalmen|V0318|2666|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||1155||1155|2666||1 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1757|3495|lyfalmen|||2|25|0||Actavis Group hf|Actavis Group hf|Metrónídazól||1757||1757|3495||1 004613|J07BC0101|Engerix-B|stl|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3481|5868|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefnavakar||3481||3481|5868||1 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4843|5164|lyfalmen|V0320|3623|2|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||2970||2970|5164||1 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001|30.06.2015|R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|776|1782|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||513||513|1782||1 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1921|2560|lyfalmen|V0317|2560|2|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||1078||1078|2560||1 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|926|1782|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||513||513|1782||1 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|1|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíð|||||1809||1 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|0|0|0|1|0|1|BIO|0|0|0|100|DKK|34724|45047|lyfsjukr|||1|4,69|0|7,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||34724||34724|45047||3 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001|30.06.2015|R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1778|3524|lyfalmen|||2|56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3524||1 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Dextrómetorfan|||||||1 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|Clikstar/JuniorStar pennar|A10AE04|01.06.2004||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|8623|12945|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||8623||8623|12945||1 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|780|2150|lyfalmen|||2|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||780||780|2150||1 004874|N05AH0308|Lazapix|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.09.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|14905|2392|lyfalmen|V0282|2392|2|56|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||956||956|2392||1 004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|5030|7191|lyfsjukr|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||5030||5030|7191||1 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|347|1554|lyfalmen|||2|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||347||347|1554||1 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|683|2016|lyfalmen|||2|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||683||683|2016||1 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|1153|2663|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1153||1153|2663||1 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|1910|3705|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||1910||1910|3705||1 005089|J07AL0103|Pneumovax|stl|||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3255|5557|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||3255||3255|5557||2 005096|J07AJ5205|Boostrix|stl|||0,5|ml|10|áf.spr|áfyllt, dreifa|J07AJ52|01.09.2014||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|19106|26707|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||||19106|26707||1 005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|8158|6794|lyfalmen|V0148|3461|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4154||4154|6794||1 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|3075|5309|lyfalmen|||2|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||3075||3075|5309||1 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2370|4338|lyfalmen|||2|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||2370||2370|4338||1 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2661|4739|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||2661||2661|4739||1 005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|18829|26357|lyfalmen|V0356|26357|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||18829||18829|26357||1 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|2972|5167|lyfalmen|||1|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||2972||2972|5167||1 005330|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.04.1996||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|52837|69370|lyfalmen|V0451|65253|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||52837||52837|69370||1 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|1661|3363|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1661||1661|3363||1 005576|R05CA0301|Tussol|mixtúra|||150|ml|1|glas||R05CA03|01.10.2001||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Slímlosandi lyf nema slímþynnir (mucolytica)- guaifenesin|||||||1 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5659|8865|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||5659||5659|8865||1 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5948|9263|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||5948||5948|9263||1 005606|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|0|0|0|0|0|0|PIS|0|0|0|100|USD|4508|7281|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4508||4508|7281||2 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|1735|3464|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||1735||1735|3464||2 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|3470|5852|lyfalmen|V0020|2561|1|60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||3470||3470|5852||2 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|5461|8593|lyfalmen|V0020|7683|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||5461||5461|8593||2 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|3989|6567|lyfalmen|V0020|3841|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||3989||3989|6567||2 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6169|8645|lyfalmen|V0324|3464|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5499||5499|8645||1 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|16698|28781|vetorma|||0|5|0||Vistor hf|Merial (MSD)|Ivermectinum||16698||16698|28781||1 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|9810|13432|lyfalmen|V0325|3676|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||8977||8977|13432||1 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|2554|4592|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2554||2554|4592||2 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|15188|19683|lyfalmen|V0326|5153|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||13552||13552|19683||1 005910|C09CA0301|Diovan|filmhtfl|80|mg|28|stk|1|þpakki||C09CA03|01.01.2001||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|3314|5638|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||3314||3314|5638||1 005963|J01CR0204|Amoxin comp|filmhtfl|875|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|ROY|0|0|1|100|IKR|1816|1968|lyfalmen|V0169|1968|2|14|0|12,2500|Medical ehf|ratiopharm Oy|Amoxicillín og ensímblokkar||648||648|1968||2 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|77442|98176|lyfsjukr|||1|1,5|0|0,7500|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíðar||77442||77442|98176||1 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5362|8457|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5362||5362|8457||1 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|93133|117691|lyfsjukr|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||93133||93133|117691||1 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5134|8143|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5134||5134|8143||1 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|145489|182808|lyfsjukr|||1|3|0|1,5000|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíðar||145489||145489|182808||1 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|71151|90352|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||71151||71151|90352||1 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2274|4206|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2274||2274|4206||1 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|3309|6448|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|||||3309|6448||1 006547|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|áf.spr||B01AX05|01.07.2012||R|0|0|0|0|G|0|TAA|0|0|0|100|GBP|7051|10781|lyfalmen|||1|5|0|10,0000|Navamedic A/S|Aspen Pharma Trading Limited|Fondaparinux||7051||7051|10781||1 006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2013||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|12216|17993|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||12216||12216|17993||1 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 006732|A16AB0401|Fabrazyme|irþ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEA|0|1|0|100|DKK|462324|576862|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||462324||462324|576862||1 006785|G03AD0101|NorLevo|töflur|750|mcg|2|stk|1|þpakki||G03AD01|01.01.2005||L|0|0|0|0|0|0|LAR|0|0|0|100|IKR|||lyflausa|||0|2|0|1,0000|Vistor hf|Laboratoire HRA Pharma|Levonorgestrel|||||||1 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|13595|19737|lyfalmen|V0099|3784|1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||13595||13595|19737||1 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3778|6276|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||3778||3778|6276||1 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12148|17907|lyfalmen|V0117|7462|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||12148||12148|17907||1 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|17941|25234|lyfalmen|V0118|12183|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||17941||17941|25234||1 007165|C09AA0105|Captopril Actavis|töflur|50|mg|100|stk|1|þpakki||C09AA01|01.05.2013||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1915|3712|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||1915||1915|3712||1 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7316|11146|lyfalmen|V0194|9355|1|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||7316||7316|11146||1 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|21755|30058|lyfalmen|V0195|24802|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||21755||21755|30058||1 007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002|30.04.2015|R|0|0|0|1|0|1|BAX|0|0|0|100|SEK|149233|187464|lyfsjukr|||1|1|0||Icepharma hf|Baxter|Prótein C||149233||149233|187464||2 007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002|30.04.2015|R|0|0|0|1|0|1|BAX|0|0|0|100|SEK|284784|356052|lyfsjukr|||1|1|0||Icepharma hf|Baxter|Prótein C||284784||284784|356052||2 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|89895|113664|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||89895||89895|113664||1 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|230194|288157|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||230194||230194|288157||1 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|2998|5203|lyfalmen|V0374|4201|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||2998||2998|5203||1 007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|1|CPS|0|0|0|100|SEK|7637|10919|lyfsjukr|||1|50|0||Icepharma hf|Clintec parenteral SA|Vítamín||7637||7637|10919||2 007449|V03AB3401|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|1|OPO|0|0|0|100|XEU|104561|131905|lyfsjukr|||1|100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||104561||104561|131905||3 007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|21681|28825|lyfsjukr|||1|250|0||Vistor hf|AbbVie Ltd.|Sevóflúran||21681||21681|28825||1 007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dæla|til inntöku|QP52AA01|01.04.2002||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1827|3149|vetorma|||0|6,67|0||Icepharma hf|Bayer Animal Health GmbH|||1827||1827|3149||2 007505|G04BD0702|Detrusitol Retard|forðahlk|2|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|5798|9057|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tólteródín||5798||5798|9057||1 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|4171|5963|lyfsjukr|||1|1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||4171||4171|5963||1 007601|A16AB0301|Replagal|irþ|1|mg/ml|3,5|ml|1|hgl|lausn|A16AB03|01.09.2014||R|0|0|0|1|0|1|SHG|0|1|0|100|XEU|230202|288167|lyfsjukr|||1|3,5|0|3,5000|Shire Human Genetics Therapies AB|Shire Human Genetic Therapies AB|Agalsídasi alfa||||230202|288167||3 007760|G04BD0702|Detrusitol Retard|forðahlk|4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4567|7362|lyfalmen|V0618|5929|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tólteródín||4567||4567|7362||1 007769|G04BD0702|Detrusitol Retard|forðahlk|4|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|16410|23297|lyfalmen|V0589|8272|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Tólteródín||16410||16410|23297||1 007778|N05AX0802|Rison|filmhtfl|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1691|2453|lyfalmen|V0290|2384|2|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1000||1000|2453||1 007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|3715|6190|lyfalmen|||1|3|0|84,0000|Vistor hf|N.V. Organon|Skeiðarinnleg með progestógeni og östrógeni||3715||3715|6190||1 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|||50|ml|50|pokar|leysir f.stungulyf|V07AB|01.08.2005||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||0|2500|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||2 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|0|ALA|0|0|0|100|USD|1432|3047|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Ólópatadín||1432||1432|3047||1 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|þpakki||H02AB01|01.09.1998||R|0|0|0|0|0|0|LOL|0|0|1|100|IKR|729|2080|lyfalmen|||0|30|1|10,0000|Lyfjaver ehf|Lyfjaver- óskráð|Betametasón||729||729|2080||3 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|353|1562|lyfalmen|V0502|854|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||353||353|1562||2 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|þpakki||N02CC04|01.03.2003||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|5112|8112|lyfalmen|V0620|5757|1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5112||5112|8112||1 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1395|2996|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||1395||1395|2996||1 008243|D07AC0101|Betnovat|húðlausn|1|mg/g|30|ml|1|plglas|í hársvörð|D07AC01|01.01.1985||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|513|1782|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||513||513|1782||1 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|830|2219|lyfalmen|||2|20|0|6,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||830||830|2219||1 008326|D07AC0101|Betnovat|húðlausn|1|mg/g|100|ml|1|plglas|í hársvörð|D07AC01|01.07.1988||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|1198|2725|lyfalmen|||1|100|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1198||1198|2725||1 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|2679|4764|lyfalmen|V0226|4764|2|100|0|33,3300|Actavis Group PTC hf|Actavis ehf|Tramadól||2679||2679|4764||1 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|4256|6934|lyfalmen|V0227|6934|2|100|0|50,0000|Actavis Group PTC hf|Actavis ehf|Tramadól||4256||4256|6934||1 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|5993|8802|lyfalmen|V0228|8802|2|100|0|66,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||5613||5613|8802||1 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|0|0|0|1|0|1|GEZ|0|0|0|100|DKK|135632|170548|lyfsjukr|||1|2|0||Vistor hf|Genzyme BV|Thýrótrópín||135632||135632|170548||1 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|483|1741|lyfalmen|V0696|1741|1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||483||483|1741||2 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|634|1941|lyfalmen|V0697|1941|1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||628||628|1941||2 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|5386|9283|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |||5386||5386|9283||2 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|10037|19213|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |||10037||10037|19213||2 008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|G|0|RGM|0|0|1|100|XEU|||lyfalmen|V0575|2242|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||2242||2 008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2683|4769|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2683||2683|4769||1 008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||||2 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|96001|121258|lyfsjukr|||1|2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||96001||96001|121258||2 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|99590|125722|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||99590||99590|125722||2 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburður, lausn|D10AF01|01.01.1994||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1797|3550|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1797||1797|3550||1 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6570|10119|lyfalmen|V0145|9510|1|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6570|10119||2 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|13028|19020|lyfalmen|V0145|19020|1|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13028|19020||2 008959|R01AA0706|Naso-ratiopharm|nefúði|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2 009078|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|30|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1631|2859|lyfalmen|V0064|2741|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Móklóbemíð||1295||1295|2859||2 009099|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|60|stk|1|þpakki||N06AG02|01.03.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4424|5481|lyfalmen|V0064|5481|2|60|0|60,0000|Medical ehf|ratiopharm GmbH|Móklóbemíð||3200||3200|5481||2 009113|B05DB0005|Balance|kvið.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7370|10537|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7370||7370|10537||2 009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|4013|4875|lyfalmen|V0063|4875|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Móklóbemíð||2760||2760|4875||2 009189|N02BA0111|ASA-ratiopharm|töflur|500|mg|50|stk|1|þpakki||N02BA01|01.09.2014||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|50|0|8,3333|Medical ehf|ratiopharm GmbH|Acetýlsalicýlsýra|||||||2 009213|B05DB0005|Balance|kvið.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7370|10537|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7370||7370|10537||2 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|0|IPI|0|0|1|100|DKK|13271|19327|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||13271||13271|19327||1 009216|B05DB0005|Balance|kvið.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7370|10537|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7370||7370|10537||2 009270|R01AA0706|Naso-ratiopharm|nefúði|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|0|0|0|0|1|IPI|0|0|0|100|DKK|48412|62071|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Limited|Voricónazól||48412||48412|62071||1 009282|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|0|0|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||0|400|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2142||2 009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|4834|7730|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||4834||4834|7730||1 009340|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|400|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2948||2 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1059|2534|lyfalmen|||1|8|0|21,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1059||1059|2534||1 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1168|2684|lyfalmen|||1|8|0|28,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1168||1168|2684||1 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1351|2936|lyfalmen|||1|8|0|42,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1351||1351|2936||1 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1692|3405|lyfalmen|||1|8|0|56,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1692||1692|3405||1 009525|B05DB0005|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6197|8860|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6197||6197|8860||2 009560|B05DB0005|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6897|9861|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6897||6897|9861||2 009591|B05DB0005|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6197|8860|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6197||6197|8860||2 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|0|0|0|0|1|IPI|0|0|0|100|DKK|175329|219920|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer Limited|Voricónazól||175329||175329|219920||1 009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|4683|7522|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||4683||4683|7522||1 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|0|0|1|0|1|GSL|0|0|0|100|DKK|52466|67113|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl||52466||52466|67113||2 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8783|13165|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||8783||8783|13165||1 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9292|13866|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9292||9292|13866||1 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8182|12338|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8182||8182|12338||1 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9292|13866|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9292||9292|13866||1 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8014|12107|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8014||8014|12107||1 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8173|12326|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||8173||8173|12326||1 009993|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|3|g|1|spr||QP52AF02|01.01.2013||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1150|1982|vetorma|||0|3|0||Icepharma hf|Zoetis Finland OY|||1150||1150|1982||2 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2017|3853|lyfalmen|V0329|1765|1|30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2017||2017|3853||1 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|þpakki||N06AX11|01.05.2003|30.04.2015|R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|5712|8938|lyfalmen|||1|30|0|45,0000|Vistor hf|N.V. Organon|Mirtazapín||5712||5712|8938||1 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|1|0|0|0|0|1|ROA|0|0|0|100|DKK|188172|235893|lyfsjukr|||1|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||188172||188172|235893||2 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|6346|9073|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||6346||6346|9073||1 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|11917|17479|lyfalmen|V0331|2590|1|96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||11917||11917|17479||1 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|16802|23793|lyfalmen|V0304|8747|1|96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||16802||16802|23793||1 010290|N06DX0101|Ebixa|mixtúra|5|mg/sk|50|g|1|fl|dæluskammtur|N06DX01|01.08.2010||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|13282|19341|lyfalmen|||1|50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||13282|19341||1 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|21531|29774|lyfalmen|V0605|6132|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||21531||21531|29774||1 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|10478|15498|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||10478||10478|15498||1 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.01.2003||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|5834|9106|lyfalmen|||1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||5834|9106||2 010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8553|12228|lyfsjukr|||1|1000|0||Icepharma hf|Fresenius Kabi|Amínósýrur||8553||8553|12228||2 010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|1168|2684|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||1168||1168|2684||2 010705|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 010716|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2373|2848|lyfalmen|V0006|1990|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1287||1287|2848||2 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.12.2002||R|1|0|0|0|0|0|APC|0|0|0|100|NOK|11918|5119|lyfalmen|V0207|2310|1|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||2937||2937|5119||1 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|319576|399323|lyfsjukr|||1|56|0|14,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||319576||319576|399323||3 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|319576|399323|lyfsjukr|||1|56|0|28,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||319576||319576|399323||3 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|43392|55827|lyfsjukr|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||43392||43392|55827||2 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|0|0|0|0|0|1|REP|0|0|0|100|SEK|2705|3867|lyfsjukr|||1|10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||2705||2705|3867||1 010947|C08CA0203|Felodipin ratiopharm|forðatfl|5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|2700|3554|lyfalmen|V0058|3554|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Felódipín||1800||1800|3554||2 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|18802|26323|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||18802||18802|26323||1 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|18583|26046|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||18583||18583|26046||1 010980|C08CA0203|Felodipin ratiopharm|forðatfl|10|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3200|4930|lyfalmen|V0059|4930|2|100|0|200,0000|Medical ehf|ratiopharm GmbH|Felódipín||2800||2800|4930||2 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|32013|43032|lyfalmen|V0683|28574|1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||32013||32013|43032||1 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|31795|42756|lyfalmen|V0684|28412|1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||31795||31795|42756||1 011163|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|15817|22547|lyfalmen|||1|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníð||15817||15817|22547||1 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|4200|6857|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||4200||4200|6857||1 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|4364|7083|lyfalmen|||1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||4364||4364|7083||1 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|18894|24961|lyfalmen|V0327|6210|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||17725||17725|24961||1 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|1114|2610|lyfalmen|||1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1114||1114|2610||1 011336|N05AH0309|Kozylex|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.10.2011||R|0|0|0|0|G|0|POF|0|0|0|100|IKR|7436|6582|lyfalmen|V0457|6582|2|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||4000||4000|6582||1 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|862|2263|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||862||862|2263||1 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2282|3270|lyfalmen|V0069|2943|2|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||1594||1594|3270||1 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|6193|9600|lyfalmen|V0357|8681|1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||6193||6193|9600||1 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|5866|8686|lyfalmen|V0691|7867|1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5529||5529|8686||1 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|2151|3075|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Esketamín||2151||2151|3075||1 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|7643|9179|lyfalmen|V0624|8393|1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5887||5887|9179||1 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|1798|3534|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |||1798||1798|3534||2 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|4386|6271|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||4386||4386|6271||1 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|fl|með skammtadælu|G03CA03|01.03.2000||R|0|0|0|0|G|0|OYL|0|0|0|100|DKK|1137|2641|lyfalmen|||2|64|0||Vistor hf|Oy Leiras Finland Ab|Estradíól||1137||1137|2641||1 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|59827|76268|lyfsjukr|||1|168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||59827||59827|76268||2 011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|SEK|2505|4923|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||2505||2505|4923||2 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|0|0|0|ACA|0|0|0|100|IKR|1796|2124|lyfalmen|V0152|2124|2|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||761||761|2124||1 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4738|3909|lyfalmen|V0323|3551|2|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||2058||2058|3909||1 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|3927|5615|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3927||3927|5615||1 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|2173|3107|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2173||2173|3107||1 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|þpakki||N06DX01|01.06.2009||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|7438|11314|lyfalmen|V0604|2815|1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||7438|11314||1 012030|J05AG0301|Stocrin|filmhtfl|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|26244|34500|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||26244||26244|34500||1 012113|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|1224|1727|lyfalmen|V0551|1723|2|7|0|1,7500|Medical ehf|ratiopharm GmbH|Flúkónazól||473||473|1727||2 012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|4244|6918|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríð||4244||4244|6918||1 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6322|9778|lyfalmen|||1|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6322||6322|9778||2 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012290|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|1731|1872|lyfalmen|||2|4|0|3,0000|Medical ehf|ratiopharm GmbH|Flúkónazól||578||578|1872|31.5.2015|2 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|9531|10187|lyfalmen|V0622|9386|1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6619||6619|10187||1 012347|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|28|stk|1|þpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|3671|3034|lyfalmen|V0552|2945|2|28|0|7,0000|Medical ehf|ratiopharm GmbH|Flúkónazól||1422||1422|3034||2 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.01.2015||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012864|M01AE0113|Ibuxin|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|ROY|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|Medical ehf|ratiopharm Oy|Íbúprófen|||||||2 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|718|2065|lyfalmen|||1|80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|2065||1 012921|G03AA1301|Evra|forðapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|4166|6810|lyfalmen|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||4166||4166|6810||1 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|0|0|0|0|G|0|LBI|0|0|0|100|DKK|5810|9073|lyfalmen|||1|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||5810||5810|9073||2 012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|2603|3716|lyfalmen|V0250|3716|2|100|0|16,6667|Medical ehf|ratiopharm GmbH|Gabapentín||1918||1918|3716||2 012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|3409|4259|lyfalmen|V0251|4259|2|100|0|22,2200|Medical ehf|ratiopharm GmbH|Gabapentín||2312||2312|4259||2 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|5484|8624|lyfalmen|||1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5484||5484|8624||1 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|6487|12478|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||6487||6487|12478||2 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|8870|13285|lyfalmen|||1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||8870||8870|13285||1 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1633|3209|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1633||1633|3209||2 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|0|0|0|0|0|1|ZLB|0|0|0|100|SEK|6244|8927|lyfsjukr|||1|2|0||Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||6244||6244|8927||2 013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|1|0|0|0|G|0|ANO|0|0|0|100|XEU|2580|4627|lyfalmen|V0042|4627|2|100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2580||2580|4627||1 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4261|8254|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4261||4261|8254||2 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|9942|19032|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||9942||9942|19032||2 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1043|2050|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1043||1043|2050||2 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|126411|159080|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||||126411|159080||3 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|þpakki||L01XE02|01.03.2010||R|0|0|0|1|0|1|AZD|0|1|0|100|SEK|325257|354023|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||283153||283153|354023||1 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|82628|104626|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||82628|104626||3 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1225|2762|lyfalmen|||1|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1225||1225|2762||2 013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|90|0||Actavis Group hf|Actavis Group hf|Blöndur|||||1610||1 013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|711|1624|lyfalmen|V0562|1624|2|100|0|33,3300|Medical ehf|ratiopharm Oy|Íbúprófen||398||398|1624||2 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2342|4300|lyfalmen|||1|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||2342||2342|4300||2 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|363|1576|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||363||363|1576||1 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|þpakki||C09DA03|01.04.2005||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|4373|7095|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og þvagræsilyf||4373||4373|7095||1 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2003||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1215|2749|lyfalmen|V0168|2665|1|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2749||1 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5734|8969|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||5734||5734|8969||1 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2260|4187|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2260||2260|4187||1 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4308|7006|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4308||4308|7006||1 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.06.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|154606|194147|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||154606||154606|194147||1 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|314463|392964|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||314463||314463|392964||1 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2235|4153|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2235||2235|4153||1 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|7138|10205|lyfsjukr|||1|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||7138||7138|10205||1 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|0|0|0|UCB|0|0|0|100|DKK|16896|23912|lyfalmen|||1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||16896||16896|23912||1 014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|52690|69184|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíð||52690||52690|69184||2 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|18580|26042|lyfalmen|V0357|26042|1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||18580||18580|26042||1 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1516|3163|lyfalmen|V0676|3163|1|30|0||Icepharma hf|Bayer AB|Azelainsýra||1516||1516|3163||2 014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|342|1547|lyfalmen|V0563|1547|2|30|0|15,0000|Medical ehf|ratiopharm Oy|Íbúprófen||342||342|1547||2 014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|fl||P01AB01|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|NOK|2133|4012|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Metrónídazól||2133||2133|4012||1 014435|QM01AE0303|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|0|VET|0|0|0|100|XEU|2138|4202|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|||||2138|4202||2 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|77045|97682|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Adefovír||||77045|97682||2 014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|24|dælur|1|pakki||QA02BX12|01.04.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|XEU|5313|10250|vetalmen|||0|24|0||Icepharma hf|Zoetis Finland OY|||5313||5313|10250||2 014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|862|1718|lyfalmen|V0564|1718|2|100|0|50,0000|Medical ehf|ratiopharm Oy|Íbúprófen||466||466|1718||2 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|1178|2698|lyfalmen|V0596|1858|1|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||1178||1178|2698||2 014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1053|2268|lyfalmen|V0558|2109|2|100|0|100,0000|Icepharma hf|Mylan AB|Hýdróklórtíazíð og kalíumsparandi lyf||866||866|2268||2 014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1229|2198|lyfalmen|V0559|2177|2|100|0|100,0000|Icepharma hf|Mylan AB|Hýdróklórtíazíð og kalíumsparandi lyf||815||815|2198||2 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|17980|25283|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||17980||17980|25283||1 014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|54254|71162|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||54254||54254|71162||1 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|36114|48219|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||36114||36114|48219||1 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|1|0|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||0|90|0|30,5400|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||||2 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|1|0|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||0|270|0|91,6200|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||||2 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2545|3971|lyfalmen|V0673|3691|2|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||2103||2103|3971||1 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|7455|11337|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||7455||7455|11337||1 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|þpakki||N06AX11|01.07.2003||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1031|2475|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1016||1016|2475||1 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|0|0|0|0|0|0|LOL|0|0|1|100|IKR|2760|4875|lyfalmen|||0|100|1|33,3333|Lyfjaver ehf|Lyfjaver- óskráð|Betametasón||2760||2760|4875||3 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1015|2473|lyfalmen|||1|8|0|14,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1015||1015|2473||1 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|2079|2703|lyfalmen|V0234|1910|1|6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1182||1182|2703||1 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|2970|2703|lyfalmen|V0233|2190|1|12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1182||1182|2703||1 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|8757|13129|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||8757||8757|13129||1 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|296198|370247|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||296198||296198|370247||3 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|85107|107709|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||85107||85107|107709||3 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4949|7888|lyfalmen|||1|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4949||4949|7888||1 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|12582|18456|lyfalmen|||1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||12582||12582|18456||1 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4949|7888|lyfalmen|||1|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4949||4949|7888||1 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|13601|19745|lyfalmen|||1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13601||13601|19745||1 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|65642|83500|lyfsjukr|||1|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||65642||65642|83500||1 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4949|7888|lyfalmen|||1|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4949||4949|7888||1 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|12449|18287|lyfalmen|||1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||12449||12449|18287||1 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|65642|83500|lyfsjukr|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||65642||65642|83500||1 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|20498|28468|lyfalmen|||1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||20498||20498|28468||1 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|40998|54396|lyfalmen|||1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||40998||40998|54396||1 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2984|5143|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|||2984||2984|5143||2 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4903|8451|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|||4903||4903|8451||2 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2226|3837|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2226||2226|3837||2 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3106|5354|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|||3106||3106|5354||2 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4691|8085|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|||4691||4691|8085||2 015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2 015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1873|3654|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||||1873|3654||1 015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|2104|3972|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||2104||2104|3972||1 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1686|3397|lyfalmen|||2|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1686||1686|3397||2 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2986|5147|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2986||2986|5147||2 015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|2151|4037|lyfalmen|||1|28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||2151||2151|4037||1 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1252|2800|lyfalmen|||2|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1252||1252|2800||2 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1327|2903|lyfalmen|||2|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1327||1327|2903||2 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2549|4585|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2549||2549|4585||1 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6643|10220|lyfalmen|V0686|8784|1|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||6643||6643|10220||1 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10071|14938|lyfalmen|V0687|13464|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||10071||10071|14938||1 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1683|3393|lyfalmen|||1|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1683||1683|3393||1 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14636|21054|lyfalmen|V0689|19351|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||14636||14636|21054||1 016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|7673|11637|lyfalmen|||1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Ísradipín||7673||7673|11637||1 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|89718|113444|lyfsjukr|||1|70|0|7,0000|Icepharma hf|Pfizer Limited|Voricónazól||89718||89718|113444||1 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|3510|5018|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||3510||3510|5018||1 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2620|4682|lyfalmen|V0685|4077|1|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2620||2620|4682||1 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016527|J01CE0206|Apocillin|mixt.kyr|50|mg/ml|200|ml|1|glerfl||J01CE02|01.06.2015||R|0|0|0|0|0|0|AGP|0|0|1|100|XEU|1226|2764|lyfalmen|||2|200|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Fenoxýmetýlpenicillín||1226||1226|2764||1 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|16388|23270|lyfalmen|||1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||16388||16388|23270||1 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||7470||1 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|32013|43032|lyfalmen|V0682|28574|1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||32013||32013|43032||1 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1026|2128|lyfalmen|V0169|1687|2|12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||764||764|2128||1 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|135287|170119|lyfsjukr|||1|2,4|0|120,0000|Icepharma hf|Roche|Epóetín||135287||135287|170119||2 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|7002|10714|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||7002||7002|10714||1 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|2860|5013|lyfalmen|V0240|5013|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||2860||2860|5013||3 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|5279|8342|lyfalmen|V0433|8342|3|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5279||5279|8342||3 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|47973|63218|lyfalmen|||1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||47973||47973|63218||1 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|70676|91933|lyfalmen|||1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||70676||70676|91933||1 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|26276|35776|lyfalmen|||1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||26276||26276|35776||1 016930|A16AB0401|Fabrazyme|irþ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEA|0|1|0|100|DKK|75239|95436|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||75239||75239|95436||1 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1667|3371|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||1667|3371||1 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|0|1|0|1|GSL|0|0|0|100|DKK|36940|47342|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín||36569||36569|47342||2 016979|N02AE0103|Norspan|forðapl|5|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|2940|5123|lyfalmen|||1|4|0|16,6700|Icepharma hf|Norpharma A/S|Búprenorfín||2940||2940|5123||2 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.12.2006||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|17563|33491|vetalmen|||0|60|0||Icepharma hf|Zoetis Finland OY|||17563||17563|33491||2 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|1430|3045|lyfalmen|||1|3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1430||1430|3045||1 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|0|0|0|1|0|1|SKY|0|1|0|100|DKK|246909|308946|lyfsjukr|||1|5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||246909||246909|308946||2 017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|0|APC|0|0|0|100|XEU|6321|9777|lyfalmen|||2|500|0|333,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||6321||6321|9777||1 017193|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|500|stk|1|glas||N05CF01|01.05.2013||R|2|0|0|0|0|0|APC|0|0|0|100|SEK|5725|8956|lyfalmen|||2|500|0|500,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||5725||5725|8956||1 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|137221|172525|lyfsjukr|||1|1|0||Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||137221||137221|172525||1 017203|M05BA0601|Bondronat|irþ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|31950|41597|lyfsjukr|||1|6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||31950||31950|41597||2 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|105212|132714|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||105212||105212|132714||2 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|1|0|0|1|0|0|ROC|0|0|0|100|DKK|44787|59189|lyfalmen|||1|28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||44787||44787|59189||2 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.08.2004||R|1|0|0|1|0|0|ROC|0|0|0|100|DKK|139083|178454|lyfalmen|||1|84|0|840,0000|Icepharma hf|Roche|Íbandrónsýra||139083||139083|178454||2 017266|N02AE0103|Norspan|forðapl|10|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|5288|8355|lyfalmen|||1|4|0|33,3300|Icepharma hf|Norpharma A/S|Búprenorfín||5288||5288|8355||2 017326|N02AE0103|Norspan|forðapl|20|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|9718|14452|lyfalmen|||1|4|0|66,6600|Icepharma hf|Norpharma A/S|Búprenorfín||9718||9718|14452||2 017331|A04AD1201|Emend|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|0|0|1|MSD|0|0|0|100|DKK|8275|11831|lyfsjukr|||1|3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||8275||8275|11831||1 017365|J01CR0201|Amoksiklav|filmhtfl|375|mg|20|stk|1|þpakki|250+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|957|2394|lyfalmen|||2|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||957||957|2394||1 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|2668|4749|lyfalmen|||1|30|0|150,0000|Vistor hf|Recip AB|Prednisón||2668||2668|4749||1 017556|J01CR0201|Amoksiklav|filmhtfl|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1459|2665|lyfalmen|V0168|2665|2|20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1154||1154|2665||1 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|6268|12062|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||6268||6268|12062||1 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|9728|14466|lyfalmen|V0197|11812|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||9728||9728|14466||1 017809|N06DA0401|Reminyl|forðahlk|24|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|38677|51461|lyfalmen|||1|84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||38677||38677|51461||1 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|8910|13340|lyfalmen|V0107|6169|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||8910||8910|13340||1 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|0|0|0|0|0|0|PIS|0|0|0|100|SEK|3591|6019|lyfalmen|V0698|6019|1|0,25|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||3591||3591|6019||2 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|0|0|0|0|0|0|PIS|0|0|0|100|SEK|3868|6400|lyfalmen|V0699|6400|1|0,5|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||3868||3868|6400||2 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|1030|1707|lyfalmen|V0243|1367|1|42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||458||458|1707||1 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|6810|10450|lyfalmen|||1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||6810||6810|10450||1 018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|12801|17781|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||12801||12801|17781||2 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|17314|24441|lyfalmen|V0441|21457|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||17314||17314|24441||1 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|01.06.2004||R|1|0|0|0|G|0|MKA|0|0|1|100|SEK|862|2263|lyfalmen|V0414|2066|1|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||862||862|2263||2 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|5484|8624|lyfalmen|V0438|7090|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5484||5484|8624||1 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|14255|20572|lyfalmen|V0440|17933|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||14255||14255|20572||1 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|31604|42515|lyfalmen|V0111|24044|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||31604||31604|42515||1 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|0|1|0|1|TEP|0|0|0|100|NOK|91712|115924|lyfsjukr|||1|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||91712||91712|115924||1 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|64541|82131|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Fosamprenavír||64541||64541|82131||1 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|1080|2123|vetalmen|||0|100|0||Icepharma hf|Kela Laboratoria NV|||1080||1080|2123||2 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|9102|13604|lyfalmen|V0221|7302|1|5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||9102||9102|13604||1 019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|6530|9336|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||6530||6530|9336||2 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|6505|10030|lyfalmen|V0220|5680|1|5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||6505||6505|10030||1 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|19850|26548|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||19850||19850|26548||2 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|3607|6041|lyfalmen|V0219|3369|1|5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||3607||3607|6041||1 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|23741|31387|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||23741||23741|31387||2 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|21346|28408|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||21346||21346|28408||2 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|28727|37588|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||28727||28727|37588||2 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|7117|10872|lyfalmen|V0223|7928|1|5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||7117||7117|10872||1 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10620|15694|lyfalmen|||1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||10620||10620|15694||1 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|0|0|0|1|0|1|THE|0|0|0|100|XEU|695450|866805|lyfsjukr|||1|10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||695450||695450|866805||1 019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|3939|7644|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||3939||3939|7644||1 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019372|C03CA0110|Impugan|töflur|20|mg|100|stk|1|glas||C03CA01|01.02.2014||R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|381|1548|lyfalmen|V0633|1548|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Fúrósemíð||343||343|1548||1 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dælur||QJ51CE09|01.04.2010||R|0|0|0|0|0|0|VET|0|0|0|100|DKK|30513|58060|vetalmen|||0|1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||30513||30513|58060||2 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6397|9881|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6397||6397|9881||2 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|43990|56571|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||43990||43990|56571||2 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6397|9881|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6397||6397|9881||2 019621|C09AA0504|Ramipril ratiopharm|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1099|1902|lyfalmen|V0496|1902|2|100|0|200,0000|Medical ehf|ratiopharm GmbH|Ramipríl||600||600|1902||2 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019669|C09AA0504|Ramipril ratiopharm|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|980|1902|lyfalmen|V0648|1902|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Ramipríl||600||600|1902||2 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019682|C09AA0504|Ramipril ratiopharm|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1543|2866|lyfalmen|V0649|2866|2|100|0|400,0000|Medical ehf|ratiopharm GmbH|Ramipríl||1300||1300|2866||2 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|3479|4974|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||3479||3479|4974||2 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|15284|20869|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||15284||15284|20869||2 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|168259|211127|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||168259||168259|211127||2 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|991|2089|lyfalmen|V0159|2087|2|20|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||736||736|2089||2 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|1|0|1|ELD|0|1|0|100|XEU|159092|199726|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||159092||159092|199726||2 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12073|17812|lyfalmen|||1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12073||12073|17812||2 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12073|17812|lyfalmen|||1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12073||12073|17812||2 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|41927|55571|lyfalmen|V0700|55571|1|1,08|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||41927|55571||1 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12073|17812|lyfalmen|||1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12073||12073|17812||2 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12073|17812|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12073||12073|17812||2 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12073|17812|lyfalmen|||1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12073||12073|17812||2 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|0|0|0|1|0|1|BIO|0|0|0|100|DKK|734135|914918|lyfsjukr|||1|6|0|8,9300|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Palifermín||734135||734135|914918||3 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|426|1663|lyfalmen|||1|12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||||426|1663||1 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|1|0|0|1|0|1|GGL|0|0|0|100|GBP|70450|89480|lyfsjukr|||1|30|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||70450||70450|89480||1 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1231|2564|lyfalmen|V0160|2537|2|30|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||1081||1081|2564||2 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020156|C08DB0109|Dilmin|töflur|60|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|2620|4682|lyfalmen|||2|100|0|25,0000|Medical ehf|ratiopharm GmbH|Diltíazem||2620||2620|4682||2 020227|J07CA0204|Boostrix Polio|stl|||0,5|ml|1|áf.spr|dreifa|J07CA02|01.09.2014||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2851|5000|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Barnaveiki, kíghósti, mænusótt, stífkrampi||||2851|5000||1 020238|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|30|stk|1|þpakki||G04CA02|01.04.2006||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|2728|4831|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||2728||2728|4831||1 020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|28516|38609|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mænusótt, stífkrampi||28516||28516|38609||1 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stíll|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|0|0|0|0|0|0|LVR|0|0|0|100|NOK|2298|4239|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2298||2298|4239||3 020282|L01XX2301|Lysodren|töflur|500|mg|100|stk|1|glas||L01XX23|01.04.2015||R|0|0|0|1|0|1|LHR|0|0|0|100|XEU|91028|115073|lyfsjukr|||1|100|0||Laboratoire HRA Pharma|Laboratoire HRA Pharma|Mitotanum||91028||91028|115073||0 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020305|C08DB0109|Dilmin|forðatfl|90|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|2970|4293|lyfalmen|||2|100|0|37,5000|Medical ehf|ratiopharm GmbH|Diltíazem||2337||2337|4293||2 020338|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|90|stk|1|þpakki||G04CA02|01.04.2006||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|6368|9841|lyfalmen|||1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||6368||6368|9841||1 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|47495|62614|lyfalmen|||1|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||47495||47495|62614||1 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|5192|4727|lyfalmen|V0530|4271|1|84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||2652||2652|4727||1 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|11785|5497|lyfalmen|||1|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||3212||3212|5497||1 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|22081|30470|lyfalmen|||1|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||22081||22081|30470||1 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|546|1828|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||546||546|1828||1 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1695|3409|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1695||1695|3409||1 020685|C08DB0109|Dilmin|forðatfl|120|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|11815|7032|lyfalmen|V0599|7032|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Diltíazem||4327||4327|7032||2 020711|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AD01|01.01.2007||L|0|0|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||||2 020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|0|0|0|0|0|0|MES|0|0|0|100|XEU|2079|3583|vetorma|||0|7,74|0||Vistor hf|Merial SAS|Ivermectinum í blöndum||2079||2079|3583||1 020861|QP52AF0203|Nematel Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|0|0|0|0|0|0|VEB|0|0|0|100|XEU|2431|4190|vetorma|||0|52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2431||2431|4190||2 020924|J01FA1003|Zithromax (Lyf og heilsa)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|1606|3287|lyfalmen|V0174|2694|3|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||1606||1606|3287||2 020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|2731|4835|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2731||2731|4835||2 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|2213|4122|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2213||2213|4122||2 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|ACA|0|0|1|100|IKR|581|1591|lyfalmen|V0188|1493|2|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||374||374|1591||1 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|0|0|0|0|G|0|GEM|0|0|0|100|XEU|1368|2959|lyfalmen|||1|10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||1368||1368|2959||1 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|ACA|0|0|1|100|IKR|1287|2150|lyfalmen|V0189|2132|2|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||780||780|2150||1 021341|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|GBP|9569|14247|lyfalmen|V0437|13540|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og fluticason||9569||9569|14247||3 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|15997|22775|lyfalmen|V0490|2294|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||15997||15997|22775||1 021365|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|GBP|7298|11121|lyfalmen|V0436|10582|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og fluticason||7298||7298|11121||3 021417|R01AD0504|Rhinocort (Lyf og heilsa)|nefúði|64|mcg/sk|120|skammtar|1|fl||R01AD05|15.12.2004||R|0|0|0|0|G|0|HOL|0|0|1|100|SEK|1456|3080|lyfalmen|V0443|3080|3|120|0|38,4000|Lyf og heilsa|Lyf og heilsa|Búdesóníð||1456||1456|3080||2 021428|A06AB0201|Dulcolax|eþ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||||1 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1475|2109|lyfsjukr|||2|100|0||Icepharma hf|Fresenius Kabi|Própófól||1475||1475|2109||2 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|4020|6609|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4020||4020|6609||1 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|12478|18324|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||12478||12478|18324||1 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12881|18834|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||12881||12881|18834||1 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|6633|10206|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||6633||6633|10206||1 021625|A07EC0203|Pentasa Sachets|forðakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|14094|20368|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||14094||14094|20368||1 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|14755|20211|lyfsjukr|||2|1000|0||Icepharma hf|Fresenius Kabi|Própófól||14755||14755|20211||2 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|21040|29153|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||21040||21040|29153||1 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|16968|22963|lyfsjukr|||2|500|0||Icepharma hf|Fresenius Kabi|Própófól||16968||16968|22963||2 021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|22711|31267|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||22711||22711|31267||1 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|þpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3966|6535|lyfalmen|V0171|5243|1|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||3966||3966|6535||1 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8484|12130|lyfsjukr|||2|500|0||Icepharma hf|Fresenius Kabi|Própófól||8484||8484|12130||2 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4282|6122|lyfsjukr|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4282||4282|6122||1 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18182|25539|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18182||18182|25539||1 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|3789|6291|lyfalmen|V0692|4859|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3789||3789|6291||2 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|5981|9309|lyfalmen|V0693|7042|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5981||5981|9309||2 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|18237|25608|lyfalmen|V0694|22943|1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||18237||18237|25608||2 021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|0|1|0|1|SHI|0|0|0|100|DKK|71756|91104|lyfsjukr|||1|100|0||Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Anagrelidum||71756||71756|91104||3 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999|30.06.2015|R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18061|25386|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18061||18061|25386||1 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|77274|97967|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||77274||77274|97967||2 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|110145|138850|lyfsjukr|||1|1200|0||Icepharma hf|Baxter Medical AB|Albúmín||110145||110145|138850||2 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríð|||||||1 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|Clikstar/JuniorStar pennar|A10AB06|01.07.2010||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|4485|7249|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||4485||4485|7249||1 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|269946|337597|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||269946||269946|337597||2 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|283923|354981|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||283923||283923|354981||2 022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|þpakki||QP52AA51|01.01.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|11804|20345|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||11804||11804|20345||2 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|0|1|0|0|ALL|0|0|0|100|SEK|21949|30303|lyfalmen|||1|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||21949||21949|30303||1 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2119|3652|vetorma|||0|2,24|0||Icepharma hf|Bayer Animal Health GmbH|||2119||2119|3652||2 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1211|2743|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1211||1211|2743||1 022281|QP52AA5102|Drontal Comp.vet.|töflur|||2|stk|1|þpakki||QP52AA51|01.10.1991||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1339|2308|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||1339||1339|2308||2 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3548|2706|lyfalmen|V0056|1992|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1184||1184|2706||1 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|6291|3660|lyfalmen|V0057|1992|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||1877||1877|3660||1 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2007|3459|vetorma|||0|1,4|0||Icepharma hf|Bayer Animal Health GmbH|||2007||2007|3459||2 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|570|1861|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||570||570|1861||1 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1715|3437|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1715||1715|3437||1 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1299|2239|vetorma|||0|0,7|0||Icepharma hf|Bayer Animal Health GmbH|||1299||1299|2239||2 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|þpakki||C09DA03|01.11.2003||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|4371|7093|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og þvagræsilyf||4371||4371|7093||1 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2129|3102|lyfalmen|V0321|3102|2|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|3102||1 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|þpakki||N06AB05|01.08.2013||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1554|2414|lyfalmen|V0321|1861|2|60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||972||972|2414||1 022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||4647||2 022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|áf.spr||B01AX05|01.10.2011||R|0|0|0|0|G|0|TAA|0|0|0|100|GBP|28056|38027|lyfalmen|||1|8|0|40,0000|Navamedic A/S|Aspen Pharma Trading Limited|Fondaparinux||28056||28056|38027||1 022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|áf.spr||B01AX05|01.10.2011||R|0|0|0|0|G|0|TAA|0|0|0|100|GBP|14028|20285|lyfalmen|||1|4|0|20,0000|Navamedic A/S|Aspen Pharma Trading Limited|Fondaparinux||14028||14028|20285||1 022831|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|áf.spr||B01AX05|01.04.2012||R|0|0|0|0|G|0|TAA|0|0|0|100|GBP|20774|28817|lyfalmen|||1|6|0|30,0000|Navamedic A/S|Aspen Pharma Trading Limited|Fondaparinux||20774||20774|28817|31.5.2015|1 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2862||2 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|ACA|0|0|0|30|IKR|1407|2940|lyfalmen|V0124|2936|2|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1354||1354|2940||1 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|ACA|0|0|0|30|IKR|2450|3402|lyfalmen|V0125|2603|2|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1690||1690|3402||1 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|74754|94833|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl og emtrícítabín||74754||74754|94833||2 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|24036|32943|lyfalmen|||1|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||24036||24036|32943||3 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|37526|50005|lyfalmen|||1|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||37526||37526|50005||3 023114|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RAT|0|0|0|30|IKR|3000|2866|lyfalmen|V0125|2603|2|30|0|20,0000|LYFIS ehf|ratiopharm GmbH|Ísótretínóín||1300||1300|2866||2 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|1|0|0|0|G|0|LUX|0|0|0|100|DKK|18593|26058|lyfalmen|||1|98|0|98,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||18593||18593|26058||1 023125|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|60|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RAT|0|0|0|30|IKR|6500|5206|lyfalmen|V0125|5206|2|60|0|40,0000|LYFIS ehf|ratiopharm GmbH|Ísótretínóín||3000||3000|5206||2 023154|N03AX1208|Gabapentin ratiopharm|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|14000|20249|lyfalmen|V0256|20249|2|100|0|44,4400|Medical ehf|ratiopharm GmbH|Gabapentín||14000||14000|20249||2 023162|N03AX1208|Gabapentin ratiopharm|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|7500|11399|lyfalmen|V0254|11399|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Gabapentín||7500||7500|11399||2 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|1|0|0|0|G|0|LUX|0|0|0|100|DKK|19196|26821|lyfalmen|||1|98|0|196,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||19196||19196|26821||1 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2424|3723|lyfalmen|V0250|3716|2|100|0|16,6667|Icepharma hf|Mylan AB|Gabapentín||1923||1923|3723||2 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3243|4268|lyfalmen|V0251|4259|2|100|0|22,2200|Icepharma hf|Mylan AB|Gabapentín||2319||2319|4268||2 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|0|0|0|0|0|0|DED|0|0|1|100|XEU|18329|25725|lyfalmen|||1|34|0||Vistor hf|Dentsply DeTrey GmbH|Blöndur||18329||18329|25725||1 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|0|0|0|1|0|1|BII|0|0|0|100|DKK|119794|150850|lyfsjukr|||1|120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||119794||119794|150850||1 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|1|0|0|0|G|0|SBM|0|0|0|100|NOK|17344|24479|lyfalmen|V0029|6662|1|100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||17344||17344|24479||1 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2918|5093|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||2918||2918|5093||2 023608|N01AB0802|Sevofluran Baxter|innönd.l|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|130496|150781|lyfsjukr|||2|1500|0||Icepharma hf|Baxter|Sevóflúran||119738||119738|150781||2 023641|C09AA0211|Enalapril Krka|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|900|2315|lyfalmen|V0066|2315|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||900||900|2315||2 023649|C09AA0211|Enalapril Krka|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1050|2522|lyfalmen|V0449|2522|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1050||1050|2522||2 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|1|0|0|1|0|1|ROC|0|0|0|100|DKK|52946|67710|lyfsjukr|||1|120|0|33,3300|Icepharma hf|Roche|Saquínavír||52946||52946|67710||2 023738|C09AA0211|Enalapril Krka|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|700|2040|lyfalmen|V0448|1917|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||700||700|2040||2 023847|N06AX1106|Mirtazapin Krka|filmhtfl|45|mg|100|stk|1|þpakki||N06AX11|01.04.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4900|5894|lyfalmen|||2|100|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||3500||3500|5894||2 023897|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2429|3691|lyfalmen|V0673|3691|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1900||1900|3691||2 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|0|1|0|1|0|1|IPI|0|0|0|100|DKK|69470|88261|lyfsjukr|||1|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||69470||69470|88261||1 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|2740|4848|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2740||2740|4848||1 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|2198|4102|lyfalmen|V0222|3774|1|5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||2198||2198|4102||1 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|1|0|0|0|G|0|TPG|0|0|0|100|DKK|18111|25449|lyfalmen|||1|30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||18111||18111|25449||1 024185|N05AH0309|Kozylex|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.09.2011||R|0|0|0|0|G|0|POF|0|0|0|100|IKR|14561|13464|lyfalmen|V0456|13189|2|28|0|28,0000|Portfarma ehf|Portfarma|Olanzapín||9000||9000|13464||2 024198|C07AB0213|Metoprololsuccinat Hexal|forðatfl|50|mg|100|stk|1|plglas|47,5 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1607|2483|lyfalmen|V0048|2483|2|100|0|31,6600|Artasan ehf|Hexal A/S|Metóprólól||1022||1022|2483||1 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.10.2005||R|1|0|0|0|G|0|TPG|0|0|0|100|DKK|59734|78094|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||59734||59734|78094||1 024231|C07AB0213|Metoprololsuccinat Hexal|forðatfl|100|mg|100|stk|1|plglas|95 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|2156|3583|lyfalmen|V0049|3583|2|100|0|63,3300|Artasan ehf|Hexal A/S|Metóprólól||1821||1821|3583||1 024253|C07AB0213|Metoprololsuccinat Hexal|forðatfl|200|mg|100|stk|1|plglas|190 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|4340|6152|lyfalmen|V0054|6152|2|100|0|126,6600|Artasan ehf|Hexal A/S|Metóprólól||3688||3688|6152||1 024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|22711|31267|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||22711||22711|31267||1 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7150|10918|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7150||7150|10918||1 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|388|1610|lyfalmen|||1|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||388||388|1610||1 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7150|10918|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7150||7150|10918||1 024504|V04CL0003|Soluprick SQ ALK106 - Rauðölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|12047|17779|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||12047||12047|17779||1 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviður|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|12067|17804|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||12067||12067|17804||1 024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|12191|17961|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||12191||12191|17961||1 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5155|8172|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5155||5155|8172||1 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|65497|85383|lyfalmen|||1|100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||65497||65497|85383||1 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|12191|17961|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||12191||12191|17961||1 024603|V04CL0001|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1468|3097|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1468||1468|3097||1 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5155|8172|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5155||5155|8172||1 024644|V04CL0015|Soluprick SQ ALK552 - Hrossaværur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7150|10918|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7150||7150|10918||1 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7150|10918|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7150||7150|10918||1 024681|V04CL0002|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1468|3097|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1468||1468|3097||1 024901|C07AB0212|Metoprolin|töflur|100|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|2162|3141|lyfalmen|V0106|3141|2|100|0|66,6660|Medical ehf|ratiopharm GmbH|Metóprólól||1500||1500|3141||2 025041|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3115|5364|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3115||3115|5364||2 025046|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2770|4889|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|4889||2 025052|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|3829|lyfalmen|V0450|3829|2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|3829||2 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|581|1876|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||581||581|1876||1 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18182|25539|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||18182||18182|25539||1 025239|C07AB0212|Metoprolin|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1480|2177|lyfalmen|V0051|2177|2|100|0|33,3333|Medical ehf|ratiopharm GmbH|Metóprólól||800||800|2177||2 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999|30.06.2015|R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18061|25386|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||18061||18061|25386||1 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|74581|94618|lyfsjukr|||1|30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||74581||74581|94618||1 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|69662|88500|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||69662||69662|88500||1 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|9010|17264|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|||9010||9010|17264||1 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|15596|22268|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||15596||15596|22268||1 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|4934|7867|lyfalmen|V0205|1257|1|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||4934||4934|7867||2 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|13222|19265|lyfalmen|V0205|3770|1|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||13222||13222|19265||2 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|50098|65906|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||50098||50098|65906||1 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|6606|9445|lyfsjukr|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||6606||6606|9445||1 025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|22711|31267|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||22711||22711|31267||1 025895|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|1448|2322|lyfalmen|V0597|2322|2|28|0|3,7300|Medical ehf|ratiopharm GmbH|Oxýcódon||905||905|2322||2 025906|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|3697|4938|lyfalmen|V0598|4938|2|98|0|13,0700|Medical ehf|ratiopharm GmbH|Oxýcódon||2806||2806|4938||2 025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|þpakki|hart|L04AX02|01.09.2011||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|48608|62315|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||48608|62315||2 025927|N06AX2601|Brintellix|filmhtfl|20|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|42161|55867|lyfalmen|||1|98|0|196,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||42161||42161|55867||1 025941|R03DC0302|Montelukast Portfarma|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.01.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|12570|3990|lyfalmen|V0492|3513|2|98|0|39,2000|Portfarma ehf|Portfarma|Montelúkast||2117||2117|3990||1 025963|R03DC0302|Montelukast Portfarma|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.01.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|4266|6132|lyfalmen|V0491|6132|2|98|0|49,0000|Portfarma ehf|Portfarma|Montelúkast||3673||3673|6132||1 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|3668|6322|vetorma|||0|1|0||Vistor hf|Merial (MSD)|Ivermectinum||3668||3668|6322|30.4.2015|1 025986|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.11.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|12858|2380|lyfalmen|V0490|2294|2|98|0|98,0000|Portfarma ehf|Portfarma|Montelúkast||947||947|2380||1 025997|A07DA0302|Loperamid Portfarma|töflur|2|mg|20|stk|1|þpakki||A07DA03|01.05.2011||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Portfarma ehf|Portfarma|Lóperamíð|||||||1 026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1837|3610|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||1837||1837|3610||1 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|8730|15047|vetorma|||0|2,5|0||Vistor hf|Merial (MSD)|Ivermectinum||8730||8730|15047||1 026086|N05AH0309|Kozylex|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|IKR|23430|14152|lyfalmen|V0475|13739|2|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||9500||9500|14152||1 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18182|25539|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||18182||18182|25539||1 026101|L01CA0501|Javlor|irþ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|40104|51738|lyfsjukr|||1|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||40104||40104|51738||1 026114|L01CA0501|Javlor|irþ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|200523|251254|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||200523||200523|251254||1 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|1709|3429|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíð||||1709|3429||1 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|6474|9987|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíð||||6474|9987||1 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|3375|5722|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíð||||3375|5722||1 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|13369|19451|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíð||||13369|19451||1 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|20034|27881|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíð||||20034|27881||1 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|26699|36311|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíð||||26699|36311||1 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1299|2864|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||1299||1299|2864||1 026698|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 026943|C09CA0106|Losatrix|filmhtfl|100|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4765|3861|lyfalmen|V0099|3861|2|100|0|200,0000|Medical ehf|ratiopharm GmbH|Lósartan||2023||2023|3861||2 026946|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|0|0|0|0|0|0|HOL|0|0|1|100|SEK|1061|2537|lyfalmen|V0160|2537|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amoxicillín||1061||1061|2537||2 026957|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|734|2087|lyfalmen|V0159|2087|3|20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||734||734|2087||2 027051|A10BX1201|Jardiance|filmhtfl|10|mg|90|stk|1|þpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|19334|26996|lyfalmen|||1|90|0||Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||19334||19334|26996||1 027058|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2043|3003|lyfalmen|V0672|3003|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1400||1400|3003||2 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|386|1608|lyfalmen|||2|50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||386||386|1608||1 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|2546|4581|lyfalmen|||1|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2546||2546|4581||1 027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|5799|9058|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Cýpróterón||5799||5799|9058||2 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|15638|7503|lyfalmen|V0341|7503|2|100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||4669||4669|7503||1 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|17953|7503|lyfalmen|V0342|7503|2|100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||4669||4669|7503||1 027505|B05BB0121|Plasmalyte|irl|||1000|ml|10|pokar|lausn|B05BB01|01.05.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2551|3647|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2551||2551|3647||2 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|6558|10103|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíð||6558||6558|10103||1 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|567|1857|lyfalmen|||2|100|0|33,3300|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||567||567|1857||1 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|653|1975|lyfalmen|||2|100|0|66,6667|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||653||653|1975||1 027733|N05AH0409|Quetiapin Orion|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.10.2012||R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|2109|2109|lyfalmen|V0284|2109|2|100|0|6,2500|Portfarma ehf|Orion Corporation|Quetíapín||750||750|2109||1 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|19282|26930|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19282||19282|26930||1 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|22212|29486|lyfsjukr|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||22212|29486||2 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|22285|30728|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||22285||22285|30728||1 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|30338|39592|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||30338||30338|39592||2 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|44829|57615|lyfsjukr|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||44829|57615||2 028045|G03AB0801|Qlaira|töflur|||84|stk|1|þpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|4039|6636|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||4039||4039|6636||2 028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|21355|29552|lyfalmen|V0387|29552|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||21355||21355|29552||1 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|19085|26681|lyfalmen|V0386|26681|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||19085||19085|26681||1 028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3237|4461|lyfalmen|V0364|3570|2|100|0|100,0000|Icepharma hf|Mylan AB|Fexófenadín||2459||2459|4461||2 028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|47587|61045|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||47587||47587|61045||1 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2477|4486|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefnavakar||2477||2477|4486||2 028333|J07CA0602|Pentavac|sts|||0,5|ml|10|hgl|+ 10 áf. spr.|J07CA06|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|38507|51246|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||38507||38507|51246||2 028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|39798|52879|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||||39798|52879||2 028360|J07BG0101|Rabies - Imovax|sts|||1|ml|1|hgl||J07BG01|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|SEK|9148|13668|lyfalmen|||1|1|0||Icepharma hf|Sanofi Pasteur MSD|Hundaæði, dauð veira||9148||9148|13668||2 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1694|3408|lyfalmen|V0202|3408|2|50|0|25,0000|Icepharma hf|Mylan AB|Baklófen||1694||1694|3408||2 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1899|3690|lyfalmen|V0428|3128|2|50|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1899||1899|3690||2 028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|1278|2835|lyfalmen|||1|56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2835||1 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|5812|3884|lyfalmen|V0245|3483|1|98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||2040||2040|3884||1 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|10358|8729|lyfalmen|V0232|7799|1|98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||5560||5560|8729||1 028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|750|2109|lyfalmen|V0266|2107|2|30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||750||750|2109||1 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|0|OCO|1|0|0|100|DKK|7478|14358|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|||7478||7478|14358||2 028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3635|5009|lyfalmen|V0267|5009|2|100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||2857||2857|5009||1 028739|C08CA0502|Adalat Oros|forðatfl|30|mg|28|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|1595|3272|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||1595|3272||2 028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1362|1723|lyfalmen|V0551|1723|2|7|0|1,7500|Portfarma ehf|Portfarma|Flúkónazól||470||470|1723||1 028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|4998|3155|lyfalmen|V0552|3155|2|30|0|7,5000|Portfarma ehf|Portfarma|Flúkónazól||1510||1510|3155||1 028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.05.2010||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|Portfarma ehf|Portfarma|Flúkónazól|||||||1 028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|523|1796|lyfalmen|V0555|1796|2|2|0|1,5000|Portfarma ehf|Portfarma|Flúkónazól||523||523|1796||1 028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|2031|1861|lyfalmen|V0556|1861|2|4|0|3,0000|Portfarma ehf|Portfarma|Flúkónazól||570||570|1861||1 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|120|skammtar|1|stauk||R01AD08|01.04.1992||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|1121|2453|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||1000||1000|2453||1 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|7138|10901|lyfalmen|||1|28|0|28,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||7138||7138|10901||2 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|17862|25134|lyfalmen|||1|84|0|84,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||17862||17862|25134||2 029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|2724|4826|lyfalmen|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||2724||2724|4826||1 029276|J04BA0202|Dapsone|töflur|50|mg|28|stk|1|þpakki||J04BA02|01.04.2013||R|0|0|0|1|G|0|AUK|0|0|0|100|XEU|1197|2724|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis UK Ltd.|Dapsón||1197||1197|2724||1 029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|þpakki||C03DB01|01.04.2009||R|0|0|0|0|G|0|AUK|0|0|0|100|GBP|356|1566|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríð||356||356|1566||1 029381|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.04.2014||L|1|0|0|0|0|0|SIV|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Vistor hf|Bayer AB|Lóratadín|||||||1 029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|58223|74273|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Eribulin||58223||58223|74273||1 029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|18520|24894|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||18520||18520|24894||1 029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|4029|5760|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||4029||4029|5760||1 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|þpakki|32+12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12207|17981|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||12207|17981||1 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|þpakki|32+25 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11842|17376|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||11842|17376||1 029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|þpakki|með br.losunarhraða|J01AA02|01.12.2011||R|1|0|0|0|0|0|GAN|0|0|1|100|SEK|5771|9020|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||5771||5771|9020||2 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEB|0|1|0|100|DKK|89574|113265|lyfsjukr|||1|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||89574||89574|113265||1 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEU|0|1|0|100|DKK|179148|224670|lyfsjukr|||1|1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||179148||179148|224670||1 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 030170|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.07.2014||R|0|0|0|0|0|0|IPI|0|0|0|100|DKK|7722|11705|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||7722||7722|11705||1 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|8690|13037|lyfalmen|V0277|8825|1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Klózapín||8690||8690|13037||1 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|HES|0|0|0|100|IKR|2886|5049|lyfalmen|V0276|3347|1|100|0|8,3333|Vistor hf|Novartis Healthcare A/S|Klózapín||2886||2886|5049||1 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|15203|26204|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||||15203|26204||2 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1255|2676|lyfalmen|V0051|2177|2|100|0|33,3333|Icepharma hf|Mylan AB|Metóprólól||1162||1162|2676||2 031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1801|3335|lyfalmen|V0106|3141|2|100|0|66,6667|Icepharma hf|Mylan AB|Metóprólól||1641||1641|3335||2 031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||L|0|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2673||1 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|2744|4853|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||2744||2744|4853||2 031201|L01BA0109|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2633|4700|lyfalmen|||1|0,25|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2633||2633|4700||2 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|1862|3639|lyfalmen|||1|100|0|33,3333|Vistor hf|Recip AB|Ísósorbíð dínítrat||1862||1862|3639||1 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5469|8604|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5469||5469|8604||1 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|20780|27705|lyfsjukr|||1|5|0|0,4200|Vistor hf|Ferring Lægemidler A/S|Terlípressín||20780||20780|27705||1 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1817|3577|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Sótalól||1817||1817|3577||2 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|0|0|0|G|0|OTS|0|0|0|100|DKK|19880|27686|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19880||19880|27686||1 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|13768|23731|vetorma|||0|200|0||Vistor hf|Merial (MSD)|Ivermectinum||13768||13768|23731||1 032706|C03EA0113|Diuramin|töflur|55|mg|100|stk|1|þpakki|5+50 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1198|2109|lyfalmen|V0558|2109|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||750||750|2109||2 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|20150|28028|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||||20150|28028||1 033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|40189|53373|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||40189|53373||1 033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|1156|1992|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||1156||1156|1992||2 033195|N02AA5501|Targin|forðatfl|15|mg|28|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|2904|5073|lyfalmen|||1|28|0|3,7400|Icepharma hf|Norpharma|Oxycodonum í blöndum||2904||2904|5073||2 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|8652|16585|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríð||||8652|16585||2 033206|N02AA5501|Targin|forðatfl|15|mg|98|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|9896|14697|lyfalmen|||1|98|0|13,0700|Icepharma hf|Norpharma|Oxycodonum í blöndum||9896||9896|14697||2 033218|N02AA5501|Targin|forðatfl|30|mg|28|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|5811|9075|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxycodonum í blöndum||5811||5811|9075||2 033229|N02AA5501|Targin|forðatfl|30|mg|98|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|17154|24238|lyfalmen|||1|98|0|26,1400|Icepharma hf|Norpharma|Oxycodonum í blöndum||17154||17154|24238||2 033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|0|G|0|CLA|0|0|1|100|USD|1384|2981|lyfalmen|||1|5|0||Vistor hf|Alcon Nordic A/S|Dexametasón||1384||1384|2981||1 033357|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|1894|2132|lyfalmen|V0189|2132|2|100|0|50,0000|Medical ehf|ratiopharm Oy|Díklófenak||767||767|2132||2 033498|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|829|1493|lyfalmen|V0188|1493|2|30|0|15,0000|Medical ehf|ratiopharm Oy|Díklófenak||303||303|1493||2 033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.04.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|17722|13940|lyfalmen|V0185|13940|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Letrózól||9346||9346|13940||2 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|88164|111511|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||88164||88164|111511||1 034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2338|4595|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2338|4595||2 034124|C09BA0202|Enalapril comp ratiopharm|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.12.2013||R|1|0|0|0|G|0|ROY|0|0|0|100|XEU|1850|2405|lyfalmen|V0098|2405|2|100|0|100,0000|Medical ehf|ratiopharm Oy|Enalapríl og þvagræsilyf||965||965|2405||2 034157|J07AM5104|Diftavax|stl|||0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|0|0|0|0|0|0|SPM|0|0|1|100|XEU|705|2047|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíð í blöndum með barnaveikistoxóíðum||705||705|2047||2 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|16066|21842|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||16066||16066|21842||2 034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.12.2009||R|0|1|0|0|G|0|ELD|0|0|0|100|XEU|7847|11877|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||7847|11877||2 034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.12.2009||R|0|1|0|0|G|0|ELD|0|0|0|100|XEU|7847|11877|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||7847|11877||2 034494|N05CM1801|Dexdor|irþ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|63616|80980|lyfsjukr|||1|40|0|4,0000|Vistor hf|Orion Corporation|Dexmedetómid||63616||63616|80980||1 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|1600|3279|lyfalmen|V0367|3279|1|6|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||1600||1600|3279||1 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|2676|4760|lyfalmen|||1|12|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||2676||2676|4760||1 034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|110436|139211|lyfsjukr|||1|2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||110436||110436|139211||2 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|7038|10062|lyfsjukr|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||7038||7038|10062||1 035113|B05XA0501|Addex-Magnesium|irþ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2117|3027|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Magnesíum súlfat||2117||2117|3027||2 035134|B01AF0201|Eliquis|filmhtfl|5|mg|14|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|2354|4316|lyfalmen|||1|14|0|14,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||2354|4316||1 035153|N02AB0306|Instanyl|nefúði|50|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|9081|13575|lyfalmen|||1|6|0|0,5000|Vistor hf|Takeda Pharma A/S|Fentanýl||9081||9081|13575||1 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|14762|21213|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||14762||14762|21213||1 035494|C07AB0211|Metoprolol ratiopharm|forðatfl|23,75|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1268|2822|lyfalmen|V0050|2431|2|100|0|15,8300|Medical ehf|ratiopharm GmbH|Metóprólól||1268||1268|2822||2 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1844|2001|lyfalmen|V0244|2001|2|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||672||672|2001||1 035528|C07AB0211|Metoprolol ratiopharm|forðatfl|47,5|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1260|2811|lyfalmen|V0048|2483|2|100|0|31,6600|Medical ehf|ratiopharm GmbH|Metóprólól||1260||1260|2811||2 035563|C07AB0211|Metoprolol ratiopharm|forðatfl|95|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|2250|3846|lyfalmen|V0049|3583|2|100|0|63,3300|Medical ehf|ratiopharm GmbH|Metóprólól||2012||2012|3846||2 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8281|12474|lyfalmen|V0080|5794|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8281||8281|12474||1 035597|C07AB0211|Metoprolol ratiopharm|forðatfl|190|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|4917|6340|lyfalmen|V0054|6152|2|100|0|126,6600|Medical ehf|ratiopharm GmbH|Metóprólól||3824||3824|6340||2 035755|M01AE0102|Ibufen|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.12.2014||R|1|0|0|0|G|0|AGP|0|0|1|100|XEU|711|1931|lyfalmen|V0562|1624|2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||621||621|1931||1 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|1|1|0|0|0|0|GZE|0|0|0|100|NOK|24989|31563|lyfalmen|V0680|27548|1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||22945||22945|31563||1 036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|110436|139211|lyfsjukr|||1|2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||110436||110436|139211||2 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7360|11207|lyfalmen|V0081|4988|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||7360||7360|11207||1 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|737|2091|lyfalmen|||1|20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||737||737|2091||1 036502|N06DA0301|Exelon|forðapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|19398|27077|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||19398||19398|27077||1 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1296|2860|lyfalmen|||1|60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1296||1296|2860||1 036529|QI09AB1302|Ingelvac MycoFLEX|stl|||50|ml|1|glas|handa svínum|QI09AB13|01.12.2013||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|4197|7234|vetorma|||1|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Óvirkar bakteríur í bóluefnum||4197||4197|7234||1 036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2558|4597|lyfalmen|||1|125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2558||2558|4597||1 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|775|2143|lyfalmen|||1|30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||775||775|2143||1 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|10176|8267|lyfalmen|V0532|6137|1|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||5224||5224|8267||1 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|20674|11833|lyfalmen|V0533|10366|1|84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||7815||7815|11833||1 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|36718|22447|lyfalmen|V0534|20563|1|84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||15738||15738|22447||1 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2672|4754|lyfalmen|V0434|4754|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2672||2672|4754||2 037584|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|30|stk|1|þpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|967|1765|lyfalmen|V0151|1765|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||500||500|1765||2 037595|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2311|2453|lyfalmen|V0322|2343|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||1000||1000|2453||2 037607|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4353|3829|lyfalmen|V0323|3623|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||2000||2000|3829||2 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||2285||1 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||3612||1 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7500|11399|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||7500|11399||1 038123|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|6278|12081|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||6278||6278|12081||2 038305|N06AX1611|Duofaxin|forðatfl|150|mg|98|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|2867|4594|lyfalmen|V0335|3078|2|98|0|147,0000|Vistor hf|MediLink A/S|Venlafaxín||2556||2556|4594||1 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|2667|3266|lyfalmen|V0321|3102|1|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3266||1 038494|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1347|2128|lyfalmen|V0110|2128|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||764||764|2128||2 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|970|2411|lyfalmen|||1|50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||970||970|2411||2 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|145346|182630|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||145346||145346|182630||1 039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|13549|19679|lyfalmen|||1|42|0|63,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||13549|19679||2 039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|0|1|0|1|PSS|0|0|0|100|SEK|30322|39572|lyfsjukr|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||30322||30322|39572||2 039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|6864|10524|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||6864||6864|10524||1 039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|þpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGA|0|0|0|100|NOK|3816|6329|lyfalmen|||1|20|0|10,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||||3816|6329||1 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGA|0|0|0|100|NOK|17646|24861|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||||17646|24861||1 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|þpakki||N06AX03|01.06.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3240|5519|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Míanserín||3228||3228|5519||2 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|404|1587|lyfalmen|V0541|1442|2|98|0|32,6667|Icepharma hf|Mylan AB|Atenólól||371||371|1587||2 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|582|1632|lyfalmen|V0542|1588|2|98|0|65,3333|Icepharma hf|Mylan AB|Atenólól||404||404|1632||2 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|1001|2454|lyfalmen|||1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1001||1001|2454||1 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|1755|3492|lyfalmen|||1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1755||1755|3492||1 039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|1201|1717|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1201||1201|1717||2 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|1630|2128|lyfalmen|V0110|2085|2|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||764||764|2128||1 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|AGP|0|0|1|100|GBP|8334|5478|lyfalmen|V0182|5343|2|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||3198||3198|5478||1 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|3009|4302|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||3009||3009|4302||2 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|AGP|0|0|1|100|GBP|2002|2040|lyfalmen|V0033|2040|2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||700||700|2040||1 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|6004|8584|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||6004||6004|8584||2 040313|N02AB0306|Instanyl|nefúði|200|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|9176|13706|lyfalmen|||1|6|0|2,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||9176||9176|13706||1 040421|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|5262|10154|vetalmen|||0|24|0||Icepharma hf|Zoetis Finland OY|||5262||5262|10154||2 040426|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.05.2012||R|1|0|0|0|G|0|APC|0|0|1|100|XEU|1232|2644|lyfalmen|V0366|2253|2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||1139||1139|2644||1 040475|C09DA0603|Candesartan/Hydrochlorothiazide Aspen|töflur|28,5|mg|100|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.04.2014||R|1|0|0|0|0|0|ART|0|0|0|100|XEU|3549|4972|lyfalmen|V0095|4972|2|100|0|100,0000|Artasan ehf|Navamedic ASA|Candesartan og þvagræsilyf||2830||2830|4972||1 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|0|0|0|0|G|0|SAC|0|0|0|100|IKR|||lyfalmen|||0|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Gervitár og aðrar óvirkar samsetningar|||||1825||1 040620|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4468|8647|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4468||4468|8647||2 040708|G02AD0601|Misodel|sk-innl|200|mcg|5|stk|1|askja||G02AD06|01.09.2014||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|84228|106616|lyfsjukr|||1|5|0||Vistor hf|Ferring Lægemidler A/S|Misóprostól||||84228|106616||1 040735|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.12.2012||R|1|0|0|0|0|0|APC|0|0|1|100|XEU|1175|2694|lyfalmen|V0174|2694|2|3|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Azitrómýcín||1175||1175|2694||1 040742|C08CA0203|Felodipin ratiopharm|forðatfl|2,5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3128|5382|lyfalmen|V0201|5382|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Felódipín||3128||3128|5382||2 041086|C01EB1701|Procoralan|filmhtfl|5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|1|0|0|LLS|0|0|0|100|DKK|9072|13563|lyfalmen|||1|56|0|28,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||9072||9072|13563||2 041105|C01EB1701|Procoralan|filmhtfl|7,5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|1|0|0|LLS|0|0|0|100|DKK|9072|13563|lyfalmen|||1|56|0|42,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||9072||9072|13563||2 041490|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2521|2177|lyfalmen|||2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||800||800|2177|30.6.2015|2 041704|QG03XA9101|Improvac|stl|300|mcg|20|ml|12|fl||QG03XA91|01.08.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|13186|22727|vetorma|||0|240|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||13186||13186|22727||2 041716|QG03XA9101|Improvac|stl|300|mcg|100|ml|10|glös||QG03XA91|01.10.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|54303|93597|vetorma|||0|1000|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||54303||54303|93597||2 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|3361|5793|vetorma|||0|100|0||Vistor hf|Intervet International BV|||3361||3361|5793||1 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1070|2549|lyfalmen|||2|90|0|15,0000|Icepharma hf|Mylan AB|Míanserín||||1070|2549||2 041938|A02BC0508|Esomeprazol Actavis|sþ-hylki|40|mg|28|stk|1|þpakki|hart|A02BC05|01.03.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|2104|2449|lyfalmen|V0005|2449|2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||997||997|2449||1 041942|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|300|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|7000|9335|lyfalmen|||2|300|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6000||6000|9335||2 041951|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|250|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|9000|9335|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6000||6000|9335||2 041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||||1 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1376|2970|lyfalmen|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1376||1376|2970||1 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|7716|11032|lyfsjukr|||1|500|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||7716||7716|11032||1 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2188|3128|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2188||2188|3128||2 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2883|4122|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||2883||2883|4122||2 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1468|2099|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||1468||1468|2099||2 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2706|3869|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2706||2706|3869||2 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1898|2714|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||1898||1898|2714||2 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1639|2343|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||1639||1639|2343||2 042549|J07BF0301|Imovax Polio|stl|||0,5|ml|1|áf.spr|með nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2152|4038|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||2152||2152|4038||2 042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3088|4415|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3088||3088|4415||2 042556|J07BF0301|Imovax Polio|stl|||0,5|ml|20|áf.spr|með nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|13906|20130|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||13906||13906|20130||2 042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1879|3693|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1879||1879|3693||2 042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2519|4950|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2519||2519|4950||2 042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5039|9730|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5039||5039|9730||2 042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5794|11163|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5794||5794|11163||2 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2274|3251|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2274||2274|3251||2 042669|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|4000|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||2 042775|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|4115|6740|lyfalmen|||3|500|0||Icepharma hf|Icepharma hf|Senna||4115||4115|6740||2 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|517|1788|lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Flúnítrazepam||517||517|1788||2 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|2869|4102|lyfsjukr|||1|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||2869||2869|4102||1 043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|17745|5474|lyfalmen|V0516|5474|2|100|0|66,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||3195||3195|5474||1 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|skammtar|1|stauk|HFA 134a|R03AC12|01.04.2007||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|4422|7163|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||4422||4422|7163||1 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|5148|7360|lyfsjukr|||1|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||5148||5148|7360||1 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|530|1806|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||530||530|1806||1 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.07.1989||R|0|0|0|0|G|0|PTL|0|0|0|100|XEU|1198|2725|lyfalmen|V0659|2661|1|30|0|30,0000|Navamedic AB|Aspen Pharma Trading Limited|Estríól||1198||1198|2725||1 043919|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3053||2 043935|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3053||2 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúðaðar|B03AA07|01.09.2009||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||||1 044360|B03AC0004|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.05.2006||R|0|0|0|0|G|0|LVR|0|0|1|100|CHF|14202|20505|lyfalmen|V0637|20505|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járn, stungulyf||14202||14202|20505||3 044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|357979|447086|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||357979|447086||1 044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|454745|567435|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||454745|567435||1 044732|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.06.2014||R|0|0|0|0|G|0|BAM|0|0|0|100|SEK|5564|8735|lyfalmen|V0156|8735|1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5564||5564|8735||2 044739|N04BC0502|Sifrol|forðatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|16098|22903|lyfalmen|V0635|20502|1|100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||16098||16098|22903||1 044752|N04BC0502|Sifrol|forðatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|46961|61938|lyfalmen|V0636|39221|1|100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||46961||46961|61938||1 044763|N04BC0502|Sifrol|forðatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|2516|4539|lyfalmen|||1|10|0|2,0800|Vistor hf|Boehringer Ingelheim International|Pramipexól||2516||2516|4539||1 044888|QN05CM9001|Domosedan, vet.|munnh.hl|7,6|mg/ml|3|ml|1|áf.spr|munnsk.dæla|QN05CM90|01.01.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|1960|3852|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|||1960||1960|3852||2 045332|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|600|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 045385|J07BF0301|Imovax Polio|stl|||0,5|ml|10|áf.spr|með nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|6952|10645|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||6952||6952|10645||2 045475|A10BX1201|Jardiance|filmhtfl|25|mg|30|stk|1|þpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|6549|10090|lyfalmen|||1|30|0||Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||6549||6549|10090||1 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|1050|1795|lyfalmen|V0109|1759|2|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||522||522|1795||1 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|868|1665|lyfalmen|V0108|1632|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||428||428|1665||1 045634|N02AA5907|Pinex Comp Forte|eþ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|0|0|0|0|0|0|AGT|0|0|1|100|XEU|390|1613|lyfalmen|||2|10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema með geðlyfjum||390||390|1613||1 045765|C03CA0110|Impugan|dropar|10|mg/ml|30|ml|1|glas||C03CA01|01.06.2013||R|0|0|0|0|G|0|AGT|0|0|0|100|SEK|1978|3799|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Fúrósemíð||1978||1978|3799||1 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|19867|37862|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|||19867||19867|37862||2 046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|30 (6x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1481|3115|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||1481||1481|3115||1 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|801|2037|lyfalmen|V0648|1902|2|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||698||698|2037||1 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|0|0|0|0|G|0|VIS|0|0|1|100|DKK|3694|6161|lyfalmen|V0382|6161|1|10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||3694||3694|6161||2 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|620|1850|lyfalmen|V0021|1755|2|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríð||562||562|1850||1 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|753|2113|lyfalmen|V0022|2104|2|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríð||753||753|2113||1 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|965|2405|lyfalmen|V0023|2387|2|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríð||965||965|2405||1 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|0|0|0|0|G|0|VIS|0|0|1|100|DKK|6152|9544|lyfalmen|||1|20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||6152||6152|9544||2 046724|R01AD0802|Nasofan|nefúði|50|mcg/sk|150|skammtar|1|glas||R01AD08|01.12.2013||R|0|0|0|0|G|0|TSB|0|0|1|100|IKR|1350|2934|lyfalmen|||2|150|0|37,5000|Medical ehf|Teva Sweden AB|Flútíkasón||1350||1350|2934|30.6.2015|2 046745|N04BC0405|Ropinirol Portfarma|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.02.2012||R|0|0|0|0|G|0|POF|0|0|0|100|GBP|5475|4271|lyfalmen|V0530|4271|2|84|0|7,0000|Portfarma ehf|Portfarma|Rópíníról||2321||2321|4271||1 046812|M05BA0603|Ibandronic acid Portfarma|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.02.2012||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|5525|3770|lyfalmen|V0205|3770|2|3|0|90,0000|Portfarma ehf|Portfarma|Íbandrónsýra||1957||1957|3770||1 046823|N05AH0308|Lazapix|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.09.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|3407|3141|lyfalmen|V0279|3141|2|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||1500||1500|3141||1 046845|N06AB0605|Sertraline Portfarma|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.08.2014||R|1|0|0|0|G|0|PEH|0|0|0|100|IKR|2240|2343|lyfalmen|V0322|2343|2|100|0|100,0000|Portfarma ehf|Portfarma ehf|Sertralín||920||920|2343||1 046867|N06AB0605|Sertraline Portfarma|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.08.2014||R|1|0|0|0|G|0|PEH|0|0|0|100|IKR|4495|3623|lyfalmen|V0323|3623|2|100|0|200,0000|Portfarma ehf|Portfarma ehf|Sertralín||1850||1850|3623||1 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|918|2340|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||918||918|2340||2 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|13388|18511|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|18511||5 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|47555|61005|lyfsjukr|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|61005||5 047986|L02BB0305|Bicalutamide Portfarma|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|11866|7847|lyfalmen|V0420|4947|2|30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíð||4919||4919|7847||1 047998|L02BB0305|Bicalutamide Portfarma|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|14248|8111|lyfalmen|V0421|7382|2|30|0|90,0000|Portfarma ehf|Portfarma|Bíkalútamíð||5111||5111|8111||1 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4639|6632|lyfsjukr|||1|250|0||Icepharma hf|Baxter Medical AB|Albúmín||4639||4639|6632||2 048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8209|11737|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||8209||8209|11737||2 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7525|10759|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Albúmín||7525||7525|10759||2 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2542|3464|lyfalmen|V0324|3464|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1735||1735|3464||1 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|2361|4326|lyfalmen|||2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2361||2361|4326||1 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|7327|3676|lyfalmen|V0325|3676|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1889||1889|3676||1 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|7199|5153|lyfalmen|V0326|5153|2|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2962||2962|5153||1 048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|3692|6158|lyfalmen|||2|28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3692||3692|6158||1 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|14395|6210|lyfalmen|V0327|6210|2|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3730||3730|6210||1 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|0|G|0|MAB|0|0|0|100|SEK|1128|2629|lyfalmen|||1|100|0||Vistor hf|Meda AB|Klídín og geðlyf||1128||1128|2629||1 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|11943|17515|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||11943||11943|17515||1 048447|G03AA0901|Marvelon|töflur|||63|stk|1|þpakki|150/30 mcg|G03AA09|01.07.1986||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1686|3397|lyfalmen|||1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1686||1686|3397||1 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|0|0|0|1|G|0|ROC|0|0|0|100|DKK|55088|72217|lyfalmen|V0187|13803|1|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||55088||55088|72217||2 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|1|0|1|GZE|0|1|0|100|NOK|816861|1017806|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||816861||816861|1017806||1 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|453|1700|lyfalmen|V0230|1616|1|100|0|16,6667|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||453||453|1700||1 048770|B05ZB0001|Hemosol BO|blóð.sk|||5000|ml|2|pokar||B05ZB|01.04.2013||R|0|0|0|1|0|1|GBL|0|0|0|100|SEK|4066|5813|lyfsjukr|||1|10000|0||Vistor hf|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||4066||4066|5813||1 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1882|3667|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||1882||1882|3667||1 049033|C08DB0108|Cardil|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.05.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|4234|4541|lyfalmen|V0599|4219|2|60|0|30,0000|Vistor hf|Orion Corporation|Diltíazem||2517||2517|4541||1 049091|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2013||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|5846|9123|lyfalmen|V0376|4933|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||||5846|9123||1 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|15651|22337|lyfalmen|||1|3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||15651||15651|22337||2 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1614|3298|lyfalmen|V0122|3298|1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||1614||1614|3298||1 049549|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|þpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|5546|8710|lyfalmen|V0663|8710|1|7|0|1,7500|Vistor hf|Eisai Europe Ltd.|Perampanel||5546||5546|8710||1 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|0|0|0|0|0|0|GAN|0|0|1|100|CHF|4522|7300|lyfalmen|V0655|4655|1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||4522||4522|7300||2 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1154|1971|lyfalmen|V0109|1759|2|98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||650||650|1971||1 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1827|2418|lyfalmen|V0110|2128|2|100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||975||975|2418||1 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.04.1993||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|7700|4967|lyfalmen|V0123|3902|1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Terbínafín||2827||2827|4967||1 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1016|2116|lyfalmen|V0496|1902|2|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||755||755|2116||1 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|DKK|||lyflausa|||0|30|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1318|2890|lyfalmen|V0649|2866|2|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1318||1318|2890||1 049834|N02BE0113|Pinex Junior|eþ-stíll|125|mg|10|stk|1|þpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||1419||1 049845|N02BE0113|Pinex Junior|eþ-stíll|250|mg|10|stk|1|þpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||1419||1 049856|N02BE0114|Pinex|eþ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1517||1 049894|N02BG1001|Sativex|munnhúði|52|mg|10|ml|3|úðagl|27 mg + 25 mg|N02BG10|01.07.2013||R|0|0|1|1|0|0|GWP|0|0|0|100|DKK|76558|99373|lyfalmen|||1|30|0|37,1400|Vistor hf|GW Pharma Ltd.|Cannabinoids||76558||76558|99373||1 049902|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|176103|220883|lyfsjukr|||1|200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||176103||176103|220883||2 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|þpakki||L04AA06|01.03.1999||R|0|0|0|1|G|0|ROC|0|0|0|100|DKK|57949|75836|lyfalmen|V0470|35805|1|300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||57949||57949|75836||2 049913|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|8806|12590|lyfsjukr|||1|10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||8806||8806|12590||2 049925|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|22013|29238|lyfsjukr|||1|25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||22013||22013|29238||2 049936|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|44026|56616|lyfsjukr|||1|50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||44026||44026|56616||2 049947|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|87889|111169|lyfsjukr|||1|100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||87889||87889|111169||2 050010|G04CB0104|Finasterid LYFIS|filmhtfl|5|mg|98|stk|1|þpakki||G04CB01|01.12.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|3083|3829|lyfalmen|||2|98|0|98,0000|LYFIS ehf|LYFIS ehf|Fínasteríð||2000||2000|3829|30.6.2015|2 050292|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|V0150|2586|0|100|0|20,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2586||1 050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.12.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|3505|5901|lyfalmen|||2|90|0|120,0000|LYFIS ehf|ratiopharm GmbH|Alfúzósín||3505||3505|5901||2 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.12.2006|31.05.2015|R|0|0|0|1|0|1|BAP|0|1|0|100|DKK|536614|669258|lyfsjukr|||1|112|0||Icepharma hf|Bayer Schering Pharma AG|Sorafeníb||536614||536614|669258||2 050346|L04AD0104|Ciqorin|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|25500|29735|lyfalmen|||2|50|0|20,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||21500||21500|29735||2 050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|66004|83950|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||66004|83950||1 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2966|5159|lyfalmen|||1|14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||2966||2966|5159||1 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|12507|18361|lyfalmen|V0688|17180|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||12507||12507|18361||1 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|5175|5032|lyfalmen|V0042|4627|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||2874||2874|5032||1 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|4615|5371|lyfalmen|V0002|5371|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||3120||3120|5371||1 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|4435|3554|lyfalmen|V0006|3554|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1800||1800|3554||1 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|7275|4415|lyfalmen|V0001|3102|2|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2426||2426|4415||1 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|1603|3283|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1603||1603|3283||1 051109|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|50|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|1633|3324|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1633||1633|3324||1 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1285|2274|lyfalmen|V0363|2274|2|30|0|45,0000|Icepharma hf|Mylan AB|Fexófenadín||870||870|2274||2 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3493|4534|lyfalmen|V0365|4534|2|100|0|150,0000|Icepharma hf|Mylan AB|Fexófenadín||2512||2512|4534||2 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|1|UCB|0|0|0|100|DKK|20660|27555|lyfsjukr|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||20660||20660|27555||1 051686|N05AE0402|Zeldox (Lyf og heilsa)|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.06.2011|31.05.2015|R|1|0|0|0|G|0|HOL|0|0|0|100|DKK|25297|25377|lyfalmen|||3|56|0|56,0000|Lyf og heilsa|Lyf og heilsa|Ziprasidon||18054||18054|25377||2 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|1482|1997|lyfalmen|V0056|1992|2|100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||669||669|1997||1 051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2489|2443|lyfalmen|V0057|1992|2|100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||993||993|2443||1 051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|skammtar|1|stauk||R03AC03|01.07.2012||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|832|2221|lyfalmen|||1|100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||832||832|2221||1 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|193|1342|lyfalmen|V0047|1342|2|20|0|5,0000|Icepharma hf|Mylan AB|Alprazólam||193||193|1342||2 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|454|1701|lyfalmen|V0305|993|2|50|0|12,5000|Icepharma hf|Mylan AB|Alprazólam||454||454|1701||2 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|287866|359885|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||287866||287866|359885||1 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|322|1504|lyfalmen|V0439|1504|2|20|0|10,0000|Icepharma hf|Mylan AB|Alprazólam||311||311|1504||2 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|793|2146|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||777||777|2146||2 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|661|1986|lyfalmen|V0305|1986|2|100|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||661||661|1986||2 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|581711|725346|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||581711||581711|725346||1 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|545390|680172|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||545390||545390|680172||1 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|0|G|0|ALL|0|0|0|100|SEK|3399|5755|lyfalmen|||1|3|0|30,0000|Vistor hf|Allergan|Tímólól í blöndum||3399||3399|5755||1 052478|D06BB0305|Zovirax (Lyf og heilsa)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|2|0||Lyf og heilsa|Lyf og heilsa|Acíklóvír||||||30.6.2015|2 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|33250|43214|lyfsjukr|||1|8212|0||Icepharma hf|Fresenius Kabi|Blöndur||33250||33250|43214||2 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|27032|35480|lyfsjukr|||1|7698|0||Icepharma hf|Fresenius Kabi|Blöndur||27032||27032|35480||2 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|27490|36050|lyfsjukr|||1|7680|0||Icepharma hf|Fresenius Kabi|Blöndur||27490||27490|36050||2 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|24104|31839|lyfsjukr|||1|7200|0||Icepharma hf|Fresenius Kabi|Blöndur||24104||24104|31839||2 052737|N05AX1205|Aripiprazol Krka|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|20582|28574|lyfalmen|V0682|28574|2|56|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||20582||20582|28574||2 052838|A10BX0701|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BX07|01.01.2012||R|0|0|0|0|0|0|NAS|0|0|0|100|DKK|14103|20379|lyfalmen|||1|6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglútíð||14103||14103|20379||1 052997|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|30|stk|1|þpakki||N05CF02|01.03.2014||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|438|1525|lyfalmen|V0060|1518|2|30|0|30,0000|Icepharma hf|Mylan AB|Zolpidem||326||326|1525||2 053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|þpakki||N05CF02|01.11.2006||R|2|0|0|0|0|0|MYL|0|0|0|100|SEK|2146|3689|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Zolpidem||1898||1898|3689||2 053025|G03HB0102|Diane mite|töflur|||63|stk|1|þpakki||G03HB01|01.07.1989|30.06.2015|R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|2046|3892|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2046||2046|3892||2 053055|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|þpakki||C01BA03|01.05.1983||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|4614|7427|lyfalmen|||1|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||4614||4614|7427||1 053155|N02AA5501|Targin|forðatfl|60|mg|28|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|11416|16789|lyfalmen|||1|28|0|14,9400|Icepharma hf|Norpharma|Oxycodonum í blöndum||11416||11416|16789||2 053166|N02AA5501|Targin|forðatfl|60|mg|98|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|34001|45546|lyfalmen|||1|98|0|52,2700|Icepharma hf|Norpharma|Oxycodonum í blöndum||34001||34001|45546||2 053200|N02AA5501|Targin|forðatfl|7,5|mg|98|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|5692|8911|lyfalmen|||1|98|0|6,5400|Icepharma hf|Norpharma|Oxycodonum í blöndum||5692||5692|8911||2 053211|N02AA5501|Targin|forðatfl|7,5|mg|28|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|1669|3367|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxycodonum í blöndum||1664||1664|3367||2 053231|J07BB0201|Fluarix|stl|||0,5|ml|10|áf.spr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|6673|10261|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||6673||6673|10261||1 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|G|0|SDE|0|0|0|100|NOK|29656|40051|lyfalmen|V0453|38300|1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíð||29656||29656|40051||1 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|17050|24107|lyfalmen|||2|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||17050||17050|24107||2 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|1460|3086|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1460||1460|3086||1 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburður, lausn|D10AF01|01.07.1985||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1088|2574|lyfalmen|||1|30|0||Icepharma hf|Pfizer ApS|Klindamýcín||1088||1088|2574||1 054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|þpakki||R03DC03|01.11.2011||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|7379|2508|lyfalmen|V0490|2341|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||1040||1040|2508||1 054213|J07AG0101|Act-Hib|sts|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3710|6183|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Haemophilus influenzae B||3710||3710|6183||2 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|4|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|2256|4181|lyfalmen|||1|15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2256||2256|4181||1 054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|3094|5335|lyfalmen|||1|20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||3094||3094|5335||1 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|40046|51666|lyfsjukr|||1|56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||40046||40046|51666||2 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 054524|N05BB0101|Atarax|filmhtfl|25|mg|100|stk|1|þpakki||N05BB01|01.06.2014||R|1|0|0|0|0|0|UCN|0|0|1|100|DKK|1418|3028|lyfalmen|||1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1418||1418|3028||1 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|0|UCN|0|0|0|100|SEK|986|2433|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||986||986|2433||1 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1606|3287|lyfalmen|V0061|3287|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1606||1606|3287||1 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|1|0|0|0|SOG|1|0|0|100|DKK|4527|8759|vetalmen|||0|10|0||Icepharma hf|Sogeval UK Limited|Buprenorphinhýdróklóríð||||4527|8759||2 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|7331|12636|vetorma|||0|20|0||Icepharma hf|Zoetis Finland OY|Medroxyprogesteronum||7331||7331|12636||2 054974|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.01.2013||R|0|0|0|0|G|0|ZEN|0|0|0|100|SEK|5235|8282|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||5235||5235|8282||1 055073|L04AA0606|Myfenax|hylki|250|mg|100|stk|1|þpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TEV|0|0|0|100|XEU|7889|11935|lyfalmen|V0470|11935|2|100|0|12,5000|Medical ehf|Teva Pharma B.V.|Mýcófenólsýra||7889||7889|11935||2 055084|L04AA0606|Myfenax|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TEV|0|0|0|100|XEU|6812|4601|lyfalmen|V0187|4601|2|50|0|12,5000|Medical ehf|Teva Pharma B.V.|Mýcófenólsýra||2561||2561|4601||2 055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|0|CLA|0|0|1|100|USD|1915|3712|lyfalmen|||1|5|0||Vistor hf|Alcon Nordic A/S|Moxífloxacín||||1915|3712||1 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|704|2045|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||704||704|2045||1 055257|G03AA0903|Benidette|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.04.2013||R|0|0|0|0|0|0|AAB|0|0|0|100|XEU|1266|2566|lyfalmen|V0065|1915|2|63|0|84,0000|Actavis Group PTC ehf|Actavis BV|Desógestrel og ethinylestradíól||1082||1082|2566||1 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|8782|13164|lyfalmen|||1|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||8782||8782|13164||1 055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|1765|2453|lyfalmen|V0467|2453|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1000||1000|2453||1 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2834|3058|lyfalmen|V0112|2728|2|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1440||1440|3058||1 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4425|3726|lyfalmen|V0113|3485|2|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||1925||1925|3726||1 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|5897|3726|lyfalmen|V0114|3485|2|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||1925||1925|3726||1 056308|N07XX0701|Fampyra|forðatfl|10|mg|28|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|30600|41245|lyfalmen|||1|28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||30600||30600|41245||2 056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|0|CES|1|0|0|100|XEU|25742|44369|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||25742||25742|44369||2 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1145|2652|lyfalmen|||1|40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1145||1145|2652||1 056664|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|AGP|0|0|0|100|XEU|3549|3514|lyfalmen|||2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1771||1771|3514||1 056675|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|AGP|0|0|0|100|XEU|3549|3514|lyfalmen|||2|100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1771||1771|3514||1 056763|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|2663|4742|lyfalmen|||1|15|0||Vistor hf|Meda AB|Pímekrólímus||2663||2663|4742||1 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|1|0|1|BIB|0|1|0|100|XEU|205241|257122|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Biogen Idec Ltd|Natalizumab||205241||205241|257122||2 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8966|13417|lyfalmen|V0095|4873|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||8966||8966|13417||1 057304|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN05|01.08.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|4|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|7191|10281|lyfsjukr|||1|5|0|1,4300|Vistor hf|Novartis Healthcare A/S|Oktreótíð||7191||7191|10281||1 057335|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3594|5138|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||3594||3594|5138||2 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|3595|5140|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S|Oktreótíð||3595||3595|5140||1 057401|N06DA0404|Galantamine Portfarma|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|21014|29121|lyfalmen|||2|84|0|84,0000|Portfarma ehf|Portfarma|Galantamín||21014||21014|29121||1 057422|B05XA3102|Tracel|irþ|||10|ml|20|plastl||B05XA31|01.01.1987||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4658|6660|lyfsjukr|||1|200|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||4658||4658|6660||2 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|2532|3620|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||2532||2532|3620||1 057492|L01XC1001|Arzerra|irþ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|NEL|0|0|0|100|GBP|329528|411701|lyfsjukr|||1|50|0||Vistor hf|Novartis Europharm Ltd|Ofatúmúmabi||329528||329528|411701||1 057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|0|0|0|1|0|1|JAS|0|1|0|100|SEK|435625|543656|lyfsjukr|||1|120|0|30,0000|Vistor hf|Janssen-Cilag AB|Abírateron||435625||435625|543656||1 057867|N06DX0107|Zalatine|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|22193|12966|lyfalmen|V0607|12592|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||8638||8638|12966||2 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|1|0|0|0|0|0|IPI|0|0|1|100|DKK|19212|26841|lyfalmen|||1|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||19212|26841||1 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|406|1635|lyfalmen|||1|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||406||406|1635||1 058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|1|0|0|1|0|1|NEL|0|1|0|100|GBP|140670|176814|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||140670||140670|176814||1 058283|QI01AD0401|Avipro Thymovac|frþlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|154655|266563|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|||||154655|266563||2 058294|QI01AD0401|Avipro Thymovac|frþlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|234936|404936|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|||||234936|404936||2 058300|N02AA0506|Oxikodon Depot Actavis|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|9545|14214|lyfalmen|V0587|14211|2|98|0|52,2700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||9545||9545|14214||1 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|926|2351|lyfalmen|||1|100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||926||926|2351||1 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|90644|114596|lyfsjukr|||1|210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||90644||90644|114596||1 058609|N05AX1302|Xeplion|stl|50|mg|1|stk|1|áf.spr|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|37602|50101|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||37602||37602|50101||1 058622|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5282|7552|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||5282||5282|7552||2 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1042|2511|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1042||1042|2511||1 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1770|3513|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1770||1770|3513||1 059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.05.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|2374|2848|lyfalmen|V0006|1990|2|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1287||1287|2848||1 059224|A04AA0501|Aloxi|stl|250|mcg|5|ml|1|hgl|lausn|A04AA05|01.04.2013||R|0|0|0|0|0|0|HBP|0|0|1|100|DKK|10519|15555|lyfalmen|||1|5|0|1,0000|Swedish Orphan Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||10519||10519|15555||3 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|89805|116127|lyfalmen|||1|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||89805||89805|116127||1 059659|J07CA0601|Infanrix-Polio + Hib|sts|||0,5|ml|10|spr||J07CA06|01.01.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|36040|48125|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||36040||36040|48125||1 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|þpakki||N03AF04|01.03.2010||R|1|0|0|0|G|0|BPC|0|0|0|100|SEK|36723|42931|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||31933||31933|42931||1 059795|C10AA0506|Atorvaratio|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|5500|3485|lyfalmen|V0114|3485|2|100|0|200,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1750||1750|3485||2 059803|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.04.2013||R|1|0|0|0|G|0|BAP|0|0|0|100|DKK|5214|8253|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||5214|8253||2 059882|L04AD0203|Modigraf|mixt.kyr|0,2|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|8528|12814|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||8528||8528|12814||1 059938|L04AD0203|Modigraf|mixt.kyr|1|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|42640|56473|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||42640||42640|56473||1 060114|N02AB0305|Fentanyl ratiopharm|forðapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|2588|3369|lyfalmen|V0219|3369|2|5|0|7,5000|Medical ehf|ratiopharm GmbH|Fentanýl||1666||1666|3369||2 060123|N02AB0305|Fentanyl ratiopharm|forðapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|4110|5680|lyfalmen|V0220|5680|2|5|0|15,0000|Medical ehf|ratiopharm GmbH|Fentanýl||3345||3345|5680||2 060132|N02AB0305|Fentanyl ratiopharm|forðapl|75|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|5328|7302|lyfalmen|V0221|7302|2|5|0|22,5000|Medical ehf|ratiopharm GmbH|Fentanýl||4523||4523|7302||2 060141|N02AB0305|Fentanyl ratiopharm|forðapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|6213|7928|lyfalmen|V0223|7928|2|5|0|30,0000|Medical ehf|ratiopharm GmbH|Fentanýl||4978||4978|7928||2 060337|QC01CE9001|Vetmedin vet.|tuggutfl|10|mg|50|stk|1|glas|fyrir hunda|QC01CE90|01.07.2015||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|7288|13997|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||7288||7288|13997||1 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|324036|412383|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||324036||324036|412383||1 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|179443|229502|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||179443||179443|229502||1 061112|L04AA3101|AUBAGIO|filmhtfl|14|mg|28|stk|1|þpakki||L04AA31|01.09.2014||R|1|1|0|1|0|1|SGA|0|1|0|100|NOK|144250|181267|lyfsjukr|||1|28|0|28,0000|Vistor hf|Sanofi-aventis groupe|Teriflúnomíð||||144250|181267||1 061227|L01XE0103|Mylaukim|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|100861|127303|lyfsjukr|||2|60|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||100861||100861|127303||2 061414|QA04AD9001|Cerenia|töflur|60|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2617|5135|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||2617|5135||2 061442|QA04AD9001|Cerenia|töflur|24|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1371|2695|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||1371|2695||2 061451|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|8098|15534|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|||||8098|15534||2 061460|G03CX0102|Livial (Lyf og heilsa)|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.04.2010||R|0|0|0|0|G|0|HOL|0|0|0|100|DKK|6651|9079|lyfalmen|V0133|7814|3|84|0|84,0000|Lyf og heilsa|Lyf og heilsa|Tíbólón||5814||5814|9079||2 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|0|0|0|0|G|0|ORG|0|0|0|100|DKK|5814|9079|lyfalmen|V0133|7814|1|84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||5814||5814|9079||1 061580|QP52AF0201|Banminth, vet.|pasta|439|mg/g|26|g|1|spr||QP52AF02|01.04.1992||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1621|2794|vetorma|||0|26|0||Icepharma hf|Zoetis Finland OY|||1621||1621|2794||2 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|3946|5642|lyfsjukr|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||3946||3946|5642||1 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|15094|20633|lyfsjukr|||1|1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||15094||15094|20633||1 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|21006|27986|lyfsjukr|||1|1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||21006||21006|27986||1 062117|N05BA1204|Tafil Retard|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|437|1678|lyfalmen|V0307|1544|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||437||437|1678||1 062202|N06DX0102|Memantine Merz|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|6376|4099|lyfalmen|V0604|3016|2|30|0|15,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||2196||2196|4099||1 062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|þpakki||L04AA06|01.08.2010||R|0|0|0|1|G|0|AGP|0|0|0|100|XEU|15368|14294|lyfalmen|V0187|13803|2|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||9603||9603|14294||1 062387|N04BC0502|Sifrol|forðatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|1570|3237|lyfalmen|V0634|1689|1|10|0|1,0400|Vistor hf|Boehringer Ingelheim International|Pramipexól||1570||1570|3237||1 062614|QG03XA9101|Improvac|stl|300|mcg|100|ml|10|glös||QG03XA91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|54303|93597|vetorma|||0|1000|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||54303||54303|93597||2 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|882|2290|lyfalmen|V0308|2021|1|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||882||882|2290||1 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|1|0|0|0|G|0|AGT|0|0|1|100|XEU|1913|3709|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||1913||1913|3709||1 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|17141|29544|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||17141||17141|29544||2 062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|14651|17904|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||12146||12146|17904||1 062996|J07BM0201|Cervarix|stl|||0,5|ml|10|áf.spr|dreifa|J07BM02|01.03.2014||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|146513|187852|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||146513||146513|187852||1 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|4008|6593|lyfalmen|||1|10|0|1,6667|Vistor hf|Novartis Healthcare A/S|Famcíclóvír||4008||4008|6593||1 063180|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.05.2015||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|1745|3478|lyfalmen|V0276|3347|2|100|0|8,3300|Actavis Group hf|Actavis Group hf|Klózapín||1745||1745|3478||1 063255|N05AH0205|Clozapine Actavis|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.07.2014||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|6888|10557|lyfalmen|V0277|8825|2|100|0|33,3333|Actavis Group hf|Actavis Group hf|Klózapín||6888||6888|10557||1 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||2962||1 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.11.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|2073|3930|lyfalmen|V0123|3902|2|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||2073||2073|3930||1 063715|R06AX2702|Aerius (Lyf og heilsa)|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.07.2011||R|1|0|0|0|G|0|HOL|0|0|1|100|XEU|3963|6407|lyfalmen|V0458|3569|3|100|0|100,0000|Lyf og heilsa|Lyf og heilsa|Deslóratadín||3873||3873|6407||2 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|7407|10590|lyfsjukr|||1|2|0||Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||7407||7407|10590||1 063923|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|0|0|0|0|0|0|ZFO|0|0|0|100|XEU|2416|4164|vetorma|||0|11,8|0||Vistor hf|Zoetis Finland Oy|||2416||2416|4164||2 063926|L04AC0701|RoActemra|stl|162|mg|4|áf.spr|1|pakki||L04AC07|01.12.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|139734|175650|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||139734||139734|175650||2 063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|926|2351|lyfalmen|V0309|1954|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||926||926|2351||1 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1940|3747|lyfalmen|V0310|2918|1|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||1940||1940|3747||1 064023|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.07.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|82629|104627|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||82629|104627||3 064034|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.07.2014||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|126411|159080|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||||126411|159080||3 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|893559|1113197|lyfsjukr|||1|20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||893559|1113197||2 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|413670|516350|lyfsjukr|||1|20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||413670|516350||2 064170|N05BA1204|Tafil Retard|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2037|3880|lyfalmen|V0311|2918|1|30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2037||2037|3880||1 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|4136701|5146758|lyfsjukr|||1|20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4136701|5146758||2 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|1624652|2022472|lyfsjukr|||1|20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1624652|2022472||2 064270|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2138|3676|lyfalmen|V0009|3472|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||1889||1889|3676||2 064281|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|100|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|6621|6662|lyfalmen|V0029|6662|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||4058||4058|6662||2 064402|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.06.2013||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1126|2213|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1126||1126|2213||1 064732|A03BB0101|Buscopan|húðuðtfl|10|mg|100|stk|1|þpakki||A03BB01|01.03.2012||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|2000|3829|lyfalmen|||1|100|0|16,6700|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2000||2000|3829||1 064733|J07BB0203|Vaxigrip|stl|||0,5|ml|1|áfspr||J07BB02|01.10.1985||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|957|2104|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||747||747|2104||2 064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|1|0|1|OCT|0|0|0|100|DKK|46912|60205|lyfsjukr|||1|1|0|1,4300|Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||46912||46912|60205||1 064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|0|G|0|TAS|0|0|1|100|DKK|791|2165|lyfalmen|||2|50|0|6,6700|Vistor hf|Takeda Nycomed AS|Metóklópramíð||791||791|2165||1 064939|G04BD0804|Solifenacin Actavis|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.03.2015||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|17216|21458|lyfalmen|V0441|21457|2|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Sólífenacín||14956||14956|21458||1 064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|0|G|0|TAS|0|0|1|100|DKK|455|1703|lyfalmen|||2|20|0|3,3300|Vistor hf|Takeda Nycomed AS|Metóklópramíð||455||455|1703||1 065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|0|0|0|0|0|0|SLL|0|0|0|100|DKK|1846|3617|lyfalmen|||1|25|0||Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||1846||1846|3617|30.6.2015|1 065076|QM01AE0302|Ketodine vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.01.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|5593|10782|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5593||5593|10782||2 065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|11491|16152|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||11491||11491|16152||2 065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|0|1|G|0|LVR|0|0|0|100|SEK|52836|65253|lyfalmen|V0451|65253|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||49582||49582|65253||3 065729|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065740|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065751|J01CR0204|Amoxin comp|mixtduft|80|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|954|1968|lyfalmen|V0163|1968|2|70|0|5,6000|Medical ehf|ratiopharm GmbH|Amoxicillín og ensímblokkar||648||648|1968||2 065752|N07BA0142|Nicorette Invisi|forðapl|10|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065775|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065786|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|3630|5190|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||3630||3630|5190||2 065934|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|28|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|571|1862|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||571||571|1862||1 065945|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|1724|3449|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||1724||1724|3449||1 065956|C08CA1301|Lerkanidipin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|3204|5486|lyfalmen|||2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||3204||3204|5486||1 066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|0|DOR|1|0|0|100|DKK|4276|8283|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|||4276||4276|8283||2 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5948|9263|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíð||5948||5948|9263||1 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|29539|38598|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||29539||29539|38598||2 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|0|GOG|0|0|1|100|DKK|896|2310|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||896||896|2310||2 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 066593|A02BC0111|Omeprazol Pensa|sþ-hylki|20|mg|100|stk|1|glas|2x50 stk|A02BC01|01.12.2012||R|1|0|0|0|G|0|PEN|0|0|0|100|IKR|2100|3829|lyfalmen|V0006|3554|2|100|0|100,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól||2000||2000|3829||3 066751|C01BD0103|Cordarone (Lyf og heilsa)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|1|0|0|0|G|0|HOL|0|0|0|100|NOK|1000|2453|lyfalmen|V0036|2453|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amíódarón||1000||1000|2453||2 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 066897|L01CD0104|Paclitaxel Actavis|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|3718|5316|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||3718||3718|5316||1 067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8220|11752|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||8220||8220|11752||2 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|14199|12776|lyfalmen|V0419|12776|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||8500||8500|12776||1 068358|L01XC1001|Arzerra|irþ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|NEL|0|0|0|100|GBP|113687|143255|lyfsjukr|||1|15|0||Vistor hf|Novartis Europharm Ltd|Ofatúmúmabi||113687||113687|143255||1 068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|þpakki||B02BX05|01.04.2011||R|1|1|0|1|0|1|NEL|0|1|0|100|GBP|80865|102433|lyfsjukr|||1|14|0|7,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||80865||80865|102433||1 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|1484|3119|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníð||1484||1484|3119||1 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|5066|8049|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníð||5066||5066|8049||1 068698|N06DA0206|Donepezil Medical|filmhtfl|10|mg|98|stk|1|þpakki||N06DA02|01.04.2012|30.06.2015|R|1|0|0|0|G|0|MED|0|0|0|100|XEU|17485|10115|lyfalmen|||2|98|0|130,6700|Medical ehf|Medical ehf|Dónepezíl||6567||6567|10115||2 068776|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||||||31.5.2015|2 068811|L01BA0109|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3264|5569|lyfalmen|||1|0,55|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3264||3264|5569||2 068896|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|2396|3426|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Natríumklóríð||2396||2396|3426||1 068905|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|2239|3201|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Kalíumklóríð||2239||2239|3201||1 068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3200||1 068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3383||1 068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3155||1 068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3334||1 069106|H01BA0201|Minirin|frþ.tfl|240|mcg|30|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|13468|19576|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||13468||13468|19576||1 069115|H01BA0201|Minirin|frþ.tfl|240|mcg|100|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|42509|56307|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||42509||42509|56307||1 069347|C02KX0501|Adempas|filmhtfl|1|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|383446|478759|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Riociguatum||383446||383446|478759||2 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 070113|B01AC0601|Hjartamagnyl|sþ-tfl|75|mg|500|stk|1|glas||B01AC06|01.10.2012||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|Actavis Group hf|Actavis Group hf|Asetýlsalicýlsýra|||||||1 070142|G04BD0704|Tolterodin Actavis|forðahlk|4|mg|100|stk|1|þpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|5228|8272|lyfalmen|V0589|8272|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||5228||5228|8272||1 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|11278|16599|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||11278||11278|16599||1 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|59162|75441|lyfsjukr|||1|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíð||59162||59162|75441||1 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|299208|373991|lyfsjukr|||1|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíð||299208||299208|373991||1 071458|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 071468|N03AX1108|Topiramat Bluefish|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1964|1754|lyfalmen|V0247|1754|2|60|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||492||492|1754||2 071479|N03AX1108|Topiramat Bluefish|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.08.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|3029|3378|lyfalmen|V0248|3378|2|60|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1672||1672|3378||2 071490|N03AX1108|Topiramat Bluefish|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|5943|3785|lyfalmen|V0249|3785|2|60|0|20,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1968||1968|3785||2 071501|N03AX1108|Topiramat Bluefish|filmhtfl|200|mg|60|stk|1|þpakki||N03AX11|01.12.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|12803|17778|lyfalmen|V0252|17778|2|60|0|40,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||12046||12046|17778||2 071591|N05AH0405|Seroquel Prolong|forðatfl|150|mg|30|stk|1|þpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|7779|11783|lyfalmen|||1|30|0|11,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||7779|11783||1 071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|10357|4936|lyfalmen|V0144|4912|3|12|0|24,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||2804||2804|4936||2 071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.09.2011||R|0|0|0|1|0|1|GZE|0|0|0|100|NOK|78257|99190|lyfsjukr|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||78257||78257|99190||1 071998|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.06.2015||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|634|1949|lyfalmen|V0697|1941|1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||634||634|1949||2 072021|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.06.2015||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|483|1741|lyfalmen|V0696|1741|1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||483||483|1741||2 072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|þpakki||B01AC04|01.01.2010||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|1992|3720|lyfalmen|V0009|3720|2|30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||1921||1921|3720||1 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|0|ORF|1|0|0|100|DKK|6681|12846|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|||6681||6681|12846||1 072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|þpakki||N07BA01|01.02.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.12.2009||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|6621|6662|lyfalmen|V0029|6662|2|100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||4058||4058|6662||1 072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|180305|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|180305||5 072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|180305|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|180305||5 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|561|802|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||561||561|802||1 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|0|0|0|0|0|0|BRI|0|0|0|100|SEK|15299|21892|lyfalmen|||1|1,2|0|20,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Exenatíð||15299||15299|21892||1 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|0|0|0|0|0|0|BRI|0|0|0|100|SEK|15299|21892|lyfalmen|||1|2,4|0|40,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Exenatíð||15299||15299|21892||1 073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|59130|75401|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||59130||59130|75401||1 073030|N05AH0410|Quetiapin Actavis|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|8449|7997|lyfalmen|V0286|7958|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||5028||5028|7997||1 073276|C02KX0401|Opsumit|filmhtfl|10|mg|30|stk|1|þpakki||C02KX04|01.09.2014||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|368488|460156|lyfsjukr|||1|30|0|30,0000|Vistor hf|Actelion Registration Ltd.|Macitentan||||368488|460156||1 073313|L01XE1601|Xalkori|hylki|200|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|IPI|0|0|0|100|SEK|640962|799037|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||640962||640962|799037||2 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|3976|6549|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríð og tamsúlósínhýdroklóríð||3976||3976|6549||1 073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.09.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|17722|13940|lyfalmen|V0185|13940|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||9346||9346|13940||1 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|290|1475|lyfalmen|V0047|1342|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||290||290|1475||1 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|911|2330|lyfalmen|V0305|1986|1|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||911||911|2330||1 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|491|1752|lyfalmen|V0439|1504|1|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||491||491|1752||1 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1333|2911|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1333||1333|2911||1 073933|C09AA0211|Enalapril Krka|töflur|2,5|mg|100|stk|1|þpakki||C09AA02|01.04.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|926|2351|lyfalmen|||2|100|0|25,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||926||926|2351||2 073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|3545|6110|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||3545||3545|6110||2 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.12.2010||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|1115|2611|lyfalmen|||1|50|0|8,3333|Artasan ehf|Aspen Pharma Trading Limited|Azatíóprín||1115||1115|2611||1 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|0|NEL|0|0|0|100|DKK|3029|5245|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3029||3029|5245||1 074083|B03BB0106|Folic Acid (Lyf og heilsa)|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.03.2011||R|1|0|0|0|G|0|HOL|0|0|1|100|GBP|442|1685|lyfalmen|V0391|1685|3|28|0|350,0000|Lyf og heilsa|Lyf og heilsa|Fólínsýra||442||442|1685||2 074348|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|þpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|22185|30602|lyfalmen|V0666|30602|1|28|0|28,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||22185||22185|30602||1 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|675|2005|lyfalmen|||2|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||675||675|2005||1 074477|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.10.2013||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Medical ehf|ratiopharm GmbH|Paracetamól|||||||2 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|630|1943|lyfalmen|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||630||630|1943||1 074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|983|2429|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||983||983|2429||1 074617|QI06AA0402|Fel-O-Vax PCT vet.|stl|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|21414|36909|vetorma|||0|25|0||Icepharma hf|Pfizer Oy Animal Health|||21414||21414|36909||2 074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|þpakki||N06AA09|01.03.2011||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|448|1693|lyfalmen|||2|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||448||448|1693||1 074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|þpakki||N06AA09|01.02.2011||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|775|2143|lyfalmen|||2|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||775||775|2143||1 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|1044|2513|lyfalmen|||1|60|0|12,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||1044||1044|2513||1 074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|557|1843|lyfalmen|||1|100|0|100,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||557||557|1843||1 075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.08.2011||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|2575|4621|lyfalmen|||1|100|0|33,3333|Artasan ehf|Aspen Pharma Trading Limited|Azatíóprín||2575||2575|4621||1 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|4649|7475|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4649||4649|7475||1 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|13945|20180|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||13945||13945|20180||1 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|4649|7475|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4649||4649|7475||1 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1564|2578|lyfalmen|V0363|2274|1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1091||1091|2578||1 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|13945|20180|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||13945||13945|20180||1 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|2|0|1|0|0|0|AGP|0|0|1|100|IKR|3144|5404|lyfalmen|||2|300|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||3144||3144|5404||1 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|2|0|1|0|0|0|AGP|0|0|1|100|IKR|4555|7346|lyfalmen|||2|300|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||4555||4555|7346||1 075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||R|0|0|0|0|0|0|NBV|0|0|0|100|DKK|2352|4314|lyfalmen|||1|4|0||Norgine BV|Norgine BV|Hægðalyf með osmótíska verkun||||2352|4314||1 075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|þpakki||G04CB01|01.05.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3907|4725|lyfalmen|V0445|4725|2|98|0|98,0000|Portfarma ehf|Portfarma|Fínasteríð||2651||2651|4725||1 075470|L01CD0201|Taxotere|irþ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|25931|34111|lyfsjukr|||1|1|0||Vistor hf|Aventis Pharma SA|Docetaxel||25931||25931|34111||1 075482|L01CD0201|Taxotere|irþ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|70696|89786|lyfsjukr|||1|4|0||Vistor hf|Aventis Pharma SA|Docetaxel||70696||70696|89786||1 075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.03.2011||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|1003|1971|vetalmen|||0|20|0||Vistor hf|Dechra Veterinary Products A/S|Medroxyprogesteronum||1003||1003|1971||1 075865|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|PEH|0|0|0|100|XEU|12169|17933|lyfalmen|V0440|17933|2|90|0|90,0000|Portfarma ehf|Portfarma ehf|Sólífenacín||12169||12169|17933||1 075869|B05DB0005|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5299|7576|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5299||5299|7576||2 075888|B05DB0005|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5299|7576|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5299||5299|7576||2 075906|B05DB0005|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5770|8249|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5770||5770|8249||2 075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|þpakki||P01BC01|01.07.2010||R|1|0|0|0|0|0|AUK|0|0|0|100|GBP|556|1842|lyfalmen|||2|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||556||556|1842||1 075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|þpakki|80+400 mg|J01EE01|01.12.2009||R|0|0|0|0|0|0|AEA|0|0|1|100|XEU|605|1909|lyfalmen|||2|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||605||605|1909||1 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|þpakki||A10BH01|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|6087|9454|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||6087||6087|9454||1 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|18649|26129|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||||18649|26129||1 076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|þpakki||A10BH01|01.02.2013||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|18744|26249|lyfalmen|||1|98|0|24,5000|Vistor hf|M.S.D.|Sítagliptín||18744||18744|26249||1 076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.10.2012||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|18744|26249|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Sítagliptín||18744||18744|26249||1 076237|G04BE0309|Vizarsin|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1605|2147|lyfalmen|V0143|1467|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||778||778|2147||2 076248|G04BE0309|Vizarsin|filmhtfl|50|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2971|3182|lyfalmen|V0143|2935|2|8|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1530||1530|3182||2 076259|G04BE0309|Vizarsin|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3742|4402|lyfalmen|V0143|4402|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||2416||2416|4402||2 076270|G04BE0309|Vizarsin|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1667|2348|lyfalmen|V0144|1637|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||924||924|2348||2 076282|G04BE0309|Vizarsin|filmhtfl|100|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3208|3513|lyfalmen|V0144|3275|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1770||1770|3513||2 076293|G04BE0309|Vizarsin|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|7023|4912|lyfalmen|V0144|4912|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||2787||2787|4912||2 076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|445|1689|lyfalmen|V0045|1689|2|20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||445||445|1689||1 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1691|2384|lyfalmen|V0290|2384|2|60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||950||950|2384||1 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1946|2315|lyfalmen|V0291|2315|2|60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||900||900|2315||1 076403|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.06.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1582|3254|lyfalmen|||1|5|0||Vistor hf|Laboratories THEA|Ketotifen||1582||1582|3254||1 076628|N05AX0806|Risperidon Krka|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.08.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2453|lyfalmen|V0290|2384|2|60|0|6,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1000||1000|2453||2 076667|B02BD0207|ReFacto AF|sts|3000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|256660|321073|lyfsjukr|||1|1|0|6,0000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||256660||256660|321073||1 076680|B02BD0207|ReFacto AF|sts|2000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|171107|214669|lyfsjukr|||1|1|0|4,0000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||171107||171107|214669||1 076691|B02BD0207|ReFacto AF|sts|1000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|85685|108428|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||85685||85685|108428||1 076702|B02BD0207|ReFacto AF|sts|500|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|43095|55458|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||43095||43095|55458||1 076871|G01AF0202|Canesten (Lyf og heilsa)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 076876|M01AE0219|Alpoxen|töflur|500|mg|25|stk|1|þpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|452|1698|lyfalmen|||2|25|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||452||452|1698||1 077324|B02BD0102|Cofact|sts|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.02.2015||R|0|0|0|1|0|1|QUI|0|0|0|100|XEU|50802|65043|lyfsjukr|||1|1|0|1,4300|Williams & Halls efh|Sanquin|Storkuþættir lX,ll,Vll,X||50802||50802|65043||2 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|367|1581|lyfalmen|||2|30|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||367||367|1581||1 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|1042|2511|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||1042||1042|2511||1 077606|N06BA0405|Medikinet|töflur|5|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|872|2277|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||872||872|2277||2 077615|N06BA0405|Medikinet|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|1025|2384|lyfalmen|V0671|2384|2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||950||950|2384||2 077624|N06BA0405|Medikinet|töflur|20|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|1700|3416|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||1700||1700|3416||2 077633|N06BA0406|Medikinet CR|hylki|10|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|3300|5618|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||3300||3300|5618||2 077642|N06BA0406|Medikinet CR|hylki|20|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|5000|7958|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||5000||5000|7958||2 077652|N06BA0406|Medikinet CR|hylki|30|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|6300|9748|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||6300||6300|9748||2 077661|N06BA0406|Medikinet CR|hylki|40|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|8120|12253|lyfalmen|||2|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||8120||8120|12253||2 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|863|2264|lyfalmen|||1|10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||863||863|2264||1 078193|D01AC0102|Canesten (Lyf og heilsa)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|20|0||Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.12.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|11524|12776|lyfalmen|V0419|11924|2|28|0|28,0000|Portfarma ehf|Portfarma|Flúkónazól||8500||8500|12776||1 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|478|1734|lyfalmen|||1|20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||478||478|1734||1 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|728|2078|lyfalmen|||1|40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||728||728|2078||1 078688|N01BB0204|Lidokain FarmaPlus|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|1326|2901|lyfalmen|V0560|2901|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1326||1326|2901||2 078699|N01BB0204|Lidokain FarmaPlus|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|1896|3686|lyfalmen|V0561|3686|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1896||1896|3686||2 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|8448|5957|lyfalmen|V0069|2943|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3546||3546|5957||1 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|þpakki||J05AH02|01.11.2002||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|3411|5771|lyfalmen|||1|10|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3411||3411|5771||2 079269|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|17489|24662|lyfalmen|V0639|24662|1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||17489||17489|24662||1 079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|þpakki||N06AB03|01.05.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3628|6070|lyfalmen|V0315|6070|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3628||3628|6070||1 079597|L02BG0305|Anastrozole Teva|filmhtfl|1|mg|100|stk|1|þpakki||L02BG03|01.05.2014||R|0|0|0|0|G|0|TSB|0|0|0|100|IKR|9500|6031|lyfalmen|V0184|5397|2|100|0|100,0000|Medical ehf|Teva Sweden AB|Anastrózól||3600||3600|6031||2 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|1964|2808|lyfsjukr|||1|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||1964||1964|2808||1 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|393|1617|lyfalmen|V0176|1617|2|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1617||1 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|638|1954|lyfalmen|V0418|1954|2|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1954||1 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|647|1967|lyfalmen|V0177|1967|2|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1967||1 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1168|2684|lyfalmen|V0411|2684|2|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2684||1 080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9628|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9628||2 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|3807|7393|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||3807|7393||2 080256|A10BB0903|Gliclazide LYFIS|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.10.2014||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|4000|5756|lyfalmen|V0020|3841|2|90|0|45,0000|LYFIS ehf|LYFIS ehf|Glíklazíð||3400||3400|5756||2 080331|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|14248|10411|lyfalmen|V0421|7382|2|30|0|90,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíð||6782||6782|10411||2 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|þpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|10319|17786|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||10319||10319|17786||2 080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|9192|6491|lyfalmen|||2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||3934||3934|6491||2 080482|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|17722|13940|lyfalmen|V0185|13940|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||9346||9346|13940||2 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|2130|4008|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2130||2130|4008||1 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|6478|9993|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||6478||6478|9993||1 080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1585|2210|lyfalmen|V0143|1467|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||824||824|2210||1 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|3364|5707|lyfalmen|||1|30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||3364||3364|5707||1 080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|3765|4546|lyfalmen|V0143|4402|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2521||2521|4546||1 080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1601|2385|lyfalmen|V0144|1637|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||951||951|2385||1 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|14175|19490|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||14175||14175|19490||1 080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|7067|5214|lyfalmen|V0144|4912|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||3006||3006|5214||1 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|27945|36616|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||27945||27945|36616||1 080987|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|þpakki||G03XB01|01.06.2015||R|0|0|0|1|0|1|LPF|0|0|0|100|XEU|3029|4326|lyfsjukr|||1|1|0|0,3300|Portfarma ehf|Linepharma France|Mifepriston||3026||3026|4326||1 081305|L01XE1601|Xalkori|hylki|250|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|IPI|0|0|0|100|SEK|696697|868356|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||696697||696697|868356||2 081490|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.07.2013||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1 081501|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.10.2013||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1 081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|7626|4102|lyfalmen|V0515|4102|2|100|0|16,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||2198||2198|4102||1 081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|þpakki||G03DA04|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|4367|7087|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lægemidler A/S|Prógesterón||4367||4367|7087||1 081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081708|G03AC0903|Desogestrel ratiopharm|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.02.2014||R|0|0|0|0|0|0|RGM|0|0|0|100|IKR|1715|3437|lyfalmen|||2|84|0|84,0000|Medical ehf|ratiopharm GmbH|Desógestrel||1715||1715|3437|31.5.2015|2 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1671|2389|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Roche|Mídazólam||1671||1671|2389||2 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|4876|7788|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||4876||4876|7788||1 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|6866|10527|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||6866||6866|10527||1 082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.03.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|16176|8886|lyfalmen|V0184|5289|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||5674||5674|8886||1 082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kælt|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5 082237|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.04.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|29185|38158|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||29185||29185|38158||2 082512|QI06AH0701|Leucofeligen FeLV/RCP|stl|||10|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|8175|14090|vetorma|||0|10|0||Vistor hf|Virbac S.A|.||8175||8175|14090||1 082523|QI06AH0701|Leucofeligen FeLV/RCP|stl|||50|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|37634|64866|vetorma|||0|50|0||Vistor hf|Virbac S.A|.||37634||37634|64866||1 082548|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|627|1939|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||627||627|1939||1 082675|N02BE0118|Paracetamol-ratiopharm|töflur|1000|mg|100|stk|1|þpakki||N02BE01|01.10.2013||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|701|2026|lyfalmen|V0229|2026|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Paracetamól||690||690|2026||2 082685|R03BA0502|Flixotide Diskus|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|3240|5536|lyfalmen|||1|60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3240||3240|5536||1 082719|R03BA0502|Flixotide Diskus|innönddu|500|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|5735|8970|lyfalmen|||1|60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5735||5735|8970||1 082797|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.02.2012||L|0|0|0|0|0|0|GGK|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|GlaxoSmithKline ehf|GlaxoSmithKline Consumer Healthcare A/S|Paracetamól|||||||1 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3554|5968|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3554||3554|5968||1 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3869|6402|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3869||3869|6402||1 082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|4372|5912|lyfalmen|V0080|5912|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||3513||3513|5912||1 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|12416|18246|lyfalmen|V0354|16626|1|56|0|9,3350|Vistor hf|Novartis Healthcare A/S|Rívastigmín||12416||12416|18246||1 083113|L02BG0301|Arimidex|filmhtfl|1|mg|28|stk|1|þpakki||L02BG03|01.03.1998||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|16997|24040|lyfalmen|V0186|24040|1|28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||16997||16997|24040||1 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|12967|18943|lyfalmen|V0344|15681|1|56|0|18,6700|Vistor hf|Novartis Healthcare A/S|Rívastigmín||12967||12967|18943||1 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5251|8304|lyfalmen|V0701|6582|1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||5251||5251|8304||1 083413|QN05CM9102|Narcostart|stl|1|mg/ml|10|mg|1|hgl|fyrir hunda og ketti|QN05CM91|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|5847|11263|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Metetomidinum||5847||5847|11263||2 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|28138|38131|lyfalmen|V0346|33490|1|112|0|74,6667|Vistor hf|Novartis Healthcare A/S|Rívastigmín||28138||28138|38131||1 083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|1237|2779|lyfalmen|V0231|2559|1|300|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||1237||1237|2779||1 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|254|1426|lyfalmen|V0642|1426|2|10|0|2,5000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||254||254|1426||1 084192|N05BA1206|Alprazolam Krka|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|1922|2918|lyfalmen|V0311|2918|2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1338||1338|2918||2 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|489|1749|lyfalmen|V0643|1749|2|20|0|5,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||489||489|1749||1 084456|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|64959|82651|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||64959||64959|82651||1 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|54801|70017|lyfsjukr|||1|0,3|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||54801||54801|70017||2 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|71442|90714|lyfsjukr|||1|0,3|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||71442||71442|90714||2 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|89303|112928|lyfsjukr|||1|0,3|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||89303||89303|112928||2 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|18268|24580|lyfsjukr|||1|0,3|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||18268||18268|24580||2 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|27401|35939|lyfsjukr|||1|0,3|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||27401||27401|35939||2 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|36534|47298|lyfsjukr|||1|0,3|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||36534||36534|47298||2 084751|B03XA0301|Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|11146|15723|lyfsjukr|||1|0,3|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||11146|15723||2 084778|B03XA0301|Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|44316|56977|lyfsjukr|||1|0,3|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||44316|56977||2 084787|B03XA0301|Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|122346|154024|lyfsjukr|||1|0,6|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||122346|154024||2 084807|L01XE2301|Tafinlar|hylki|75|mg|28|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|GBP|239173|299324|lyfsjukr|||1|28|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||239173||239173|299324||1 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.09.2007||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|847|2242|lyfalmen|V0660|2242|1|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíð||847||847|2242||1 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.09.2007||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|10052|14912|lyfalmen|V0661|14912|1|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíð||10052||10052|14912||1 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.09.2007||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|32713|43917|lyfalmen|V0662|43917|1|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíð||32713||32713|43917||1 084924|J05AG0301|Stocrin|filmhtfl|200|mg|90|stk|1|glas||J05AG03|01.10.2013||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|41232|53141|lyfsjukr|||1|90|0|30,0000|Vistor hf|M.S.D.|Efavirenz||41232||41232|53141||1 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|11931|17498|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||11931||11931|17498|30.6.2015|1 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|0|1|G|0|GAN|0|0|0|100|NOK|36195|48321|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||36195||36195|48321||2 085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|2478|4487|lyfalmen|||1|15|0||Icepharma hf|Santen Oy|Levófloxacín||2478||2478|4487||2 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|28138|38131|lyfalmen|V0345|33490|1|112|0|56,0000|Vistor hf|Novartis Healthcare A/S|Rívastigmín||28138||28138|38131||1 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|756|2117|lyfalmen|||1|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||756||756|2117||1 085488|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4870|6963|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4870||4870|6963||2 085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|16918|23940|lyfalmen|V0412|21824|1|375|0|12,5000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||16918|23940||1 085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|32500|43648|lyfalmen|V0412|43648|1|750|0|25,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||32500|43648||1 085574|B01AF0201|Eliquis|filmhtfl|5|mg|100|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|16402|22177|lyfalmen|V0652|22177|1|100|0|100,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||15524||15524|22177||1 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|þpakki||G04BE08|01.12.2010||R|0|0|0|1|0|1|ELD|0|0|0|100|XEU|85793|108562|lyfsjukr|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||85793||85793|108562||2 085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|þpakki||N07XX02|01.11.2012||R|1|0|0|1|G|0|AGP|0|0|0|100|SEK|19508|27216|lyfalmen|V0579|27216|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Rílúzól||19508||19508|27216||1 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|37591|50087|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||37591||37591|50087||1 085830|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|4015|5740|lyfsjukr|||2|60|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||4015||4015|5740||1 085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|API|0|0|0|100|SEK|2651|4725|lyfalmen|V0465|3953|1|3|0|30,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||2651||2651|4725||1 085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|API|0|0|0|100|SEK|7835|11860|lyfalmen|V0465|11860|1|9|0|90,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||7835||7835|11860||1 085860|N05CF0101|Imovane|filmhtfl|5|mg|30|stk|1|þpakki||N05CF01|01.12.2013||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|387|1609|lyfalmen|||1|30|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||387||387|1609||1 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1812|3570|lyfalmen|V0364|3570|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1812||1812|3570||1 086018|N02CC0404|Rizatriptan Actavis|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.09.2013||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|3548|1857|lyfalmen|||2|6|0|6,0000|Actavis Group hf|Actavis Group PTC ehf|Rizatriptan||567||567|1857|30.6.2015|1 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|4605|5272|lyfalmen|V0365|4534|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3048||3048|5272||1 086142|N07XX0701|Fampyra|forðatfl|10|mg|56|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|61200|79948|lyfalmen|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||61200||61200|79948||2 086191|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|22185|30602|lyfalmen|V0666|30602|1|28|0|28,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||22185||22185|30602||1 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|8984|12845|lyfsjukr|||1|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8984||8984|12845||1 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|9751|13941|lyfsjukr|||1|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||9751||9751|13941||1 086324|A02BC0501|Nexium|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12856|18802|lyfalmen|V0012|5298|1|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||12856||12856|18802||1 086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|27754|37645|lyfalmen|||1|600|0|20,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||27754|37645||1 086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|50247|66094|lyfalmen|||1|1200|0|40,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||50247|66094||1 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|49067|62886|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||49067||49067|62886||1 086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|0|BOY|0|0|0|100|DKK|15876|22622|lyfalmen|||1|1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) með prógestógen||||15876|22622||2 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|47065|60396|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||47065||47065|60396||2 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||1 087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|þpakki||N05CF02|01.08.2012||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|359|1570|lyfalmen|V0060|1518|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||359||359|1570||1 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VII|0|0|0|100|DKK|116445|146685|lyfsjukr|||1|60|0|15,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||116445||116445|146685||1 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|243|1411|lyfalmen|V0312|403|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||243||243|1411||1 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|214|1371|lyfalmen|V0312|1208|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||214||214|1371||1 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|1802|3557|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||1802||1802|3557||1 087332|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|APC|0|0|0|100|XEU|47006|18697|lyfalmen|||2|250|0|166,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||12773||12773|18697||1 087354|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|APC|0|0|0|100|XEU|47006|18697|lyfalmen|||2|250|0|333,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||12773||12773|18697||1 087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|0|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||3700||1 087727|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1961|3775|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1961||1961|3775||1 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|þpakki||G03GB02|01.07.1986||R|0|0|0|0|G|0|MEC|0|0|0|100|SEK|888|2299|lyfalmen|||1|5|0|27,7778|Icepharma hf|Merck AB|Klómífen||888||888|2299||2 087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2138|3546|lyfalmen|V0009|3472|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||1794||1794|3546||1 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|þpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|29674|51146|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|||29674||29674|51146||2 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|þpakki||A02BX13|01.10.1993||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1 087969|QD07AC0001|Cortavance|húðúði|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3566|6936|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||3566||3566|6936||1 088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|0|CES|1|0|0|100|SEK|25208|43449|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||25208||25208|43449||2 088235|G03AA1204|Yasmin 28|filmhtfl|||84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2013||R|0|0|0|0|0|0|BYP|0|0|0|100|DKK|2948|5134|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||2948||2948|5134||2 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|0|G|0|GGL|0|0|1|100|GBP|1362|2951|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1362||1362|2951||1 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|þpakki||M01AX01|01.04.1995||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|1375|2969|lyfalmen|||1|20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1375||1375|2969||1 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|þpakki||M01AX01|01.04.1995||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|5304|8377|lyfalmen|||1|100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||5304||5304|8377||1 088445|N05AX1205|Aripiprazol Krka|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|20454|28412|lyfalmen|V0684|28412|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||20454||20454|28412||2 088558|N06AX2601|Brintellix|filmhtfl|15|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|9060|13547|lyfalmen|||1|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||9060||9060|13547||1 088612|N06DA0207|Donepezil Bluefish|filmhtfl|10|mg|98|stk|1|þpakki||N06DA02|01.04.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|12241|7503|lyfalmen|V0342|7353|2|98|0|130,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Dónepezíl||4669||4669|7503||2 088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|4573|7371|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||4573||4573|7371||1 088697|N06AX1611|Duofaxin|forðatfl|75|mg|98|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|2752|4453|lyfalmen|V0334|3078|2|98|0|73,5000|Vistor hf|MediLink A/S|Venlafaxín||2453||2453|4453||1 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|7552|11471|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||7552||7552|11471||1 088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|13944|20178|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||13944||13944|20178||1 088737|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.06.2014|30.06.2015|R|0|0|0|1|0|1|ABV|0|0|0|100|DKK|5398|7718|lyfsjukr|||1|30|0|2,5000|Vistor hf|AbbVie Ltd.|Ritonavír||5398||5398|7718||1 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.12.2008||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|14248|10456|lyfalmen|V0421|7382|2|30|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||6815||6815|10456||1 088882|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|17563|33491|vetalmen|||0|60|0||Icepharma hf|Zoetis Finland OY|||17563||17563|33491||2 088964|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2010||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|2802|4933|lyfalmen|V0376|4933|2|7,5|0|75,0000|Portfarma ehf|Portfarma|Latanóprost||2802||2802|4933||1 088975|G03AA1005|Harmonet|töflur|||63|stk|1|þpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1391|2991|lyfalmen|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||1391||1391|2991||1 089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|22090|30481|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||22090||22090|30481||2 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|þpakki||A02BX13|01.01.1989||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||5800||1 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VII|0|0|0|100|DKK|116445|146685|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||116445||116445|146685||1 089156|A03AA0406|Mebeverin dura|filmhtfl|135|mg|100|stk|1|þpakki||A03AA04|01.07.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3604|6037|lyfalmen|||2|100|0|45,0000|Icepharma hf|Mylan AB|Mebeverín||3604||3604|6037||2 089190|H01AC0101|Genotropin|sts|5|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|20551|27420|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||20551||20551|27420||1 089212|H01AC0101|Genotropin|sts|12|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|49323|63204|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||49323||49323|63204||1 089281|R06AX1305|Loratadin LYFIS|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||||2 089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.05.2012||L|1|0|0|0|G|0|LYF|0|0|1|100|XEU|||lyfalmen|V0362|2047|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||2047||2 089801|B03AC0001|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC|01.10.2012||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|23316|32032|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||23316||23316|32032||1 089936|B03AC0001|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC|01.10.2012||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|93262|120500|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||93262||93262|120500||1 090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|1522|3171|lyfalmen|||1|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1522||1522|3171||2 090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.05.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|3043|5265|lyfalmen|||1|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||3043||3043|5265||2 090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|713|2058|lyfalmen|||1|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||713||713|2058||2 090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|1|PAD|0|0|0|100|DKK|5468|7818|lyfsjukr|||1|10|0|3,3333|Icepharma hf|PharmaCoDane ApS|Cefazólín||5468||5468|7818||2 090547|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.10.2014||R|0|1|0|1|G|0|BIO|0|0|0|100|DKK|122543|157534|lyfalmen|V0140|157534|1|1|0|1,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Clostridíum||122543||122543|157534||3 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|1483|3118|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1483||1483|3118||1 090784|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|847|2242|lyfalmen|V0660|2242|1|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíð||847||847|2242||1 090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|1|0|1|CLA|0|0|0|100|USD|16675|22599|lyfsjukr|||1|60|0||Vistor hf|Alcon Nordic A/S|Flúorescein||||16675|22599||1 091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2458|3514|lyfsjukr|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2458||2458|3514||1 091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4253|6081|lyfsjukr|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||4253||4253|6081||1 091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|12484|17387|lyfsjukr|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||12484||12484|17387||1 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|3723|6201|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||3723||3723|6201||1 091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|6167|9565|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||6167||6167|9565||1 091627|J01CR0501|Piperacillin/Tazobactam Actavis|irs|2,5|g|1|hgl|1|pakki|2 g/ 0,5 g|J01CR05|01.08.2014||R|0|1|0|0|0|1|APC|0|0|0|100|SEK|1126|1610|lyfsjukr|||2|1|0|0,1400|Actavis Group PTC ehf|Actavis Group PTC ehf|Piperacillín og ensimblokkar||1126||1126|1610||1 091638|J01CR0501|Piperacillin/Tazobactam Actavis|irs|4,5|g|1|hgl|1|pakki|4 g/ 0,5 g|J01CR05|01.11.2014|30.04.2015|R|0|1|0|0|0|1|APC|0|0|0|100|SEK|1425|2037|lyfsjukr|||2|1|0|0,2800|Actavis Group PTC ehf|Actavis Group PTC ehf|Piperacillín og ensimblokkar||1425||1425|2037||1 091662|L01DB0105|Doxorubicin Actavis|sts|50|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|6915|9887|lyfsjukr|||2|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||6915|9887||1 091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|0|0|0|0|G|0|CHA|0|0|1|100|DKK|3728|6208|lyfalmen|||1|30|0||Vistor hf|CCS Healthcare AB|Dexametasón||3728||3728|6208||1 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1051|1755|lyfalmen|V0021|1755|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||493||493|1755||1 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1816|2104|lyfalmen|V0022|2104|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||747||747|2104||1 091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|587|1884|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||587||587|1884||1 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|8607|16500|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||8607||8607|16500||2 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|1|0|0|0|G|0|SBM|0|0|0|100|NOK|4919|7847|lyfalmen|V0009|3472|1|28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||4919||4919|7847||1 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092554|N06DX0105|Memantine Mylan|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|11047|5598|lyfalmen|V0606|5149|2|28|0|28,0000|Icepharma hf|Generics UK Ltd|Memantín||3285||3285|5598||2 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2132|4011|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2132||2132|4011||1 092750|N05AH0203|Leponex (Lyf og heilsa)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|1|0|0|0|G|0|HOL|0|0|0|100|DKK|8690|13037|lyfalmen|V0277|8825|3|100|0|33,3333|Lyf og heilsa|Lyf og heilsa|Klózapín||8690||8690|13037||2 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|622|1932|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||622||622|1932||1 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|1182|2703|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||1182||1182|2703||1 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.05.2010||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|3150|2801|lyfalmen|V0203|2801|2|12|0|84,0000|Williams & Halls efh|Williams & Halls ehf|Alendrónsýra||1253||1253|2801||2 092989|C03DA0403|Eplerenon Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.10.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|7800|6169|lyfalmen|V0107|6169|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||3700||3700|6169||2 093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|935|2363|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxýcódon||935||935|2363||2 093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2147|4031|lyfalmen|||1|28|0|3,7300|Icepharma hf|Norpharma|Oxýcódon||2147||2147|4031||2 093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|4175|6823|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxýcódon||4175||4175|6823||2 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|6856|10513|lyfalmen|||1|1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||6856||6856|10513||1 093284|G04BD1201|Betmiga|forðatfl|50|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|5551|8717|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5551||5551|8717||1 093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1376|2970|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||1376||1376|2970||1 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|24805|42754|vetorma|||0|100|0||Icepharma hf|Zoetis Finland OY|Medroxyprogesteronum||24805||24805|42754||2 093668|N01BB0203|Xylocain|húðúði|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.2014||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2391|4367|lyfalmen|V0656|4367|1|50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2391||2391|4367||1 093725|C03BA0802|Metolazon Abcur|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.01.2014||R|0|0|0|0|G|0|ABC|0|0|0|100|SEK|35165|47019|lyfalmen|||2|100|0|100,0000|Icepharma hf|Abcur AB|Metólazón||35165||35165|47019||2 093736|L02AE0305|Zoladex LA (Lyf og heilsa)|vefjalyf|10,8|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|0|0|0|1|G|0|HOL|0|0|0|100|SEK|53037|65630|lyfalmen|||3|1|0|83,7209|Lyf og heilsa|Lyf og heilsa|Góserelín||49880||49880|65630|30.4.2015|2 093747|C09AA0503|Ramipril Actavis (Lyf og heilsa)|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.11.2011||R|1|0|0|0|G|0|HOL|0|0|0|100|XEU|755|2116|lyfalmen|V0496|1902|3|100|0|200,0000|Lyf og heilsa|Lyf og heilsa|Ramipríl||755||755|2116||2 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|8976|13431|lyfalmen|||1|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||8976||8976|13431||2 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|23265|31968|lyfalmen|V0588|21603|1|98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||23265||23265|31968||2 093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|373093|465883|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||373093||373093|465883||1 093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|421205|525721|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||421205||421205|525721||1 094111|N02CC0501|Almogran|filmhtfl|12,5|mg|6|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|4587|7390|lyfalmen|V0236|6955|1|6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||4587||4587|7390||1 094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|6797|10432|lyfalmen|V0236|10432|1|9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||6797||6797|10432||1 094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|1671|3284|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|||1671||1671|3284||1 094441|J05AB0103|Aclovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.04.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|XEU|994|2301|lyfalmen|V0044|2301|2|25|0|1,2500|Medical ehf|ratiopharm GmbH|Acíklóvír||890||890|2301||2 094652|B01AC0602|Hjarta-Aspirín|sþ-tfl|75|mg|500|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 094757|N04BC0406|Ropinirole Portfarma|forðatfl|8|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|29114|20563|lyfalmen|V0534|20563|2|84|0|112,0000|Portfarma ehf|Portfarma|Rópíníról||14248||14248|20563||1 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|þpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|87576|110780|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||87576||87576|110780||1 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|0|APE|0|0|1|100|XEU|44488|58810|lyfalmen|||1|1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||44488|58810||1 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|6070|10462|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||6070||6070|10462||2 095005|B02BC3001|TachoSil|vefjal.n|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.01.2014||R|0|0|0|1|0|1|TAG|0|0|0|100|DKK|37862|48950|lyfsjukr|||2|1|0||Vistor hf|Takeda Austria GmbH|Blöndur||37862||37862|48950||1 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|1577|3247|lyfalmen|||0|100|1|50,0000|Distica|Distica - óskráð lyf|Magnesíum hýdroxíð||1577||1577|3247||1 095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|4743|3196|lyfalmen|V0143|2935|3|8|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1540||1540|3196||2 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|0|G|0|AGT|0|0|0|100|DKK|6912|10590|lyfalmen|||1|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||6912||6912|10590||1 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|16032|22819|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||16032||16032|22819||1 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|16032|22819|lyfalmen|||1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||16032||16032|22819||1 095692|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|100|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|1801|2575|lyfsjukr|||2|100|0|0,4000|Portfarma ehf|Portfarma|Cíprófloxacín||1801||1801|2575||1 095704|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|2820|4032|lyfsjukr|||2|200|0|0,8000|Portfarma ehf|Portfarma|Cíprófloxacín||2820||2820|4032||1 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|16032|22819|lyfalmen|||1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||16032||16032|22819||1 095715|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|2093|2992|lyfsjukr|||2|50|0|0,5000|Portfarma ehf|Portfarma|Flúkónazól||||2093|2992||1 095726|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|3271|4677|lyfsjukr|||2|100|0|1,0000|Portfarma ehf|Portfarma|Flúkónazól||||3271|4677||1 095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|1|0|1|0|G|0|AGP|0|0|1|100|XEU|937|1543|lyfalmen|V0225|1543|2|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||339||339|1543||1 095767|R03BA0203|Budesonide Teva|innúðal|0,5|mg/ml|2|ml|20|lykjur||R03BA02|01.07.2015||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|4482|6582|lyfalmen|V0701|6582|2|40|0|13,3400|Medical ehf|Teva Pharma B.V.|Búdesóníð||4000||4000|6582||2 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|4156|8055|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4156||4156|8055||2 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|5733|11047|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5733||5733|11047||2 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|9534|18258|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9534||9534|18258||2 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990|30.04.2015|R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|29296|38296|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||29296||29296|38296||2 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl||J06BA01|01.10.2008||R|0|0|0|1|0|1|OCT|0|1|0|100|DKK|89090|112663|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||89090||89090|112663||1 096203|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2248|2389|lyfalmen|V0088|2389|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og þvagræsilyf||954||954|2389||2 096227|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2340|2688|lyfalmen|V0089|2688|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og þvagræsilyf||1171||1171|2688||2 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|0|0|0|0|0|0|GGL|0|0|1|100|GBP|1956|3769|lyfalmen|||1|5|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||1956||1956|3769||1 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|14129|20412|lyfalmen|V0347|17842|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||14129||14129|20412||1 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|643755|802511|lyfsjukr|||1|21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||643755||643755|802511||2 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|682415|850593|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||682415||682415|850593||2 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|687296|856664|lyfsjukr|||1|21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||687296||687296|856664||2 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|749223|933684|lyfsjukr|||1|21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||749223||749223|933684||2 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|15074|21608|lyfalmen|V0349|19217|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||15074||15074|21608||1 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|1230|2769|lyfalmen|||1|30|0|18,0000|Icepharma hf|Servier|Indapamíð||1230||1230|2769||2 096768|L02AE0102|Suprecur|nefúði|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|0|0|0|1|G|0|SNO|0|0|0|100|NOK|12511|18366|lyfalmen|||1|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||12511||12511|18366||1 097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.04.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|25281|33302|lyfsjukr|||2|10000|0||Actavis Group hf|Braun|Hýdróxyetýl sterkja||25281||25281|33302||1 097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|68734|118470|vetorma|||1|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||68734||68734|118470||2 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|0|AUW|1|0|0|100|XEU|7584|14559|vetalmen|||0|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||7584|14559||2 097269|J01FF0103|Dalacin (Lyf og heilsa)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|2040|3884|lyfalmen|V0461|3884|3|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2040||2040|3884||2 097498|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.12.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|540|1820|lyfalmen|V0333|785|1|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||540||540|1820||1 097531|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.07.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10395|15384|lyfalmen|V0334|3078|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||10395||10395|15384||1 097577|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.09.2011||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|19736|27504|lyfalmen|V0335|3078|1|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||19736|27504||1 097599|N05BA0603|Temesta|töflur|1|mg|100|stk|1|þpakki||N05BA06|01.02.2012||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|2270|4201|lyfalmen|||0|100|1|40,0000|Distica|Distica - óskráð lyf|Lórazepam||2270||2270|4201||1 097662|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5794|11163|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5794||5794|11163||2 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2607|2387|lyfalmen|V0023|2387|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||952||952|2387||1 097887|N02CC0104|Sumacta|húðuðtfl|50|mg|12|stk|1|þpakki||N02CC01|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|IKR|2738|2190|lyfalmen|V0233|2190|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||809||809|2190||1 097896|N02CC0104|Sumacta|húðuðtfl|100|mg|6|stk|1|þpakki||N02CC01|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|IKR|1917|1910|lyfalmen|V0234|1910|2|6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||606||606|1910||1 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|1030|1942|lyfalmen|V0329|1765|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||629||629|1942||1 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3144|3738|lyfalmen|V0678|3416|2|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||1934||1934|3738||1 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|5237|3738|lyfalmen|V0679|3691|2|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||1934||1934|3738||1 098074|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|3|spr|f. hesta|QM01AE90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5335|10292|vetalmen|||0|90|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||5335||5335|10292||2 098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|612|1919|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||612||612|1919||2 098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|612|1919|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||612||612|1919||2 098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2 098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|1063|1627|lyfalmen|V0243|1627|2|50|0|4,1600|Medical ehf|ratiopharm GmbH|Lamótrigín||400||400|1627||2 098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|1812|1902|lyfalmen|V0244|1787|2|50|0|8,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||600||600|1902||2 098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|5116|3554|lyfalmen|V0245|3554|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||1800||1800|3554||2 098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|9166|7958|lyfalmen|V0232|7958|2|100|0|66,6600|Medical ehf|ratiopharm GmbH|Lamótrigín||5000||5000|7958||2 098713|V03AB2502|Flumazenil B. Braun|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5565|7956|lyfsjukr|||2|25|0||Actavis Group hf|Braun|Flúmazeníl||5565||5565|7956||1 098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|15142|21694|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||15142||15142|21694||2 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|1|0|1|ASZ|0|0|0|100|SEK|71416|90682|lyfsjukr|||1|10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||71416||71416|90682||1 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2944|2188|lyfalmen|V0284|2109|2|100|0|6,2500|Icepharma hf|Mylan AB|Quetíapín||808||808|2188||2 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|6137|4410|lyfalmen|V0285|4311|2|100|0|25,0000|Icepharma hf|Mylan AB|Quetíapín||2422||2422|4410||2 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|9539|8019|lyfalmen|V0286|7958|2|100|0|50,0000|Icepharma hf|Mylan AB|Quetíapín||5044||5044|8019||2 099705|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2751|2011|lyfalmen|V0247|1754|2|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||679||679|2011||1 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|3804|3879|lyfalmen|V0248|3378|2|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2036||2036|3879||1 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|7727|4413|lyfalmen|V0249|3785|2|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2424||2424|4413||1 099863|L01XE0401|Sutent|hylki|12,5|mg|28|stk|1|þpakki||L01XE04|01.12.2012||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|163629|205369|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||163629||163629|205369||1 099872|L01XE0401|Sutent|hylki|25|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|315393|394121|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||315393||315393|394121||1 099881|L01XE0401|Sutent|hylki|50|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|630764|786354|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||630764||630764|786354||1 099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|þpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|689|2025|lyfalmen|V0414|2025|2|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||689||689|2025||1 100211|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|25|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|6459|10412|veteldis|||0|25|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||6459||6459|10412||1 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|10874|16043|lyfalmen|||1|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||10874|16043||2 100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1882|3382|lyfalmen|V0672|3003|2|100|0|50,0000|Actavis Group hf|Actavis hf|Mirtazapín||1675||1675|3382||1 100807|N03AX1603|Pregabalin Krka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2180|4077|lyfalmen|V0685|4077|2|56|0|4,6667|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2180||2180|4077||2 100884|J01AA0401|Lymecycline Actavis|hylki|300|mg|100|stk|1|þpakki||J01AA04|01.07.2015||R|0|0|0|0|0|0|AGP|0|0|1|100|XEU|4603|7412|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Lymecycline||4603||4603|7412||1 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|10725|12672|lyfalmen|V0254|11399|1|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||8425||8425|12672||1 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|16228|23067|lyfalmen|V0256|20249|1|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||16228||16228|23067||1 101148|QI10AB0301|Alpha Ject 5-3|stl|||500|ml|1|poki||QI10AB03|01.09.2013||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|67744|109203|veteldis|||0|500|0||Vistor hf|Pharmaq AS|Aeromónas + moritella + vibrio||67744||67744|109203||1 101195|N06DX0105|Memantine Mylan|filmhtfl|10|mg|28|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|5915|3072|lyfalmen|V0604|2815|2|28|0|14,0000|Icepharma hf|Generics UK Ltd|Memantín||1450||1450|3072||2 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|1269|2173|lyfalmen|V0330|1765|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||797||797|2173||1 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|2608|3009|lyfalmen|V0331|2590|2|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1404||1404|3009||1 101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2457|2479|lyfalmen|V0088|2438|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og þvagræsilyf||1019||1019|2479||1 101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3119|2802|lyfalmen|V0089|2743|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og þvagræsilyf||1254||1254|2802||1 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|11645|22263|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|||11645||11645|22263||1 101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|5772|9021|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||5772||5772|9021||2 101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|17123|24199|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||17123||17123|24199||2 102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1002|2455|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1002||1002|2455||1 102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1561|3225|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1561||1561|3225||1 102121|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|6004|8584|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||6004||6004|8584||2 102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|þpakki||N02BE01|01.03.2013||R|1|0|0|0|0|0|APC|0|0|1|100|XEU|392|1616|lyfalmen|V0230|1616|2|100|0|16,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||392||392|1616||1 102404|R03DX0701|Daxas|filmhtfl|500|mcg|30|stk|1|þpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|TAK|0|0|0|100|DKK|6797|10432|lyfalmen|||1|30|0|30,0000|Vistor hf|Takeda GmbH|Roflumílast||6797||6797|10432||1 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3341|5675|lyfalmen|V0041|2701|1|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||3341||3341|5675||1 102952|G04BD0803|Solifenacin Portfarma|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|PEH|0|0|0|100|XEU|14955|21457|lyfalmen|V0441|21457|2|90|0|180,0000|Portfarma ehf|Portfarma ehf|Sólífenacín||14955||14955|21457||1 103050|N05CF0205|Zovand|filmhtfl|10|mg|30|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|1|100|IKR|321|1518|lyfalmen|V0060|1518|2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||321||321|1518||2 103610|L01DB0105|Doxorubicin Actavis|irþ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.03.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|818|1170|lyfsjukr|||2|25|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||818||818|1170||1 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2501|2739|lyfalmen|V0088|2389|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||1208||1208|2739||1 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|3172|3325|lyfalmen|V0089|2688|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||1634||1634|3325||1 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2416|3513|lyfalmen|V0069|2943|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||1770||1770|3513||1 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|1904|2040|lyfalmen|V0033|2040|2|10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||700||700|2040||1 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|þpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|7938|5269|lyfalmen|V0182|5089|2|40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||3046||3046|5269||1 103678|N06AX1604|Venlafaxin (Portfarma)|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|4454|3554|lyfalmen|V0334|3141|2|100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||1800||1800|3554||1 103687|N06AX1604|Venlafaxin (Portfarma)|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|7148|4380|lyfalmen|V0335|3141|2|100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||2400||2400|4380||1 103791|M01AE0115|Alvofen Express|hylki|400|mg|10|stk|1|þpakki||M01AE01|01.01.2015||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Portfarma ehf|Alvogen IPco S.á.r.l.|Íbúprófen|||||||1 103806|N02AB0305|Fentanyl ratiopharm|forðapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|1960|3774|lyfalmen|V0222|3774|2|5|0|3,6000|Medical ehf|ratiopharm GmbH|Fentanýl||1960||1960|3774||2 103813|B02BC3002|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|308337|385345|lyfsjukr|||1|40|0||Icepharma hf|Baxter AG|Blöndur||308337||308337|385345||2 103854|L01XE1701|INLYTA|filmhtfl|1|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PZE|0|1|0|100|DKK|115217|145158|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd.|Axitinib||115217||115217|145158||1 103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|3722|7232|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníð og amídín-Klórhexidín í blöndum||3722||3722|7232||1 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1952||1 103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|9819|14038|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||9819||9819|14038||2 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|2655|4731|lyfalmen|||1|2,5|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||2655||2655|4731||1 104489|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|1|úðagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|6363|9834|lyfalmen|||1|5|0|20,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||6363||6363|9834||1 104760|A07EC0202|Pentasa|eþ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|7337|11175|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||7337||7337|11175||1 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|3803|6311|lyfalmen|V0017|5720|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||3803||3803|6311||1 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|4927|7858|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4927||4927|7858||1 104856|R03AK1101|Flutiform|innúðal|55|mcg/sk|120|skammtar|1|pakki|50+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|4260|6940|lyfalmen|||1|120|0|30,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||4260||4260|6940||2 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|103302|130339|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||103302|130339||1 105315|G03AA0705|Microgynon (Lyf og heilsa)|töflur|||63|stk|1|þpakki||G03AA07|01.05.2009||R|0|0|0|0|0|0|HOL|0|0|0|100|DKK|1209|2738|lyfalmen|V0545|1904|3|63|0|84,0000|Lyf og heilsa|Lyf og heilsa|Levónorgestrel og ethinylestradíól||1207||1207|2738||2 105363|C03DA0403|Eplerenon Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|7800|6169|lyfalmen|V0107|6169|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||3700||3700|6169||2 105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|12617|18500|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||12617||12617|18500||1 105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|14823|21290|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||14823||14823|21290||1 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2172|4066|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2172||2172|4066||1 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2568|4611|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2568||2568|4611||1 106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|1725|3451|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1725||1725|3451||2 106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|3304|5624|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3304||3304|5624||2 106182|G03AA1203|Yasminelle|filmhtfl|||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.04.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3300|5618|lyfalmen|V0191|4866|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||3300||3300|5618||2 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|20240|27033|lyfsjukr|||1|5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||20240||20240|27033||1 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|11193|15781|lyfsjukr|||1|5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||11193||11193|15781||1 106932|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.11.2012||R|1|1|0|0|G|0|TEV|0|0|0|100|XEU|6737|4036|lyfalmen|V0572|4034|2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||2150||2150|4036||2 107002|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|151454|190226|lyfsjukr|||1|3|0|1,5000|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíðar||151454||151454|190226||1 107203|R06AX2201|Kestine|filmhtfl|10|mg|30|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1472|3102|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1472||1472|3102||1 107265|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.10.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|9000|11812|lyfalmen|V0197|11812|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||7800||7800|11812||2 107464|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|PEH|0|0|0|100|XEU|4369|7090|lyfalmen|V0438|7090|2|30|0|30,0000|Portfarma ehf|Portfarma ehf|Sólífenacín||4369||4369|7090|| 107575|N01AB0803|Sevoflurane Piramal|innö.guf|100|%|250|ml|1|fl||N01AB08|01.03.2015||R|0|0|0|0|0|1|PIR|0|0|0|100|XEU|20109|23881|lyfsjukr|||1|250|0||Williams & Halls efh|Piramal Healthcare UK Limited|Sevóflúran||17706||17706|23881||2 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||R|0|0|0|0|0|0|CRO|0|0|0|100|XEU|1445|2491|vetorma|||0|6,42|0||Portfarma ehf|Cross Vetpharm Group Ltd.|Ivermectinum||1445||1445|2491||1 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|867|2270|lyfalmen|||2|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||867||867|2270||1 107657|N05AX1205|Aripiprazol Krka|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|20582|28574|lyfalmen|V0683|28574|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||20582||20582|28574||2 107935|QN01AX0304|Aniketam vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2015||R|0|0|1|0|0|0|VEB|1|0|0|100|IKR|9085|17407|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketaminum||||9085|17407||2 108103|M05BA0804|Zoledronic acid medac|irl|4|mg/glasi|100|ml|1|glas|lausn|M05BA08|01.12.2013||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|13651|18838|lyfsjukr|||2|100|0|1,0000|Williams & Halls efh|medac Gesellschaft|Zoledronsýra||13651||13651|18838||2 108126|G04BD0402|Oxybutynin Mylan|töflur|5|mg|100|stk|1|þpakki||G04BD04|01.05.2013||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|2308|4253|lyfalmen|||2|100|0|33,3300|Icepharma hf|Mylan AB|Oxýbútýnín||2308||2308|4253||2 108433|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.10.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|51260|65613|lyfsjukr|||1|4|0|26,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||51260||51260|65613||1 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|þpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|3087|5325|lyfalmen|||1|30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3087||3087|5325||1 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|9162|13687|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||9162||9162|13687||1 108697|A16AA0601|Cystadane|duft|1|g|180|g|1|glas||A16AA06|01.07.2013||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|69786|90807|lyfalmen|||1|180|0|30,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Betain anhydrous||69786||69786|90807||3 108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1457|3082|lyfalmen|V0443|3080|1|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1457||1457|3082||1 109212|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|glas||N03AX14|01.12.2014|30.06.2015|R|1|0|0|0|0|0|APC|0|0|0|100|XEU|17635|5675|lyfalmen|||2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3341||3341|5675||1 109357|A02BC0508|Esomeprazol Actavis|sþ-hylki|20|mg|28|stk|1|þpakki|hart|A02BC05|01.03.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|1253|2206|lyfalmen|V0004|2206|2|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||821||821|2206||1 109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|22711|31267|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||22711||22711|31267||1 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18182|25539|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18182||18182|25539||1 109569|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|2825|3364|lyfalmen|V0584|3364|2|28|0|7,4700|Medical ehf|ratiopharm GmbH|Oxýcódon||1662||1662|3364||2 109578|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|7024|8286|lyfalmen|V0585|8286|2|98|0|26,1300|Medical ehf|ratiopharm GmbH|Oxýcódon||5238||5238|8286||2 109588|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|4753|6326|lyfalmen|V0586|6326|2|28|0|14,9300|Medical ehf|ratiopharm GmbH|Oxýcódon||3814||3814|6326||2 109597|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|13723|14211|lyfalmen|V0587|14211|2|98|0|52,2700|Medical ehf|ratiopharm GmbH|Oxýcódon||9543||9543|14211||2 109615|N02AA0505|Oxycodone ratiopharm|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|21067|21605|lyfalmen|V0588|21603|2|98|0|104,5300|Medical ehf|ratiopharm GmbH|Oxýcódon||15072||15072|21605||2 110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||||2 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|486|1745|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||486||486|1745||2 110094|G04BE0308|Sildenafil Portfarma|tuggutfl|100|mg|12|stk|1|þpakki||G04BE03|01.09.2013||R|1|0|0|0|0|0|PEH|0|0|0|100|XEU|7023|4988|lyfalmen|||2|12|0|24,0000|Portfarma ehf|Portfarma ehf|Síldenafíl||2750||2842|4988|30.6.2015|1 110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110287|N05AX0806|Risperidon Krka|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2315|lyfalmen|V0291|2315|2|60|0|12,0000|LYFIS ehf|Krka Sverige AB|Risperídón||900||900|2315||2 110306|N05AX0806|Risperidon Krka|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2700|3760|lyfalmen|V0292|3760|2|60|0|24,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1950||1950|3760||2 110324|N05AX0806|Risperidon Krka|filmhtfl|3|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4210|5343|lyfalmen|V0296|5343|2|60|0|36,0000|LYFIS ehf|Krka Sverige AB|Risperídón||3100||3100|5343||2 110342|N05AX0806|Risperidon Krka|filmhtfl|4|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|5000|6720|lyfalmen|V0297|6720|2|60|0|48,0000|LYFIS ehf|Krka Sverige AB|Risperídón||4100||4100|6720||2 110395|G03AA0902|Mercilon|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.07.1990||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1440|3058|lyfalmen|V0065|1915|1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1440||1440|3058||1 110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.01.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|3682|6144|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||3682||3682|6144||1 110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|86288|109178|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Raltegravír||86288||86288|109178||1 111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|4940|7058|lyfalmen|V0373|7058|2|15|0|75,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||4346||4346|7058||1 111678|A06AB5802|CitraFleet|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.12.2013||L|0|0|0|0|0|0|CAS|0|0|0|100|IKR|||lyflausa|||0|2|0||Vistor hf|Casen Recordati S.L.|Natríumpicosúlfat|||||||1 111795|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.09.2014||L|1|0|0|0|0|0|SIV|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Vistor hf|Bayer AB|Lóratadín|||||||1 111863|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.04.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3557|5086|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Mesna||3557||3557|5086||2 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|701|2041|lyfalmen|V0229|2026|1|100|0|33,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||701||701|2041||1 112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|20349|28279|lyfalmen|||1|1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||20349||20349|28279||1 112056|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|3|innö.t||R03BB05|01.01.2013||R|0|0|0|0|G|0|ZEN|0|0|0|100|SEK|15705|22406|lyfalmen|||1|180|0|90,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||15705||15705|22406||1 112191|C02KX0501|Adempas|filmhtfl|1|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|190351|238603|lyfsjukr|||1|42|0||Icepharma hf|Bayer Pharma AG|Riociguatum||190351||190351|238603||2 113058|N07BA0148|Nicovel Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 113143|N05AX1205|Aripiprazol Krka|töflur|30|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|40598|40486|lyfalmen|||2|56|0|112,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||30000||30000|40486||2 113247|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.03.2014||R|0|1|0|1|G|0|BIO|0|0|0|100|DKK|122543|157534|lyfalmen|V0140|157534|1|1|0|1,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Clostridíum||122543||122543|157534||3 113251|D01AE1602|Amorolfin ratiopharm|lakk|5|%|5|ml|1|glas||D01AE16|01.09.2014||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyfalmen|V0655|4655|2|5|0||LYFIS ehf|ratiopharm Oy|Amorolfín|||||4655||2 113331|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|þpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|1759|3497|lyfalmen|||2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1759||1759|3497||2 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|7253|11059|lyfalmen|V0024|9290|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||7253||7253|11059||1 113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|20026|27871|lyfalmen|V0024|27871|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||20026||20026|27871||1 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|6533|10068|lyfalmen|V0025|8144|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6533||6533|10068||1 113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|2172|3105|lyfsjukr|||1|100|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||2172||2172|3105||2 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|2922|5098|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2922||2922|5098||1 113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|17308|24433|lyfalmen|V0025|24433|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||17308||17308|24433||1 113648|N06BA0404|Methylphenidate Sandoz|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2015||R|1|0|1|0|0|0|SHS|0|0|0|100|DKK|5504|8652|lyfalmen|V0681|8652|2|30|0|27,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||5504||5504|8652||1 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|5018|7983|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||5018||5018|7983||1 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|468346|584351|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||468346||468346|584351||1 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|597|1898|lyfalmen|||1|20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||597||597|1898||1 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|756|2117|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||756||756|2117||1 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1151|2661|lyfalmen|||1|40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1151||1151|2661||1 114033|R03AC0210|Ventolin Diskus|innönddu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|732|2084|lyfalmen|||1|60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||732||732|2084||1 114072|A07DA0301|Imodium|filmhtfl|2|mg|16|stk|1|þpakki||A07DA03|01.02.2014||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1 114134|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|21442|28528|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||21442|28528||2 114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|33125|43058|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||||33125|43058||2 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3866|6397|lyfalmen|||1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||3866||3866|6397||1 114512|D06BB0401|Condyline|áburður|5|mg/ml|3,5|ml|1|glas|til penslunar|D06BB04|01.11.2010||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|2074|3931|lyfalmen|||1|3,5|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2074||2074|3931||2 114531|L01AA0201|Leukeran|filmhtfl|2|mg|25|stk|1|glas||L01AA02|01.04.2013||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|10300|15253|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Chlorambucíl||10300||10300|15253|30.6.2015|1 114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|5566|8737|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíð||5566||5566|8737||2 114755|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2014||R|0|0|0|0|G|0|MED|0|0|0|100|IKR|14000|14840|lyfalmen|V0420|14840|2|90|0|90,0000|Medical ehf|Medical ehf|Bíkalútamíð||10000||10000|14840||2 114912|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5685|9799|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5685||5685|9799||2 114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2330|2738|lyfalmen|V0278|2738|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1207||1207|2738||2 114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|3047|4124|lyfalmen|V0279|3141|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||2214||2214|4124||2 114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|10573|15629|lyfalmen|V0280|5406|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||10573||10573|15629||2 114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|11125|16389|lyfalmen|V0282|2392|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||11125||11125|16389||2 114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|7255|6582|lyfalmen|V0457|6582|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||4000||4000|6582||2 115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|14207|13189|lyfalmen|V0456|13189|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||8800||8800|13189||2 115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|23237|13739|lyfalmen|V0475|13739|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||9200||9200|13739||2 115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|35825|19911|lyfalmen|V0540|19911|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13733||13733|19911||2 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1782|3529|lyfalmen|||1|10|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1782||1782|3529||1 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|8301|11868|lyfsjukr|||2|10|0||Actavis Group hf|Braun|Naloxón||8301||8301|11868||1 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1195|2603|lyfalmen|V0158|2453|2|20|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||1109||1109|2603||2 115309|N05AH0206|Clozapin Medical|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|1955|3347|lyfalmen|V0276|3347|2|100|0|8,3300|Medical ehf|Medical ehf|Klózapín||1650||1650|3347||2 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|10688|15787|lyfalmen|||1|60|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10688||10688|15787||1 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1782|3529|lyfalmen|||1|10|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1782||1782|3529||1 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|9764|14515|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||9764||9764|14515||1 115554|B03AC0001|Monofer|irl|100|mg/ml|10|ml|1|hgl||B03AC|01.07.2013||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|48535|63929|lyfalmen|||1|10|0|10,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||48535||48535|63929||1 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|1775|3519|lyfalmen|V0369|2963|1|5|0|16,6667|Vistor hf|M.S.D.|Dorzólamíð||1775||1775|3519||1 115931|R03AC1202|Serevent Diskus|innönddu|50|mcg/sk|60|skammtar|1|pakki||R03AC12|01.01.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|4020|6609|lyfalmen|||1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||4020||4020|6609||1 115980|P03AX0301|Prioderm|húðlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983|30.04.2015|L|0|0|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||0|55|0||Icepharma hf|Norpharma |Malatíón|||||||2 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|4038|5773|lyfsjukr|||1|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||4038||4038|5773||1 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|2111|3018|lyfsjukr|||1|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2111||2111|3018||1 116198|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1153|1992|lyfalmen|V0056|1992|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|1992||2 116220|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1826|1992|lyfalmen|V0057|1992|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|1992||2 116244|D11AF01|Verucid|áburður|||10|ml|1|glas||D11AF|01.11.1981||L|0|0|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||0|10|0||Icepharma hf|Galderma Nordic AB|Lyf við vörtum og líkþornum|||||||2 116449|N05AH0313|Olanzapin Sandoz|filmhtfl|5|mg|250|stk|1|glas||N05AH03|01.05.2013||R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|18480|12986|lyfalmen|||2|250|0|125,0000|Artasan ehf|Sandoz A/S|Olanzapín||8653||8653|12986||1 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen|||||||1 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen|||||||1 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|354|1547|lyfalmen|V0563|1547|2|30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||342||342|1547||1 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|glas||M01AE01|01.05.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|851|2228|lyfalmen|V0564|1718|2|100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||837||837|2228||1 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|14804|21266|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||14804||14804|21266||1 116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|5009|5090|lyfalmen|V0081|5090|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||2916||2916|5090||1 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|5646|8847|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||5646||5646|8847||1 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|6063|9421|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6063||6063|9421||1 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|15870|22614|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||15870||15870|22614||1 116769|N06DX0108|Memantine Alvogen|munndr.t|20|mg|56|stk|1|þpakki||N06DX01|01.05.2014||R|0|0|0|0|G|0|IPC|0|0|0|100|DKK|11577|9026|lyfalmen|||2|56|0|56,0000|Portfarma ehf|Alvogen IPco S.á.r.l.|Memantín||5776||5776|9026||1 116841|D07AC1302|Ovixan|húðlausn|0,1|%|30|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|674|2004|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||||674|2004||1 117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|XEU|9164|17556|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum með D-vítamíni/eða öðrum efnum||9164||9164|17556||2 117424|M01AE0303|Orudis|forðahlk|100|mg|100|stk|1|glas||M01AE03|01.12.2014||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1581|3252|lyfalmen|||1|100|0|66,6700|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||1581||1581|3252||1 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|4242|6915|lyfalmen|V0435|6816|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4242||4242|6915||2 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|13236|16926|lyfalmen|||1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||11515||11515|16926||1 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|0|0|0|G|0|ASZ|0|0|0|100|SEK|23392|28283|lyfalmen|V0273|24044|1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||20352||20352|28283||1 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1503|3145|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1503||1503|3145||2 117573|N05AH0405|Seroquel Prolong|forðatfl|300|mg|10|stk|1|þpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|4045|6644|lyfalmen|||1|10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4045|6644||1 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|0|0|0|G|0|ASZ|0|0|0|100|SEK|37542|43853|lyfalmen|V0272|36059|1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||32662||32662|43853||1 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|46784|61714|lyfalmen|V0261|49340|1|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||46784|61714||1 117676|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|1|0|1|JCI|0|1|0|100|SEK|53288|68135|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||53288||53288|68135||1 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|9094|15674|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|||9094||9094|15674||2 117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|6112|11766|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||6112||6112|11766||2 117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|XEU|10852|20759|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||10852||10852|20759||2 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1696|3411|lyfalmen|V0278|2738|2|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1696||1696|3411||1 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2781|4904|lyfalmen|V0279|3141|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2781||2781|4904||1 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|9990|2793|lyfalmen|V0282|2392|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1247||1247|2793||1 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1640|3334|lyfalmen|V0283|3334|2|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1640||1640|3334||1 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|9512|13599|lyfsjukr|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|13599||5 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|16226|5406|lyfalmen|V0280|5406|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3146||3146|5406||1 118525|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.03.2015||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|6030|8621|lyfsjukr|||2|45|0||Alvogen HS|Hospira Nordic AB|Karbóplatín||6030||6030|8621||1 118575|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5039|9730|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5039||5039|9730||2 118612|A07EC0203|Pentasa Sachets|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|20510|28483|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||20510||20510|28483||1 118658|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|3009|4302|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||3009||3009|4302||2 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|þpakki||C01AA05|01.12.2010||R|1|0|0|0|G|0|APP|0|0|0|100|XEU|458|1707|lyfalmen|||1|120|0|30,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||458||458|1707||1 119394|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.04.2013||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|1476|3108|lyfalmen|||1|50|0|8,3333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||1476||1476|3108||1 119825|N05BA1206|Alprazolam Krka|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|903|1954|lyfalmen|V0309|1954|2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||638||638|1954||2 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|GGL|0|1|0|100|GBP|403832|504114|lyfsjukr|||1|30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||403832||403832|504114||1 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|GGL|0|1|0|100|GBP|361221|451118|lyfsjukr|||1|30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||361221||361221|451118||1 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|1070|2549|lyfalmen|||1|10|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Cýklópentólat||1070||1070|2549||1 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|1|0|1|LIL|0|1|0|100|XEU|40252|51922|lyfsjukr|||1|1|0||Icepharma hf|Lilly ICOS Limited|Pemetrexed||40252||40252|51922||2 120768|C10AA0703|Rosuvastatin Krka|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|10373|12432|lyfalmen|V0118|12432|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||8250||8250|12432||2 120798|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|27431|35976|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||27431||27431|35976||1 121104|L01XC1401|Kadcyla|irþ|160|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|423865|529029|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Trastuzumab emtansine||423865||423865|529029||2 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|4583|7384|lyfalmen|||1|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4583||4583|7384||1 121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|0|0|0|0|0|1|ORG|0|0|0|100|DKK|7185|10273|lyfsjukr|||1|50|0||Vistor hf|N.V. Organon|Rókúrón, brómíð||7185||7185|10273||1 121302|N02BA5102|Treo|freyðit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|60|0|10,0000|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||1 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|skammtar|1|stauk||R03AC02|01.12.1972||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|439|1681|lyfalmen|||1|200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||439||439|1681||1 121550|A02BC0507|Esomeprazole Portfarma|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC05|01.11.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|3829|5278|lyfalmen|V0011|5149|2|98|0|65,3300|Portfarma ehf|Portfarma|Esómeprazól||3053||3053|5278||1 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|508|1776|lyfalmen|V0391|1685|2|28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||508||508|1776||1 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1649|3346|lyfalmen|V0314|2850|1|100|0|25,0000|Vistor hf|Novartis Healthcare A/S|Klómípramín||1649||1649|3346||1 121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|þpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|339|1543|lyfalmen|||2|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||339||339|1543||1 122301|R01AD0802|Nasofan|nefúði|50|mcg/sk|60|skammtar|1|glas||R01AD08|01.05.2014||L|0|0|0|0|0|0|TSB|0|0|1|100|IKR|||lyflausa|||2|60|0|15,0000|Medical ehf|Teva Sweden AB|Flútíkasón|||||||2 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|9501|16376|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9501||9501|16376||1 122547|N07BC0202|Metadon Abcur|töflur|5|mg|20|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|627|1939|lyfalmen|||1|20|0|5,0000|Icepharma hf|Abcur AB|Metadón||627||627|1939||2 122577|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|2815|3815|lyfalmen|V0381|3815|2|10|0|2,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||1990||1990|3815||2 122588|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|50|stk|1|þpakki||A04AA01|01.11.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|9198|12065|lyfalmen|||2|50|0|12,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||7984||7984|12065||2 122610|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|10|stk|1|þpakki||A04AA01|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|3320|3712|lyfalmen|||2|10|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||1915||1915|3712|30.6.2015|2 122643|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|50|stk|1|þpakki||A04AA01|01.11.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|14342|11997|lyfalmen|||2|50|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||7934||7934|11997|30.6.2015|2 123216|N05BA0105|Stesolid|eþ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|826|2213|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||826||826|2213||1 123224|N05BA0105|Stesolid|eþ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1059|2534|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1059||1059|2534||1 123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|29367|50617|vetorma|||0|100|0||Icepharma hf|Icepharma hf|||29367||29367|50617||2 123456|R03DX0701|Daxas|filmhtfl|500|mcg|90|stk|1|þpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|TAK|0|0|0|100|DKK|20014|27856|lyfalmen|||1|90|0|90,0000|Vistor hf|Takeda GmbH|Roflumílast||20014||20014|27856||1 123493|C10AA0506|Atorvaratio|filmhtfl|80|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|0|0|TSB|0|0|0|100|IKR|7844|11873|lyfalmen|V0115|11873|2|100|0|400,0000|Medical ehf|Teva Sweden AB|Atorvastatín||7844||7844|11873||2 123641|QP51AJ0102|Baycox Sheep vet.|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.03.2014||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|29832|51418|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||29832||29832|51418||2 123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|230|1393|lyfalmen|||2|100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||230|1393||1 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|1|0|0|1|G|0|AVS|0|0|0|100|NOK|23896|32766|lyfalmen|V0579|27216|1|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||23896||23896|32766||1 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|1707|3355|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|||||1707|3355||2 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|þpakki||B01AC04|01.09.2009||R|1|0|0|0|0|0|SBM|0|0|0|100|NOK|31670|42598|lyfalmen|||1|30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||31670|42598||1 124168|N07BC0202|Metadon Abcur|töflur|20|mg|100|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|9404|14020|lyfalmen|||1|100|0|100,0000|Icepharma hf|Abcur AB|Metadón||9404||9404|14020||2 124207|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.04.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1790|1916|lyfalmen|V0234|1910|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||610||610|1916||2 124251|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|þpakki||N02CC01|01.04.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2557|2197|lyfalmen|V0233|2190|2|12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||814||814|2197||2 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|936|2365|lyfalmen|||1|30|0|18,7500|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||936||936|2365||1 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|þpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|439|1681|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||439||439|1681||1 124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|10468|15484|lyfalmen|V0464|15484|1|7,5|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||10468||10468|15484||1 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|958|2323|lyfalmen|V0066|2315|2|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||906||906|2323||1 125125|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2013||R|0|0|0|1|G|0|APP|0|0|0|100|XEU|11901|17457|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Melphalan||11901||11901|17457||1 125457|N05AH0411|Quetiapine Teva|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|4400|4380|lyfalmen|V0285|4311|2|100|0|25,0000|Medical ehf|Teva Sweden AB|Quetíapín||2400||2400|4380||2 125973|D01BA0206|Terbinafin Bluefish|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.08.2012||R|1|0|0|0|0|0|BLP|0|0|0|100|XEU|2330|4283|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Terbínafín||2330||2330|4283|30.4.2015|2 126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|23762|31413|lyfsjukr|||1|1|0|0,5417|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||23762||23762|31413||2 126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|7920|11323|lyfsjukr|||1|1|0|0,1354|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||7920||7920|11323||2 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|32131|41822|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||32131||32131|41822||2 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|64263|81785|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||64263||64263|81785||2 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|128525|161709|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||128525||128525|161709||2 126803|S01LA0501|Eylea|stl|40|mg/ml|1|hgl|1|pakki|lausn|S01LA05|01.10.2013||R|0|0|0|1|0|1|BGB|0|1|0|100|DKK|126950|159750|lyfsjukr|||1|1|0||Icepharma hf|Bayer Pharma AG|Aflibercept||126950||126950|159750||2 126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|32121|43169|lyfalmen|||1|100|0|150,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||32121|43169||2 126949|S01BC1001|Nevanac|augndr|3|mg/ml|3|ml|1|glas||S01BC10|01.02.2014||R|0|0|0|0|G|0|ALA|0|0|1|100|USD|3460|5839|lyfalmen|||1|3|0||Vistor hf|Alcon Laboratories Ltd.|Nepafenak||||3460|5839||1 127362|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3899|5254|lyfalmen|V0011|5254|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3035||3035|5254||1 127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|þpakki||R02AA03|01.01.2009||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 127542|G04BE0307|Sildenafil Mylan|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|1682|2383|lyfalmen|V0144|1637|2|4|0|8,0000|Icepharma hf|Mylan AB|Síldenafíl||949||949|2383||2 127881|N07BA0149|Nicovel Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 128003|N05CF0205|Zovand|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|IKR|1644|2549|lyfalmen|V0313|2549|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||1070||1070|2549||2 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|ELD|0|0|0|100|XEU|8168|6000|lyfalmen|V0279|3141|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3577||3577|6000||2 128131|QG51AG0101|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|þpakki||QG51AG01|01.03.2009||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|13525|25830|vetalmen|||0|30|0||Vistor hf|Boehringer Ingelheim Danmark|Súlfónamíðar í blöndu með öðrum lyfjum||13525||13525|25830||1 128146|N06DX0108|Memantine Alvogen|munndr.t|10|mg|56|stk|1|þpakki||N06DX01|01.05.2014||R|0|0|0|0|G|0|IPC|0|0|0|100|DKK|4678|4497|lyfalmen|||2|56|0|28,0000|Portfarma ehf|Alvogen IPco S.á.r.l.|Memantín||2485||2485|4497||1 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1153|2663|lyfalmen|||1|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1153||1153|2663||1 128625|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2015||R|0|0|0|0|0|0|PIS|0|0|0|100|SEK|3868|6400|lyfalmen|V0699|6400|1|0,5|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||3868||3868|6400||2 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990|30.04.2015|R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3571|5106|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Mesna||3571||3571|5106||2 129024|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|2500|2177|lyfalmen|V0003|1648|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2177||2 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|ELD|0|0|0|100|XEU|32005|22030|lyfalmen|V0282|2392|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||15408||15408|22030||2 129124|N02AA0506|Oxikodon Depot Actavis|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|15070|21603|lyfalmen|V0588|21603|2|98|0|104,5300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||15070||15070|21603||1 129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|þpakki||H02AB06|01.02.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|247|1416|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||247||247|1416||1 129483|J01DH0202|Merinfec|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.08.2013||R|0|0|0|0|0|1|AGP|0|0|0|100|XEU|17258|23324|lyfsjukr|||1|10|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Meropenem||||17258|23324||1 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||0|100|0||Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3083||1 129817|R03BB0101|Atrovent|innúðal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|3132|5387|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||3132||3132|5387||1 129936|N06BA0406|Medikinet CR|hylki|50|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|9929|14743|lyfalmen|||2|30|0|50,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||9929||9929|14743||2 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|2082|3942|lyfalmen|||2|10|0|20,0000|Icepharma hf|Mylan AB|Adrenalín tartrat||2082||2082|3942||2 130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|16215|30934|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||16215||16215|30934||1 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|3739|6223|lyfalmen|V0644|6223|2|125|0|31,2500|Vistor hf|Takeda Pharma A/S|Fúrósemíð||3739||3739|6223||1 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1627|3316|lyfalmen|||2|10|0|3,3400|Icepharma hf|Mylan AB|Atrópínsúlfat||1627||1627|3316||2 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|1|0|0|0|0|0|IPI|0|0|1|100|DKK|10641|15723|lyfalmen|||1|53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||10641|15723||1 130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|53570|86355|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||53570|86355||1 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|2983|5182|lyfalmen|||2|10|0|10,0000|Icepharma hf|Mylan AB|Efedrínhýdróklóríð||||2983|5182||2 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|421|1656|lyfalmen|||2|100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||421||421|1656||1 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|662|1987|lyfalmen|||2|100|0|15,0000|Vistor hf|Recip AB|Fenemal||662||662|1987||1 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|883|2292|lyfalmen|||2|100|0|50,0000|Vistor hf|Recip AB|Fenemal||883||883|2292||1 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|977|2421|lyfalmen|||2|100|0|100,0000|Vistor hf|Recip AB|Fenemal||977||977|2421||1 131565|G03CA0306|Evorel|forðapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993|30.04.2015|R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|5056|8035|lyfalmen|||1|26|0|182,0000|Vistor hf|Janssen-Cilag AB|Estradíól||5056||5056|8035||1 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 131817|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AF01|01.05.2009|30.06.2015|R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|3217|5504|lyfalmen|||1|10|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||3217|5504||2 131828|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AF01|01.05.2009|30.06.2015|R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|9650|14359|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||9650|14359||2 131840|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AF01|01.05.2009|30.06.2015|R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|31908|42899|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||31908|42899||2 132260|N06DA0404|Galantamine Portfarma|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|7120|10876|lyfalmen|||2|28|0|14,0000|Portfarma ehf|Portfarma|Galantamín||7120||7120|10876||1 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4950|2987|lyfalmen|V0581|2728|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||1388||1388|2987||1 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|3077|2987|lyfalmen|V0580|2728|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||1388||1388|2987||1 132546|A06AX0401|Constella|hylki|290|mcg|28|stk|1|glas||A06AX04|01.05.2013||R|0|0|0|0|G|0|ALM|0|0|0|100|DKK|9420|14042|lyfalmen|||1|28|0|28,0000|Vistor hf|Almirall S.A.|Linaclotídum||9420||9420|14042||1 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|1|0|1|0|G|0|REP|0|0|1|100|SEK|1322|2896|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Kódein||1322||1322|2896||1 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|6210|9519|lyfalmen|V0681|8652|1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6134||6134|9519||1 132717|QN05CM9204|Nerfasin vet.|stl|100|mg/ml|50|ml|1|hgl|fyrir nautgripi og hesta|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|9018|17279|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet B.V.|||9018||9018|17279||2 132748|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3141|lyfalmen|V0335|3141|2|100|0|150,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3141||2 132761|D08AG0201|Betadine|húðlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|0|SAC|0|0|0|100|USD|1220|2756|lyfalmen|||1|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||1220||1220|2756||1 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1 132902|G03AB0402|Trinovum 28|töflur|||84|stk|1|þpakki||G03AB04|01.01.1993||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1138|2643|lyfalmen|||1|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1138||1138|2643||1 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|24194|31951|lyfsjukr|||1|0,5|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||24194||24194|31951||1 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|32169|41869|lyfsjukr|||1|1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||32169||32169|41869||1 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|43742|56263|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||43742|56263||1 133411|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|+ leysir, lausn|B06AC01|01.03.2013||R|0|1|0|1|0|1|SPR|0|0|0|100|DKK|178078|223339|lyfsjukr|||1|2|0||Lyfjaver ehf|ViroPharma SPRL|C1 hemill||178078||178078|223339||3 133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||||1 133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||||1 133551|J05AG0101|Viramune|töflur|200|mg|14|stk|1|þpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|7978|11406|lyfsjukr|||1|14|0|7,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||7978||7978|11406||1 133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|SEK|||lyfalmen|V0592|6202|0|50|0|25,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||6202||1 133919|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|1765|lyfalmen|V0329|1765|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1765||2 133949|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.02.2015||R|0|0|0|0|G|0|STI|0|0|0|100|NOK|3082|5318|lyfalmen|||1|5|0|13,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||3082||3082|5318||3 133974|N06AX1610|Venlafaxine Bluefish|forðahlk|37,5|mg|30|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|1661|3363|lyfalmen|V0333|3363|2|30|0|11,2500|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1661||1661|3363||2 134019|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3141|lyfalmen|V0334|3141|2|100|0|75,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3141||2 134085|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3141|lyfalmen|V0335|3141|2|100|0|150,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3141||2 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3743|6228|lyfalmen|V0378|5507|1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||3743||3743|6228||2 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|11220|16520|lyfalmen|V0378|16520|1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||11220||11220|16520||2 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|2542|3634|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Epírúbicín||2542||2542|3634||1 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|56093|71624|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||56093||56093|71624||1 134844|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.04.2014||L|1|0|0|0|G|0|SIV|0|0|1|100|DKK|||lyfalmen|V0362|2047|1|100|0|100,0000|Vistor hf|Bayer AB|Lóratadín|||||8707||1 134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|112599|141902|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||112599||112599|141902||2 134906|A02BC0307|Gasterix|sþ-hylki|30|mg|100|stk|1|glas||A02BC03|01.02.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4200|3416|lyfalmen|V0007|3416|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Lansóprazól||1700||1700|3416||2 134939|A02BC0307|Gasterix|sþ-hylki|15|mg|100|stk|1|glas||A02BC03|01.02.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|2560|3829|lyfalmen|||2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Lansóprazól||2000||2000|3829||2 135090|C02KX0501|Adempas|filmhtfl|1,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|383446|478759|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Riociguatum||383446||383446|478759||2 135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|49323|63204|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||49323||49323|63204||1 135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|900|2315|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Verapamíl||900||900|2315||2 135434|R03BA0502|Flixotide Diskus|innönddu|100|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|1468|3097|lyfalmen|||1|60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||1468||1468|3097||1 135559|L01CD0202|Docetaxel Actavis|irþ|20|mg/ml|4|ml|1|hgl|lausn|L01CD02|01.04.2013||R|0|0|0|1|0|1|AVB|0|0|0|100|XEU|5012|7166|lyfsjukr|||2|4|0||Actavis Group PTC ehf|Actavis BV|Docetaxel||5012||5012|7166||1 136168|G03AB0401|Trinovum|töflur|||63|stk|1|þpakki||G03AB04|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1138|2643|lyfalmen|||1|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1138||1138|2643||1 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|6174|9574|lyfalmen|||1|100|0|100,0000|Vistor hf|Recip AB|Ísóníazíð||6174||6174|9574||1 136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|64959|82651|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||64959||64959|82651||1 136653|N06AX2601|Brintellix|filmhtfl|5|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|3019|5232|lyfalmen|||1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||3019||3019|5232||1 136658|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|429|1544|lyfalmen|V0307|1544|2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||340||340|1544||2 136964|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|2193|3135|lyfsjukr|||2|5|0||Alvogen HS|Hospira UK Ltd.|Paklítaxel||2193||2193|3135||1 136975|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|6866|9816|lyfsjukr|||2|16,7|0||Alvogen HS|Hospira UK Ltd.|Paklítaxel||6866||6866|9816||1 136987|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|5060|7234|lyfsjukr|||2|25|0||Alvogen HS|Hospira UK Ltd.|Paklítaxel||5060||5060|7234||1 136998|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|7887|11276|lyfsjukr|||2|50|0||Alvogen HS|Hospira UK Ltd.|Paklítaxel||7887||7887|11276||1 137110|L01XA0302|Oxaliplatin Hospira|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|5545|7928|lyfsjukr|||2|20|0||Alvogen HS|Hospira UK Ltd.|Oxalíplatín||5545||5545|7928||1 137635|N05AH0413|Quetiapin ratiopharm|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|G|0|TEV|0|0|0|100|IKR|39000|49340|lyfalmen|V0261|49340|2|100|0|100,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||37000||37000|49340||2 137809|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|20179|26957|lyfsjukr|||2|25|0|1,2500|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||20179||20179|26957||1 137820|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|5866|8387|lyfsjukr|||2|10|0|0,5000|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||5866||5866|8387||1 137831|M05BA0302|Pamidronatdinatrium Hospira|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|5124|7326|lyfsjukr|||2|10|0|1,0000|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||5124||5124|7326||1 137842|M05BA0302|Pamidronatdinatrium Hospira|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|5791|8280|lyfsjukr|||2|10|0|1,5000|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||5791||5791|8280||1 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.04.1997||R|0|0|0|0|0|1|ENH|0|0|0|100|XEU|695|994|lyfsjukr|||2|1|0|0,2500|Alvogen HS|Hospita Enterprises B.V. (I)|Vankómýcín||695||695|994||1 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|hgl|1|pakki||J01XA01|01.04.1997||R|0|0|0|0|0|1|ENH|0|0|0|100|XEU|979|1400|lyfsjukr|||2|1|0|0,5000|Alvogen HS|Hospita Enterprises B.V. (I)|Vankómýcín||979||979|1400||1 138302|N03AX1603|Pregabalin Krka|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|13290|19351|lyfalmen|V0689|19351|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||13290||13290|19351||2 138318|L01BA0109|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2893|5058|lyfalmen|||1|0,35|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2893||2893|5058||2 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1602|3281|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1602||1602|3281||2 138603|N07BB0501|Selincro|filmhtfl|18|mg|28|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|16028|22814|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||16028||16028|22814||1 139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.01.2012||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|4407|7058|lyfalmen|V0373|7058|2|15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||4346||4346|7058||1 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||L|1|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín|||||4911||1 140141|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|315717|394524|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||315717||315717|394524||1 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|1352|2937|lyfalmen|V0266|2107|1|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1352||1352|2937||1 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|1|LBK|0|0|0|100|DKK|10380|14770|lyfsjukr|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||10380||10380|14770||1 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|0|0|0|0|0|1|SIG|0|0|0|100|DKK|593|848|lyfsjukr|||1|5|0|3,3333|Swedish Orphan Biovitrum A/S|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||593||593|848||3 140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|baðlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|0|SRR|0|0|0|100|NOK|77602|147397|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||77602||77602|147397||1 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|1131|2633|lyfalmen|V0413|2402|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1131||1131|2633||1 141063|S01BC1001|Nevanac|augndr|1|mg/ml|5|ml|1|dropaí||S01BC10|01.08.2013||R|0|0|0|0|G|0|ALA|0|0|1|100|USD|3460|5839|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Nepafenak||||3460|5839||1 141129|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|1201|1717|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1201||1201|1717||2 141153|R01AB0601|Otrivin Comp|nefúði|1,1|mg/ml|10|ml|1|glas|0,5+0,6 mg/ml|R01AB06|01.05.2013||L|0|0|0|0|0|0|NAA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S|Xýlómetazóín og Ípratrópíum|||||||1 141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3577|5114|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3577||3577|5114||2 141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|15476|22116|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||15476|22116||2 141569|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.01.2013||R|1|0|0|0|G|0|SPR|0|0|1|100|DKK|40709|54031|lyfalmen|||1|50|0|8,3300|Lyfjaver ehf|ViroPharma SPRL|Hýdrókortisón||40709||40709|54031||2 141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|3763|6256|lyfalmen|V0193|5044|1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||3763|6256||2 141856|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|KAB|0|0|0|100|IKR|||lyfalmen|||0|200|0||Icepharma hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3053||2 141872|R03DC0304|Montelukast Teva|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.02.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|12507|3513|lyfalmen|V0492|3513|2|98|0|39,2000|Medical ehf|Teva Pharma B.V.|Montelúkast||1770||1770|3513||2 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|8012|12104|lyfalmen|V0267|5009|1|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||8012||8012|12104||1 142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1754|3402|lyfalmen|V0127|3168|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||1690||1690|3402||2 142123|R07AX0101|INOmax|innö.gas|800|ppm|2|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|21720|28874|lyfsjukr|||1|2|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||21720|28874||5 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|820|2205|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||820||820|2205||1 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|2564|4605|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2564||2564|4605||1 142615|C07AG0205|Carveratio|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|1750|3485|lyfalmen|||2|100|0|16,6700|Medical ehf|ratiopharm GmbH|Carvedílól||1750||1750|3485||2 143139|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|5000|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||16398||2 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|1344|2926|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1344||1344|2926||1 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2111|3018|lyfsjukr|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2111||2111|3018||1 143511|J07BC2002|Twinrix Paediatric|stl|||0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|4126|6755|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4126||4126|6755||1 143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|547|1620|lyfalmen|V0542|1620|2|100|0|66,6700|Actavis Group hf|Actavis Group PTC ehf|Atenólól||395||395|1620||1 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|0|SAC|0|0|0|100|USD|1008|2464|lyfalmen|||1|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Trópíkamíð||1008||1008|2464||1 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1272|2827|lyfalmen|V0173|2358|1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1272||1272|2827||1 143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|6151|9543|lyfalmen|V0387|8443|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||6151||6151|9543||1 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|þpakki||N02CX02|01.04.1974||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1236|2778|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||1236||1236|2778||1 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|6219|9636|lyfalmen|V0386|7623|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||6219||6219|9636||1 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|546|1828|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||546||546|1828||1 143787|N06AX1611|Duofaxin|forðatfl|225|mg|28|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|0|0|MEV|0|0|0|100|DKK|1514|3016|lyfalmen|||2|28|0|63,0000|Vistor hf|MediLink A/S|Venlafaxín||1409||1409|3016||1 143800|N05AN0101|Litarex|forðatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|0|G|0|AGT|0|0|0|100|DKK|2532|4561|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||2532||2532|4561||1 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1606|3287|lyfalmen|V0174|2694|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1606||1606|3287||1 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1944|3752|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1944||1944|3752||1 144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|21375|29577|lyfalmen|||1|60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||21375||21375|29577||1 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|64867|82536|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||64867||64867|82536||1 144242|C10AA0106|Simvastatin Bluefish|filmhtfl|80|mg|100|stk|1|þpakki||C10AA01|01.05.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|5000|3815|lyfalmen|||2|100|0|266,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||1990||1990|3815||2 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|43251|55652|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||43251||43251|55652||1 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|21626|28757|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||21626||21626|28757||1 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|572|1864|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||572||572|1864||1 145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|1|0|1|0|1|CEO|0|1|0|100|DKK|73091|92765|lyfsjukr|||1|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||73091||73091|92765||1 145440|QG04CX9001|Ypozane|töflur|1,875|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1674|3290|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||1674||1674|3290||1 145451|QG04CX9001|Ypozane|töflur|3,75|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|2539|4987|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||2539||2539|4987||1 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|1|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|8|0|1,1400|Vistor hf|Recip AB|Pýrvín|||||||1 145616|QG04CX9001|Ypozane|töflur|7,5|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3908|7585|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||3908||3908|7585||1 145627|QG04CX9001|Ypozane|töflur|15|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|5450|10510|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||5450||5450|10510||1 145784|B03AC0005|Ferinject|irl|50|mg/ml|2|ml|1|hgl||B03AC|01.06.2014||R|0|0|0|0|G|0|VIF|0|0|1|100|CHF|5623|8816|lyfalmen|||1|2|0|1,0000|Vistor hf|Vifor France SA|Járn, stungulyf||5623||5623|8816||1 145806|B03AC0005|Ferinject|irl|50|mg/ml|10|ml|1|hgl||B03AC|01.06.2014||R|0|0|0|0|G|0|VIF|0|0|1|100|CHF|29704|40112|lyfalmen|||1|10|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||29704||29704|40112||1 146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|32978|42875|lyfsjukr|||1|1|0|4,8000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||||32978|42875||1 146207|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|2832|4049|lyfsjukr|||2|2|0||Alvogen HS|Hospira UK Ltd.|Írinótekan||2832||2832|4049||1 146218|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|5754|8227|lyfsjukr|||2|5|0||Alvogen HS|Hospira UK Ltd.|Írinótekan||5754||5754|8227||1 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.01.2010||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|16653|23605|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||16653||16653|23605||2 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|725|2074|lyfalmen|||1|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||725||725|2074||1 146692|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|15|ml|1|hgl||L01XA02|01.03.2015||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|2201|3147|lyfsjukr|||2|15|0||Alvogen HS|Hospira Nordic AB|Karbóplatín||2201||2201|3147||1 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|2349|3358|lyfsjukr|||2|5|0||Alvogen HS|Hospira Nordic AB|Cýtarabín||2349||2349|3358||1 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|1455|2080|lyfsjukr|||2|10|0||Alvogen HS|Hospira Nordic AB|Cýtarabín||1455||1455|2080||1 147426|N06BA0404|Methylphenidate Sandoz|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.04.2015||R|1|0|1|0|0|0|SHS|0|0|0|100|DKK|4934|7867|lyfalmen|V0691|7867|2|30|0|18,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||4934||4934|7867||1 147578|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|KAB|0|0|0|100|IKR|||lyfalmen|||0|400|0||Icepharma hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2948||2 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|0|0|0|0|ROA|0|0|1|100|DKK|105226|135632|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||105226||105226|135632||2 148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1125|2355|lyfalmen|V0577|2355|2|20|0|6,6667|Portfarma ehf|Orion Corporation|Pívmecillínam||929||929|2355||1 148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1674|3380|lyfalmen|||2|30|0|10,0000|Portfarma ehf|Orion Corporation|Pívmecillínam||1674||1674|3380||1 148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|5756|8615|lyfalmen|||2|100|0|33,3300|Portfarma ehf|Orion Corporation|Pívmecillínam||5477||5477|8615||1 148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLI|0|0|0|100|DKK|70130|91242|lyfalmen|||1|30|0|15,0000|GlaxoSmithKline ehf|Stiefel Laboratories (Ireland) Ltd.|Alítretínóín||70130||70130|91242||1 148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLI|0|0|0|100|DKK|70130|91242|lyfalmen|||1|30|0|45,0000|GlaxoSmithKline ehf|Stiefel Laboratories (Ireland) Ltd.|Alítretínóín||70130||70130|91242||1 148411|C03CA0110|Impugan|töflur|40|mg|100|stk|1|glas||C03CA01|01.08.2013||R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|411|1540|lyfalmen|V0601|1540|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Fúrósemíð||337||337|1540||1 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|1|0|0|0|G|0|LFS|0|0|0|100|DKK|795|2171|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||795||795|2171||1 148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|62097|79091|lyfsjukr|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíð og súrefni||62097||62097|79091||5 148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|6111|8737|lyfsjukr|||2|5|0||Alvogen HS|Hospira Nordic AB|Vínkristín||6111||6111|8737||1 148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|12811|17793|lyfsjukr|||2|10|0||Alvogen HS|Hospira Nordic AB|Vínkristín||12811||12811|17793||1 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|27406|35945|lyfsjukr|||1|1|0||Alvogen HS|Hospira Nordic AB|Raltítrexed||27406||27406|35945||1 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|3389|6600|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|||3389||3389|6600||2 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|þpakki||N05AG02|01.03.2004||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|3146|5406|lyfalmen|||0|75|1|18,7500|Distica|Distica - óskráð lyf|Pímózíð||3146||3146|5406||1 149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|973|2416|lyfalmen|V0376|1644|2|2,5|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||973||973|2416||1 149525|QA04AD9001|Cerenia|töflur|60|mg|4|stk|1|þpakki||QA04AD90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2617|5135|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||2617|5135||2 150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|4697|7541|lyfalmen|||1|24|0||Vistor hf|Laboratories THEA|Ketotifen||4697||4697|7541||1 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|41320|53251|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||41320|53251||1 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|6126|9508|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||6126||6126|9508||1 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|978|2422|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||978||978|2422||1 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|14876|21357|lyfalmen|V0606|5149|1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||14876|21357||1 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|45934|57871|lyfalmen|V0607|12592|1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||43745||43745|57871||1 151532|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|395|1620|lyfalmen|V0633|1548|2|100|0|50,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||395||395|1620||1 151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|4472|7232|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||||4472|7232||2 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.05.2006||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|4784|3608|lyfalmen|V0148|3461|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||1839||1839|3608||2 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1469|3098|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1469||1469|3098||1 151975|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4359|3554|lyfalmen|V0006|3554|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1800||1800|3554||2 152197|C07AB0213|Metoprololsuccinat Hexal|forðatfl|25|mg|100|stk|1|plglas|23,75 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1090|2431|lyfalmen|V0050|2431|2|100|0|15,8300|Artasan ehf|Hexal A/S|Metóprólól||984||984|2431||1 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|1781|2546|lyfsjukr|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S|Baklófen||1781||1781|2546||1 152318|D01BA0204|Terbinafine (Lyf og heilsa)|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.12.2010||R|1|0|0|0|0|0|HOL|0|0|0|100|XEU|2072|3902|lyfalmen|V0123|3902|3|28|0|28,0000|Lyf og heilsa|Lyf og heilsa|Terbínafín||2053||2053|3902||2 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|2901|5069|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2901||2901|5069||1 152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4655|7483|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4655||4655|7483||1 152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|8511|12791|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||8511||8511|12791||1 152635|B01AC0601|Hjartamagnyl|sþ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|1|0|0|0|0|0|AGP|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1 152653|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|1427|2040|lyfalmen|V0033|2040|2|10|0|1,6667|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||700||700|2040||2 152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|17604|24808|lyfalmen|||3|100|0|28,0000|LYFIS ehf|LYFIS ehf|Pramipexól||17604||17604|24808||2 152675|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|5140|5343|lyfalmen|V0182|5343|2|42|0|7,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||3100||3100|5343||2 152687|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|90|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|12712|10711|lyfalmen|||2|90|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||7000||7000|10711||2 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki|hart|J02AC02|01.01.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|1090|2577|lyfalmen|||1|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1090||1090|2577||1 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1596|3273|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín í blöndum||1596||1596|3273||1 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|30990|40403|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||30990|40403||1 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2016|3851|lyfalmen|V0561|3686|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2016||2016|3851||1 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1410|3017|lyfalmen|V0560|2901|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1410||1410|3017||1 153288|R06AE0704|Histasin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|G|0|ACA|0|0|1|100|XEU|||lyfalmen|V0575|2242|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín|||||3729||1 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|1|GSL|0|0|0|100|DKK|200396|251097|lyfsjukr|||1|10|0|14,2857|Gilead Nordic|Gilead Science International Ltd|Amfóterícín||200396||200396|251097||2 153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|510|1778|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||510|1778||1 153507|L02BG0602|Exemestan- Actavis|filmhtfl|25|mg|100|stk|1|þpakki||L02BG06|01.08.2011||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|28398|38460|lyfalmen|V0452|38460|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||28398||28398|38460||1 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|3541|5950|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||3541||3541|5950||1 153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|602|1905|lyfalmen|||2|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||602||602|1905||1 153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|981|2427|lyfalmen|||2|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||981||981|2427||1 154014|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|TEV|0|0|1|100|XEU|1139|2253|lyfalmen|V0366|2253|2|30|0|30,0000|Medical ehf|Teva Pharma B.V.|Deslóratadín||855||855|2253||2 154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|8801|13190|lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||8801||8801|13190||1 154558|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|þpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|22185|30602|lyfalmen|V0668|30602|1|28|0|42,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||22185||22185|30602||1 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|987|2435|lyfalmen|||1|20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||987||987|2435||1 154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|18969|25452|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||18969||18969|25452||2 154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|21674|28816|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||21674||21674|28816||2 154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|27113|35581|lyfsjukr|||1|7880|0||Icepharma hf|Fresenius Kabi|Blöndur||27113||27113|35581||2 154651|B05BA1021|SmofKabiven|irl|2700|kcal|2463|ml|3|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|24737|32626|lyfsjukr|||1|7389|0||Icepharma hf|Fresenius Kabi|Blöndur||24737||24737|32626||2 154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|25075|33046|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||25075||25075|33046||2 154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|30390|39657|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||30390||30390|39657||2 154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|16172|21973|lyfsjukr|||1|4824|0||Icepharma hf|Fresenius Kabi|Blöndur||16172||16172|21973||2 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|3079|5314|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3079||3079|5314||1 154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|23899|31584|lyfsjukr|||1|7616|0||Icepharma hf|Fresenius Kabi|Blöndur||23899||23899|31584||2 154728|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|28|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1426|3039|lyfalmen|V0336|2343|2|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1426||1426|3039||1 154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4054|3153|lyfalmen|V0334|3078|2|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1509||1509|3153||1 154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|6506|3153|lyfalmen|V0335|3078|2|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1509||1509|3153||1 154952|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|þpakki|hart|L04AX05|01.07.2012||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|356431|453356|lyfalmen|||1|252|0|28,0300|Icepharma hf|Roche Registration Limited|Pírfenidon||356431||356431|453356||2 155033|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|5337|3016|lyfalmen|V0604|3016|2|30|0|15,0000|Medical ehf|ratiopharm GmbH|Memantín||1409||1409|3016||2 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|10164|15066|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Chlorambucíl||10164||10164|15066||1 155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2073|2011|lyfalmen|V0247|1754|2|60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||679||679|2011||1 155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3493|3859|lyfalmen|V0248|3378|2|60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||2022||2022|3859||1 155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|6280|4413|lyfalmen|V0249|3785|2|60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||2424||2424|4413||1 155246|C10BA0501|Atozet|filmhtfl|30|mg|90|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|16541|23463|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||16541||16541|23463||1 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1422|3034|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1422||1422|3034||1 155410|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|1500|2177|lyfalmen|V0466|1787|2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2177||2 155415|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|11341|7028|lyfalmen|V0253|6307|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4324||4324|7028||1 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|609|1915|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||609||609|1915||1 155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|1567|3094|lyfalmen|V0590|3094|2|84|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||1466||1466|3094||1 155494|M01AE0113|Ibuxin|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|ROY|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Medical ehf|ratiopharm Oy|Íbúprófen|||||||2 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|5791|9047|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||5791||5791|9047||1 156439|L04AC1001|Cosentyx|stl|150|mg|2|áf.spr|1|þpakki||L04AC10|01.07.2015||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|153026|164627|lyfsjukr|||1|2|0||Vistor hf|Novartis Europharm Ltd|Secukinumab||130871||130871|164627||1 156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|5050|8027|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5050||5050|8027||2 156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|5654|8858|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5654||5654|8858||2 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|þpakki||J01XE01|01.08.2010||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|387|1609|lyfalmen|||2|15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||387||387|1609||1 156563|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|2201|3147|lyfsjukr|||2|15|0||Alvogen HS|Hospira Nordic AB|Karbóplatín||2201||2201|3147||1 156574|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|1291|1846|lyfsjukr|||2|5|0||Alvogen HS|Hospira Nordic AB|Karbóplatín||1291||1291|1846||1 156585|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|6030|8621|lyfsjukr|||2|45|0||Alvogen HS|Hospira Nordic AB|Karbóplatín||6030||6030|8621||1 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|9164|13690|lyfalmen|||1|84|0|28,0000|Icepharma hf|Roche|Orlístat||9164||9164|13690||2 156597|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|8077|11548|lyfsjukr|||2|60|0||Alvogen HS|Hospira Nordic AB|Karbóplatín||8077||8077|11548||1 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|776|2144|lyfalmen|||1|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||776||776|2144||1 156723|QN01AX0303|Ketador vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2013||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|11007|21053|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Ketaminum||11007||11007|21053||2 157015|QP54AB5207|Equest Pramox vet|hlaup|||14,4|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.08.2014||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|2660|4585|vetorma|||0|14,4|0||Icepharma hf|Zoetis Finland OY|||2660||2660|4585||2 157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|þpakki||N03AF01|01.01.2010||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1425|3038|lyfalmen|V0239|3038|1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1425||1425|3038||1 157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|DKK|6276|9715|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||6276||6276|9715||1 158098|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|6|lykjur||C01BD01|01.08.2013||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|1032|1475|lyfsjukr|||1|18|0|4,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||||1032|1475||1 158163|N05AH0405|Seroquel Prolong|forðatfl|50|mg|10|stk|1|þpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|1407|3013|lyfalmen|V0695|2813|1|10|0|1,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||1407|3013||1 158185|N05AH0405|Seroquel Prolong|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|25929|35337|lyfalmen|||1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||25929|35337||1 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|þpakki||N03AF01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|888|2299|lyfalmen|V0239|1519|1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||888||888|2299||1 158431|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|95272|120352|lyfsjukr|||1|1|0|0,0200|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||||95272|120352||1 158442|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|177297|222368|lyfsjukr|||1|1|0|0,0400|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||||177297|222368||1 158453|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|476360|594318|lyfsjukr|||1|1|0|0,1000|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||||476360|594318||1 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|42621|54869|lyfsjukr|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||42621|54869||1 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|56099|71631|lyfsjukr|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||56099||56099|71631||1 158725|M01AB0516|Diklofenak Mylan|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.12.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|919|1979|lyfalmen|V0469|1902|2|100|0|50,0000|Icepharma hf|Mylan AB|Díklófenak||656||656|1979||2 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|1975|3369|lyfalmen|V0219|3369|2|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1666||1666|3369||1 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|3386|5680|lyfalmen|V0220|5680|2|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3345||3345|5680||1 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|4861|7305|lyfalmen|V0221|7302|2|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4525||4525|7305||1 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|5433|7928|lyfalmen|V0223|7928|2|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4978||4978|7928||1 159295|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3218|2728|lyfalmen|V0581|2728|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og þvagræsilyf||1200||1200|2728||2 159341|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|90|stk|1|þpakki||L02BB03|01.06.2015||R|0|0|0|0|G|0|LYF|0|0|0|100|IKR|27000|22146|lyfalmen|V0421|22146|2|90|0|270,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíð||15500||15500|22146||2 159672|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|471|1725|lyfalmen|||2|25|0|10,0000|Icepharma hf|Mylan AB|Acetýlcýstein||471||471|1725||2 159683|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|1429|3043|lyfalmen|||2|100|0|40,0000|Icepharma hf|Mylan AB|Acetýlcýstein||1429||1429|3043||2 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|1|APC|0|0|0|100|DKK|128203|161309|lyfsjukr|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||128203||128203|161309||1 159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|3938|7642|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||3938||3938|7642||2 160164|M01AE0219|Alpoxen|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.05.2014||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||2|20|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen|||||||1 160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|5300|2453|lyfalmen|V0010|2067|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1000||1000|2453||1 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|7045|4255|lyfsjukr|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2976||2976|4255||1 160343|G03AA1206|Cleodette|filmhtfl|||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|2753|4866|lyfalmen|V0191|4866|2|63|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2753||2753|4866||1 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|828|2216|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||828||828|2216||1 160852|R01AX0301|Atrovent|nefúði|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|0|0|0|0|G|0|BOI|0|0|1|100|DKK|1125|2625|lyfalmen|||1|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð||1125||1125|2625||1 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|556|1842|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||556||556|1842||1 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|862|1232|lyfsjukr|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||862||862|1232||1 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|783|1119|lyfsjukr|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||783||783|1119||1 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|568|1858|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||568||568|1858||1 161133|G03CA0306|Evorel|forðapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993|30.04.2015|R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|4492|7259|lyfalmen|||1|26|0|136,5000|Vistor hf|Janssen-Cilag AB|Estradíól||4492||4492|7259||1 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|56433|73918|lyfalmen|V0452|38460|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||56433||56433|73918||1 161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|11500|16163|lyfsjukr|||1|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||11500||11500|16163||1 162080|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|137154|172441|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||137154||137154|172441||1 162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|510838|648650|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||510838||510838|648650||1 162276|A10BB0904|Zodediab|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.03.2015||R|1|0|0|0|G|0|IPC|0|0|0|100|IKR|2658|4735|lyfalmen|||2|180|0|90,0000|Portfarma ehf|Alvogen IPco S.á.r.l.|Glíklazíð||2658||2658|4735|30.6.2015|1 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1797|3550|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1797||1797|3550||1 162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|0|LEV|1|0|0|100|XEU|5099|9844|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|||||5099|9844||2 162808|C01DA1404|Fem-Mono Retard|forðatfl|60|mg|100|stk|1|þpakki||C01DA14|01.10.2013||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2574|2756|lyfalmen|V0041|2756|2|100|0|150,0000|Icepharma hf|Mylan AB|Ísósorbíð mónónítrat||1220||1220|2756||2 162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|445|1682|lyfalmen|V0500|1660|2|100|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||440||440|1682||2 162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|745|2102|lyfalmen|||2|100|0|42,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||745||745|2102||2 162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|918|1902|lyfalmen|V0502|1709|2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||600||600|1902||2 162874|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|743|1665|lyfalmen|V0108|1665|2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||428||428|1665||2 162885|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|836|1795|lyfalmen|V0109|1795|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||522||522|1795||2 162896|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1347|2128|lyfalmen|V0110|2128|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||764||764|2128||2 162903|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíð 20 mg|S01ED51|01.01.2012|30.06.2015|R|0|0|0|0|G|0|APC|0|0|0|100|XEU|1528|3115|lyfalmen|||2|5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||1481||1481|3115||1 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|1601|3280|lyfalmen|||1|120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||1601||1601|3280||1 163036|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|10052|14912|lyfalmen|V0661|14912|1|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíð||10052||10052|14912||1 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|1188|2711|lyfalmen|V0671|2384|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||1188||1188|2711||1 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|1395|2996|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1395||1395|2996||1 163354|C10BA0501|Atozet|filmhtfl|30|mg|30|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5912|9214|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5912||5912|9214||1 163429|C01CA0601|Fenylefrin Abcur|stl|0,1|mg/ml|5|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|11933|16701|lyfsjukr|||2|50|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||11933||11933|16701||2 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|2794|4922|lyfalmen|||1|120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2794||2794|4922||1 163494|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.06.2013||R|0|0|0|1|0|1|BYP|0|1|0|100|DKK|491044|612581|lyfsjukr|||1|112|0||Icepharma hf|Bayer Pharma AG|Sorafeníb||491044||491044|612581||2 163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|656|1718|lyfalmen|||2|30|0|20,0000|Medical ehf|ratiopharm Oy|Íbúprófen||466||466|1718||2 163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|1574|2621|lyfalmen|||2|100|0|66,6700|Medical ehf|ratiopharm Oy|Íbúprófen||1122||1122|2621||2 163709|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.01.2000||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|9612|14306|lyfalmen|||0|454|1|10,0800|Distica|Distica - óskráð lyf|Pólýstýren súlfónat||9612||9612|14306||1 164119|J05AE1101|Incivo|filmhtfl|375|mg|42|stk|1|glas||J05AE11|01.02.2012|30.04.2015|R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|293167|366478|lyfsjukr|||1|42|0|7,0000|Vistor hf|Janssen-Cilag International N.V.|Telaprevír||293167||293167|366478||1 164125|R01AA0707|Otrivin Junior ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas||R01AA07|01.02.2014||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3636|5198|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3636||3636|5198||2 164324|L01BB0202|Xaluprine|mixtúra|20|mg/ml|100|ml|1|glas||L01BB02|01.05.2015||R|0|0|0|1|0|1|VON|0|0|0|100|DKK|36990|47865|lyfsjukr|||1|100|0||Williams & Halls efh|Nova Laboratories Limited|Merkaptópúrín||36990||36990|47865||2 164592|QN03AX9001|Pexion|töflur|400|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|9000|17245|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||9000||9000|17245||1 164724|QA07XA9101|VetZin|forbl|1000|mg/g|25|kg|1|poki|forblanda f, lyfjabl. fóður|QA07XA91|01.03.2014||R|0|0|0|0|0|0|VEP|0|0|0|100|DKK|41246|78422|vetalmen|||0|25|0||Orion Pharma A/S Animal Health|Vepidan Aps|Zink Oxide||41246||41246|78422||2 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2683|4769|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Selegilín||||2683|4769||2 164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|8844|13249|lyfalmen|||2|100|0|200,0000|Icepharma hf|Mylan AB|Selegilín||8844||8844|13249||2 164827|C02KX0501|Adempas|filmhtfl|2,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|383446|478759|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Riociguatum||383446||383446|478759||2 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1091|2578|lyfalmen|||2|100|0|10,0000|Icepharma hf|Mylan AB|Klómípramín||1091||1091|2578||2 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1289|2850|lyfalmen|V0314|2850|2|100|0|25,0000|Icepharma hf|Mylan AB|Klómípramín||1289||1289|2850||2 164871|A07EC0204|Asacol|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|5625|8819|lyfalmen|V0014|8819|1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||5625|8819||2 165019|C05AA0102|Proctosedyl|eþ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1 165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|0|AGT|0|0|0|100|XEU|1230|2769|lyfalmen|||2|100|0|33,3300|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||1230||1230|2769||1 165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|0|LAS|1|0|0|100|XEU|6488|12480|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||6488||6488|12480||2 165449|C08CA0202|Plendil|forðatfl|10|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4539|7324|lyfalmen|V0059|4831|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4539||4539|7324||1 165507|L01XX1904|Irinotecan Actavis|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.04.2013||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|6993|9998|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Írinótekan||6993||6993|9998||1 165548|C08CA0202|Plendil|forðatfl|5|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2930|5109|lyfalmen|V0058|3483|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||2930||2930|5109||1 165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|172740|216700|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|E. Merck AB|Sómatrópín||172740||172740|216700||2 165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|30169|39382|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||30169||30169|39382||2 165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|43926|56492|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||43926||43926|56492||2 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|628|1941|lyfalmen|||1|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||628||628|1941||1 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|182|1327|lyfalmen|||1|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||182||182|1327||1 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|1|0|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||||1 165799|C02KX0501|Adempas|filmhtfl|2|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|190351|238603|lyfsjukr|||1|42|0||Icepharma hf|Bayer Pharma AG|Riociguatum||190351||190351|238603||2 165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3920|5605|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3920||3920|5605||2 165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|58601|74743|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||58601||58601|74743||2 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4386|8492|vetalmen|||0|60|0||Vistor hf|Intervet International BV|||||4386|8492||1 166120|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.04.2013||R|0|0|0|1|0|0|MSE|0|0|0|100|SEK|416594|529450|lyfalmen|||1|120|0||Icepharma hf|Merck Serono Europe Ltd|Saprópterín||416594||416594|529450||2 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1538|3193|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1538||1538|3193||1 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|0|1|G|0|PER|0|0|0|100|DKK|14242|20555|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||14242||14242|20555||1 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1988|3813|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1988||1988|3813||2 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3763|6256|lyfalmen|V0428|6256|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||3763||3763|6256||2 166858|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.09.2011||R|0|1|0|1|G|0|BIO|0|0|0|100|DKK|122543|157534|lyfalmen|V0140|157534|1|1|0|1,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Clostridíum||122543||122543|157534||3 166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||||1 167319|N06AX1608|Venlafaxin Actavis|forðahlk|37,5|mg|7|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|421|1656|lyfalmen|V0333|785|2|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||421||421|1656||1 167905|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|1683|2449|lyfalmen|V0005|2449|2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||997||997|2449||1 168038|J05AR0901|Stribild|filmhtfl|745|mg|30|stk|1|glas|150+150+200+245 mg|J05AR09|01.11.2013||R|0|1|0|1|0|1|GSL|0|0|0|100|DKK|166040|208367|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín,tenófóvír disóproxíl,elvítegravír og cobícístat||166040||166040|208367||2 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.06.2009||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|576|1869|lyfalmen|V0119|1627|2|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||576|1869||1 168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|4452|3650|lyfalmen|V0007|3348|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||1870||1870|3650||1 168589|N02CC0402|Maxalt Smelt|frþ.tfl|10|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|4198|6854|lyfalmen|V0621|1766|1|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||4198||4198|6854||1 168618|L01BA0109|Metoject|stl|50|mg/ml|0,15|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2214|4124|lyfalmen|||1|0,15|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2214||2214|4124||2 168629|L01BA0109|Metoject|stl|50|mg/ml|0,2|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2372|4341|lyfalmen|||1|0,2|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2372||2372|4341||2 168640|L01BA0109|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2606|4663|lyfalmen|||1|0,3|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2606||2606|4663||2 168651|L01BA0109|Metoject|stl|50|mg/ml|0,4|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2946|5131|lyfalmen|||1|0,4|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2946||2946|5131||2 168662|L01BA0109|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3103|5347|lyfalmen|||1|0,5|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3103||3103|5347||2 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2861|5014|lyfalmen|V0240|5013|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||2861||2861|5014||1 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|5280|8344|lyfalmen|V0433|8342|1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||5280||5280|8344||1 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|27736|36356|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||27736||27736|36356||1 169175|N03AX1603|Pregabalin Krka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|11700|17180|lyfalmen|V0688|17180|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||11700||11700|17180||2 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|138678|174337|lyfsjukr|||1|50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||138678||138678|174337||1 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|19335|25907|lyfsjukr|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||19335||19335|25907||2 169664|J07BK0101|Varilrix|sts|||0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|5790|9046|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluð veira||5790||5790|9046||1 169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.10.2009||R|0|1|0|1|G|0|POF|0|0|0|30|IKR|1407|2936|lyfalmen|V0124|2936|2|30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2936||1 169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.10.2009||R|0|1|0|1|G|0|POF|0|0|0|30|IKR|2450|2852|lyfalmen|V0125|2603|2|30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||1290||1290|2852||1 169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1168|2684|lyfalmen|V0411|2684|2|20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2684||1 169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|647|1967|lyfalmen|V0177|1967|2|10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1967||1 169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|638|1954|lyfalmen|V0418|1954|2|20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1954||1 169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|393|1617|lyfalmen|V0176|1617|2|10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1617||1 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2644|4716|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2644||2644|4716||1 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2846|4994|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2846||2846|4994||1 170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|18597|24989|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||18597|24989||2 170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|46050|59133|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||46050|59133||2 170092|J07BC2001|Twinrix Adult|stl|||1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|6079|9443|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||6079||6079|9443||1 170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|92101|116408|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||92101||92101|116408||2 170489|G04BD0705|Tolterodine Sandoz|forðahlk|4|mg|28|stk|1|plglas||G04BD07|01.08.2013||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|3239|5534|lyfalmen|V0618|5534|1|28|0|28,0000|Artasan ehf|Sandoz A/S|Tólteródín||||3239|5534||1 170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|þpakki||J04AB02|01.07.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|12661|18556|lyfalmen|||1|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||12661||12661|18556||2 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2163|4053|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín í blöndum||2163||2163|4053||1 170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|10728|15203|lyfsjukr|||2|1600|0|6,6700|Actavis Group hf|Braun|Gentamícín||10728||10728|15203||1 170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|25809|33959|lyfsjukr|||2|1600|0|20,0000|Actavis Group hf|Braun|Gentamícín||25809||25809|33959||1 170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|38713|50008|lyfsjukr|||2|2400|0|30,0000|Actavis Group hf|Braun|Gentamícín||38713||38713|50008||1 170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|3150|2801|lyfalmen|V0203|2801|2|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||1253||1253|2801||1 170763|M05BA0706|Risedronate sodium Portfarma|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.03.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|12363|2310|lyfalmen|V0207|2310|2|12|0|84,0000|Portfarma ehf|Portfarma|Rísedrónsýru||896||896|2310||1 170997|L01BC0701|Vidaza|sts|25|mg/ml|4|ml|1|hgl|dreifa|L01BC07|01.09.2009||R|0|0|0|1|0|1|CEE|0|1|0|100|XEU|53998|69018|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||53998||53998|69018||2 171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|2567|5041|vetalmen|||0|25|0||Vistor hf|Dechra Veterinary Products A/S|||2567||2567|5041||1 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3278|5588|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3278||3278|5588||1 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3309|5631|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3309||3309|5631||1 171765|QA04AD9001|Cerenia|töflur|24|mg|4|stk|1|þpakki||QA04AD90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1371|2695|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||1371|2695||2 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2740|4848|lyfalmen|V0247|1754|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2740||2740|4848||1 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|4788|7667|lyfalmen|V0248|3378|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4788||4788|7667||1 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|41985|54078|lyfsjukr|||1|75|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||41985||41985|54078||2 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|27991|36673|lyfsjukr|||1|50|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||27991||27991|36673||2 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|8737|13102|lyfalmen|V0249|3785|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||8737||8737|13102||1 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|15946|22711|lyfalmen|V0252|17778|1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||15946||15946|22711||1 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|64378|81928|lyfsjukr|||1|100|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||64378||64378|81928||2 172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|30803|33490|lyfalmen|V0346|33490|3|112|0|74,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||24469||24469|33490||2 172567|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.04.2015||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|17868|30797|vetorma|||0|200|0||Icepharma hf|Zoetis Finland OY|Doramectinum||17868||17868|30797||2 172592|N06AX2601|Brintellix|filmhtfl|10|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|21081|29205|lyfalmen|||1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||21081||21081|29205||1 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|9943|14762|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýstingslækkandi lyf||9943||9943|14762||1 172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|5964|9285|lyfalmen|||1|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||5964||5964|9285||2 172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|11079|16325|lyfalmen|||1|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||11079||11079|16325||2 172723|N05AH0410|Quetiapin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.07.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2858|2160|lyfalmen|V0284|2109|2|100|0|6,2500|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||787||787|2160||1 172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|19222|26854|lyfalmen|||1|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||19222||19222|26854||2 172895|H01CB0501|Signifor|stl|0,9|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|573812|728299|lyfalmen|||1|60|0|45,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||573812||573812|728299||1 172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|25067|34247|lyfalmen|||1|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||25067||25067|34247||2 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|375|1592|lyfalmen|||1|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||375||375|1592||1 173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|9988|12275|lyfalmen|V0118|12183|2|98|0|196,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||8136||8136|12275||1 173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3114|5362|lyfalmen|||2|100|0|16,6667|Icepharma hf|Mylan AB|Búspírón hýdróklóríð||3114||3114|5362||2 173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3524||1 173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|5509|8659|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Búspírón hýdróklóríð||5509||5509|8659||2 173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|12405|17288|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||12405||12405|17288||1 173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|13541|18701|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||13541||13541|18701||1 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1794|2565|lyfsjukr|||2|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1794||1794|2565||1 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|561|1848|lyfalmen|||1|14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||561||561|1848||1 174354|J01CA0414|Amoxicilline Actavis Disper|töflur|500|mg|20|stk|1|þpakki|hræra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1226|2764|lyfalmen|||2|20|0|10,0000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1226||1226|2764||1 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|571|1862|lyfalmen|||1|14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||571||571|1862||1 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|0|G|0|API|0|0|0|100|SEK|1596|3273|lyfalmen|V0368|2506|1|5|0|25,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Brímónidín||1596||1596|3273||1 174522|N04BC0505|Oprymea|forðatfl|0,26|mg|30|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|2900|5068|lyfalmen|V0634|5068|2|30|0|3,1200|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||2900||2900|5068|| 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|0|G|0|API|0|0|0|100|SEK|4680|7518|lyfalmen|V0368|7518|1|15|0|75,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Brímónidín||4680||4680|7518||1 175058|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|10|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|0|0|TEV|0|0|0|100|IKR|1262|2813|lyfalmen|V0695|2813|2|10|0|1,2500|Medical ehf|Teva Pharma B.V.|Quetíapín||1262||1262|2813||2 175333|QM01AC0603|Rheumocam|mixtúra|15|mg/ml|100|ml|1|glas|handa hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|5015|9685|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||5015||5015|9685||2 175600|G03AA0904|Denise|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.04.2014||R|0|0|0|0|0|0|RGM|0|0|0|100|IKR|1477|2728|lyfalmen|V0065|1915|2|63|0|84,0000|Medical ehf|ratiopharm GmbH|Desógestrel og ethinylestradíól||1200||1200|2728||2 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|2753|2427|lyfalmen|V0033|2040|1|10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||981||981|2427||1 175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6223|4837|lyfalmen|V0278|2738|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2732||2732|4837||2 176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|5542|8177|lyfalmen|V0429|8177|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||5159||5159|8177||2 176616|N05CH0101|Circadin|forðatfl|2|mg|30|stk|1|þpakki||N05CH01|01.10.2012||R|1|0|0|0|0|0|RAD|0|0|1|100|DKK|2586|4636|lyfalmen|||2|30|0|30,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||2586||2586|4636||1 176862|C07AG0204|Carvedilol HEXAL|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.01.2015||R|1|0|0|0|G|0|PCO|0|0|0|100|DKK|2049|3897|lyfalmen|||2|100|1|16,6700|Distica|Distica - óskráð lyf|Carvedílól||2049||2049|3897||1 177176|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|8123|11614|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||8123||8123|11614||2 177454|N02BE0107|Paratabs|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.05.2013||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1077|2559|lyfalmen|V0231|2559|2|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1077||1077|2559||1 177627|QH02AB0201|Dexaject|stl|2|mg/ml|100|ml|1|hgl||QH02AB02|01.06.2013||R|0|0|0|0|0|0|DOR|1|0|0|100|XEU|4305|8338|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Dexamethasón||4305||4305|8338||2 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|723|2071|lyfalmen|||0|1|1|5,3330|Distica|Distica - óskráð lyf|Tríamcínólón||723||723|2071||1 178223|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|32121|43169|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||32121||32121|43169||2 178722|N06AB0404|Citalopram Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|5438|3623|lyfalmen|V0320|3623|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||1850||1850|3623||2 179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|132926|167183|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||132926||132926|167183||1 179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|9068|13558|lyfalmen|||1|28|0|42,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||9068|13558||2 179557|C10BA0501|Atozet|filmhtfl|50|mg|90|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|16771|23754|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||16771||16771|23754||1 180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|109743|138350|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||109743||109743|138350||2 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|4649|7475|lyfalmen|||1|100|0|25,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||4649||4649|7475||1 180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2012||R|1|0|0|0|G|0|MED|0|0|0|100|XEU|2442|3846|lyfalmen|V0148|3846|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||2012||2012|3846||2 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|747|2104|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||747||747|2104||1 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 181552|QJ51DD1201|Pathozone vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DD12|01.10.1995||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|7544|14483|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|Cefoperazone||7544||7544|14483||2 181750|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|9171|13112|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||9171||9171|13112||1 181980|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5740|8977|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||5740||5740|8977||1 182086|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|3|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||5990||2 182307|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.11.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|11304|16635|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||11304||11304|16635||1 182435|A10BB0903|Gliclazide LYFIS|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.10.2014||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|8700|7683|lyfalmen|V0020|7683|2|180|0|90,0000|LYFIS ehf|LYFIS ehf|Glíklazíð||4800||4800|7683||2 182502|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|5|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|16086|21866|lyfsjukr|||2|50|0|8,3300|Icepharma hf|Abcur AB|Noradrenalín||16086||16086|21866||2 182831|QN51AA0102|Exagon vet.|stl|400|mg/ml|100|ml|5|hgl||QN51AA01|01.09.2014||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|19401|36978|vetalmen|||0|500|0||Icepharma hf|Richter Pharma AG|Pentobarbital||||19401|36978||2 182862|N04BC0507|Pramipexole Sandoz|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|32422|40678|lyfalmen|V0636|39221|2|100|0|84,0000|Artasan ehf|Sandoz A/S|Pramipexól||30152||30152|40678||1 183093|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2015||R|0|0|0|0|0|0|PIS|0|0|0|100|SEK|3591|6019|lyfalmen|V0698|6019|1|0,25|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||3591||3591|6019||2 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|5057|9765|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||5057||5057|9765||1 183516|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.03.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1790|1916|lyfalmen|V0234|1910|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||610||610|1916||2 183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|G|0|ALK|0|0|1|100|DKK|5430|8550|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5430|8550||1 183735|J05AE1101|Incivo|filmhtfl|375|mg|168|stk|1|pakki||J05AE11|01.03.2012|30.04.2015|R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|1172669|1460332|lyfsjukr|||1|168|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Telaprevír||1172669||1172669|1460332||1 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|0|G|0|BRS|0|0|0|100|DKK|1115|2611|lyfalmen|||1|100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1115||1115|2611||1 184014|A10BX0901|Forxiga|filmhtfl|10|mg|28|stk|1|þpakki||A10BX09|01.10.2013||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|6110|9486|lyfalmen|||1|28|0|28,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozín||6110||6110|9486||1 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|552|1836|lyfalmen|||2|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||552||552|1836||1 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1517|2312|lyfalmen|||2|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||898||898|2312||1 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|3374|5720|lyfalmen|V0017|5720|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||3374|5720||2 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.1998||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|20235|28135|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||20235||20235|28135|31.5.2015|1 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|50271|66125|lyfalmen|V0185|13940|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||50271||50271|66125||1 184341|J01CR0201|Amoksiklav|filmhtfl|625|mg|16|stk|1|þpakki|500+125 mg|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|1274|2830|lyfalmen|||2|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1274||1274|2830||1 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|þpakki||N02CC03|01.05.2001||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|4770|7642|lyfalmen|V0235|6065|1|6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||4770||4770|7642||1 185025|R01AC0102|Glinor|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.03.2015||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|15|0|1,9500|Medical ehf|ratiopharm GmbH|Krómóglíkatsýra|||||||2 186713|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|905|2322|lyfalmen|V0597|2322|2|28|0|3,7300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||905||905|2322||1 186790|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|34046|12849|lyfalmen|V0607|12849|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Memantín||8553||8553|12849||2 186867|C10BA0501|Atozet|filmhtfl|20|mg|30|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5844|9120|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5844||5844|9120||1 187154|N06AX1611|Duofaxin|forðatfl|225|mg|98|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|4259|6541|lyfalmen|||2|98|0|220,5000|Vistor hf|MediLink A/S|Venlafaxín||3970||3970|6541||1 187191|A10BX0204|Repaglinide Krka|töflur|0,5|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2459|3829|lyfalmen|V0462|3829|2|120|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2000||2000|3829||2 187399|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5485|9454|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5485||5485|9454||2 187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|4116|6742|lyfalmen|||1|30|0||Vistor hf|Meda AB|Pímekrólímus||4116||4116|6742||1 188338|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|1|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2714||2 188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|72394|91898|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer Limited|Tigecýklín||72394||72394|91898||2 188405|N02CC0403|Rizatriptan Portfarma|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.09.2013||R|0|0|0|0|G|0|PEH|0|0|0|100|XEU|3161|2323|lyfalmen|V0621|1766|2|6|0|6,0000|Portfarma ehf|Portfarma ehf|Rizatriptan||906||906|2323||1 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|0|0|0|G|0|DEA|0|0|0|100|XEU|2752|4864|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2752||2752|4864||1 189052|M05BA0604|Iasibon|irþ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|0|0|1|PSA|0|0|0|100|DKK|9054|12945|lyfsjukr|||2|2|0|0,3400|Portfarma ehf|Pharmathen S.A.|Íbandrónsýra||9054||9054|12945||1 189148|J05AG0501|EDURANT|filmhtfl|25|mg|30|stk|1|glas||J05AG05|01.04.2013||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|43238|55636|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Rilpívírin||43238||43238|55636||1 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|6716|9602|lyfsjukr|||1|10|0||Vistor hf|Novartis Healthcare A/S|Deferoxamín||6716||6716|9602||1 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|2340|4297|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2340||2340|4297||1 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|963|2402|lyfalmen|V0413|2402|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||963||963|2402||1 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|466|1718|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||466||466|1718||1 189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|432|618|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Metótrexat||432||432|618||1 190320|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|254|1426|lyfalmen|V0642|1426|2|10|0|2,5000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||254||254|1426||1 190425|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|7243|11046|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||7243|11046||2 190702|M01AB0101|Confortid|eþ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.01.2012||R|0|0|0|0|G|0|AGT|0|0|1|100|DKK|1732|3460|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||1732||1732|3460||1 190728|M01AB0101|Confortid|eþ-stíll|50|mg|10|stk|1|þpakki||M01AB01|01.08.2012||R|0|0|0|0|G|0|AGT|0|0|1|100|DKK|1046|2516|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||1046||1046|2516||1 191045|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|V0149|2574|0|100|0|10,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2574||1 191064|B05XC03|Vitalipid Infant|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3623|5180|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3623||3623|5180||2 191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|6575|7523|lyfalmen|V0117|7462|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||4684||4684|7523||1 191247|B05XC02|Vitalipid Adult|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3413|4880|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3413||3413|4880||2 191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3561|5091|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3561||3561|5091||2 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 191587|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.03.2015||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|8077|11548|lyfsjukr|||2|60|0||Alvogen HS|Hospira Nordic AB|Karbóplatín||8077||8077|11548||1 191742|C08CA0202|Plendil|forðatfl|2,5|mg|98|stk|1|þpakki||C08CA02|01.08.2012||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3638|6084|lyfalmen|V0201|5274|1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3638||3638|6084||1 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|489|1749|lyfalmen|||1|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||489||489|1749||2 192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|þpakki||N06AX11|01.12.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|3597|6027|lyfalmen|||2|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3597||3597|6027||1 192514|M01AH0106|Celecoxib Actavis|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|AGP|0|0|1|100|XEU|6007|8177|lyfalmen|V0429|8177|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||5159||5159|8177||1 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1507|3151|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1507||1507|3151||1 192644|C10BA0501|Atozet|filmhtfl|90|mg|30|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|6127|9510|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||6127||6127|9510||1 192699|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7111|10167|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7111||7111|10167||2 192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|1|0|1|API|0|1|0|100|SEK|167131|209724|lyfsjukr|||2|1|0||Vistor hf|Allergan Pharmaceuticals Ireland|Dexametasón||167131||167131|209724||1 193122|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|þpakki||N02CC01|01.07.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2557|2197|lyfalmen|V0233|2190|2|12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||814||814|2197||2 193242|A07DA0301|Imodium|filmhtfl|2|mg|100|stk|1|þpakki||A07DA03|01.02.2014||R|1|0|0|0|G|0|MCS|0|0|0|100|SEK|924|2348|lyfalmen|V0447|2205|1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||924||924|2348||1 193432|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|22185|30602|lyfalmen|||1|28|0|35,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||22185||22185|30602||1 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyfalmen|||0|20|0|7,5500|Artasan ehf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2338||1 193999|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|250|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|47112|75945|veteldis|||0|250|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||47112||47112|75945||1 194356|J02AC0102|Candizol|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|2031|1902|lyfalmen|V0556|1861|2|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||600||600|1902||1 194404|QM01AC0606|Meloxidolor|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|5138|9918|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5138||5138|9918||2 194672|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|6098|5298|lyfalmen|V0012|5298|2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3067||3067|5298||1 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|1642|3336|lyfalmen|||2|250|0|83,3300|Icepharma hf|Mylan AB|Atenólól||1642||1642|3336||2 195445|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|13436|19536|lyfalmen|V0609|19536|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||13436||13436|19536||1 195455|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.07.2013||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyfalmen|||0|5000|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||12898||2 195472|A02BC0507|Esomeprazole Portfarma|sþ-tfl|40|mg|98|stk|1|þpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|9142|6000|lyfalmen|||2|98|0|130,6700|Portfarma ehf|Portfarma|Esómeprazól||3577||3577|6000|31.5.2015|1 195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|57580|73473|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|E. Merck AB|Sómatrópín||57580||57580|73473||2 195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|131843|165836|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||131843||131843|165836||1 195618|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|945|2377|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||945||945|2377||1 195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|652|1974|lyfalmen|||1|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||652||652|1974||1 195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|347|1554|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||347||347|1554||1 195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|734|2087|lyfalmen|||1|100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||734||734|2087||1 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|2099|3965|lyfalmen|||2|250|0|166,6700|Icepharma hf|Mylan AB|Atenólól||2099||2099|3965||2 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|þp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|1443|3062|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Levónorgestrel og ethinylestradíól||1443||1443|3062||2 196444|M04AA0105|Allonol|töflur|300|mg|100|stk|1|þpakki||M04AA01|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1681|3390|lyfalmen|||2|100|0|75,0000|Medical ehf|ratiopharm GmbH|Allópúrinol||1681||1681|3390||2 196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|8113|12243|lyfalmen|||1|100|0|0,8333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||8113||8113|12243||1 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|20660|27555|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||20660|27555||1 197160|M04AA0105|Allonol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.05.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|575|1627|lyfalmen|V0119|1627|2|100|0|25,0000|Medical ehf|ratiopharm GmbH|Allópúrinol||400||400|1627||2 197320|L04AB0204|Inflectra|irþ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2015||R|0|0|0|1|0|1|SCO|0|1|0|100|XEU|59514|75879|lyfsjukr|||2|1|0|26,6700|Scope Pharma ehf|Hospira UK Limited|Infliximab||59514||59514|75879||1 197554|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|1|fl|1 x 150 úðaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|0,4400|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|798|2175|lyfalmen|||1|20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||798||798|2175||1 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|þpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2613|4673|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||2613||2613|4673||1 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1906|3700|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1906||1906|3700||1 198220|QJ51DD1201|Pathozone vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DD12|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|7544|14483|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|Cefoperazone||7544||7544|14483||2 198334|M02AA1502|Voltaren|hlaup|11,6|mg/g|150|g|1|túpa||M02AA15|01.02.2015||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|150|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 198582|C09CA0106|Losatrix|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|2212|3003|lyfalmen|V0069|3003|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Lósartan||1400||1400|3003||2 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|6689|9563|lyfsjukr|||1|200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||6689||6689|9563||1 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|33613|45056|lyfalmen|||1|100|0||Icepharma hf|Pfizer ApS|Estramústín||33613||33613|45056||1 199272|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.12.2011|30.06.2015|R|1|0|0|0|0|0|APC|0|0|0|100|XEU|7905|4082|lyfalmen|||2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||2184||2184|4082||1 199319|A10BG0304|Pioglitazone Accord|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.12.2013||R|1|1|0|0|G|0|AHL|0|0|0|100|XEU|5821|4016|lyfalmen|||2|98|0|49,0000|Portfarma ehf|Accord Healthcare Limited|Píóglítazón||2136||2136|4016|30.6.2015|1 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|590|1888|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||590||590|1888||1 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|87780|111034|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||87780|111034||1 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4352|7066|lyfalmen|V0126|7066|1|8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||4352||4352|7066||1 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|0|0|0|0|0|1|JAB|0|0|0|100|XEU|49910|63934|lyfsjukr|||1|5|0|0,4000|Janssen Biologics B.V.|Janssen Biologics B.V.|Abciximab||49910||49910|63934||2 199940|L01XC1101|Yervoy|stþ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|2406504|2994877|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2406504||2406504|2994877||1 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|583|834|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||583||583|834||2 370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|30986|58957|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||30986||30986|58957||1 370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1425|2743|lyfalmen|||2|20|0|7,5000|Medical ehf|ratiopharm GmbH|Amoxicillín||1211||1211|2743||2 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|0|0|0|0|0|1|PAD|0|0|0|100|DKK|547|782|lyfsjukr|||1|1|0|0,3333|Icepharma hf|PharmaCoDane ApS|Cefazólín||547||547|782||2 371284|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|8937|13377|lyfalmen|||1|60|0||Vistor hf|Meda AB|Pímekrólímus||8937||8937|13377||1 371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1 371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1 371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|DKK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||9459||1 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3906|6453|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3906||3906|6453||1 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|3410|5770|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3410||3410|5770||2 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 373001|G03AB0501|Gracial|töflur|||66|stk|1|pakki|þp 3 x (15+7 stk)|G03AB05|01.07.1998||R|0|0|0|0|0|0|PTL|0|0|0|100|DKK|2338|4294|lyfalmen|||1|66|0|66,0000|Navamedic AB|Aspen Pharma Trading Limited|Desógestrel og ethinylestradíól||2338||2338|4294||1 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|13093|19102|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||13093||13093|19102||1 373251|L03AB1301|Plegridy|stl|||2|áf-penni|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|120752|152042|lyfsjukr|||1|2|0||Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||120752||120752|152042||2 373324|R03AK0602|Seretide Diskus|innönddu|150|mcg/sk|60|skammtar|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4450|7201|lyfalmen|||1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||4450||4450|7201||1 373340|R03AK0602|Seretide Diskus|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|6906|10582|lyfalmen|V0436|10582|1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||6906||6906|10582||1 373365|R03AK0602|Seretide Diskus|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|9055|13540|lyfalmen|V0437|13540|1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||9055||9055|13540||1 373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|MED|0|0|0|100|XEU|5913|8693|lyfalmen|V0420|4947|2|30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíð||5534||5534|8693||2 373857|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|414|1471|lyfalmen|V0541|1471|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||287||287|1471||1 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1473|3104|lyfalmen|V0126|1767|1|2|0|2,0000|Icepharma hf|Pfizer ApS|Kabególín||1473||1473|3104||1 374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|347916|434570|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||347916||347916|434570||1 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|505|1771|lyfalmen|V0500|1660|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||505||505|1771||2 374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5345|7642|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5345||5345|7642||2 374279|L04AD0104|Ciqorin|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|6800|6857|lyfalmen|||2|50|0|5,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||4200||4200|6857||2 374319|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|þpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|19715|27478|lyfalmen|||2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||19715||19715|27478||2 374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|3580|6004|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3580||3580|6004||1 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|12412|18241|lyfalmen|||1|60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||12412||12412|18241||1 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 374527|J07CA0602|Pentavac|sts|||0,5|ml|1|hgl|leysir, dreifa|J07CA06|01.04.2015||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|4250|6926|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||4250||4250|6926||2 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|7033|10757|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7033||7033|10757||1 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|8301|12502|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||8301||8301|12502||1 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|9721|14456|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||9721||9721|14456||1 376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|27744|37633|lyfalmen|V0459|37633|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||27744||27744|37633||1 376387|R03AK1001|Relvar Ellipta|innönddu|206|mcg/sk|30|skammtar|1|pakki|184+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|8295|12494|lyfalmen|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Vilanterol og flútícason||8295||8295|12494||1 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|16931|23956|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||16931||16931|23956||1 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|86979|112553|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||86979||86979|112553||1 376974|L01XX4301|Erivedge|hylki|150|mg|28|stk|1|glas||L01XX43|01.10.2014||R|1|1|0|1|0|1|RRL|0|0|0|100|DKK|812580|1012482|lyfsjukr|||1|28|0||Icepharma hf|Roche Registration Limited|Vismodegibum||812580||812580|1012482||2 377134|QP54AA0105|Noromectin|stl|1|% w/v|250|ml|1|hgl|lausn|QP54AA01|01.03.2014||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|11894|20500|vetorma|||0|250|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||11894||11894|20500||2 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|1|0|0|0|0|0|ABS|0|0|1|100|DKK|3998|6579|lyfalmen|V0116|4793|1|14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||3998||3998|6579||1 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|12022|8607|lyfalmen|V0182|5343|1|42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||5471||5471|8607||1 378535|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1844|3614|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1844||1844|3614||1 378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|15288|21878|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||15288||15288|21878||1 379158|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.02.2015||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1652|3350|lyfalmen|V0677|3350|1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1652||1652|3350||1 379521|QP54AB5208|Cydectin TriclaMox|mixtúra|51|mg/ml|1|l|1|glas|1 mg/ml + 50 mg/ml|QP54AB52|01.03.2014||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|7767|13387|vetorma|||0|1|0||Icepharma hf|Zoetis Finland OY|||7767||7767|13387||2 379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|145836|183239|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||145836|183239||1 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|93470|118111|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S|Oktreótíð||93470||93470|118111||1 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|122947|154772|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S|Oktreótíð||122947||122947|154772||1 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|158778|199335|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||158778||158778|199335||1 379760|L03AB1001|PegIntron|sts|150|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|134692|169379|lyfsjukr|||1|4|0|80,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||134692||134692|169379||1 379796|N04BC0406|Ropinirole Portfarma|forðatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|8573|6137|lyfalmen|V0532|6137|2|84|0|28,0000|Portfarma ehf|Portfarma|Rópíníról||3677||3677|6137||1 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1563|3228|lyfalmen|||2|12,5|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1563||1563|3228||1 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|2088|3950|lyfalmen|||2|12,5|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||2088||2088|3950||1 380162|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|3|úðagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|19492|27195|lyfalmen|||1|15|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||19492||19492|27195||1 380374|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1516|3163|lyfalmen|V0676|3163|1|30|0||Icepharma hf|Bayer AB|Azelainsýra||1516||1516|3163||2 380466|B01AF0201|Eliquis|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|27557|37396|lyfalmen|V0653|37396|1|168|0|84,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||27557|37396||1 380732|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|20000|25308|lyfalmen|V0195|25308|2|100|0|400,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||18000||18000|25308||2 380833|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|30|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|10582|5517|lyfalmen|V0606|5517|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Memantín||3226||3226|5517||2 381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 381231|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2963|5107|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2963||2963|5107||2 381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|7114|4422|lyfalmen|V0143|4402|3|12|0|12,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||2431||2431|4422||2 381589|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.06.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|41927|55571|lyfalmen|V0700|55571|1|1,08|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||41927|55571||1 382162|N04BC0406|Ropinirole Portfarma|forðatfl|4|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|15151|10366|lyfalmen|V0533|10366|2|84|0|56,0000|Portfarma ehf|Portfarma|Rópíníról||6749||6749|10366||1 382190|G04BE0307|Sildenafil Mylan|filmhtfl|25|mg|4|stk|1|þpakki||G04BE03|01.03.2014||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|3695|4226|lyfalmen|V0141|4226|2|4|0|2,0000|Icepharma hf|Mylan AB|Síldenafíl||2288||2288|4226||2 382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 382474|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|20|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 382764|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|4705|7552|lyfalmen|||2|120|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||4705||4705|7552||1 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|6246|9673|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||6246||6246|9673||1 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|þpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1199|2067|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||1199||1199|2067||2 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|þpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|7225|12453|vetorma|||0|20|0||Icepharma hf|Bayer Animal Health GmbH|||7225||7225|12453||2 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|60|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|120|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1 383428|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1521|3170|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1521||1521|3170||1 383445|J05AG0101|Viramune|forðatfl|400|mg|30|stk|1|þpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|36964|47833|lyfsjukr|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||36964||36964|47833||1 384064|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|56|stk|1|þpakki|hart|A02BC01|01.06.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2373|2848|lyfalmen|V0006|1990|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1287||1287|2848||2 384125|A10BX1201|Jardiance|filmhtfl|10|mg|30|stk|1|þpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|6549|10090|lyfalmen|||1|30|0||Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||6549||6549|10090||1 385214|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|25|lykja|dreifa|H02AB01|01.07.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|10468|15484|lyfalmen|||1|25|0|116,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||10468||10468|15484||1 385238|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|7078|10818|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||7078||7078|10818||1 386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|5754|3528|lyfalmen|V0144|3275|3|8|0|16,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1781||1781|3528||2 386465|QC01CE9001|Vetmedin vet.|tuggutfl|5|mg|50|stk|1|glas|fyrir hunda|QC01CE90|01.07.2015||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|5082|9812|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||5082||5082|9812||1 386953|L02BG0301|Arimidex|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.03.1998||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|45613|60233|lyfalmen|V0184|5289|1|98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||45613||45613|60233||1 386959|C03DA0402|Eplerenone Portfarma|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2014||R|1|0|0|0|0|0|PEH|0|0|0|100|DKK|27020|24818|lyfalmen|V0111|24044|2|100|0|100,0000|Portfarma ehf|Portfarma ehf|Eplerenón||17612||17612|24818||1 387012|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|3|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|UKL|0|0|0|100|USD|8806|13197|lyfalmen|V0670|13197|1|15|0||Vistor hf|Alcon Laboratories (UK) Ltd.|Brimoníð og brinzolamið||8806||8806|13197||1 387579|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|867|2021|lyfalmen|V0308|2021|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||686||686|2021||2 387759|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|108590|136916|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||108590||108590|136916||1 387854|QM01AE9103|Carprofelican|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|5387|10391|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5387||5387|10391||2 387991|R03DC0304|Montelukast Teva|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|12507|6157|lyfalmen|V0491|6132|2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||3691||3691|6157||2 388198|L01XE0901|Torisel|irþ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|142097|178589|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Temsirolímus||142097||142097|178589||1 388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2969|5163|lyfalmen|||1|25|0||Vistor hf|AstraZeneca A/S DK|Blöndur||2969||2969|5163||1 388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3743|6228|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Blöndur||3743||3743|6228||1 388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|AstraZeneca A/S DK|Blöndur|||||||1 388278|N01AH0601|Remifentanil Actavis|sts/irs|5|mg|5|hgl|1|pakki|þykkni,lausn|N01AH06|01.04.2013||R|0|0|1|0|0|1|AGP|0|0|0|100|XEU|7319|10464|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||7319||7319|10464||1 388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|7263|11073|lyfalmen|||1|20|0||Vistor hf|AstraZeneca A/S DK|Blöndur||7263||7263|11073||1 388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|1559|1787|lyfalmen|V0466|1787|2|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||516||516|1787||1 388898|S01ED5116|Taptiqom|augndr|||0,3|ml|90|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|9147|13666|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||9147||9147|13666||2 389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|2516|4539|lyfalmen|V0410|4539|1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2516||2516|4539||1 389122|G03FB0503|Femasekvens|töflur|||84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|1790|3540|lyfalmen|||1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||1790||1790|3540||1 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|687|2022|lyfalmen|V0128|2022|1|84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||687||687|2022||1 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|545|1826|lyfalmen|||1|84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||545||545|1826||1 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|839|2231|lyfalmen|V0367|1640|1|3|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||839||839|2231||1 389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|2516|2154|lyfalmen|V0143|1467|3|4|0|4,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||783||783|2154||2 389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|3634|5009|lyfalmen|V0267|5009|3|100|0|7,2000|LYFIS ehf|LYFIS ehf|Pramipexól||2857||2857|5009||2 389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|44533|58867|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||44533|58867||2 389939|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|30|stk|1|þpakki||N05CF01|01.05.2013||R|1|0|0|0|0|0|APC|0|0|0|100|SEK|339|1208|lyfalmen|V0312|1208|2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||96||96|1208||1 389944|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|16089|22891|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||16089||16089|22891||1 390699|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|76791|97367|lyfsjukr|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||76791||76791|97367||1 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|0|0|0|0|G|0|BRS|0|0|1|100|DKK|2734|4839|lyfalmen|||1|100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||2734||2734|4839||1 390784|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|28|stk|1|þpakki||A10BG03|01.11.2012||R|1|1|0|0|G|0|TEV|0|0|0|100|XEU|2358|1954|lyfalmen|||2|28|0|14,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||638||638|1954||2 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|6552|10094|lyfalmen|V0429|8177|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||6552||6552|10094||1 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|2588|4638|lyfalmen|V0037|3657|1|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2588||2588|4638||1 391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|23190|31873|lyfalmen|||1|0,75|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||23190|31873||2 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|12627|18513|lyfalmen|V0196|14759|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||12627||12627|18513||1 391376|J05AE1401|Olysio|hylki|150|mg|28|stk|1|pakki||J05AE14|01.09.2014||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|1387006|1726907|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Simeprevír||||1387006|1726907||1 391653|L01XE0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|AHL|0|1|0|100|DKK|323959|257497|lyfsjukr|||2|30|0||Portfarma ehf|Accord Healthcare Limited|Imatiníb||205542||205542|257497||1 391730|N01BB0203|Xylocain|húðúði|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.1990||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2391|4367|lyfalmen|V0656|4367|1|50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2391||2391|4367||1 391954|N07BC0202|Metadon Abcur|töflur|20|mg|20|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|2279|4213|lyfalmen|||1|20|0|20,0000|Icepharma hf|Abcur AB|Metadón||2279||2279|4213||2 392000|G03AA0706|Erlibelle|töflur|||63|stk|1|þpakki||G03AA07|01.08.2014||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|601|1904|lyfalmen|V0545|1904|2|63|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Levónorgestrel og ethinylestradíól||601||601|1904||1 392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|198647|248921|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||198647||198647|248921||2 392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4274|5680|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3345||3345|5680||1 392438|N07XX0901|Tecfidera|hylki|120|mg|14|stk|1|þpakki||N07XX09|01.12.2014||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|44225|56864|lyfsjukr|||1|14|0|3,5000|Icepharma hf|Biogen Idec Ltd|Dimethyl fumarate||44225||44225|56864||2 392563|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.03.2013||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|9785|14544|lyfalmen|||1|50|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||9785||9785|14544||1 393192|N05AH0409|Quetiapin Orion|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.10.2012||R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|20927|9679|lyfalmen|||2|100|0|50,0000|Portfarma ehf|Orion Corporation|Quetíapín||6250||6250|9679|31.5.2015|1 393642|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3053||2 393735|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.01.2013||R|1|0|0|0|G|0|SPR|0|0|1|100|DKK|66940|87208|lyfalmen|||1|50|0|33,3300|Lyfjaver ehf|ViroPharma SPRL|Hýdrókortisón||66940||66940|87208||2 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.09.1983||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|5262|10154|vetalmen|||0|24|0||Icepharma hf|Zoetis Finland OY|||5262||5262|10154||2 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 393939|S01EE0403|Travoprost Portfarma|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.01.2015||R|0|0|0|0|G|0|POF|0|0|0|100|USD|2180|4037|lyfalmen|V0669|4037|2|2,5|0|25,0000|Portfarma ehf|Portfarma|Travóprost||2151||2151|4037||1 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|139214|173925|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||138347||138347|173925||1 395539|C10BA0501|Atozet|filmhtfl|50|mg|30|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5988|9318|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5988||5988|9318||1 395732|C09CA0305|Valsartan ratiopharm|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3895|3691|lyfalmen|V0679|3691|2|98|0|196,0000|Medical ehf|ratiopharm GmbH|Valsartan||1900||1900|3691||2 395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|NOK|19056|26644|lyfalmen|V0356|26357|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||19056||19056|26644||3 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|167943|210734|lyfsjukr|||1|300|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||167943||167943|210734||2 396120|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|4635|7456|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||4635||4635|7456||1 396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|3793|6297|lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||3793||3793|6297||1 396319|QN01BA0201|Procamidor vet.|stl|20|mg/ml|100|ml|10|hgl||QN01BA02|01.03.2014||R|0|0|0|0|0|0|RPG|1|0|0|100|DKK|19943|38006|vetalmen|||0|1000|0||Icepharma hf|Richter Pharma AG|Procaine Hydrochlorid||19943||19943|38006||2 396865|QN03AX9001|Pexion|töflur|100|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|5267|10163|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||5267||5267|10163||1 397161|J01CA0414|Amoxicilline Actavis Disper|töflur|375|mg|20|stk|1|þpakki|hræra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1185|2707|lyfalmen|||2|20|0|7,5000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1185||1185|2707||1 397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|1|0|1|MKA|0|1|0|100|SEK|26816|35212|lyfsjukr|||1|20|0||Icepharma hf|Merck KgaA|Cetúxímab||26816||26816|35212||2 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|5169|7390|lyfsjukr|||1|60|0||Icepharma hf|Roche|Capecitabín||5169||5169|7390||2 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|29721|38825|lyfsjukr|||1|120|0||Icepharma hf|Roche|Capecitabín||29721||29721|38825||2 397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||0|2|0||Vistor hf|Ferring Lægemidler A/S|Natríumpicosúlfat|||||5406||1 398698|N05AH0412|Quetiapin Sandoz|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|42080|49744|lyfalmen|V0261|49340|2|100|0|100,0000|Artasan ehf|Sandoz A/S|Quetíapín||37320||37320|49744||1 398821|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|40|mg|56|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|7175|3829|lyfalmen|V0012|2967|3|56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||2000||2000|3829||2 399241|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.07.2010|30.06.2015|R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|2124|3660|lyfalmen|||3|28|0|28,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||1877||1877|3660||2 399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|SEK|353|1562|lyfalmen|V0225|1543|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||353||353|1562||1 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|2049|2310|lyfalmen|V0244|2001|1|56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||896||896|2310||1 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|8449|12706|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8449||8449|12706||1 399746|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.03.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|33536|43569|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||33536|43569||1 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír|||||||1 399856|L03AB1101|Pegasys|stl|180|mcg/pen|0,5|ml|4|lyfjap|áfylltur lyfjapenni|L03AB11|01.05.2012||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|106794|134682|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||106794||106794|134682||2 400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|1242|2786|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1242||1242|2786||1 400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Blöndur|||||||1 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4768|7639|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||4768||4768|7639||1 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|209|1364|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||209||209|1364||1 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|380|1599|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||380||380|1599||1 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|181|1325|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||181||181|1325||1 400573|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5048|8024|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||5048||5048|8024||1 400574|N07XX0901|Tecfidera|hylki|240|mg|56|stk|1|þpakki||N07XX09|01.12.2014||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|176898|221872|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Dimethyl fumarate||176898||176898|221872||2 401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2188|3657|lyfalmen|V0037|3657|2|20|0|20,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||1875||1875|3657||2 401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|9586|14270|lyfalmen|V0459|12544|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||9586||9586|14270||1 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|710|2054|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||710||710|2054||1 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1136|2640|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1136||1136|2640||1 402203|D07AC1302|Ovixan|húðlausn|0,1|%|100|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|1403|3007|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||1403||1403|3007||1 402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1861|3658|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1861||1861|3658||1 402873|N06DA0302|Exelon (Lyfjaver)|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|13184|19217|lyfalmen|V0349|19217|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||13184||13184|19217|| 402988|J02AC0102|Candizol|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|5748|3279|lyfalmen|V0552|3155|2|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||1600||1600|3279||1 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|4811|9298|vetalmen|||0|20|0||Vistor hf|Intervet International BV|||4811||4811|9298||1 403550|C08CA0302|Lomir Retard|forðahlk|2,5|mg|100|stk|1|þpakki||C08CA03|01.10.1992||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|5151|8166|lyfalmen|||1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Ísradipín||5151||5151|8166||1 403856|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|34619|44916|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Metótrexat||||34619|44916||1 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|1185|2707|lyfalmen|||1|13,5|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1185||1185|2707||1 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||1905||2 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|60975|77696|lyfsjukr|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||60975||60975|77696||1 404818|C03AA0305|Hydromed|töflur|25|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1114|2610|lyfalmen|||2|100|0|100,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||1114||1114|2610||1 404832|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||36|stk|1|þpakki||R02AA03|01.03.2014||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|641|916|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||641||641|916||2 404997|A10BX1001|Lyxumia|stl|||2|áf-penni|1|pakki|10 og 20 mcg|A10BX10|01.10.2013||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|10516|15551|lyfalmen|||1|2|0|1,5000|Vistor hf|Sanofi-aventis groupe|Lixisenatíd||10516||10516|15551||1 405019|C03CA0110|Impugan|töflur|40|mg|250|stk|1|glas||C03CA01|01.11.2013||R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|834|2224|lyfalmen|||2|250|0|250,0000|Actavis Group hf|Actavis Group hf|Fúrósemíð||834||834|2224||1 405076|C03EA0114|Diuramin mite|töflur|27,5|mg|100|stk|1|þpakki|2,5+25 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1398|2177|lyfalmen|V0559|2177|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||800||800|2177||2 405129|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|2962|5105|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2962||2962|5105||2 405168|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|KAB|0|0|0|100|DKK|||lyfalmen|||0|400|0||Icepharma hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2142||2 405466|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2011||R|0|0|0|0|0|0|AEL|1|0|0|100|XEU|7638|14661|vetalmen|||0|10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||7638||7638|14661|30.4.2015|2 405589|J07BD5203|Priorix|sts|||0,5|ml|1|hgl|+ einnota dæla|J07BD52|01.03.1999||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|1933|3737|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||1933||1933|3737||1 405597|J07BD5203|Priorix|sts|||0,5|ml|10|hgl||J07BD52|01.11.2001||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|20599|28596|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||20599||20599|28596||1 405677|J01DD0401|Rocephalin|irþ|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|3417|4885|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Roche|Ceftríaxón||3417||3417|4885||2 405823|C10BA0501|Atozet|filmhtfl|90|mg|90|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|17186|24279|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||17186||17186|24279||1 405998|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.11.2014||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|460|1709|lyfalmen|V0502|1709|2|60|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||460||460|1709||1 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|19142|26753|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||19142||19142|26753||1 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|57716|75541|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||57716||57716|75541||1 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|67753|88236|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||67753||67753|88236||1 406894|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|67705|86066|lyfsjukr|||1|7,5|0|37,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||67705||67705|86066||1 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|157|1292|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||157||157|1292||1 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|341|1546|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||341||341|1546||1 408145|B01AF0101|Xarelto|filmhtfl|2,5|mg|100|stk|1|þpakki|stakskammtaþynna|B01AF01|01.04.2015||R|1|1|0|0|G|0|BGB|0|0|0|100|DKK|15935|22697|lyfalmen|||1|100|0|25,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||15935||15935|22697||2 408156|A10BB0904|Zodediab|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.03.2015||R|1|0|0|0|G|0|IPC|0|0|0|100|IKR|2744|4853|lyfalmen|||2|90|0|45,0000|Portfarma ehf|Alvogen IPco S.á.r.l.|Glíklazíð||2744||2744|4853|30.6.2015|1 408266|N05BA1206|Alprazolam Krka|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|1833|2918|lyfalmen|V0310|2918|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1338||1338|2918||2 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1605|3285|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1605||1605|3285||1 409019|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|3077|5304|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3077||3077|5304||2 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|3606|6040|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||3606||3606|6040||1 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|skammtar|1|stauk||R01AD05|01.01.1992||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|3792|6296|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3792||3792|6296||1 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|9557|14231|lyfalmen|||1|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||9557||9557|14231||1 409745|N05AX1302|Xeplion|stl|100|mg|1|stk|1|áf.spr|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|69663|90652|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||69663||69663|90652||1 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|7751|11745|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||7751||7751|11745||1 409927|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|16202|23034|lyfalmen|V0651|23034|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16202||16202|23034||1 409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|10679|14759|lyfalmen|V0196|14759|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||9941||9941|14759||2 410077|N02CC0402|Maxalt Smelt|frþ.tfl|5|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|5112|8112|lyfalmen|V0620|5757|1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5112||5112|8112||1 410173|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|2905|4938|lyfalmen|V0598|4938|2|98|0|13,0700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||2806||2806|4938||1 410382|C03DA0103|Spiron|töflur|100|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|3470|5193|lyfalmen|V0093|5193|2|100|0|133,3300|Portfarma ehf|Orion Corporation|Spírónólaktón||2991||2991|5193||1 410469|L04AB0202|Remsima|irþ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2014||R|0|1|0|1|0|1|CHH|0|1|0|100|DKK|51642|66088|lyfsjukr|||2|1|0|26,6700|Portfarma ehf|Celltrion Healthcare Hungary Kft.|Infliximab||51642||51642|66088||1 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|1017|2476|lyfalmen|||1|20|0|6,2000|Vistor hf|Recip AB|Klórókín||1017||1017|2476||1 410649|C09CA0305|Valsartan ratiopharm|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|0|0|RGM|0|0|0|100|IKR|820|2205|lyfalmen|||2|14|0|7,0000|Medical ehf|ratiopharm GmbH|Valsartan||820||820|2205||2 410757|V03AE0203|Sevelamercarbonat W&H|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.04.2015||R|1|1|0|0|0|0|WEH|0|0|0|100|XEU|21207|27548|lyfalmen|V0680|27548|2|180|0|22,5000|Williams & Halls efh|Williams & Halls ehf|Sevelamer||19771||19771|27548||2 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|608|1913|lyfalmen|||2|50|0|10,0000|Icepharma hf|Mylan AB|Baklófen||608||608|1913||2 411076|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.12.2014||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1657|3357|lyfalmen|V0557|3357|1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1657||1657|3357||1 411184|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|100|stk|1|glas||N02BE01|01.10.2013||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|453|1624|lyfalmen|V0230|1616|2|100|0|16,6667|Medical ehf|ratiopharm GmbH|Paracetamól||398||398|1624||2 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|4563|6524|lyfsjukr|||1|50|0|16,6667|Icepharma hf|Roche|Mídazólam||4563||4563|6524||2 411616|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.11.2013||R|1|0|1|0|0|0|SHS|0|0|0|100|DKK|8017|8393|lyfalmen|V0624|8393|2|30|0|36,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||5316||5316|8393||1 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|27379|35912|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||27379||27379|35912||1 411859|J02AC0102|Candizol|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.02.2014||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|V0554|1871|2|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól|||||1871||1 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|skammtar|1|pakki||N02CC01|01.07.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|8010|12101|lyfalmen|||1|6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||8010||8010|12101||1 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|19566|27289|lyfalmen|||1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||19566||19566|27289||1 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|3115|4454|lyfsjukr|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3115||3115|4454||1 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|0|MER|1|0|0|100|XEU|2914|5699|vetalmen|||0|100|0||Vistor hf|Merial|||2914||2914|5699||1 412468|QM01AC0606|Meloxidolor|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|4624|8943|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||4624||4624|8943||2 412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|96604|122008|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||96604||96604|122008||2 412581|N05AX1302|Xeplion|stl|75|mg|1|stk|1|áf.spr|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|54179|71068|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||54179||54179|71068||1 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|3054|5280|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Tamoxífen||3054||3054|5280||2 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3151|5413|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Tamoxífen||3151||3151|5413||2 413177|N05AH0412|Quetiapin Sandoz|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|24503|25330|lyfalmen|V0273|24044|2|100|0|50,0000|Artasan ehf|Sandoz A/S|Quetíapín||18017||18017|25330||1 413220|V03AB1703|Methylthioninium chloride Proveblue|stl|5|mg/ml|10|ml|5|lykjur||V03AB17|01.05.2015||R|0|0|0|0|0|1|ROP|0|0|0|100|DKK|31530|41074|lyfsjukr|||1|50|0||Williams & Halls efh|Provepharm SAS|Metýltíónín||31530||31530|41074||2 413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 414006|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|30|stk|1|þpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|890|1765|lyfalmen|||2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||500||500|1765||2 414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|þpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|17594|7503|lyfalmen|V0342|7353|2|98|0|130,6700|Williams & Halls efh|Williams & Halls ehf|Dónepezíl||4669||4669|7503||2 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|3562|5979|lyfalmen|||1|90|0|54,0000|Icepharma hf|Servier|Indapamíð||3562||3562|5979||2 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1237|2779|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1237||1237|2779||1 415338|N05AA0201|Nozinan|filmhtfl|25|mg|100|stk|1|þpakki||N05AA02|01.11.2012||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1712|3433|lyfalmen|||1|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||1712||1712|3433||1 415368|C02KX0501|Adempas|filmhtfl|2,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|190351|238603|lyfsjukr|||1|42|0||Icepharma hf|Bayer Pharma AG|Riociguatum||190351||190351|238603||2 415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|9902|6340|lyfalmen|V0253|6307|2|100|0|33,3300|Portfarma ehf|Pharmathen S.A.|Levetíracetam||3824||3824|6340||1 416371|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|1|spr|f. hesta|QM01AE90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1778|3494|vetalmen|||0|30|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||1778||1778|3494||2 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|8888|9143|lyfalmen|V0088|2389|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||5861||5861|9143||1 416630|N06BA0702|Modafinil Bluefish|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.10.2014||R|1|0|0|1|0|0|BLP|0|0|0|100|IKR|7200|8234|lyfalmen|V0657|8234|2|30|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Modafinil||5200||5200|8234||2 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.03.2013||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4993|7949|lyfalmen|||1|300|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||4993||4993|7949||1 416859|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|0|G|0|GOG|0|0|1|100|XEU|2710|4806|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||2710||2710|4806||2 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|945|2377|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||945||945|2377||2 417266|N05AH0409|Quetiapin Orion|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.10.2012||R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|10510|4311|lyfalmen|V0285|4311|2|100|0|25,0000|Portfarma ehf|Orion Corporation|Quetíapín||2350||2350|4311||1 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|44813|57595|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||44813||44813|57595||1 417880|B02BD0901|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD09|01.07.2012||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|93035|117569|lyfsjukr|||1|1|0|2,2200|Icepharma hf|Pfizer Limited|Storkuþáttur IX||93035||93035|117569||1 418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|30168|40698|lyfalmen|V0460|40698|1|180|0|122,7200|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||30168|40698||1 418122|H02AB0205|Dexametason Abcur|töflur|4|mg|20|stk|1|þpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|3943|6503|lyfalmen|||2|20|0|53,3300|Icepharma hf|Abcur AB|Dexametasón||3943||3943|6503||2 418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|0|0|0|1|0|1|BIO|0|0|0|100|DKK|126074|158661|lyfsjukr|||1|18,76|0|28,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||126074||126074|158661||3 418731|A07EC0201|Mesasal|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|6138|9525|lyfalmen|V0014|8819|1|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||6138||6138|9525||1 418981|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.05.2012||R|1|0|0|0|G|0|APC|0|0|1|100|XEU|2200|4104|lyfalmen|V0458|3569|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||2200||2200|4104||1 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|2584|4633|lyfalmen|||1|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||2584||2584|4633||1 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|6660|10243|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||6660||6660|10243||1 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|46596|59812|lyfsjukr|||1|180|0|30,0000|Vistor hf|M.S.D.|Indínavír||46596||46596|59812||1 419828|N06BA0406|Medikinet CR|hylki|5|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|3450|5825|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||3450||3450|5825||2 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|0|1|0|1|ORP|0|0|0|100|DKK|35201|45640|lyfsjukr|||1|100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||35201||35201|45640||3 419945|D07AD0101|Dermovat|húðlausn|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|779|2149|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||779||779|2149||1 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|11289|16614|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||11289||11289|16614||1 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1001|2454|lyfalmen|V0036|2453|1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1001||1001|2454||1 421816|QN04BC0201|Prascend|töflur|1|mg|160|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|31682|60278|vetalmen|||0|160|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||31682||31682|60278||1 421938|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|XEU|2200|3569|lyfalmen|V0458|3569|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||1811||1811|3569||2 422115|N02AA0506|Oxikodon Depot Actavis|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|568|1858|lyfalmen|V0596|1858|2|28|0|1,8600|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||568||568|1858||1 422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.05.2009||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1354|2940|lyfalmen|V0051|2177|1|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1354||1354|2940||1 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3041|5262|lyfalmen|V0049|3511|1|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||3041||3041|5262||1 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|5001|7960|lyfalmen|V0054|6029|1|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||5001||5001|7960||1 422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|1|0|1|CSB|0|0|0|100|SEK|63707|81094|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||63707||63707|81094||2 422738|G03GA0503|Bemfola|stl|75|ae|0,125|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|3076|5310|lyfalmen|||1|0,125|0|1,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||3076||3076|5310||3 422937|B01AF0101|Xarelto|filmhtfl|2,5|mg|56|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|BGB|0|0|0|100|DKK|8945|13388|lyfalmen|||1|56|0|14,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||8945||8945|13388||2 423361|G03AA1201|Yasmin|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.01.2014||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3020|5233|lyfalmen|V0192|4336|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||||3020|5233||2 423527|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|20|mg|56|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|4596|3829|lyfalmen|V0011|2942|3|56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2000||2000|3829||2 423703|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.05.2014||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|729|2080|lyfalmen|||1|10|0||Vistor hf|Laboratories THEA|Nafazólín í blöndum með öðrum efnum||729||729|2080||1 423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|20507|27365|lyfsjukr|||2|1200|0|15,0000|Actavis Group hf|B.Braun Melsungen AG|Gentamícín||20507||20507|27365||1 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|964|2403|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Flúnítrazepam||964||964|2403||2 425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|4082|5836|lyfsjukr|||1|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||4082||4082|5836||1 425679|C07AG0204|Carvedilol HEXAL|töflur|25|mg|100|stk|1|þpakki||C07AG02|01.01.2015|30.06.2015|R|1|0|0|0|G|0|PCO|0|0|0|100|DKK|3627|6069|lyfalmen|||2|100|1|66,6700|Distica|Distica - óskráð lyf|Carvedílól||3627||3627|6069||1 425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|1|0|0|0|G|0|AHF|0|0|0|100|IKR|2248|4000|lyfalmen|||2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group hf|Lósartan||2124||2124|4000||1 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|604|1908|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||604||604|1908||1 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|789|2162|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||789||789|2162||1 426859|N03AX1407|Levetiracetam Teva|filmhtfl|250|mg|50|stk|1|þpakki||N03AX14|01.02.2015||R|1|0|0|0|0|0|TEV|0|0|0|100|IKR|2129|2109|lyfalmen|V0515|2051|2|50|0|8,3300|Medical ehf|Teva Pharma B.V.|Levetíracetam||750||750|2109||2 427075|M01AE0115|Alvofen Express|hylki|400|mg|50|stk|1|þpakki||M01AE01|01.04.2014||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Portfarma ehf|Alvogen IPco S.á.r.l.|Íbúprófen|||||||1 427186|C10BA0201|Inegy|töflur|90|mg|28|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|7958|12030|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||7958||7958|12030||1 427321|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|3|glös||S01EE04|01.10.2014||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|7610|11551|lyfalmen|V0658|11551|1|7,5|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Travóprost||7610||7610|11551||1 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2846||1 427803|R03AK0604|Relanio|innönddu|300|mcg/sk|180|skammtar|1|pakki|50+250 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|19495|20882|lyfalmen|||2|180|0|90,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||14500||14500|20882||2 428018|R06AX2201|Kestine|filmhtfl|10|mg|10|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 428089|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|V0136|1778|0|25|0|5,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||1778||1 428579|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.03.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|39878|51457|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||39878|51457||1 428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|28356|31362|lyfalmen|V0344|31362|3|112|0|37,3300|LYFIS ehf|LYFIS ehf|Rívastigmín||22786||22786|31362||2 429098|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3535|5054|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3535||3535|5054||2 429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|glas||J02AC04|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|90410|114305|lyfsjukr|||1|105|0|5,2500|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||90410||90410|114305||1 429703|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.04.2014||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|6060|5272|lyfalmen|||2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3048||3048|5272|30.6.2015| 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3825|6341|lyfalmen|V0093|5193|1|100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||3825||3825|6341||1 429875|G03GA0503|Bemfola|stl|225|ae|0,375|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|10164|15066|lyfalmen|||1|0,375|0|3,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||10164||10164|15066||3 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|991|1417|lyfsjukr|||1|50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||991||991|1417||1 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1350|1930|lyfsjukr|||1|50|0|3,3333|Icepharma hf|Roche|Mídazólam||1350||1350|1930||2 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4189|8118|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||4189||4189|8118||1 430232|L03AB1001|PegIntron|sts|100|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|90550|114479|lyfsjukr|||1|4|0|53,3300|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||90550||90550|114479||1 430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.08.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|18765|5289|lyfalmen|V0184|5289|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Anastrózól||3061||3061|5289||2 430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|2778|2356|lyfalmen|V0144|1637|3|4|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||930||930|2356||2 430710|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áfspr||J07AP03|01.07.1994||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2298|4239|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefnavakar||2298||2298|4239||2 430862|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|2|stk|1|þpakki||J01FA10|01.05.2013||R|1|0|0|0|0|0|AHF|0|0|1|100|XEU|931|2358|lyfalmen|V0173|2358|2|2|0|3,3300|Actavis Group PTC ehf|Actavis Group hf|Azitrómýcín||931||931|2358||1 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1036|2502|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1036||1036|2502||1 431154|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.11.2013||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 431193|N02AB0306|Instanyl|nefúði|100|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|9176|13706|lyfalmen|||1|6|0|1,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||9176||9176|13706||1 431495|L01CD0201|Taxotere|irþ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.04.2011||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|139935|175900|lyfsjukr|||1|8|0||Vistor hf|Aventis Pharma SA|Docetaxel||139935||139935|175900||1 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|1323|2897|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1323|2897||1 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|4105|6726|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||4105||4105|6726||1 431930|N06BA0406|Medikinet CR|hylki|60|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|11696|17175|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||11696||11696|17175||2 431985|D07XC0101|Diprosalic|húðlausn|||100|ml|1|glas|0,5 mg/ml+20 mg/ml|D07XC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1941|3748|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1941||1941|3748||1 432410|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|4900|7545|lyfalmen|V0693|7545|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||4700||4700|7545||2 432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.10.2011||R|0|0|0|0|G|0|NDR|0|0|0|100|SEK|29778|40205|lyfalmen|||1|12,5|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||29778|40205||1 432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|pakki||QJ01CR02|01.02.2012||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|2937|5743|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||2937||2937|5743||2 433126|N02BE0102|Panodil Brus|freyðit|500|mg|20|stk|1|þpakki||N02BE01|01.05.2014||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyfalmen|||0|20|0|3,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||1755||1 433194|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.01.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1657|3357|lyfalmen|V0557|3357|1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1657||1657|3357||1 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|10353|15326|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||10353||10353|15326||1 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2421|4409|lyfalmen|||1|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2421||2421|4409||1 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|5300|8371|lyfalmen|||1|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||5300||5300|8371||1 434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|0|1|BYP|0|0|0|100|DKK|164170|206042|lyfsjukr|||1|150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||164170||164170|206042||2 434091|N06DX0102|Memantine Merz|filmhtfl|10|mg|100|stk|1|þpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|17224|9541|lyfalmen|V0605|6132|2|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||6150||6150|9541||1 434169|R03DC0304|Montelukast Teva|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|6542|2294|lyfalmen|V0490|2294|2|98|0|98,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||885||885|2294||2 434261|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|1000|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|NOK|79309|121374|veteldis|||0|1000|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||75294||75294|121374||1 434461|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|8382|12613|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíð||8382||8382|12613||1 434576|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|3931|3691|lyfalmen|V0010|3617|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1900||1900|3691||2 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|MCS|0|0|1|100|SEK|803|2182|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||803||803|2182||1 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|5061|8042|lyfalmen|||1|1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5061||5061|8042||1 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|5061|8042|lyfalmen|||1|1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5061||5061|8042||1 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|1|0|0|0|0|0|ELI|0|0|0|100|XEU|9633|14335|lyfalmen|V0315|6070|1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||9633||9633|14335||2 435728|N06AX1105|Mirtazapine Bluefish|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|0|0|BLP|0|0|0|100|IKR|5573|8747|lyfalmen|V0304|8747|2|96|0|144,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||5573||5573|8747||2 436010|L01AA0901|Levact|irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|203929|255491|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||203929||203929|255491||2 436022|C09DA0308|Diovan Comp 80/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|3311|5634|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og þvagræsilyf||3311||3311|5634||1 436042|R03DC0305|Montelukast Navamedic|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.04.2014||R|1|0|0|0|G|0|ART|0|0|0|100|XEU|6672|6977|lyfalmen|V0491|6132|2|98|0|49,0000|Artasan ehf|Navamedic ASA|Montelúkast||4287||4287|6977||1 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 436394|H01BA0202|Octostim|nefúði|0,15|mg/sk|2,5|ml|1|úðagl||H01BA02|01.01.2013||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|40380|52081|lyfsjukr|||1|2,5|0|150,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||40380||40380|52081||1 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1014|2472|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1014||1014|2472||1 436471|N06DX0105|Memantine Mylan|filmhtfl|10|mg|98|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|15990|6395|lyfalmen|V0605|6009|2|98|0|49,0000|Icepharma hf|Generics UK Ltd|Memantín||3864||3864|6395||2 436877|L01AA0901|Levact|irþ|2,5|mg/ml|25|mg|20|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|226676|283781|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||226676||226676|283781||2 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|857|2256|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||857||857|2256||1 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|þpakki||N05AD01|01.12.1972|30.04.2015|R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|3146|5406|lyfalmen|||1|100|0|50,0000|Vistor hf|Janssen-Cilag AB|Halóperídól||3146||3146|5406||1 437013|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|100|stk|1|þpakki||B01AC04|01.07.2010|30.06.2015|R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|7785|6627|lyfalmen|||3|100|0|100,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||4033||4033|6627||2 437223|V10XX0301|Xofigo|stl|1000|kBq/ml|6|ml|1|hgl||V10XX03|01.06.2015||R|0|0|0|1|0|1|BGB|0|1|0|100|DKK|598956|746794|lyfsjukr|||1|6|0||Icepharma hf|Bayer Pharma AG|radium-223 dichloride||598956||598956|746794||2 437427|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|10|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|10|0|10,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||||||31.5.2015|2 437935|L01AA0901|Levact|irþ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|58629|74778|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||58629||58629|74778||2 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|0|0|0|0|G|0|CLA|0|0|1|100|USD|1349|2933|lyfalmen|||1|10|0||Vistor hf|Alcon Nordic A/S|Hýdrókortisón og sýkingalyf||1349||1349|2933||1 438432|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10395|15384|lyfalmen|V0334|3078|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||10395||10395|15384||1 438639|N06DX0107|Zalatine|filmhtfl|10|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|10145|6188|lyfalmen|V0605|6009|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||3714||3714|6188||2 438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|þpakki||L01XE15|01.08.2012||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|226397|266539|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration Limited|Vemurafeníb||212812||212812|266539||2 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.1989||L|1|0|0|0|0|0|SIV|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Vistor hf|Bayer AB|Lóratadín|||||||1 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.1989||L|1|0|0|0|0|0|SIV|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Vistor hf|Bayer AB|Lóratadín|||||||1 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.1989||L|1|0|0|0|G|0|SIV|0|0|1|100|DKK|||lyfalmen|V0362|2047|1|100|0|100,0000|Vistor hf|Bayer AB|Lóratadín|||||8707||1 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|154049|193454|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||154049||154049|193454||1 439198|N04BC0505|Oprymea|forðatfl|0,26|mg|10|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|1300|2866|lyfalmen|V0634|1689|2|10|0|1,0400|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||1300||1300|2866||2 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|5577|8753|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýstingslækkandi lyf||5577||5577|8753||1 439594|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|20020|27863|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||20020||20020|27863||1 439719|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|1|glas||S01EE04|01.10.2014||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|2537|4568|lyfalmen|V0658|3850|1|2,5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Travóprost||2537||2537|4568||1 439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 439908|G03AA0904|Denise|töflur|||126|stk|1|þpakki|150/20 mcg|G03AA09|01.05.2014||R|0|0|0|0|0|0|RGM|0|0|0|100|IKR|2900|3829|lyfalmen|V0065|3829|2|126|0|168,0000|Medical ehf|ratiopharm GmbH|Desógestrel og ethinylestradíól||2000||2000|3829||2 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1066|2314|lyfalmen|V0163|1968|1|70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||899||899|2314||1 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1319|1886|lyfsjukr|||2|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1319||1319|1886||1 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|2080|2974|lyfsjukr|||2|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2080||2080|2974||1 440713|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|100|stk|1|þpakki||A02BC05|01.06.2014|30.04.2015|R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3964|5323|lyfalmen|||2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3085||3085|5323||1 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|866|2268|lyfalmen|V0046|1987|1|100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||866||866|2268||1 441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|1096|2585|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||1096||1096|2585||1 441341|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|984|2431|lyfalmen|V0046|1987|2|100|0|33,3333|Vistor hf|Takeda Pharma A/S|Spírónólaktón||984||984|2431||1 441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|113205|142655|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, rilpívírin og tenófóvír||113205||113205|142655||2 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|þpakki||G03DC02|01.12.1972||R|0|0|0|0|G|0|BAP|0|0|0|100|DKK|982|2428|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||982||982|2428||2 442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|13541|19669|lyfalmen|V0283|3334|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13541||13541|19669||2 442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|10688|15787|lyfalmen|V0460|13566|1|60|0|40,9000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||10688|15787||1 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dæla|H04AA01|01.01.1989||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|3141|5400|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3141||3141|5400||1 443181|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1260|2476|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1260||1260|2476||2 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|24607|33665|lyfalmen|||1|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||24607||24607|33665||1 443500|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|3336|4770|lyfsjukr|||2|45|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||3336||3336|4770||1 443904|J01FA0902|Clarithromycin ratiopharm|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSB|0|0|1|100|IKR|2700|4793|lyfalmen|V0116|4793|2|14|0|14,0000|Medical ehf|Teva Sweden AB|Klaritrómýcín||2700||2700|4793||2 444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|7125|10883|lyfalmen|||1|20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7125||7125|10883||1 444102|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|1079|2561|lyfalmen|||3|60|0||Icepharma hf|Icepharma hf|Senna||1079||1079|2561||2 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|1|0|0|0|0|0|ELI|0|0|0|100|DKK|2925|5102|lyfalmen|V0061|3287|1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||2925||2925|5102||2 444362|N01AF0302|Pentocur|sts|1|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|22813|30233|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||22813||22813|30233||2 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|2334|4289|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2334||2334|4289||2 444574|N07CA0102|Betahistin ratiopharm|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|0|0|ROY|0|0|0|100|IKR|2250|4173|lyfalmen|||2|100|0|33,3300|Medical ehf|ratiopharm Oy|Betahistín||2250||2250|4173||2 444765|A05AA0207|Ursochol|hylki|250|mg|100|stk|1|þpakki||A05AA02|01.11.2014||R|1|0|0|0|G|0|IRO|0|0|0|100|XEU|5163|8183|lyfalmen|||2|100|0|33,3300|Artasan ehf|Orifarm Generics A/S|Úrsódeoxýkól sýra||5163||5163|8183||1 445149|R03AK1001|Relvar Ellipta|innönddu|114|mcg/sk|30|skammtar|1|pakki|92+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|6481|9997|lyfalmen|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Vilanterol og flútícason||6481||6481|9997||1 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|0|G|0|LEO|0|0|1|100|DKK|1486|3122|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1486||1486|3122||1 445357|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.03.2015||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|1765|lyfalmen|V0329|1765|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1765||2 445479|N04BC0407|Ropinirol Actavis|forðatfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|8078|6137|lyfalmen|V0532|6137|2|84|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||3677||3677|6137||1 446268|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|4768|7639|lyfalmen|||1|98|0|65,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||4768|7639||2 446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|17437|24596|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai Ltd|Rúfínamíð||17437||17437|24596||1 447040|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|18000|23411|lyfalmen|V0694|23411|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||16500||16500|23411||2 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|9909|14715|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||9909||9909|14715||1 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|5647|8849|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||5647||5647|8849||1 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|6990|10697|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||6990||6990|10697||1 447145|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.09.2014||R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|847|2242|lyfalmen|||1|30|0|5,0000|Icepharma hf|Bayer Pharma AG|Acarbósa||||847|2242||2 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|8318|12525|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8318||8318|12525||1 447596|C07AG0205|Carveratio|töflur|25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|2887|5050|lyfalmen|||2|100|0|66,6700|Medical ehf|ratiopharm GmbH|Carvedílól||2887||2887|5050||2 447753|N06AX1105|Mirtazapine Bluefish|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|1262|1765|lyfalmen|V0330|1765|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1765||2 447785|C10AA0703|Rosuvastatin Krka|filmhtfl|5|mg|30|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|3300|5618|lyfalmen|V0171|5618|2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||3300||3300|5618||2 448125|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|2333|4287|lyfalmen|||1|100|0|33,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||2333|4287||2 448217|C05AA0801|Doloproct|eþ-stíll|||10|stk|1|pakki||C05AA08|01.01.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|698|2037|lyfalmen|V0675|2037|1|10|0||Icepharma hf|Bayer AB|Flúókortólón||698||698|2037||2 448233|C05AA0801|Doloproct|eþ-krem|||30|g|1|túpa||C05AA08|01.01.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1279|2837|lyfalmen|V0674|2837|1|30|0||Icepharma hf|Bayer AB|Flúókortólón||1279||1279|2837||2 448245|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|1981|3803|lyfalmen|V0202|3408|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S|Baklófen||1981||1981|3803||1 449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|1075|1537|lyfsjukr|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1075||1075|1537||1 449485|N03AX1603|Pregabalin Krka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|5800|8784|lyfalmen|V0686|8784|2|56|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||5600||5600|8784||2 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1031|2495|lyfalmen|||2|98|0|130,6667|Icepharma hf|Mylan AB|Atenólól||1031||1031|2495||2 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|4932|7051|lyfsjukr|||2|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||4932||4932|7051||1 449868|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|3238|5533|lyfalmen|||1|10|0|10,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||3238||3238|5533||2 449911|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2012||R|0|0|0|0|G|0|ELI|0|0|0|100|XEU|4784|7661|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||4784||4784|7661||2 450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|1|0|0|0|LEV|1|0|0|100|XEU|4376|8473|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||4376||4376|8473||2 450054|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.12.2014||R|0|0|0|0|G|0|PTL|0|0|0|100|DKK|1151|2661|lyfalmen|V0659|2661|1|30|0|30,0000|Navamedic AB|Aspen Pharma Trading Limited|Estríól||1151||1151|2661||1 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|þpakki|875+125 mg|J01CR02|01.01.1997||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1115|2314|lyfalmen|V0169|1687|1|12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||899||899|2314||1 450201|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|126287|158926|lyfsjukr|||1|20|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||126287||126287|158926||1 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|2535|3683|lyfalmen|V0313|2549|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||1894||1894|3683||1 450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|7269|12529|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||7269||7269|12529||2 450993|R07AX0101|INOmax|innö.gas|800|ppm|10|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|20041|26785|lyfsjukr|||1|10|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||20041|26785||5 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|39730|51273|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||39730||39730|51273||2 451293|N05AX1204|ABILIFY MAINTENA|sts|400|mg|1|hgl|1|pakki||N05AX12|01.07.2014||R|0|0|0|0|0|0|UKA|0|0|0|100|DKK|44858|59278|lyfalmen|||1|1|0|26,6700|Lundbeck Export A/S|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||44858||44858|59278||1 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|44171|56796|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||44171||44171|56796||2 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|58896|75110|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||58896||58896|75110||2 451761|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2013||R|0|0|0|1|G|0|APP|0|0|0|100|XEU|42749|56611|lyfalmen|||1|100|0||Artasan ehf|Aspen Pharma Trading Limited|Búsúlfan||42749||42749|56611||1 452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|120|0||Vistor hf|McNeil Sweden AB|Ketókónazól|||||||1 452258|R03AK1101|Flutiform|innúðal|260|mcg/sk|120|skammtar|1|pakki|250+10 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|7704|11680|lyfalmen|||1|120|0|60,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||7704||7704|11680||2 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|0|0|0|0|G|0|ROA|0|0|1|100|DKK|1371|2963|lyfalmen|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1371||1371|2963||2 452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|10463|18034|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||10463||10463|18034||2 452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|2000|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||5391||1 452594|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|3500|2453|lyfalmen|V0010|2067|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2453||2 452814|QC01CE9001|Vetmedin vet.|tuggutfl|1,25|mg|50|stk|1|glas|fyrir hunda|QC01CE90|01.07.2015||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|1592|3129|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||1592||1592|3129||1 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|0|LAB|0|0|1|100|SEK|9475|14118|lyfalmen|||1|3000|0||Vistor hf|Laboratories 3M Santé|Imikvímóð||9475||9475|14118||1 452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|7728|11049|lyfsjukr|||1|100|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||7728||7728|11049||2 452896|A06AD1701|Phosphoral|mixtúra|||45|ml|2|fl||A06AD17|01.03.1999||R|0|0|0|0|0|0|LCC|0|0|0|100|DKK|2200|4104|lyfalmen|||1|90|0||Clean Chemical Sweden AB|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||2200||2200|4104|30.4.2015|1 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|1446|3067|lyfalmen|V0597|2322|1|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||1446||1446|3067||2 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|3901|6446|lyfalmen|V0598|4938|1|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||3901||3901|6446||2 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|2750|4861|lyfalmen|V0584|3364|1|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||2750||2750|4861||2 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|1382|2382|vetorma|||0|6,4|0||Vistor hf|Merial (MSD)|Ivermectinum||1382||1382|2382||1 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|7487|11381|lyfalmen|V0585|8286|1|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||7487||7487|11381||2 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|5301|8373|lyfalmen|V0586|6326|1|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||5301||5301|8373||2 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|14774|21228|lyfalmen|V0587|14211|1|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||14774||14774|21228||2 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2578|3686|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2578||2578|3686||1 454036|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.07.2013||R|1|0|0|0|G|0|APR|0|0|0|100|DKK|2994|5197|lyfalmen|||1|100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||2994||2994|5197||1 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|14361|20706|lyfalmen|||1|28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||14361||14361|20706||1 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|40743|36921|lyfalmen|V0341|7353|1|98|0|65,3333|Icepharma hf|Pfizer ApS|Dónepezíl||27181||27181|36921||1 454491|A02BC0507|Esomeprazole Portfarma|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|1131|2209|lyfalmen|V0004|2206|2|28|0|18,6700|Portfarma ehf|Portfarma|Esómeprazól||823||823|2209||1 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|16121|22932|lyfalmen|||1|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||16121||16121|22932||1 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|44889|41127|lyfalmen|V0342|7353|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||30507||30507|41127||1 454819|N02BE0115|Paracet|eþ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól|||||||1 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|0|0|0|1|0|1|NOE|0|0|0|100|GBP|54918|70163|lyfsjukr|||1|1|0||Vistor hf|Novartis Europharm Ltd|Tópótecan||54918||54918|70163||1 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1075|2113|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1075||1075|2113||1 454955|J01CA0414|Amoxicilline Actavis Disper|töflur|750|mg|20|stk|1|þpakki|hræra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1383|2980|lyfalmen|||2|20|0|15,0000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1383||1383|2980||1 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.12.1997|31.05.2015|R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|1008|2464|lyfalmen|||1|30|0|5,0000|Icepharma hf|Bayer Pharma AG|Acarbósa||1008||1008|2464||2 455406|L01XA0101|Cisplatin Strides|irþ|1|mg/ml|100|ml|1|hgl||L01XA01|01.11.2013||R|0|0|0|1|0|1|HAS|0|0|0|100|IKR|6344|9070|lyfsjukr|||2|100|0||LYFIS ehf|Mylan Hospital AS|Cisplatín||||6344|9070||2 455501|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|3|spr|f. hesta|QM01AE90|01.02.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5335|10292|vetalmen|||0|90|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||5335||5335|10292||2 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|þpakki||J05AB09|01.10.1995|30.04.2015|R|1|0|0|0|G|0|HES|0|0|1|100|DKK|20589|28583|lyfalmen|||1|21|0|14,0000|Vistor hf|Novartis Healthcare A/S|Famcíclóvír||20589||20589|28583||1 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|491|1752|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||491||491|1752||1 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|849|2245|lyfalmen|||2|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||849||849|2245||1 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|1733|3462|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1733||1733|3462||1 456895|N05AH0206|Clozapin Medical|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|5630|8825|lyfalmen|V0277|8825|2|100|0|33,3300|Medical ehf|Medical ehf|Klózapín||5630||5630|8825||2 456989|R03AK0604|Relanio|innönddu|550|mcg/sk|180|skammtar|1|pakki|50+500 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|26905|26586|lyfalmen|||2|180|0|90,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||19010||19010|26586||2 457508|J07AH0801|Nimenrix|sts|5|mcg|0,5|ml|1|hgl|+áfyllt sprauta|J07AH08|01.07.2013||R|0|0|0|0|0|0|GSB|0|0|0|100|GBP|7551|11470|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals|Hreinsaðir fjórgildi A,C,Y,W-135 og fl.||7551||7551|11470||1 457692|L01BA0109|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3120|5371|lyfalmen|||1|0,45|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3120||3120|5371||2 457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|2551|1648|lyfalmen|V0003|1648|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||415||415|1648||1 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|0|CHE|0|0|1|100|DKK|1072|2552|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1072||1072|2552||1 458149|L01XE2101|Stivarga|filmhtfl|40|mg|84|stk|1|glas|3 x 28|L01XE21|01.06.2014||R|0|0|0|1|0|1|BGB|0|0|0|100|DKK|644048|802875|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Regorafenib||644048||644048|802875||2 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1235|2776|lyfalmen|V0577|2355|1|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1235||1235|2776||1 458491|C05AA0801|Doloproct|eþ-krem|||30|g|1|túpa||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1279|2837|lyfalmen|V0674|2837|1|30|0||Icepharma hf|Bayer AB|Flúókortólón||1279||1279|2837||2 458805|B01AF0201|Eliquis|filmhtfl|2,5|mg|60|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|9852|13428|lyfalmen|V0653|13356|1|60|0|30,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||8974||8974|13428||1 459037|L01XE2301|Tafinlar|hylki|75|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|GBP|1178783|1467936|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||1178783||1178783|1467936||1 459242|L03AB1301|Plegridy|stl|||2|áf.spr|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|120752|152042|lyfsjukr|||1|2|0||Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||120752||120752|152042||2 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|802|1147|lyfsjukr|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||802||802|1147||1 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|1470|2102|lyfsjukr|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1470||1470|2102||1 459447|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|19867|37862|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|||19867||19867|37862||2 459766|N05AH0501|Sycrest|tungur.t|5|mg|20|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|7125|10883|lyfalmen|||1|20|0|5,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7125||7125|10883||1 459812|N05AH0411|Quetiapine Teva|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|2500|2177|lyfalmen|V0284|2109|2|100|0|6,2500|Medical ehf|Teva Sweden AB|Quetíapín||800||800|2177||2 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|1|0|0|0|G|0|MAS|0|0|1|100|SEK|1594|3270|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||1594||1594|3270||1 460170|J07BC0202|Avaxim|stl|||0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3770|6265|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3770||3770|6265||2 460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|þpakki||J04AB02|01.09.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|7708|11686|lyfalmen|||1|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||7708||7708|11686||2 460339|L01XC0301|Herceptin|stl|600|mg/hgl|5|ml|1|hgl||L01XC03|01.12.2013||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|228145|285608|lyfsjukr|||1|5|0||Icepharma hf|Roche|Trastuzumab||228145||228145|285608||2 460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|pakki||QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|5888|11341|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||5888||5888|11341||2 461107|L03AB1001|PegIntron|sts|80|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|81697|103468|lyfsjukr|||1|4|0|42,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||81697||81697|103468||1 461113|L01XE1801|Jakavi|töflur|20|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|523374|652791|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||523374||523374|652791||1 461206|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.08.2013||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyfalmen|V0554|1871|2|1|0|0,7500|Medical ehf|ratiopharm GmbH|Flúkónazól|||||1871||2 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|202|1354|lyfalmen|||2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||202||202|1354||1 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|508|1776|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||508||508|1776||1 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|566|1855|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||566||566|1855||1 462049|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|2689|4777|lyfalmen|||1|100|0|66,6667|Icepharma hf|Bayer Pharma AG|Nífedipín||||2689|4777||2 462358|A07EA0601|Entocort|endaþ.dr|20|mcg/ml|7|stk|1|þpakki|samsett pk|A07EA06|01.04.1993||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|6188|9593|lyfalmen|||1|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||6188||6188|9593||1 462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.01.2011||R|1|0|0|0|G|0|XEL|0|0|1|100|DKK|15590|22260|lyfalmen|||2|28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||15590||15590|22260||1 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|6278|12081|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||||6278|12081||2 463197|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||C10AA01|01.10.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|743|1665|lyfalmen|V0108|1665|2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||428||428|1665||2 463251|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|16747|6132|lyfalmen|V0605|6132|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Memantín||3673||3673|6132||2 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|5008|9672|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||5008||5008|9672||2 463642|J01XA0107|Vancomycin Xellia|irs|1|g/hgl|1|hgl|1|pakki||J01XA01|01.04.2013||R|0|0|0|0|0|1|XEL|0|0|0|100|XEU|661|945|lyfsjukr|||2|1|0|0,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||661||661|945||1 463654|J05AE1001|Prezista|filmhtfl|800|mg|30|stk|1|plglas||J05AE10|01.08.2013||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|54224|69299|lyfsjukr|||1|30|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||||54224|69299||1 463861|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2042|3887|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||2042||2042|3887||1 463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.11.2012||L|1|0|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||||2 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|1|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 464226|C07AG0205|Carveratio|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|2614|4674|lyfalmen|||2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Carvedílól||2614||2614|4674||2 464591|J01FA0902|Clarithromycin ratiopharm|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSB|0|0|1|100|IKR|1756|3493|lyfalmen|||2|14|0|7,0000|Medical ehf|Teva Sweden AB|Klaritrómýcín||1756||1756|3493||2 465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|0|0|0|0|G|0|APC|0|0|0|100|DKK|2802|4933|lyfalmen|V0376|4933|2|7,5|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||2802||2802|4933||1 465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1112|2186|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1112||1112|2186||1 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1126|2213|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1126||1126|2213||1 465333|L01BA0109|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3457|5835|lyfalmen|||1|0,6|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3457||3457|5835||2 465472|M05BA0803|Zoledronic acid Actavis|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.06.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|10451|14858|lyfsjukr|||2|5|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zoledronsýra||10451||10451|14858||1 465848|A07DA0303|Immex|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.06.2015||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|820|2205|lyfalmen|V0447|2205|2|100|0|20,0000|Portfarma ehf|Portfarma|Lóperamíð||820||820|2205||1 466003|N06AB0310|Seromex|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1601|2177|lyfalmen|V0038|2177|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Flúoxetín||800||800|2177||2 466029|N06AB0310|Seromex|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4767|3829|lyfalmen|V0039|3829|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Flúoxetín||2000||2000|3829||2 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|625|1937|lyfalmen|||1|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||625||625|1937||1 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2296|4237|lyfalmen|||1|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||2296||2296|4237||1 466122|G03AA0702|Microgyn|töflur|||63|stk|1|þpakki||G03AA07|01.08.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|1210|2742|lyfalmen|V0545|1904|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Levónorgestrel og ethinylestradíól||||1210|2742||2 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|1384|2981|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1384||1384|2981||1 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|4797|7679|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||4797||4797|7679||1 466278|L01XC1401|Kadcyla|irþ|100|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|264915|331340|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Trastuzumab emtansine||264915||264915|331340||2 466394|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|19659|27407|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíð||19659||19659|27407||1 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2574|4619|lyfalmen|||1|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2574||2574|4619||1 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|7000|10711|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||7000||7000|10711||1 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|4234|6904|lyfalmen|||1|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4234||4234|6904||1 466723|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|2,5|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|2,5|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|1|0|0|0|G|0|MAS|0|0|0|100|SEK|3729|6209|lyfalmen|V0063|4875|1|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíð||3729||3729|6209||1 467432|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|8607|16500|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||8607||8607|16500||2 467459|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6437|9203|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6437||6437|9203||2 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|13696|19865|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||13696||13696|19865||1 467699|G03FA1701|Angemin|töflur|||84|stk|1|þpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|5818|9084|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||5818||5818|9084||2 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|26169|35641|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||26169||26169|35641||1 467756|A10BX1001|Lyxumia|stl|20|mcg|2|áf-penni|1|pakki||A10BX10|01.10.2013||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|10516|15551|lyfalmen|||1|2|0|2,0000|Vistor hf|Sanofi-aventis groupe|Lixisenatíd||10516||10516|15551||1 467810|J01DI0201|Zinforo|irþ|600|mg|10|hgl|1|pakki|lausn|J01DI02|01.04.2013||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|84304|106711|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Ceftarólin||84304||84304|106711||1 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|1|JAS|0|0|0|100|SEK|433|619|lyfsjukr|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||433||433|619||1 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|6001|6428|lyfalmen|V0317|2560|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3888||3888|6428||1 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|291|416|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||291||291|416||1 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|8738|6133|lyfalmen|V0318|2666|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3674||3674|6133||1 468537|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2203|3797|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2203||2203|3797||2 468568|J01XA0107|Vancomycin Xellia|irs|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.04.2013||R|0|0|0|0|0|1|XEL|0|0|0|100|XEU|376|538|lyfsjukr|||2|1|0|0,2500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||376||376|538||1 468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.03.2011||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|4530|2310|lyfalmen|V0207|2310|2|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||896||896|2310||1 468825|QM01AC0603|Rheumocam|stl|20|mg/ml|50|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|5845|11260|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals|||5845||5845|11260||2 468996|A02BC0402|Rabeprazol Actavis|sþ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|4172|5200|lyfalmen|V0467|4380|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2996||2996|5200||1 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3818|6331|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||3818||3818|6331||1 469375|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.11.2012|30.06.2015|R|1|0|0|0|0|0|APC|0|0|0|100|XEU|11270|6991|lyfalmen|||2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4297||4297|6991||1 469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|7247|10361|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7247||7247|10361||2 469794|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|5909|9209|lyfalmen|V0228|8802|1|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||5909||5909|9209||2 469847|M01AH0106|Celecoxib Actavis|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|AGP|0|0|1|100|XEU|2357|3657|lyfalmen|V0037|3657|2|20|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||1875||1875|3657||1 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|4804|7689|lyfalmen|V0227|6934|1|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||4804||4804|7689||2 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|3136|5393|lyfalmen|V0226|4764|1|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||3136||3136|5393||2 470148|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.09.2013||R|1|0|1|0|0|0|SHS|0|0|0|100|DKK|10138|9386|lyfalmen|V0622|9386|2|30|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||6037||6037|9386||1 470352|M05BA0804|Zoledronic acid medac|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.12.2013||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|13651|18838|lyfsjukr|||2|5|0|1,0000|Williams & Halls efh|medac Gesellschaft|Zoledronsýra||13651||13651|18838||2 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|5088|8079|lyfalmen|||1|120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5088||5088|8079||1 470397|N05CM1801|Dexdor|irþ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|25447|33509|lyfsjukr|||1|16|0|1,6000|Vistor hf|Orion Corporation|Dexmedetómid||25447||25447|33509||1 470933|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadælur|QJ51RC20|01.03.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4202|8143|vetalmen|||0|72|0||Icepharma hf|Zoetis Finland OY|||4202||4202|8143||2 471042|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1043|2050|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1043||1043|2050||2 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|864|2266|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíð||864||864|2266||1 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.01.1988||R|0|0|0|0|G|0|BAM|0|0|0|100|SEK|5564|8735|lyfalmen|V0156|8735|1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5564||5564|8735||2 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|0|ORC|1|0|0|100|DKK|4458|8628|vetalmen|||0|10|0||Vistor hf|Orion Corporation|Atipamesól||4458||4458|8628||1 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1874|3656|lyfalmen|V0048|2433|1|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1874||1874|3656||1 472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|þpakki||R02AA03|01.08.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 472332|J07BC0201|Havrix|stl|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3397|5752|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3397||3397|5752||1 472338|S01AA2701|APROKAM|sts|50|mg|10|hgl|1|pakki|lausn|S01AA27|01.04.2013||R|0|0|0|1|0|1|TEA|0|0|0|100|SEK|11779|16510|lyfsjukr|||1|10|0||Vistor hf|Laboratories THEA|Cefuroxím||11779||11779|16510||1 472599|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|6868|5371|lyfalmen|V0012|5192|3|98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||3120||3120|5371||2 472759|R06AX2701|Aerius|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|4301|6996|lyfalmen|V0458|3569|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||4301||4301|6996||1 472984|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|1|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|UKL|0|0|0|100|USD|3004|5211|lyfalmen|V0670|4399|1|5|0||Vistor hf|Alcon Laboratories (UK) Ltd.|Brimoníð og brinzolamið||3004||3004|5211||1 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|10964|15496|lyfsjukr|||1|400|0||Vistor hf|Meda AB|Dextran||10964||10964|15496||1 474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|þykkni,lausn|N01AH06|01.06.2012||R|0|0|1|0|0|1|AGP|0|0|0|100|XEU|2625|3753|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||2625||2625|3753||1 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|15|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474551|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.05.1998||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1652|3350|lyfalmen|V0677|3350|1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1652||1652|3350||1 474608|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC|01.08.2011||R|0|0|0|0|0|0|PHM|0|0|0|100|DKK|28469|54182|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||28469||28469|54182||2 474628|N05AH0313|Olanzapin Sandoz|filmhtfl|10|mg|250|stk|1|glas||N05AH03|01.05.2013||R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|30111|12020|lyfalmen|||2|250|0|250,0000|Artasan ehf|Sandoz A/S|Olanzapín||7951||7951|12020||1 474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|749|2107|lyfalmen|V0266|2107|3|30|0|1,0600|LYFIS ehf|LYFIS ehf|Pramipexól||749||749|2107||2 475338|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.10.2014||R|0|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|1100|2590|lyfalmen|||2|100|0|26,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Warfarín||1100||1100|2590||1 475467|G03CA0306|Evorel|forðapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993|30.04.2015|R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|2760|4875|lyfalmen|||1|26|0|91,0000|Vistor hf|Janssen-Cilag AB|Estradíól||2760||2760|4875||1 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|497|1760|lyfalmen|||2|20|0|6,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||497||497|1760||1 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|627|1939|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||627||627|1939||1 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|1|0|1|0|0|0|AGP|0|0|1|100|IKR|1486|3122|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||1486||1486|3122||1 475798|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2736|4842|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||2736||2736|4842||1 475822|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|3569|5989|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||3569||3569|5989||1 475862|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|þpakki|hart|A02BC01|01.04.2015||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|61982|78948|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||61982|78948||1 476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|1146|2654|lyfalmen|||1|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1146||1146|2654||1 477017|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|16496|23406|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||16496||16496|23406||1 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|5595|8777|lyfalmen|||1|12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||5595||5595|8777||1 477295|N05AH0413|Quetiapin ratiopharm|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|G|0|TEV|0|0|0|100|IKR|28055|36059|lyfalmen|V0272|36059|2|100|0|75,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||26500||26500|36059||2 477382|N05AH0410|Quetiapin Actavis|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|34009|39856|lyfalmen|V0272|36059|2|100|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||29502||29502|39856||1 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2979||2 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||50|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3057||2 477631|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja|dreifa|H02AB01|01.10.2013||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|688|2023|lyfalmen|||1|1|0|4,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||688||688|2023||1 477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2979||2 477760|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3057||2 477941|L01XX4401|Zaltrap|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XX44|01.06.2013||R|0|0|0|1|0|1|SGA|0|0|0|100|NOK|47409|60824|lyfsjukr|||1|4|0||Vistor hf|Sanofi-aventis groupe|Afliberceptum||47409||47409|60824||1 478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|429|1660|lyfalmen|V0500|1660|2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||424||424|1660||1 478360|QM01AC0603|Rheumocam|stl|5|mg/ml|20|ml|1|hgl|handa hundum og köttum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|7117|13673|vetalmen|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|||7117||7117|13673||2 479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|24304|33282|lyfalmen|||2|100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíð||24304||24304|33282||2 479904|L01XE1401|Bosulif|filmhtfl|100|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PZE|0|0|0|100|DKK|114591|144379|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd.|Bósútíníb||114591||114591|144379||1 480223|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.04.2015||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|5026|8663|vetorma|||0|50|0||Icepharma hf|Zoetis Finland OY|Doramectinum||5026||5026|8663||2 480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|þpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|15325|7503|lyfalmen|V0341|7353|2|98|0|65,3333|Williams & Halls efh|Williams & Halls ehf|Dónepezíl||4669||4669|7503||2 480932|A10BX0901|Forxiga|filmhtfl|10|mg|98|stk|1|þpakki||A10BX09|01.10.2013||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|19744|27514|lyfalmen|||1|98|0|98,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozín||19744||19744|27514||1 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|15083|21619|lyfalmen|||1|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||15083||15083|21619||1 481208|D07AC1302|Ovixan|krem|0,1|%|30|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|741|2096|lyfalmen|||0|30|0||Vistor hf|Galenica AB|Mómetasón||741||741|2096||1 481375|R03AC1901|Striverdi Respimat|innöndl|2,5|mcg|60|skammtar|1|rörlyk||R03AC19|01.08.2014||R|0|0|0|0|G|0|BII|0|0|1|100|DKK|4579|7379|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International|Olodaterol||4579||4579|7379||1 481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|SEK|298|1486|lyfalmen|V0055|1349|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||298||298|1486||1 482183|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|hgl||G03BA03|01.05.2014||R|0|0|0|0|G|0|BGB|0|0|0|100|DKK|15254|21835|lyfalmen|V0641|21835|1|4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||15254||15254|21835||2 482457|N02BA5102|Treo|freyðit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||1 483104|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|1|0|1|0|1|AEB|0|0|0|100|DKK|64352|81896|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||64352||64352|81896||1 483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|31069|41838|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||31069|41838||2 483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|6184|8841|lyfsjukr|||1|400|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||6184||6184|8841||2 483477|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|1765|2453|lyfalmen|V0467|2453|2|56|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2453||2 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2596|3712|lyfsjukr|||1|50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||2596||2596|3712||1 483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|0|G|0|SHS|0|0|1|100|DKK|6361|9832|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||6361||6361|9832||1 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4480|6405|lyfsjukr|||1|100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||4480||4480|6405||1 483711|S01ED5114|Latanoprost/Timolol Portfarma|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|2270|4201|lyfalmen|V0374|4201|2|2,5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||2270||2270|4201||1 483968|C03AA0305|Hydromed|töflur|12,5|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|0|0|0|0|G|0|MEV|0|0|0|100|DKK|897|2311|lyfalmen|||2|100|0|50,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||897||897|2311||1 483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|þpakki||N02AX02|01.09.2011||R|1|0|1|0|G|0|AGP|0|0|1|100|XEU|273|1349|lyfalmen|V0055|1349|2|20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||198||198|1349||1 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|53546|68456|lyfsjukr|||1|3|0|112,5000|Vistor hf|Ferring|Triptórelín||53546||53546|68456||1 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|5157|8174|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríð||5157||5157|8174||1 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|126388|159051|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||126388||126388|159051||1 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|1233|2773|lyfalmen|||1|300|0|50,0000|Vistor hf|Meda AB (V)|Benzýdamín||1233||1233|2773||1 484658|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|9715|14448|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||9715||9715|14448||2 484721|L04AD0201|Advagraf|forðahlk|3|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|47647|62806|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||47647||47647|62806||1 485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|0|G|0|ANS|0|0|1|100|XEU|1165|2680|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1165||1165|2680||1 485252|L01CD0202|Docetaxel Actavis|irþ|20|mg/ml|7|ml|1|hgl|lausn|L01CD02|01.04.2013||R|0|0|0|1|0|1|AVB|0|0|0|100|XEU|8354|11944|lyfsjukr|||2|7|0||Actavis Group PTC ehf|Actavis BV|Docetaxel||8354||8354|11944||1 485304|C02KX0501|Adempas|filmhtfl|2|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|383446|478759|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Riociguatum||383446||383446|478759||2 485549|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|13659|19818|lyfalmen|||2|180|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||13659||13659|19818||1 485764|J05AX1201|Tivicay|filmhtfl|50|mg|30|stk|1|glas||J05AX12|01.04.2014||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|94342|119195|lyfsjukr|||1|30|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Dolutegravír||94342||94342|119195||1 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|0|G|0|SAC|0|0|1|100|USD|515|1785|lyfalmen|||1|5|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Dexametasón||515||515|1785||1 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|0|G|0|SAC|0|0|1|100|USD|735|2088|lyfalmen|||1|5|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Dexametasón||735||735|2088||1 487341|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.09.2012||R|1|1|0|0|G|0|APC|0|0|0|100|XEU|11665|14339|lyfalmen|V0573|14339|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||9636||9636|14339||1 487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|30938|40338|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Limited|Etanercept||30938||30938|40338||1 487725|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|51921|66435|lyfsjukr|||1|1,2|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||51921||51921|66435||1 487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|28961|38300|lyfalmen|V0453|38300|2|100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíð||28272||28272|38300||2 487827|M01AB0517|Diclomex|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.04.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|IKR|1033|1902|lyfalmen|V0469|1902|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Díklófenak||600||600|1902||2 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|þpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|853|2250|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||853||853|2250||1 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|2370|4338|lyfalmen|V0198|2809|1|60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2370||2370|4338||1 488468|L01XE1801|Jakavi|töflur|5|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|263172|329172|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||263172||263172|329172||1 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|0|0|1|G|0|APC|0|0|0|100|DKK|6328|9786|lyfalmen|||1|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||6328||6328|9786||1 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|0|0|1|G|0|APC|0|0|0|100|DKK|10496|15523|lyfalmen|||1|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||10496||10496|15523||1 489050|N06AX1105|Mirtazapine Bluefish|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|2700|2590|lyfalmen|V0331|2590|2|96|0|96,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||1100||1100|2590||2 489149|G03GA0503|Bemfola|stl|150|ae|0,25|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|6636|10210|lyfalmen|||1|0,25|0|2,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||6636||6636|10210||3 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|84568|107039|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||84568|107039||1 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|þpakki||M01AB05|01.01.1996||R|1|0|0|0|0|0|HES|0|0|1|100|DKK|325|1330|lyfalmen|V0188|498|1|10|0|5,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||184||184|1330||1 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|849|1694|lyfalmen|V0188|1493|1|30|0|15,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||449||449|1694||1 490417|G03FB0504|Evorel Sequi|forðapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|2109|3979|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2109||2109|3979||1 490425|G03FA0104|Evorel Conti|forðapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|1953|3764|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1953||1953|3764||1 490510|G03CX0103|Tibolon Orifarm|töflur|2,5|mg|84|stk|1|þpakki|3 x 28 stk|G03CX01|01.11.2014||R|0|0|0|0|G|0|IRO|0|0|0|100|XEU|5027|7814|lyfalmen|V0133|7814|2|84|0|84,0000|Artasan ehf|Orifarm Generics A/S|Tíbólón||4895||4895|7814||1 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3704|6175|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3704||3704|6175||1 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10137|10121|lyfalmen|V0112|2728|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6571||6571|10121||1 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3753|6242|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3753||3753|6242||1 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|12376|13668|lyfalmen|V0113|3485|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||9148||9148|13668||1 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14531|16967|lyfalmen|V0114|3485|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||11545||11545|16967||1 491213|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|22185|30602|lyfalmen|V0665|30602|1|28|0|21,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||22185||22185|30602||1 491313|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2012||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|33536|43569|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||33536|43569||1 491321|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.08.2013||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|126814|159581|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||126814|159581||1 491753|C10AC0103|Questran Loc|mixtduft|4|g|50|sk-pokar|1|pakki||C10AC01|01.12.2014||R|0|0|0|0|0|0|BBB|0|0|0|100|DKK|3518|5918|lyfalmen|||1|50|0|14,2800|Vistor hf|Bristol-Myers Squibb AB|Kólestýramín||3518||3518|5918||1 492377|L01XE1401|Bosulif|filmhtfl|500|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PZE|0|0|0|100|DKK|515657|643193|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd.|Bósútíníb||515657||515657|643193||1 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3074|5307|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3074||3074|5307||2 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|þpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6934|10620|lyfalmen|V0002|5371|1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||6934||6934|10620||1 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492815|C10BA0501|Atozet|filmhtfl|20|mg|90|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|16336|23204|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||16336||16336|23204||1 493113|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 493218|B03AC0001|Monofer|irl|100|mg/ml|5|ml|1|hgl||B03AC|01.07.2013||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|26154|35622|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||26154||26154|35622||1 493313|G04BD0704|Tolterodin Actavis|forðahlk|2|mg|100|stk|1|þpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3608|6042|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||3608||3608|6042||1 493401|R03DC0305|Montelukast Navamedic|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.04.2014||R|1|0|0|0|G|0|ART|0|0|0|100|XEU|6631|5797|lyfalmen|V0492|3513|2|98|0|39,2000|Artasan ehf|Navamedic ASA|Montelúkast||3430||3430|5797||1 493689|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.07.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|17745|5704|lyfalmen|V0516|5474|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3362||3362|5704||1 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1133|2636|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1133||1133|2636||1 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2310|4256|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Pízótífen||2310||2310|4256||1 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|67623|85964|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration Limited|Rítúxímab||67623||67623|85964||2 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|169056|212118|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration Limited|Rítúxímab||169056||169056|212118||2 494466|J05AE1401|Olysio|hylki|150|mg|7|stk|1|pakki||J05AE14|01.09.2014||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|346748|433117|lyfsjukr|||1|7|0||Vistor hf|Janssen-Cilag International N.V.|Simeprevír||||346748|433117||1 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburður, fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1885|3671|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1885||1885|3671||1 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2115|3987|lyfalmen|V0128|2022|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2115||2115|3987||1 494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3074|5307|lyfalmen|V0410|4539|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3074||3074|5307||1 494740|QA12CC0203|Sedaman vet|irl|200|mg/ml|100|ml|1|hgl||QA12CC02|01.04.2014||R|0|0|0|0|0|0|OOR|0|0|0|100|DKK|2067|4062|vetalmen|||0|100|0||Icepharma hf|Orion Corporation|||2067||2067|4062||2 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|1710|3430|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1710||1710|3430||1 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|20108|6868|lyfalmen|||1|15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||4208||4208|6868||1 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|7821|6991|lyfalmen|V0382|6161|1|10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||4297||4297|6991||1 495757|N06AX2601|Brintellix|filmhtfl|10|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6039|9388|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||6039||6039|9388||1 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|skammtar|1|stauk|+diskhaler|J05AH01|01.02.2000||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3068|5299|lyfalmen|||1|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||3068||3068|5299||1 496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|30803|33490|lyfalmen|V0345|33490|3|112|0|56,0000|LYFIS ehf|LYFIS ehf|Rívastigmín||24469||24469|33490||2 496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4285|8300|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4285||4285|8300||2 496468|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.09.2012||R|1|1|0|0|G|0|APC|0|0|0|100|XEU|6737|4034|lyfalmen|V0572|4034|2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||2149||2149|4034||1 496644|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.12.2011||R|0|0|0|1|0|1|SOI|0|1|0|100|DKK|75286|95495|lyfsjukr|||1|3|0|9,0000|Swedish Orphan International AB|Swedish Orphan International AB|Interferón-alfa natural||75286||75286|95495||3 496648|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|489|1749|lyfalmen|V0643|1749|2|20|0|5,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||489||489|1749||1 496935|N02AG0201|Ketogan|eþ-stíll|||10|stk|1|pakki||N02AG02|01.07.1994||R|0|0|1|0|G|0|PER|0|0|0|100|DKK|439|1681|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||439||439|1681||1 496950|N02AG0201|Ketogan|töflur|||20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|792|2166|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||792||792|2166||1 497003|L01XE0103|Mylaukim|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|184912|231839|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||184912||184912|231839||2 497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|þpakki||A07AA12|01.08.2012||R|1|0|0|0|0|1|APE|0|0|0|100|XEU|232135|290571|lyfsjukr|||1|20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||232135||232135|290571||1 497065|M01AE0219|Alpoxen|töflur|500|mg|100|stk|1|þpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|1678|3168|lyfalmen|V0127|3168|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||1520||1520|3168||1 497099|N02AG0201|Ketogan|töflur|||100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|3022|5236|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3022||3022|5236||1 497107|M01AE0219|Alpoxen|töflur|250|mg|100|stk|1|þpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|832|2221|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||832||832|2221||1 497286|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1153|1992|lyfalmen|V0056|1992|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|1992||2 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|319|1515|lyfalmen|||2|30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||319||319|1515||1 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|611|1917|lyfalmen|V0448|1917|2|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||611||611|1917||1 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1135|2531|lyfalmen|V0449|2522|2|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||1057||1057|2531||1 497885|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1633|3209|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1633||1633|3209||2 497983|N04BC0407|Ropinirol Actavis|forðatfl|4|mg|84|stk|1|þpakki||N04BC04|01.12.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|14115|10366|lyfalmen|V0533|10366|2|84|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||6749||6749|10366||1 497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|1411|2963|lyfalmen|V0369|2963|2|5|0|16,6667|Portfarma ehf|Portfarma|Dorzólamíð||1371||1371|2963||1 498051|A10BX0204|Repaglinide Krka|töflur|2|mg|120|stk|1|þpakki||A10BX02|01.11.2014||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2300|3829|lyfalmen|V0472|3829|2|120|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2000||2000|3829||2 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15874|22619|lyfalmen|V0608|16060|1|56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||15874||15874|22619||1 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|16933|23959|lyfalmen|V0609|19536|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||16933||16933|23959||1 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|21093|29220|lyfalmen|V0610|19333|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||21093||21093|29220||1 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|25483|34773|lyfalmen|V0611|25560|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||25483||25483|34773||1 499070|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|skammtar|1|fl||R01AD05|01.03.2013||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1050|2522|lyfalmen|||1|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1050||1050|2522||1 499189|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|22185|30602|lyfalmen|V0664|30602|1|28|0|14,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||22185||22185|30602||1 499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|9068|13558|lyfalmen|||1|28|0|56,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||9068|13558||2 499436|R03AK1101|Flutiform|innúðal|130|mcg/sk|120|skammtar|1|pakki|125+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|5873|9160|lyfalmen|||1|120|0|30,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||5873||5873|9160||2 499920|N06AX2601|Brintellix|filmhtfl|20|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|12080|17821|lyfalmen|||1|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||12080||12080|17821||1 501225|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|185|mg|98|stk|1|þpakki|160/25 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4880|3861|lyfalmen|||2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og þvagræsilyf||2023||2023|3861||2 501278|G04BD1201|Betmiga|forðatfl|25|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|5551|8717|lyfalmen|||1|30|0|15,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5551||5551|8717||1 501660|B01AF0101|Xarelto|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|BGB|0|0|0|100|DKK|26426|35966|lyfalmen|||1|168|0|42,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||26426||26426|35966||2 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2865|5020|lyfalmen|V0434|4754|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2865||2865|5020||2 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|19596|26232|lyfsjukr|||1|1|0|37,5000|Vistor hf|Ferring|Triptórelín||19596||19596|26232||1 503266|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|22185|30602|lyfalmen|V0665|30602|1|28|0|21,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||22185||22185|30602||1 503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|6799|8313|lyfalmen|V0354|8313|3|28|0|4,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||5258||5258|8313||2 504014|N04BC0407|Ropinirol Actavis|forðatfl|8|mg|84|stk|1|þpakki||N04BC04|01.12.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|27649|20563|lyfalmen|V0534|20563|2|84|0|112,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||14248||14248|20563||1 504020|B05AA0114|Albuman|irl|40|g/líter|250|ml|1|hgl|lausn|B05AA01|01.04.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|4031|5763|lyfsjukr|||1|250|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||4031||4031|5763||2 504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.11.2011||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1551|2678|lyfalmen|V0494|2617|2|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Glímepíríð||1164||1164|2678||1 504120|R03AL0301|ANORO|innönddu|77|mcg/sk|30|skammtar|1|innö.t|55+22 mcg|R03AL03|01.11.2014||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|8236|12412|lyfalmen|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Vilanterol og umeclidinium bromide||8236||8236|12412||1 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.01.1988||R|0|0|0|0|G|0|PTL|0|0|0|100|DKK|1602|3281|lyfalmen|||1|90|0|45,0000|Navamedic AB|Aspen Pharma Trading Limited|Estríól||1602||1602|3281||1 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|þpakki||N05BA08|01.01.1987||R|1|0|0|0|0|0|ROC|0|0|1|100|DKK|1087|2572|lyfalmen|||1|100|0|30,0000|Icepharma hf|Roche|Brómazepam||1087||1087|2572||2 504923|QN04BC0201|Prascend|töflur|1|mg|60|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|13108|25039|vetalmen|||0|60|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||13108||13108|25039||1 505647|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|300|skammtar|1|fl|2 x 150 úðaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|0,8800|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|1689|2415|lyfsjukr|||1|5|0||Icepharma hf|Pfizer ApS|Doxórúbicín||1689||1689|2415||1 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|3374|4824|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3374||3374|4824||1 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|7699|11007|lyfsjukr|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||7699||7699|11007||1 506036|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|22185|30602|lyfalmen|V0664|30602|1|28|0|14,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||22185||22185|30602||1 506176|N07BC0202|Metadon Abcur|töflur|5|mg|100|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|2351|4312|lyfalmen|||1|100|0|25,0000|Icepharma hf|Abcur AB|Metadón||2351||2351|4312||2 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2307|4252|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2307||2307|4252||1 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|þpakki||A06AB02|01.12.1975||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|þpakki||A06AB02|01.12.1975||R|1|0|0|0|0|0|ERC|0|0|0|100|DKK|375|1592|lyfalmen|||1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||375||375|1592||1 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|617|1063|vetorma|||0|24|0||Icepharma hf|Zoetis Finland OY|||617||617|1063||2 507315|L03AB1001|PegIntron|sts|120|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|120856|152171|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||120856||120856|152171||1 507758|R03AK0604|Relanio|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|9000|9748|lyfalmen|||2|60|0|30,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||6300||6300|9748||2 507834|N07CA0102|Betahistin ratiopharm|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|0|0|ROY|0|0|0|100|IKR|3105|5350|lyfalmen|||2|100|0|66,6700|Medical ehf|ratiopharm Oy|Betahistín||3105||3105|5350||2 507915|C03DA0103|Spiron|töflur|50|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|1827|3591|lyfalmen|V0092|3591|2|100|0|66,6600|Portfarma ehf|Orion Corporation|Spírónólaktón||1827||1827|3591||1 508350|N03AX1603|Pregabalin Krka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|9400|13464|lyfalmen|V0687|13464|2|56|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||9000||9000|13464||2 508589|J02AC0102|Candizol|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.02.2015||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|612|1851|lyfalmen|V0555|1796|2|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1851||1 508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993||R|1|0|0|0|G|0|ABS|0|0|0|100|DKK|2394|4371|lyfalmen|||1|98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2394||2394|4371||1 508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4783|9245|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||4783|9245||2 508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4309|8346|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4309||4309|8346||2 508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|12768|24394|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||12768||12768|24394||2 508921|L01CD0401|Jevtana|irþ|60|mg|1|hgl|1|pakki|+ leysir|L01CD04|01.08.2011||R|0|0|0|1|0|1|SAA|0|1|0|100|NOK|598307|745986|lyfsjukr|||1|1|0||Vistor hf|Sanofi - Aventis|Cabazitaxel||598307||598307|745986||1 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|8513|12794|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||8513||8513|12794||1 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988|30.06.2015|L|0|0|0|0|G|0|PTL|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Navamedic AB|Aspen Pharma Trading Limited|Estríól|||||2800||1 509359|N06AX1611|Duofaxin|forðatfl|75|mg|28|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|0|0|MEV|0|0|0|100|DKK|1032|2343|lyfalmen|V0336|2343|2|28|0|21,0000|Vistor hf|MediLink A/S|Venlafaxín||920||920|2343||1 509504|QJ51CR0201|Clavubactin vet.|töflur|312,5|mg|100|stk|1|þpakki|250 mg+ 62,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|5785|11146|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||5785||5785|11146||2 509577|G03HB0102|Diane mite|töflur|||63|stk|1|þpakki||G03HB01|01.06.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|2060|3912|lyfalmen|V0134|3098|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Cýpróterón og östrógen||2060||2060|3912||2 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|52008|66543|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||52008||52008|66543||1 509696|N05AH0314|Olanzapine Mylan|filmhtfl|10|mg|28|stk|1|þpakki||N05AH03|01.12.2013|30.06.2015|R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|1799|1751|lyfalmen|||2|28|0|28,0000|Icepharma hf|Generics UK Ltd|Olanzapín||490||490|1751||2 510200|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|82628|104626|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||82628|104626||2 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|15576|21232|lyfsjukr|||1|1,8|0|12,0000|Icepharma hf|Roche|Epóetín||15576||15576|21232||2 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|23315|30857|lyfsjukr|||1|1,8|0|18,0000|Icepharma hf|Roche|Epóetín||23315||23315|30857||2 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|38244|49425|lyfsjukr|||1|1,8|0|30,0000|Icepharma hf|Roche|Epóetín||38244||38244|49425||2 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|59110|75376|lyfsjukr|||1|3,6|0|60,0000|Icepharma hf|Roche|Epóetín||59110||59110|75376||2 510553|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|450|1696|lyfalmen|V0601|1540|2|100|0|100,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||450||450|1696||1 510608|L01XX4401|Zaltrap|irþ|25|mg/ml|8|ml|1|hgl|lausn|L01XX44|01.06.2013||R|0|0|0|1|0|1|SGA|0|0|0|100|NOK|94817|119786|lyfsjukr|||1|8|0||Vistor hf|Sanofi-aventis groupe|Afliberceptum||94817||94817|119786||1 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|154473|193981|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||154473|193981||1 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3906|4725|lyfalmen|V0445|4725|2|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríð||2651||2651|4725||1 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2520|4545|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2520||2520|4545||1 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|20877|27825|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||20877||20877|27825||1 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|||500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|13060|18103|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||13060||13060|18103||1 511932|G02BA0303|Jaydess|leginnle|13,5|mg|1|stk|1|þpakki||G02BA03|01.01.2014||R|0|1|0|0|0|0|BAB|0|0|0|100|DKK|15197|21763|lyfalmen|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||15197||15197|21763||2 512608|B05XA3101|Peditrace|irþ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4919|7033|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||4919||4919|7033||2 513133|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1826|1992|lyfalmen|V0057|1992|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|1992||2 513195|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|836|1795|lyfalmen|V0109|1795|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||522||522|1795||2 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|35|0||Vistor hf|AstraZeneca A/S DK|Lídókaín|||||||1 513391|QJ51CR0201|Clavubactin vet.|töflur|62,5|mg|100|stk|1|þpakki|50 mg + 12,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2789|5462|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||2789||2789|5462||2 513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|21375|29577|lyfalmen|||1|60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||21375||21375|29577||1 513494|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2519|4950|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2519||2519|4950||2 513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|1986|3903|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||1986||1986|3903||2 513947|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|9942|19032|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||9942||9942|19032||2 514090|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.06.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|3829|lyfalmen|V0450|3829|2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|3829||2 514265|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|200|skammtar|1|stauk||R03AC03|01.07.1993||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1638|3331|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1638||1638|3331||1 514840|N06BA0901|Strattera|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2013||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|19200|26826|lyfalmen|||1|28|0|35,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||||19200|26826||2 514870|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|3800|5206|lyfalmen|V0692|5206|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||3000||3000|5206||2 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|1|0|0|0|G|0|PER|0|0|0|100|IKR|4026|4340|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2371||2371|4340||1 515239|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|V0149|2574|0|100|0|10,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2574||1 515247|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|V0150|2586|0|100|0|20,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2586||1 515399|G03GA0503|Bemfola|stl|300|ae|0,5|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|13355|19433|lyfalmen|||1|0,5|0|4,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||13355||13355|19433||3 516219|J01FA1006|Azithromycin Eberth|irs|500|mg|10|ml|1|hgl||J01FA10|01.12.2012||R|0|0|0|0|0|1|FRI|0|0|0|100|DKK|5030|6194|lyfsjukr|||1|10|0|1,0000|Portfarma ehf|Dr. Friedrich Eberth Arzneimittel GmbH|Azitrómýcín||4332||4332|6194||1 517693|N05AH0413|Quetiapin ratiopharm|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|G|0|TEV|0|0|0|100|IKR|18600|24044|lyfalmen|V0273|24044|2|100|0|50,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||17000||17000|24044||2 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2765|4882|lyfalmen|V0462|2872|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2765||2765|4882||1 517728|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|32713|43917|lyfalmen|V0662|43917|1|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíð||32713||32713|43917||1 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3011|5221|lyfalmen|V0471|2872|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||3011||3011|5221||1 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3237|5532|lyfalmen|V0472|2872|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||3237||3237|5532||1 517824|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|10|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|32172|41873|lyfsjukr|||2|100|0|16,6600|Icepharma hf|Abcur AB|Noradrenalín||32172||32172|41873||2 517990|R06AX2201|Kestine|filmhtfl|20|mg|10|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|1|0|0|0|G|0|AGT|0|0|1|100|DKK|1019|2479|lyfalmen|||1|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||1019||1019|2479||1 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki|með breyttan losunarhraða|M01AB05|01.11.2000||R|1|0|0|0|G|0|AGT|0|0|1|100|DKK|3234|5528|lyfalmen|||1|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3234||3234|5528||1 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1951|3762|lyfalmen|V0590|3094|1|84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||1951||1951|3762||1 518750|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|1187|2206|lyfalmen|V0004|2206|2|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||821||821|2206||1 518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|18026|25341|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||18026||18026|25341||1 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|989|2438|lyfalmen|||1|125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||989||989|2438||1 519450|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|3739|6223|lyfalmen|V0644|6223|2|125|0|31,2500|Vistor hf|Takeda Pharma A/S|Fúrósemíð||3739||3739|6223||1 519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|0|APP|0|0|1|100|SEK|1481|3115|lyfalmen|||1|100|0|2,5000|Artasan ehf|Aspen Pharma Trading Limited|Súlfametoxazól og trímetóprím||1481||1481|3115||1 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|G|0|NYC|0|0|0|100|DKK|6796|10430|lyfalmen|||2|2|0|5,7222|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||6796||6796|10430||1 520029|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.04.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|7954|4102|lyfalmen|V0515|4102|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||2198||2198|4102||1 520186|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|22390|30861|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||22390|30861||1 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4418|7157|lyfalmen|V0141|4226|1|4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4418||4418|7157||1 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5088|8079|lyfalmen|V0143|1467|1|4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5088||5088|8079||1 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14336|20674|lyfalmen|V0143|4402|1|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||14336||14336|20674||1 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5457|8587|lyfalmen|V0144|1637|1|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5457||5457|8587||1 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15098|21638|lyfalmen|V0144|4912|1|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||15098||15098|21638||1 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1355|2040|lyfalmen|V0056|1992|2|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||700||700|2040||1 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2163|2040|lyfalmen|V0057|1992|2|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||700||700|2040||1 520759|M03BC5101|Norgesic|töflur|||30|stk|1|þpakki||M03BC51|01.03.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|319|1515|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||319||319|1515||1 520874|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|V0135|1769|0|25|0|2,5000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1769||1 520882|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|V0136|1778|0|25|0|5,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1778||1 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2005|31.05.2015|R|0|0|0|0|G|0|BII|0|0|0|100|DKK|29792|40223|lyfalmen|||1|100|0|28,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||29792||29792|40223||1 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ51RC23|01.12.1982||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|9057|17353|vetalmen|||0|320|0||Vistor hf|Boehringer Ingelheim Danmark|Prókaínpenicillín í blöndum með öðrum sýklalyfjum||9057||9057|17353||1 522399|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|10886|16060|lyfalmen|V0608|16060|2|56|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||10886||10886|16060||1 522427|L03AB1301|Plegridy|stl|125|mcg|2|áf-penni|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|120752|152042|lyfsjukr|||1|2|0||Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||120752||120752|152042||2 522599|J07CA0202|Tetravac|stl|||0,5|ml|1|spr|einnota dæla|J07CA02|01.10.1999||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2142|4025|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mænusótt, stífkrampi||2142||2142|4025||2 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|165146|207255|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||165146||165146|207255||1 522797|N02AX0204|Tradolan|filmhtfl|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|2591|4643|lyfalmen|||1|250|0|41,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||2591||2591|4643||1 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998|30.04.2015|R|0|0|1|0|G|0|GLP|0|0|1|100|DKK|370|1586|lyfalmen|||1|10|0|1,6667|Vistor hf|G.L.Pharma GmbH|Tramadól||370||370|1586||1 523008|G03AA1208|Cleosensa|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|2368|4336|lyfalmen|V0192|4336|2|63|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2368||2368|4336||1 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|982|2428|lyfalmen|||2|40|0|13,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||982||982|2428||1 523151|N05AH0410|Quetiapin Actavis|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|5458|4389|lyfalmen|V0285|4311|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||2407||2407|4389||1 523274|S01XA2008|Artelac|augndr|||10|ml|1|plglas||S01XA20|01.05.1998||L|0|0|0|0|G|0|GEM|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1495||1 523758|L01XE0801|Tasigna|hylki|150|mg|112|stk|1|þpakki||L01XE08|01.03.2013||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|307457|384250|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||307457||307457|384250||1 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1049|2520|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1049||1049|2520||1 523967|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|1662|3364|lyfalmen|V0584|3364|2|28|0|7,4700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||1662||1662|3364||1 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|369|1584|lyfalmen|||1|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||369||369|1584||1 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2294|4234|lyfalmen|||1|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||2294||2294|4234||1 524257|L02BB0001|Xtandi|hylki|40|mg|112|stk|1|þpakki||L02BB|01.07.2014||R|1|0|0|0|0|1|APE|0|1|0|100|XEU|458025|571515|lyfsjukr|||1|112|0||Vistor hf|Astellas Phama Europe B.V.|Enzalutamid||458025||458025|571515||1 524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|8619|6080|lyfalmen|V0010|3617|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6080||1 524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|1|spr|f. hesta|QM01AE90|01.07.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1778|3494|vetalmen|||0|30|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||1778||1778|3494||2 525014|M03BC5101|Norgesic|töflur|||100|stk|1|þpakki||M03BC51|01.06.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|658|1982|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||658||658|1982||1 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|0|0|0|0|0|0|HES|0|0|1|100|DKK|724|2073|lyfalmen|||1|15|0|3,7500|Vistor hf|Novartis Healthcare A/S|Díklófenak||724||724|2073||1 525147|M01AB0504|Klofen-L|forðahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|1608|3290|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1608||1608|3290||1 525170|M01AB0504|Klofen-L|forðahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|4659|7489|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||4659||4659|7489||1 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.03.2002||R|1|0|0|1|0|0|TBP|0|0|0|100|DKK|6996|8798|lyfalmen|V0657|8234|1|30|0|10,0000|Vistor hf|Teva Pharma B.V.|Modafinil||5610||5610|8798||1 525219|QG03XA9101|Improvac|stl|300|mcg|20|ml|12|fl||QG03XA91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|13186|22727|vetorma|||0|240|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||13186||13186|22727||2 525593|N06DX0103|Nemdatine|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.08.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|17764|6294|lyfalmen|V0605|6132|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||3791||3791|6294||1 525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|32121|43169|lyfalmen|||1|100|0|200,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||32121|43169||2 525757|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|glas||C10AA07|01.03.2014||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|13176|19207|lyfalmen|V0117|7614|1|100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||13176||13176|19207||1 525857|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5081|7264|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Kalíumklóríð||5081||5081|7264||1 525865|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|4626|6614|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Natríumklóríð||4626||4626|6614||1 525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4442||1 526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4504||1 526367|N02BE0119|Therimin Honung & Citron|mixtduft|500|mg|10|sk-pokar|1|pakki||N02BE01|01.01.2015||L|0|0|0|0|0|0|NAA|0|0|1|100|IKR|||lyflausa|||0|10|0|16,6700|Artasan ehf|Novartis Healthcare A/S|Paracetamól|||||||1 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|4170|6816|lyfalmen|V0435|6816|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4170||4170|6816||2 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|3890|6431|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3890||3890|6431||1 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|3328|5657|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3328||3328|5657||1 527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|þpakki||N02BE01|01.09.2011||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|12682|17633|lyfsjukr|||1|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||12682||12682|17633||1 527453|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|17745|5704|lyfalmen|V0516|5474|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3362||3362|5704||1 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|1361|2950|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Emedastín||1361||1361|2950||1 528055|C03DA0103|Spiron|töflur|25|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|938|1987|lyfalmen|V0046|1987|2|100|0|33,3333|Portfarma ehf|Orion Corporation|Spírónólaktón||662||662|1987||1 528214|N04BC0505|Oprymea|forðatfl|0,52|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|16800|20502|lyfalmen|V0635|20502|2|100|0|20,8000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||14200||14200|20502||2 528267|A02BC0501|Nexium|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10788|6586|lyfalmen|V0011|5254|1|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4003||4003|6586||1 528374|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2012||R|0|0|0|0|G|0|BGB|0|0|0|100|DKK|15318|21916|lyfalmen|V0641|21835|1|4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||15318||15318|21916||2 528418|D07AC1302|Ovixan|krem|0,1|%|100|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|2129|4007|lyfalmen|||0|100|0||Vistor hf|Galenica AB|Mómetasón||2129||2129|4007||1 528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|NOK|6428|9924|lyfalmen|V0356|8786|3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||6428||6428|9924||3 528584|A07EC0202|Pentasa|forðatfl|1|g|60|stk|1|þpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|0|G|0|FEL|0|0|0|100|DKK|6430|9927|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lægemidler A/S|Mesalazín (5-amínósalicýlsýra)||6430||6430|9927||1 528874|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|18|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|8872|5298|lyfalmen|V0621|5298|2|18|0|18,0000|Medical ehf|ratiopharm GmbH|Rizatriptan||3067||3067|5298||2 529289|R02AA0301|Strepsils|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 529438|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadælur|QJ51RC20|01.06.1998||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4202|8143|vetalmen|||0|72|0||Icepharma hf|Zoetis Finland OY|||4202||4202|8143||2 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4468|8647|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4468||4468|8647||2 529449|A02BC0112|Omezolmyl|sþ-hylki|40|mg|98|stk|1|þpakki||A02BC01|01.09.2013|30.06.2015|R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|9210|3105|lyfalmen|||2|98|0|196,0000|Icepharma hf|Mylan AB|Ómeprazól||1474||1474|3105||2 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|64143|81636|lyfsjukr|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||64143||64143|81636||1 529993|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1879|3693|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1879||1879|3693||2 530109|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|30|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|6500|10023|lyfalmen|V0194|10023|2|30|0|120,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6500||6500|10023||2 530162|A06AD6502|Movicol|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.07.2014||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|8|0||Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|V0592|6202|0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||6607||1 530322|B01AC0602|Hjarta-Aspirín|sþ-tfl|75|mg|100|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 530701|QN05CM9204|Nerfasin vet.|stl|20|mg/ml|25|ml|1|hgl|nautg. hestar,hundar og kettir|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|1528|3003|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet B.V.|||1528||1528|3003||2 530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2671|4753|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2671||2671|4753||1 530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5688|8132|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||5688||5688|8132||2 531459|R03CC0303|Bricanyl Retard|forðatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2658|4735|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2658||2658|4735||1 531611|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.04.2015||R|0|0|0|0|0|1|STI|0|0|0|100|NOK|4709|6733|lyfsjukr|||1|5|0|3,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||4709||4709|6733||3 531829|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2015||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|1765|lyfalmen|V0329|1765|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1765||2 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|588|1886|lyfalmen|||1|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||588||588|1886||1 532671|J01EA0107|Trimetoprim Meda|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.2010|30.04.2015|R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|312|1506|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Trímetóprím||312||312|1506||1 532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|250|1420|lyfalmen|||1|14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||250||250|1420||1 532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|1442|3061|lyfalmen|||1|100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1442||1442|3061||1 532983|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2060|2945|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2060||2060|2945||2 533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1802|3557|lyfalmen|||1|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||1802||1802|3557||1 533779|A02BC0111|Omeprazol Pensa|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.12.2012||L|1|0|0|0|0|0|PEN|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól|||||||3 534166|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.04.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|17489|24662|lyfalmen|V0639|24662|1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||17489||17489|24662||1 534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|þpakki||L04AA10|01.06.2012||R|0|0|0|1|G|0|IPI|0|0|0|100|DKK|54903|71983|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||54903||54903|71983||1 534497|QJ01CA0402|Vetrimoxin L.A.|stl|150|mg/ml|100|ml|1|hgl||QJ01CA04|01.11.2014||R|0|0|0|0|0|0|CES|0|0|0|100|XEU|2018|3966|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|||2018||2018|3966||2 534512|C10AA0703|Rosuvastatin Krka|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|7700|7614|lyfalmen|V0117|7614|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||4750||4750|7614||2 534652|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|þpakki||G03XB01|01.05.2014||R|0|0|0|1|0|1|LPF|0|0|0|100|XEU|3029|4326|lyfsjukr|||1|1|0|0,3300|Portfarma ehf|Linepharma France|Mifepriston||3026||3026|4326||1 534885|L01AA0601|Holoxan|sts/irs|1000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|5523|7896|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||5523||5523|7896||2 535265|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|2101|3968|lyfalmen|V0092|3591|2|100|0|66,6667|Vistor hf|Takeda Pharma A/S|Spírónólaktón||2101||2101|3968||1 535446|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|5238|8286|lyfalmen|V0585|8286|2|98|0|26,1300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||5238||5238|8286||1 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|480|1737|lyfalmen|||1|10|0|25,0000|Vistor hf|S.A. Alcon - Couvreur N.V.|Pílókarpín||480||480|1737||1 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|612|1919|lyfalmen|||1|10|0|25,0000|Vistor hf|S.A. Alcon - Couvreur N.V.|Pílókarpín||612||612|1919||1 536133|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|30|stk|1|þpakki||A10BA02|01.11.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|379|1445|lyfalmen|V0502|854|2|30|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||268||268|1445||1 536289|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|27917|36581|lyfsjukr|||1|1,2|0|15,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||27917||27917|36581||1 536460|N05AX1302|Xeplion|stl|150|mg|1|stk|1|áf.spr|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|96603|124725|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||96603||96603|124725||1 536745|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2762|3949|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||2762||2762|3949||2 537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5693|8139|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||5693||5693|8139||2 537811|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|0|0|0|0|G|0|PTL|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Navamedic AB|Aspen Pharma Trading Limited|Estríól|||||2424||1 537866|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|V0135|1769|0|25|0|2,5000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||1769||1 538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|110437|139213|lyfsjukr|||1|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||110437||110437|139213||2 538696|C09CA0305|Valsartan ratiopharm|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3328|3416|lyfalmen|V0678|3416|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan||1700||1700|3416||2 538794|N05AH0412|Quetiapin Sandoz|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|31975|36498|lyfalmen|V0272|36059|2|100|0|75,0000|Artasan ehf|Sandoz A/S|Quetíapín||26847||26847|36498||1 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|1|0|0|1|G|0|SNO|0|0|0|100|NOK|7247|11051|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||7247||7247|11051||1 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|593|1893|lyfalmen|||2|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||593||593|1893||1 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|599|1901|lyfalmen|||2|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||599||599|1901||1 539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|1680|3389|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1680||1680|3389||1 540009|B05BA1021|SmofKabiven|irl|550|kcal|493|ml|6|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|20511|27370|lyfsjukr|||1|2958|0||Icepharma hf|Fresenius Kabi|Blöndur||20511||20511|27370||2 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|2608|4666|lyfalmen|||1|250|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2608||2608|4666||2 540544|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|3197|3243|lyfalmen|V0621|1766|2|6|0|6,0000|Medical ehf|ratiopharm GmbH|Rizatriptan||1574||1574|3243||2 540970|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2012||R|0|0|0|0|0|0|ZOE|0|0|0|100|XEU|2416|4164|vetorma|||0|11,8|0||Icepharma hf|Zoetis Finland OY|||2416||2416|4164||2 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.07.2000||R|0|0|0|0|G|0|SAO|0|0|0|100|DKK|5502|8649|lyfalmen|V0373|7058|1|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||5502||5502|8649||2 541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 541834|N06DA0207|Donepezil Bluefish|filmhtfl|5|mg|98|stk|1|þpakki||N06DA02|01.04.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|12241|7503|lyfalmen|V0341|7353|2|98|0|65,3300|LYFIS ehf|Bluefish Pharmaceuticals AB|Dónepezíl||4669||4669|7503||2 541846|C02KX0501|Adempas|filmhtfl|0,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|190351|238603|lyfsjukr|||1|42|0||Icepharma hf|Bayer Pharma AG|Riociguatum||190351||190351|238603||2 542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5503|7868|lyfsjukr|||2|800|0|3,3300|Actavis Group hf|Braun|Gentamícín||5503||5503|7868||1 542937|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|13276|19333|lyfalmen|V0610|19333|2|56|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||13276||13276|19333||1 543236|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|þpakki||N05AA02|01.10.2012||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|585|1882|lyfalmen|||1|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||585||585|1882||1 543274|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|15526|22179|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||15526|22179||1 543320|M05BA0409|Alendronat Bluefish|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.09.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|3561|2801|lyfalmen|V0203|2801|2|12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Alendrónsýra||1253||1253|2801||2 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|þpakki||C07AA03|01.12.1983||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2719|4819|lyfalmen|||1|98|0|65,3333|Vistor hf|Novartis Healthcare A/S|Pindólól||2719||2719|4819||1 543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|2075|3127|lyfalmen|V0373|2353|2|5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||1490||1490|3127||1 543592|N01AB0701|Suprane|innönd.l|||240|ml|6|glas||N01AB07|01.09.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|73324|93055|lyfsjukr|||1|1440|0||Icepharma hf|Baxter Medical AB|Desflúran||||73324|93055||2 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|0|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)|||||||1 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 543755|R03DC0305|Montelukast Navamedic|töflur|10|mg|98|stk|1|þpakki||R03DC03|01.04.2014||R|1|0|0|0|G|0|ART|0|0|0|100|XEU|6821|2531|lyfalmen|V0490|2294|2|98|0|98,0000|Artasan ehf|Navamedic ASA|Montelúkast||1057||1057|2531||1 543972|J05AE1201|Victrelis|hylki|200|mg|336|stk|1|þpakki|hörð|J05AE12|01.01.2012||R|0|1|0|1|0|1|MLD|0|1|0|100|DKK|444606|554825|lyfsjukr|||1|336|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Boceprevír||444606||444606|554825||1 544186|G04BE0307|Sildenafil Mylan|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|3743|4488|lyfalmen|V0143|4402|2|12|0|12,0000|Icepharma hf|Mylan AB|Síldenafíl||2479||2479|4488||2 544385|J06BA0208|Privigen|irl|100|mg/ml|400|ml|1|hgl||J06BA02|01.02.2014||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|255177|319229|lyfsjukr|||1|400|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||255177||255177|319229||2 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|12181|17949|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||12181||12181|17949||1 545090|N04BC0505|Oprymea|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|50000|39221|lyfalmen|V0636|39221|2|100|0|84,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||29000||29000|39221||2 545104|L01XC0201|MabThera|stl|1400|mg|11,7|ml|1|hgl|lausn|L01XC02|01.10.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|242826|303868|lyfsjukr|||1|11,7|0||Icepharma hf|Roche Registration Limited|Rítúxímab||242826||242826|303868||2 545176|G03HB0103|Cypretyl|töflur|||63|stk|1|þpakki||G03HB01|01.10.2012||R|0|0|0|0|0|0|RGM|0|0|0|100|XEU|1623|3098|lyfalmen|V0134|3098|2|63|0|84,0000|Medical ehf|ratiopharm GmbH|Cýpróterón og östrógen||1469||1469|3098||2 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|1059|2534|lyfalmen|||1|15|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||1059||1059|2534||1 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|847|2242|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||847||847|2242||1 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|2089|3952|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2089||2089|3952||1 545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|28277|38307|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||28277||28277|38307||1 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|22798|31377|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||22798||22798|31377||1 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|28443|38517|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||28443||28443|38517||1 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|24164|33105|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||24164||24164|33105||1 546143|N02BE0108|Paratabs Retard|forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||||1 546168|N02BE0108|Paratabs Retard|forðatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1279|2837|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||1279||1279|2837|30.6.2015|1 546722|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|92,5|mg|98|stk|1|þpakki|80/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3218|2728|lyfalmen|V0580|2728|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og þvagræsilyf||1200||1200|2728||2 546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|3931|3691|lyfalmen|V0010|3691|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1900||1900|3691||1 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|1|0|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4912||1 547659|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|2267|2453|lyfalmen|V0004|2206|3|28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||1000||1000|2453||2 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|11106|15673|lyfsjukr|||1|100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||11106||11106|15673||1 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|3571|5106|lyfsjukr|||1|10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||3571||3571|5106||1 548121|L03AB0801|Betaferon|sts|250|mcg/ml|15|spr|1|pakki|+leysir|L03AB08|01.07.2013||R|0|0|0|1|0|1|BYP|0|0|0|100|DKK|99849|126044|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Bayer Pharma AG|Interferón beta-1b||99849||99849|126044||2 548154|N06DX0103|Nemdatine|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.08.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|36233|13209|lyfalmen|V0607|12849|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||8815||8815|13209||1 548326|M01AE0112|ibuxin rapid|filmhtfl|400|mg|10|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2 548506|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|620|1930|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||620||620|1930||1 548563|S01XA2011|Oculac|augndr|50|mg/ml|10|ml|1|glas|með rotvörn|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|DKK|||lyfalmen|||0|10|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||1731||1 548894|B02BC3002|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|158249|198677|lyfsjukr|||1|20|0||Icepharma hf|Baxter AG|Blöndur||158249||158249|198677||2 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|8491|12763|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||8491||8491|12763||1 549255|N06DX0102|Memantine Merz|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|11901|6905|lyfalmen|V0606|5149|2|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||4235||4235|6905||1 549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|31069|41838|lyfalmen|||1|98|0|147,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||31069|41838||2 550020|J07AP0302|Typherix|stl|||0,5|ml|1|spr|m/ aðsk. nál|J07AP03|01.08.2013||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2532|4081|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsaðir mótefnavakar||2183||2183|4081||1 550256|J02AC0102|Candizol|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1567|1748|lyfalmen|V0551|1723|2|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||488||488|1748||1 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 550731|N02BE0103|Panodil Junior|eþ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 550803|A10BX0204|Repaglinide Krka|töflur|1|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2518|3829|lyfalmen|V0471|3829|2|120|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2000||2000|3829||2 551043|B01AC0701|Persantin|húðuðtfl|100|mg|100|stk|1|þpakki||B01AC07|01.05.2014||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1614|3298|lyfalmen|V0122|3298|1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||1614||1614|3298||1 551328|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.06.2013||L|0|0|0|0|0|0|TEA|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratories THEA|Ketotifen|||||||1 551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|8104|11586|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||8104||8104|11586||2 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|8031|12130|lyfalmen|V0235|12130|1|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||8031||8031|12130||1 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|1636|3328|lyfalmen|||1|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1636||1636|3328||1 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|2619|4681|lyfalmen|V0198|4681|1|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||2619||2619|4681||1 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|738|2092|lyfalmen|||0|20|1|2,0000|Parlogis hf|Parlogis - óskráð lyf|Morfín||738||738|2092||2 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|2157|1854|lyfalmen|V0466|1787|1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1854||1 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|3752|3544|lyfalmen|V0467|2453|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3544||1 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|1510|1105|lyfalmen|V0003|824|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1105||1 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|3631|1854|lyfalmen|V0003|1648|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1854||1 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|7272|3544|lyfalmen|V0010|2067|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3544||1 551989|N03AX1406|Zelta|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|17745|5704|lyfalmen|V0516|5474|2|100|0|66,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||3362||3362|5704||2 552328|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1420|2030|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1420||1420|2030||2 552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 552764|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|100|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|18997|30623|veteldis|||0|100|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||18997||18997|30623||1 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|3078|5313|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||3078||3078|5313||1 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|11229|16532|lyfalmen|V0237|16532|1|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||11229|16532||1 553231|C10AA0506|Atorvaratio|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|3260|2728|lyfalmen|V0112|2728|2|100|0|50,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1200||1200|2728||2 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3840|6362|lyfalmen|V0237|5511|1|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||3840||3840|6362||1 553720|L01XE1801|Jakavi|töflur|15|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|523374|652791|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||523374||523374|652791||1 553923|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|42118|54243|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||42118|54243||2 554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|10784|20630|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|||10784||10784|20630||1 554582|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.11.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|6621|6662|lyfalmen|V0029|6662|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||4058||4058|6662||1 555196|L04AC1001|Cosentyx|stl|150|mg|2|áf-penni|1|pakki||L04AC10|01.07.2015||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|153026|164627|lyfsjukr|||1|2|0||Vistor hf|Novartis Europharm Ltd|Secukinumab||130871||130871|164627||1 555235|N05AB0303|Peratsin|húðuðtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|2126|4003|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||2126||2126|4003||1 555268|N05AB0303|Peratsin|húðuðtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|2423|4411|lyfalmen|||2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||2423||2423|4411||1 555292|N05AB0303|Peratsin|húðuðtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|1828|3592|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||1828||1828|3592||1 555572|S01XA2201|JETREA|stþ|0,5|mg/hgl|0,2|ml|1|hgl||S01XA22|01.12.2014||R|0|1|0|1|0|1|THO|0|0|0|100|USD|537031|669776|lyfsjukr|||1|0,2|0||Vistor hf|ThromboGenics NV|Ocriplasmínum||537031||537031|669776||1 555864|G04BD0804|Solifenacin Actavis|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.03.2015||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|13774|17933|lyfalmen|V0440|17933|2|90|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Sólífenacín||12169||12169|17933||1 556556|D07AC0104|Diproderm|húðlausn|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.2015||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2108|3978|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2108||2108|3978||1 556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|20350|27170|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|E. Merck AB|Sómatrópín||20350||20350|27170||2 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|4561|7354|lyfalmen|||1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||4561||4561|7354||1 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|8892|13315|lyfalmen|||1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||8892||8892|13315||1 557546|D10AF0202|Zineryt|áburður|||30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|0|0|0|0|0|0|ASP|0|0|0|100|XEU|1496|3135|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1496||1496|3135||1 557907|N02BE0109|Panodil Hot|mixtduft|500|mg|10|skammtar|1|pakki||N02BE01|01.10.2014||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2689|4523|lyfalmen|||2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2504||2504|4523||2 558175|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4261|8254|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4261||4261|8254||2 558335|C07AG0204|Carvedilol HEXAL|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.01.2015|30.06.2015|R|1|0|0|0|G|0|PCO|0|0|0|100|DKK|2460|4462|lyfalmen|||2|100|1|33,3300|Distica|Distica - óskráð lyf|Carvedílól||2460||2460|4462||1 558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|229578|287391|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||229578|287391||1 559021|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.1995||R|1|0|0|0|G|0|ABS|0|0|0|100|DKK|1816|3576|lyfalmen|||1|98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1816||1816|3576||1 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1464|3091|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1464||1464|3091||2 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|4630|7449|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||4630||4630|7449||1 559971|C01DA0201|Discotrine|forðapl|10|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|0|0|0|0|G|0|MEB|0|0|0|100|SEK|2905|5075|lyfalmen|||1|30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||2905||2905|5075||1 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|0|G|0|GEM|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1493||1 560244|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|30|stk|1|þpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|791|1765|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||500||500|1765|30.6.2015|2 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|1391|2871|lyfalmen|V0044|2301|1|25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1304||1304|2871||1 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|2|0||GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||||1 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|1647|3343|lyfalmen|||1|4,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1647||1647|3343||1 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|5630|8825|lyfalmen|||1|125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||5630||5630|8825||1 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|6195|9603|lyfalmen|||1|100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6195||6195|9603||1 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|91833|116075|lyfsjukr|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||91833||91833|116075||1 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|422433|527248|lyfsjukr|||1|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||422433||422433|527248||1 560695|L01XE0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|AHL|0|1|0|100|DKK|159646|141298|lyfsjukr|||2|60|0||Portfarma ehf|Accord Healthcare Limited|Imatiníb||112114||112114|141298||1 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1607|3288|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1607||1607|3288||2 561780|C02KX0501|Adempas|filmhtfl|1,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|190351|238603|lyfsjukr|||1|42|0||Icepharma hf|Bayer Pharma AG|Riociguatum||190351||190351|238603||2 562014|C09BA0201|Darazið|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|1844|2644|lyfalmen|V0098|2405|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og þvagræsilyf||1139||1139|2644||1 562176|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2013||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|46585|59799|lyfsjukr|||1|1|0|1,1100|Icepharma hf|Pfizer Limited|Storkuþáttur IX||46585||46585|59799||1 562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|90 (18x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|4443|7192|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||4443||4443|7192||1 562577|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|265989|332676|lyfsjukr|||1|300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||265989||265989|332676||2 562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|98939|124912|lyfsjukr|||1|1|0|16,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||98939||98939|124912||1 563111|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|þpakki|hart|L04AX05|01.07.2012||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|106138|136785|lyfalmen|||1|63|0|7,0000|Icepharma hf|Roche Registration Limited|Pírfenidon||106138||106138|136785||2 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|741|2096|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||741||741|2096||1 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|736|2089|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||736||736|2089||1 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|1292|2855|lyfalmen|||1|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1292||1292|2855||1 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3354|5693|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3354||3354|5693||2 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3477|5862|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3477||3477|5862||2 563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|434213|551735|lyfalmen|||1|60|0|15,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||434213||434213|551735||1 563779|M05BA0708|Risedronate Bluefish|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.07.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2323|2311|lyfalmen|||2|12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Rísedrónsýru||897||897|2311|31.5.2015|2 563899|QP54AA0105|Noromectin|áhella|0,5|% w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|10646|18349|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||10646||10646|18349||2 563918|N02AA0505|Oxycodone ratiopharm|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|1401|2630|lyfalmen|V0596|1858|2|28|0|1,8600|Medical ehf|ratiopharm GmbH|Oxýcódon||1129||1129|2630||2 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|65167|82910|lyfsjukr|||1|168|0|33,6000|Vistor hf|Merck Sharp & Dohme Limited|Ribavirin||65167||65167|82910||1 564110|A02BX1302|Galieve Cool Mint|mixtúra|||150|ml|1|glas|dreifa|A02BX13|01.10.2014||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|150|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|1033|2498|lyfalmen|||1|120|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||1033||1033|2498||1 564931|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|5|ml|1|hgl||L01XA02|01.03.2015||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|1291|1846|lyfsjukr|||2|5|0||Alvogen HS|Hospira Nordic AB|Karbóplatín||1291||1291|1846||1 565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 565400|N05AH0411|Quetiapine Teva|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|7600|7958|lyfalmen|V0286|7958|2|100|0|50,0000|Medical ehf|Teva Sweden AB|Quetíapín||5000||5000|7958||2 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|9839|14619|lyfalmen|||1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||9839||9839|14619||1 565685|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|8098|15534|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|||||8098|15534||2 565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|22953|30407|lyfsjukr|||1|42,5|0|0,3600|Vistor hf|Ferring Lægemidler A/S|Terlípressín||22953||22953|30407||1 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|1520|3168|lyfalmen|V0444|2416|1|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Brinzólamíð||1520||1520|3168||1 566243|G03AA1207|Cleonita|filmhtfl|||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|2883|5044|lyfalmen|V0193|5044|2|84|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2883||2883|5044||1 566924|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|13854|20065|lyfalmen|||2|360|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||13854||13854|20065||1 567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|1|0|0|1|0|1|NEL|0|0|0|100|GBP|223551|279895|lyfsjukr|||1|84|0||Vistor hf|Novartis Europharm Ltd|Labatinibum||223551||223551|279895||1 567338|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|glas||G04BD12|01.07.2014||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|16202|23034|lyfalmen|V0651|23034|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16202||16202|23034||1 567400|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.06.2015||L|0|0|0|0|G|0|PTL|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Navamedic AB|Aspen Pharma Trading Limited|Estríól|||||2811||1 567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|G|0|ALK|0|0|1|100|DKK|5430|8550|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5430|8550||1 567503|N05AX0801|Risperdal|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|3003|5210|lyfalmen|V0291|2315|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||3003||3003|5210||1 567510|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.06.2013||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|3127|5380|lyfalmen|||1|100|0|33,3333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||3127||3127|5380||1 567511|N05AX0801|Risperdal|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|6078|9442|lyfalmen|V0292|3760|1|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||6078||6078|9442||1 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|1183|2705|lyfalmen|||1|3|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1183||1183|2705||1 568812|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|5546|8710|lyfalmen|V0663|8710|1|7|0|1,7500|Vistor hf|Eisai Europe Ltd.|Perampanel||5546||5546|8710||1 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2719|3993|lyfalmen|V0058|3554|2|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||2119||2119|3993||1 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3666|5455|lyfalmen|V0059|4930|2|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||3181||3181|5455||1 569257|J05AR1301|Triumeq|filmhtfl|950|mg|30|stk|1|glas|50+600+300 mg|J05AR13|01.12.2014||R|0|1|0|1|0|1|VII|0|0|0|100|GBP|153568|192856|lyfsjukr|||1|30|0||GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír, dolutegravír og lamivudín||153568||153568|192856||1 569378|L01AA0601|Holoxan|sts/irs|2000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|11080|15640|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||11080||11080|15640||2 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|14393|19761|lyfsjukr|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||14393||14393|19761||1 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|16552|22446|lyfsjukr|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||16552||16552|22446||1 571030|QM01AA9001|Danilon equidos|kyrni|1,5|g|10|g|18|pokar||QM01AA90|01.07.2014||R|0|0|0|0|0|0|EST|0|0|0|100|DKK|3172|6188|vetalmen|||0|180|0||Vistor hf|Laboratorios Dr. ESTEVE S.A.|Suxibuzone||3172||3172|6188||1 571181|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|77442|98176|lyfsjukr|||1|1,5|0|0,7500|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíðar||77442||77442|98176||1 571217|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|42117|54242|lyfsjukr|||1|1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||42117|54242||3 571358|L01XC1501|Gazyvaro|irþ|1000|mg|1|hgl|1|pakki||L01XC15|01.02.2015||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|510409|636666|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Obinutuzumab||510409||510409|636666||2 571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 572422|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|74880|97250|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||74880||74880|97250||1 572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 573065|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|3828|5371|lyfalmen|V0011|5149|3|98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||3120||3120|5371||2 573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.12.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|5300|3504|lyfalmen|V0245|3483|2|98|0|32,6700|Actavis Group hf|Actavis hf|Lamótrigín||1764||1764|3504||1 573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|3899|6443|lyfalmen|V0464|5161|1|2,5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||3899||3899|6443||1 573287|G03CA0306|Evorel|forðapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993|30.04.2015|R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|2908|5079|lyfalmen|||1|26|0|45,5000|Vistor hf|Janssen-Cilag AB|Estradíól||2908||2908|5079||1 573436|N06DX0102|Memantine Merz|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|34997|19412|lyfalmen|V0607|12592|2|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||13338||13338|19412||1 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|80238|101654|lyfsjukr|||1|1|0||Icepharma hf|Roche|Trastuzumab||80238||80238|101654||2 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|15928|21670|lyfsjukr|||1|5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||15928||15928|21670||1 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|26114|34339|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||26114||26114|34339||1 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|2382|2702|lyfalmen|V0189|2132|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||1181||1181|2702||1 573999|G04BE0307|Sildenafil Mylan|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|5464|5013|lyfalmen|V0144|4912|2|12|0|24,0000|Icepharma hf|Mylan AB|Síldenafíl||2860||2860|5013||2 574377|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.09.2013||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|39878|51457|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||39878|51457||1 574423|L01XC1301|Perjeta|irþ|420|mg|14|ml|1|hgl||L01XC13|01.06.2013||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|390964|488110|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration Limited|Pertuzumab||390964||390964|488110||2 574900|N05AH0410|Quetiapin Actavis|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.09.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|21244|25836|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||18417||18417|25836|30.4.2015|1 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2314|2136|lyfalmen|V0151|1647|1|28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||770||770|2136||1 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|7157|6641|lyfalmen|||1|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4043||4043|6641|31.5.2015|1 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4268|2136|lyfalmen|V0152|2124|1|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||770||770|2136||1 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|12993|6681|lyfalmen|V0323|3551|1|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4072||4072|6681||1 575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1117|2140|lyfalmen|V0159|2087|2|20|0|10,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||773||773|2140||2 575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1285|2549|lyfalmen|V0160|2537|2|30|0|15,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1070||1070|2549||2 575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1453|2453|lyfalmen|V0158|2453|2|20|0|15,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1000||1000|2453||2 576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.12.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1150|1539|lyfalmen|V0243|1367|2|42|0|3,5000|Actavis Group hf|Actavis hf|Lamótrigín||336||336|1539||1 576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|9527|14189|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Merkaptópúrín||9527||9527|14189||1 577455|C10AA0506|Atorvaratio|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|4000|3485|lyfalmen|V0113|3485|2|100|0|100,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1750||1750|3485||2 577711|C01CA0601|Fenylefrin Abcur|stl|0,05|mg/ml|10|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|11933|16701|lyfsjukr|||2|100|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||11933||11933|16701||2 578261|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.07.2015||R|0|0|0|0|0|0|PIS|0|0|0|100|USD|4508|7281|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4508||4508|7281||2 578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|6249|10771|vetorma|||0|20|0||Icepharma hf|Icepharma hf|||6249||6249|10771||2 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1153|2663|lyfalmen|||1|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1153||1153|2663||1 579421|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|40|mg|28|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|1671|2453|lyfalmen|V0005|2449|3|28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||1000||1000|2453||2 579854|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|342|1547|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||342||342|1547||1 579932|C03DA0402|Eplerenone Portfarma|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.06.2014||R|1|0|0|0|0|0|PEH|0|0|0|100|DKK|7594|6275|lyfalmen|V0107|6169|2|30|0|15,0000|Portfarma ehf|Portfarma ehf|Eplerenón||3777||3777|6275||1 579972|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|30623|24044|lyfalmen|V0111|24044|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||17000||17000|24044||2 580042|C05AA0801|Doloproct|eþ-stíll|||10|stk|1|þpakki||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|698|2037|lyfalmen|V0675|2037|1|10|0||Icepharma hf|Bayer AB|Flúókortólón||698||698|2037||2 580104|N07BB0501|Selincro|filmhtfl|18|mg|14|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|8014|12107|lyfalmen|||1|14|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||8014||8014|12107||1 580960|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1644|2350|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1644||1644|2350||2 581417|S01ED5116|Taptiqom|augndr|||0,3|ml|30|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3049|5273|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3049||3049|5273||2 581619|N03AX1407|Levetiracetam Teva|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.03.2015||R|1|0|0|0|0|0|TEV|0|0|0|100|IKR|5500|6307|lyfalmen|V0253|6307|2|100|0|33,3300|Medical ehf|Teva Pharma B.V.|Levetíracetam||3800||3800|6307||2 581661|N02CC0403|Rizatriptan Portfarma|munndr.t|5|mg|6|stk|1|þpakki||N02CC04|01.01.2015||R|0|0|0|0|G|0|PEH|0|0|0|100|XEU|3401|5757|lyfalmen|V0620|5757|2|6|0|3,0000|Portfarma ehf|Portfarma ehf|Rizatriptan||3401||3401|5757||1 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|13482|25749|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||13482||13482|25749||2 581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|0|G|0|ASN|0|0|0|100|USD|2537|4568|lyfalmen|V0669|4037|0|2,5|0|25,0000|Alcon Nordic A/S|Alcon Laboratories Ltd.|Travóprost||2537||2537|4568||1 581991|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|6487|12478|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||6487||6487|12478||2 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|20471|27320|lyfsjukr|||1|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||20471||20471|27320||2 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|40060|51683|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||40060||40060|51683||2 582122|G03GA0503|Bemfola|stl|450|ae|0,75|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|18176|25531|lyfalmen|||1|0,75|0|6,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||18176||18176|25531||3 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|80120|101507|lyfsjukr|||1|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||80120||80120|101507||2 582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|26119|34345|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||26119||26119|34345||2 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|29962|39124|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||29962||29962|39124||2 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|68034|86475|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||68034||68034|86475||2 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|26560|34893|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||26560||26560|34893||2 582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|34548|44828|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|E. Merck AB|Sómatrópín||34548||34548|44828||2 583105|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.08.2013||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|2383|3707|lyfalmen|V0376|1644|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||1911||1911|3707||1 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|54259|69343|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||54259||54259|69343||2 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|983|2429|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Sótalól||983||983|2429||2 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|91631|115823|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||91631||91631|115823||2 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|29030|37965|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||29030||29030|37965||2 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|46448|59628|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||46448||46448|59628||2 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|87089|110174|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||87089||87089|110174||2 583776|L01XE2301|Tafinlar|hylki|50|mg|28|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|GBP|183359|229907|lyfsjukr|||1|28|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||183359||183359|229907||1 584133|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|17309|23388|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||17309||17309|23388||1 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|þpakki||N06AG02|01.07.1995||R|1|0|0|0|G|0|MAS|0|0|0|100|SEK|1639|3332|lyfalmen|||1|30|0|30,0000|Vistor hf|Meda AS|Móklóbemíð||1639||1639|3332|30.6.2015|1 584479|G04BE0307|Sildenafil Mylan|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|1620|2201|lyfalmen|V0143|1467|2|4|0|4,0000|Icepharma hf|Mylan AB|Síldenafíl||817||817|2201||2 585130|N06DA0301|Exelon|forðapl|13,3|mg/sólh|60|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|40298|53511|lyfalmen|||1|60|0|84,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||40298||40298|53511||1 585516|A10BX1201|Jardiance|filmhtfl|25|mg|90|stk|1|þpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|19334|26996|lyfalmen|||1|90|0||Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||19334||19334|26996||1 585661|B01AB0101|Heparin Leo|stl|100|ae/ml|10|ml|10|hgl||B01AB01|01.03.2014||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|5649|8852|lyfalmen|||1|100|0|1,0000|Vistor hf|LEO Pharma A/S|Heparín||5649||5649|8852||1 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|4213|6023|lyfsjukr|||1|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||4213||4213|6023||1 585869|J07BC0201|Havrix|stl|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|4794|7675|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4794||4794|7675||1 585975|C07AB0312|Atenolol LYFIS|filmhtfl|25|mg|100|stk|1|þpakki||C07AB03|01.05.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|438|1471|lyfalmen|V0541|1471|2|100|0|33,3300|LYFIS ehf|LYFIS ehf|Atenólól||287||287|1471||2 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|28785|38949|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||28785||28785|38949||1 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1623|3310|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1623||1623|3310||1 586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|13240|18327|lyfsjukr|||2|800|0|10,0000|Actavis Group hf|Braun|Gentamícín||13240||13240|18327||1 586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|þpakki|hart hylki+innönd.tæki|J01GB01|01.04.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|353391|441379|lyfsjukr|||1|224|0|56,0000|Vistor hf|Novartis Europharm Ltd|Tobramýcín||353391||353391|441379||1 586694|N06DX0103|Nemdatine|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|11375|5221|lyfalmen|V0606|5149|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||3011||3011|5221||1 586967|B01AF0201|Eliquis|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|27557|37396|lyfalmen|V0652|37257|1|168|0|168,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||27557|37396||1 587112|M01AH0106|Celecoxib Actavis|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|AGP|0|0|1|100|XEU|11270|14759|lyfalmen|V0196|14759|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||9941||9941|14759||1 587141|N05AE0403|Ziprasidon Actavis|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|18199|25560|lyfalmen|V0611|25560|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||18199||18199|25560||1 587437|N06DX0103|Nemdatine|filmhtfl|10|mg|28|stk|1|þpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|4971|3034|lyfalmen|V0604|2815|2|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||1422||1422|3034||1 587522|L04AB0601|Simponi|stl|100|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.11.2014||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|148687|186785|lyfsjukr|||1|1|0|60,2400|Vistor hf|Janssen Biologics B.V.|Golimumab||148687||148687|186785||1 587613|A02BC0112|Omezolmyl|sþ-hylki|40|mg|100|stk|1|þpakki||A02BC01|01.03.2015||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|6680|3102|lyfalmen|V0001|3102|2|100|0|200,0000|Icepharma hf|Mylan AB|Ómeprazól||1472||1472|3102||2 587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|4333|5166|lyfalmen|V0095|4972|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og þvagræsilyf||2971||2971|5166||1 588457|N06DX0105|Memantine Mylan|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|32488|13443|lyfalmen|V0607|12592|2|98|0|98,0000|Icepharma hf|Generics UK Ltd|Memantín||8985||8985|13443||2 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2041|3886|lyfalmen|V0461|3884|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2041||2041|3886||1 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|7952|12021|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||7952||7952|12021||1 588669|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|22185|30602|lyfalmen|V0668|30602|1|28|0|42,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||22185||22185|30602||1 588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|8758|5281|lyfalmen|V0282|4271|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3055||3055|5281||1 588982|R03AK0604|Relanio|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|6000|7683|lyfalmen|||2|60|0|30,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||4800||4800|7683||2 589153|L01XE2301|Tafinlar|hylki|50|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|GBP|785854|979242|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||785854||785854|979242||1 589358|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5685|9799|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5685||5685|9799||2 589366|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2203|3797|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2203||2203|3797||2 589374|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5485|9454|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5485||5485|9454||2 589382|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2963|5107|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2963||2963|5107||2 589390|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|3077|5304|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3077||3077|5304||2 589408|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|2962|5105|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2962||2962|5105||2 589888|N01AF0302|Pentocur|sts|0,5|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|11690|16399|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||11690||11690|16399||2 590092|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar|áfylltur penni|L04AB04|01.07.2013||R|0|1|0|1|0|1|ABV|0|1|0|100|DKK|127325|160217|lyfsjukr|||1|1,6|0|27,5900|Vistor hf|AbbVie Ltd.|Adalimumab||127325||127325|160217||1 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2868|3233|lyfalmen|V0041|2701|2|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíð mónónítrat||1567||1567|3233||1 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|159320|200009|lyfsjukr|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||159320||159320|200009||1 591260|N06DA0302|Exelon (Lyfjaver)|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|12097|17842|lyfalmen|V0347|17842|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||12097||12097|17842||3 591317|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.10.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|30623|24044|lyfalmen|V0111|24044|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||17000||17000|24044||2 591445|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|þpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|8795|13182|lyfalmen|||2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||8795||8795|13182||2 592534|L04AD0104|Ciqorin|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|12500|14152|lyfalmen|||2|50|0|10,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||9500||9500|14152||2 592687|A02BC0112|Omezolmyl|sþ-hylki|40|mg|28|stk|1|þpakki||A02BC01|01.09.2013|30.06.2015|R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|2514|2281|lyfalmen|||2|28|0|56,0000|Icepharma hf|Mylan AB|Ómeprazól||875||875|2281||2 592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|709902|884779|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||709902||709902|884779||1 593200|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|22239|29519|lyfsjukr|||1|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||22239|29519||3 593379|A10BG0304|Pioglitazone Accord|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.12.2013||R|1|1|0|0|G|0|AHL|0|0|0|100|XEU|10143|14339|lyfalmen|V0573|14339|2|98|0|98,0000|Portfarma ehf|Accord Healthcare Limited|Píóglítazón||9636||9636|14339||1 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|482|1740|lyfalmen|V0238|782|1|50|0|3,1250|Icepharma hf|Roche|Klónazepam||482||482|1740||2 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|923|2347|lyfalmen|V0238|2347|1|150|0|9,3750|Icepharma hf|Roche|Klónazepam||923||923|2347||2 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1260|2811|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1260||1260|2811||2 593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|18453|25881|lyfalmen|||1|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||18453||18453|25881||1 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|315|543|vetorma|||0|10|0||Icepharma hf|Zoetis Finland OY|||315||315|543||2 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|5280|7549|lyfsjukr|||1|5|0|5,0000|Vistor hf|Novartis Healthcare A/S|Samtengt laxakalsítónín||5280||5280|7549||1 595198|G04BD1201|Betmiga|forðatfl|25|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|16202|23034|lyfalmen|||1|90|0|45,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16202||16202|23034||1 595966|B02BD0207|ReFacto AF|sts|250|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|21786|28956|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||21786||21786|28956||1 595991|J07BB0201|Fluarix|stl|||0,5|ml|1|áfspr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|669|1997|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||669||669|1997||1 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|51651|66099|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||51651|66099||1 596196|G04BE0308|Sildenafil Portfarma|tuggutfl|100|mg|4|stk|1|þpakki||G04BE03|01.09.2013||R|1|0|0|0|0|0|PEH|0|0|0|100|XEU|1601|2270|lyfalmen|V0144|1637|2|4|0|8,0000|Portfarma ehf|Portfarma ehf|Síldenafíl||867||867|2270||1 596881|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|15904|21640|lyfsjukr|||1|10|0|1,0000|Vistor hf|Orion Corporation|Dexmedetómid||15904||15904|21640||1 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2181|4078|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2181||2181|4078||1 597433|L01XC1101|Yervoy|stþ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|601627|750116|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||601627||601627|750116||1 597565|L03AB1301|Plegridy|irl|125|mcg|2|áf.spr|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|120752|152042|lyfsjukr|||1|2|0||Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||120752||120752|152042||2 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 598021|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.06.2014||R|1|0|0|0|G|0|MPH|0|0|0|100|SEK|2771|4890|lyfalmen|||1|100|0|33,3333|Icepharma hf|Mercury Pharmaceuticals Ltd.|Acetazólamíð||2771||2771|4890||2 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|0|0|0|0|0|0|SNO|0|0|1|100|NOK|376|1594|lyfalmen|||1|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||376||376|1594||1 598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2 598925|M01AE0114|Nurofen Apelsin|mixtúra|40|mg/ml|100|ml|1|glas||M01AE01|01.04.2013||L|0|0|0|0|0|0|REC|0|0|1|100|DKK|||lyfalmen|||0|100|0|3,3333|Vistor hf|Reckitt Benckiser Healthcare Ltd|Íbúprófen|||||1793||1 599010|L01XE1701|INLYTA|filmhtfl|5|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PZE|0|1|0|100|DKK|576084|718347|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd.|Axitinib||576084||576084|718347||1 599320|QV03AB9002|Narcostop|stl|5|mg/ml|10|ml|1|hgl|fyrir hunda og ketti|QV03AB90|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|4233|8201|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Atipamesól||4233||4233|8201||2 599460|S01XA2011|Oculac|augndr|50|mg/ml|0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|DKK|||lyfalmen|||0|8|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2087||1 599462|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|28814|38986|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||28814|38986||1 599883|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3141|lyfalmen|V0334|3141|2|100|0|75,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3141||2 692098|N06BA0104|Amfetamin Glostrup|töflur|5|mg|100|stk|1|glas||N06BA01|01.07.2011||R|0|0|1|0|0|0|PCO|0|0|0|100|DKK|3840|6362|lyfalmen|||0|100|1|33,3300|Distica|Distica - óskráð lyf|Amfetamín||||3840|6362||1 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|þpakki||A03FA03|01.05.1998||R|0|0|0|0|0|0|PCO|0|0|1|100|SEK|2470|4476|lyfalmen|||0|100|1|33,3333|Distica|Distica - óskráð lyf|Dómíperídón||2470||2470|4476||1 923351|S01XA2006|Lacri - Lube|augnsm|||3,5|g|1|túpa||S01XA20|01.01.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|480|1737|lyfalmen|||0|3,5|1||Distica|Distica - óskráð lyf|Gervitár og aðrar óvirkar samsetningar||480||480|1737||1 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|GBP|6671|10258|lyfalmen|||0|100|1|50,0000|Parlogis hf|Parlogis - óskráð lyf|Kolkisín||6671||6671|10258||2 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|0|0|0|0|0|0|LDR|0|0|0|100|GBP|19166|26783|lyfalmen|||0|100|1|2,0000|Parlogis hf|Parlogis - óskráð lyf|Kaptópríl||19166||19166|26783||2 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|3127|5380|lyfalmen|||0|1|1|33,3300|Distica|Distica - óskráð lyf|Testósterón||3127||3127|5380||1 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|5046|8022|lyfalmen|||0|100|1|13,3300|Distica|Distica - óskráð lyf|Kortisón||5046||5046|8022||1 944852|A06AX0102|Glycerol infant|eþ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|545|1826|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráð lyf|Glýceról||545||545|1826||2 944985|A06AX0103|Glycerol adult|eþ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|664|1990|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráð lyf|Glýceról||664||664|1990||2 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|2293|4232|lyfalmen|||0|10|1|10,0000|Distica|Distica - óskráð lyf|Prómetazín||2293||2293|4232||1 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|5033|8004|lyfalmen|||0|100|1|66,6667|Parlogis hf|Parlogis - óskráð lyf|Kortisón||5033||5033|8004||2 951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|5046|8022|lyfalmen|||0|100|1|3,3300|Distica|Distica - óskráð lyf|Hýdrókortisón||5046||5046|8022||1 954851|V09AB0301|DaTSCAN|stl|74|MBq/ml|5|ml|1|hgl||V09AB03|01.10.2013||R|0|0|0|1|0|1|GEL|0|0|0|100|NOK|130986|164770|lyfsjukr|||1|5|0||Icepharma hf|GE Healthcare Limited|Lofendýlat||130986||130986|164770||2 957657|A12BA0201|Polycítra - forskriftarlyf|mixtúra|||500|ml|1|fl|Potassium citrats 102 mg/g|A12BA02|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|15120|21666|lyfalmen|||0|500|0|12,7500|PharmArctica ehf|PharmArctica - forskriftarlyf|potassium citrate||15120||15120|21666||2 957665|A12BA0102|Kalíum Klórið - forskriftarlyf|mixtúra|33|mg/g|300|ml|1|fl|35,34 mg/ml|A12BA01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2610|4669|lyfalmen|||0|300|0|3,5400|PharmArctica ehf|PharmArctica - forskriftarlyf|Kalíumklóríð||2610||2610|4669||2 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|þpakki||A04AD05|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1257|2806|lyfalmen|||0|20|1|20,0000|Parlogis hf|Parlogis - óskráð lyf|Metópímazín||1257||1257|2806||2 961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|þpakki||H02AB09|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1430|3045|lyfalmen|||0|20|1|6,6700|Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||1430||1430|3045||2 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|6231|9653|lyfalmen|||0|25|1|16,7000|Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||6231||6231|9653||2 962234|R05DA2001|SEM mixtúra - forskriftarlyf|mixtúra|||300|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|1610|3292|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1610||1610|3292||2 962242|R05DA2001|SEM mixtúra - forskriftarlyf|mixtúra|||100|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|1030|2494|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1030||1030|2494||2 962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|þpakki||R06AB02|01.11.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|3707|6179|lyfalmen|||0|30|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|Dexklórfeníramín||3707||3707|6179||2 965858|QI04AB0901|Gudair|stl|||30|ml|1|glas|dreifa|QI04AB09|01.09.2014||R|0|0|0|0|0|0|CZV|1|0|0|100|XEU|6185|10660|vetorma|||0|30|0||Vistor hf|CZ Veterinaria SA|Bóluefni gegn Mycobacterium||||6185|10660||1 967359|N05AH0408|Quetiapin Bluefish|filmhtfl|200|mg|60|stk|1|þpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|12500|3829|lyfalmen|||2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||2000||2000|3829|31.5.2015|2 967367|N05AH0408|Quetiapin Bluefish|filmhtfl|300|mg|60|stk|1|þpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|25000|26953|lyfalmen|||2|60|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||19300||19300|26953||2 968365|D07CB0101|TNG-smyrsl - forskriftarlyf|smyrsli|||15|ml|1|dos||D07CB01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|1522|3171|lyfalmen|||0|15|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Triamcinolonum og sýklalyf||1522||1522|3171||2 968373|V03AB1505|Naloxonhydrochlorid - forskriftarlyf|mixtúra|1|mg/ml|500|ml|1|fl||V03AB15|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|18870|26409|lyfalmen|||0|500|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naloxón||18870||18870|26409||2 968399|A03AA0704|Dicykloverine hydrochloride-forsk.lyf|mixtúra|2|mg/ml|100|ml|1|fl||A03AA07|01.04.2014||R|0|0|0|1|0|0|PAR|0|0|0|100|IKR|7066|10802|lyfalmen|||0|100|0|2,5000|PharmArctica ehf|PharmArctica - forskriftarlyf|Dícýklóverín||7066||7066|10802||2 968406|D05AA0001|Tjara 26 / ASVEP - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2929|5108|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||2929||2929|5108||2 968414|D05AA0002|Koltjörusmyrsl - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|3650|6100|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||3650||3650|6100||2 969123|L02BA0108|Tamoxifen Aliud|töflur|10|mg|100|stk|1|þpakki||L02BA01|01.03.2014|30.04.2015|R|0|0|0|0|G|0|LDR|0|0|0|100|XEU|3348|5685|lyfalmen|||2|100|1|50,0000|Parlogis hf|Parlogis - óskráð lyf|Tamoxífen||||3348|5685||2 969149|H03BB0102|Carbimazol|töflur|5|mg|100|stk|1|þpakki||H03BB01|01.02.2014||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1380|2976|lyfalmen|||0|100|1|33,3333|Parlogis hf|Parlogis - óskráð lyf|Karbímazól||1380||1380|2976||2 969181|N02AA0111|Morfin "DAK"|töflur|10|mg|100|stk|1|pakki||N02AA01|01.05.2014||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|2948|5134|lyfalmen|||0|100|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|Morfín||2948||2948|5134||2 969412|J01CA0416|Amoxicillin AL|mixt.kyr|50|mg/ml|100|ml|1|glas||J01CA04|01.08.2014||R|0|0|0|0|0|0|PCO|0|0|1|100|XEU|2104|3972|lyfalmen|||2|100|1|5,0000|Distica|Distica - óskráð lyf|Amoxicillín||||2104|3972||1 969438|J01CA0417|Amoxicillin Sandoz|mixt.kyr|50|mg/ml|100|ml|1|glas||J01CA04|01.04.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|XEU|2104|3972|lyfalmen|||2|100|1|5,0000|Distica|Distica - óskráð lyf|Amoxicillín||2104||2104|3972||1 969777|N02AA0111|Morfin "DAK"|töflur|10|mg|10|stk|1|þpakki||N02AA01|01.07.2014||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|450|1696|lyfalmen|||0|10|1|1,0000|Parlogis hf|Parlogis - óskráð lyf|Morfín||450||450|1696||2 970013|A01AD1102|Magical Mouthwash - forskriftarlyf|mixtúra|||100|ml|1|fl||A01AD11|01.04.2015||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|3988|6565|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Ýmis lyf||3988||3988|6565||2 980005|C07AA0513|Propranolol hydrochloride-forskriftarlyf|mixtúra|2|mg/ml|100|ml|1|fl||C07AA05|01.12.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|4995|7951|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Própranólól||4995||4995|7951||2